Antimicrobial Stewardship

Bibliography

Last updated Nov 6, 2017.

Antimicrobial Resistance

Recently Added
2017
2016
2015

2014
2013
2012
2011
2010
2000-2009 

Recently Added

Bitew A, Molalign T, Chanie M. Species distribution and antibiotic susceptibility profile of bacterial uropathogens among patients complaining urinary tract infections. BMC Infect Dis 2017 (published online Sep 29)

Cohen ME, Salmasian H, Li J, et al. Surgical antibiotic prophylaxis and risk for postoperative antibiotic-resistant infections. J Am Coll Surg 2017 (published online Oct 10)

Cordoba G, Holm A, Hansen F, et al. Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care, Denmark. BMC Infect Dis 2017 (published online Oct 10)

Goto M, McDanel JS, Jones MM, et al. Antimicrobial nonsusceptibility of gram-negative bloodstream isolates, Veterans Health Administration System, United States, 2003–2013. Emerg Infect Dis 2017 (published online Oct 16)

Lachiewicz AM, Hauck CG, Weber DJ, et al. Bacterial infections after burn injuries: impact of multidrug resistance. Clin Infect Dis 2017 (published online Oct 8)

Malcolm W, Fletcher E, Kavanagh K, et al. Risk factors for resistance and MDR in community urine isolates: population-level analysis using the NHS Scotland Infection Intelligence Platform. J Antimicrob Chemother 2017 (published online Oct 10)

Piddock LJV. Understanding drug resistance will improve the treatment of bacterial infections. Nat Rev Microbiol 2017 (published online Oct 12)

Rattanaumpawan P, Boonyasiri A, Vong S, et al. Systematic review of electronic surveillance of infectious diseases with emphasis on antimicrobial resistance surveillance in resource-limited settings. Am J Infect Control 2017 (published online Oct 10)

Sahbudak Bal Z, Bekmezci N, Soylu M, et al. The prospective evaluation of risk factors and clinical influence of carbapenem resistance in children with gram-negative bacteria infection. Am J Infect Control 2017 (published online Oct 2)

Wang A, Daneman N, Tan C, et al. Evaluating the relationship between hospital antibiotic use and antibiotic resistance in common nosocomial pathogens. Infect Control Hosp Epidemiol 2017 (published online Oct 26)

Weston EJ, Wi T, Papp J. Strengthening global surveillance for antimicrobial-resistant Neisseria gonorrhoeae through the Enhanced Gonococcal Antimicrobial Surveillance Program (EGASP). Emerg Infect Dis 2017 (published online Oct 18)

Workneh M, Katz MJ, Lamorde M, et al. Antimicrobial resistance in sub-Saharan Africa. Open Forum Infect Dis 2017 (published online Oct 6)

Wushouer H, Zhang ZX, Wang JH, et al. Trends and relationship between antimicrobial resistance and antibiotic use in Xinjiang Uyghur Autonomous Region, China: based on a 3 year surveillance data, 2014-2016. J Infect Public Health 2017 (published online Oct 7)

Zheng X, Wang JF, Xu WL, et al. Clinical and molecular characteristics, risk factors and outcomes of Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in the intensive care unit. Antimicrob Resist Infect Control 2017 (published online Oct 2)

Back to top

2017

Agaba P, Tumukunde J, Tindimwebwa JVB, et al. Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study. BMC Res Notes 2017 (published online Jul 28)

Ahmed M, Mirambo MM, Mushi MF, et al. Bacteremia caused by multidrug-resistant bacteria among hospitalized malnourished children in Mwanza, Tanzania: a cross sectional study. BMC Res Notes 2017 (published online Jan 25)

Andam CP, Worby CJ, Gierke R, et al. Penicillin resistance of nonvaccine type Pneumococcus before and after PCV13 introduction, United States. Emerg Infect Dis 2017 (published online Apr 18)

Arendrup MC, Patterson TF. Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis 2017 (published online Sep 5)

Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control 2017 (published online May 15)

Babell LM, Ngonzi J, Bazira J, et al. Antimicrobial-resistant infections among postpartum women at a Ugandan referral hospital. PLoS One 2017 (published online Apr 13)

Bagheri-Nesami M, Rezai MS, Ahangarkani F, et al. Multidrug and co-resistance patterns of non-fermenting gram-negative bacilli involved in ventilator-associated pneumonia carrying class 1 integron in the north of Iran. Germs 2017 (published online Sep 1)

Barrasa-Villar JI, Aibar-Remon C, Prieto-Andres P, et al. Impact on morbidity, mortality and length of stay of hospital acquired infections by resistant microorganisms. Clin Infect Dis 2017 (published online May 2)

Bassetti M, Poulakou G, Ruppe E, et al. Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach. Intensive Care Med 2017 (published online Jul 21)

Bernabe KJ, Langendorf C, Ford N, et al. Antibiotic resistance in West Africa: a systematic review and meta-analysis. Int J Antimicrob Agents 2017 (published online Jul 11)

Bidell MR, Opraseuth MP, Yoon M, et al. Effect of prior receipt of antibiotics on the pathogen distribution and antibiotic resistance profile of key gram-negative pathogens among patients with hospital-onset urinary tract infections. BMC Infect Dis 2017 (published online Feb 28)

Biswal M, Rudramurthy SM, Jain N, et al. Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions. J Hosp Infect 2017 (published online Sep 19)

Bitew A, Molalign T, Chanie M. Species distribution and antibiotic susceptibility profile of bacterial uropathogens among patients complaining urinary tract infections. BMC Infect Dis 2017 (published online Sep 29)

Boix-Palop L, Xercavins M, Badia C, et al. Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case–control–control study. Int J Antimicrob Agents 2017 (published online May 24)

Brown JD, Willcox SJ, Franklin N, et al. Shigella species epidemiology and antimicrobial susceptibility: the implications of emerging azithromycin resistance for guiding treatment, guidelines and breakpoints. J Antimicrob Chemother 2017 (published online Aug 10)

Butin M, Martins- Simoes P, Rasigade JP, et al. Worldwide endemicity of a multidrug-resistant Staphylococcus capitis clone involved in neonatal sepsis. Emerg Infect Dis 2017 (published online Jan 26)

Cai B, Echols R, Magee G, et al. Prevalence of carbapenem-resistant gram-negative infections in the United States predominated by Acinetobacter baumannii and Pseudomonas aeruginosa. Open Forum Infect Dis 2017 (published online Aug 16)

Carrel M, Goto M, Schweizer ML, et al. Diffusion of clindamycin-resistant and erythromycin-resistant methicillin-susceptible Staphylococcus aureus (MSSA), potential ST398, in United States Veterans Health Administration Hospitals, 2003-2014. Antimicrob Resist Infect Control 2017 (published online Jun 5)

Carruth L, Roess AA, Terefe Y, et al. Antimicrobial resistance and food safety in Africa. Lancet Infect Dis 2017 Jun;17(6):575-6

Chang YT, Coombs G, Ling T, et al. Epidemiology and trends in the antibiotic susceptibilities of gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010–2013. Int J Antimicrob Agents 2017 (published online Apr 20)

Cheikh A, Belefquih B, Chajai Y, et al. Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) colonization as a risk factor for developing ESBL infections in pediatric cardiac surgery patients: “retrospective cohort study.” BMC Infect Dis 2017 (published online Mar 29)

Chen K, Huang Y, Song Q, et al. Drug-resistance dynamics of Staphylococcus aureus between 2008 and 2014 at a tertiary teaching hospital, Jiangxi Province, China. BMC Infect Dis 2017 (published online Jan 25)

Claeys KC, Zasowski EJ, Lagnf AM, et al. Novel application of published risk factors for methicillin-resistant S. aureus in acute bacterial skin and skin structure infections. Int J Antimicrob Agents 2017 (published online Jun 28)

Cohen ME, Salmasian H, Li J, et al. Surgical antibiotic prophylaxis and risk for postoperative antibiotic-resistant infections. J Am Coll Surg 2017 (published online Oct 10)

Cordoba G, Holm A, Hansen F, et al. Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care, Denmark. BMC Infect Dis 2017 (published online Oct 10)

Cronin KM, Poy Lorenzo YS, Olenski ME, et al. Risk factors for KPC-producing Enterobacteriaceae acquisition and infection in a healthcare setting with possible local transmission: a case control study. J Hosp Infect 2017 (published online Feb 14)

Das B, Chaudhuri S, Srivastava R, et al. Fostering research into antimicrobial resistance in India. BMC 2017 (published online Sep 6)

Dat VQ, Vu HN, The HN, et al. Bacterial bloodstream infections in a tertiary infectious diseases hospital in northern Vietnam: aetiology, drug resistance, and treatment outcome. BMC Infect Dis 2017 (published online Jul 12)

Deyno S, Fekadu S, Astatkie A. Resistance of Staphylococcus aureus to antimicrobial agents in Ethiopia: a meta-analysis. Antimicrob Resist Infect Control 2017 (published online Aug 23)

Dharmapalan D, Shet A, Yewale V, et al. High reported rates of antimicrobial resistance in Indian neonatal and pediatric blood stream infections. J Pediatric Infect Dis Soc 2017 (published online Feb 18)

Dicks KV, Anderson DJ, Baker AW, et al. Clinical outcomes and healthcare utilization related to multidrug-resistant gram-negative infections in community hospitals. Infect Control Hosp Epidemiol 2017 Jan;38(1):31-8

Doernberg SB, Lodise TP, Thaden JT, et al. Gram-positive bacterial infections: research priorities, accomplishments, and future directions of the Antibacterial Resistance Leadership Group. Clin Infect Dis 2017 (published online Mar 2)

Doi Y, Bonomo RA, Hooper DC, et al. Gram-negative bacterial infections: research priorities, accomplishments, and future directions of the Antibacterial Resistance Leadership Group. Clin Infect Dis 2017 (published online Mar 2)

Doll M, Masroor N, Major Y, et al. Carbapenem-resistant Enterobacteriaceae at a low prevalence tertiary care center: patient-level risk factors and implications for an infection prevention strategy. Am J Infect Control 2017 (published online May 29)

Drum BE, Collinsworth K, Arnold BD, et al. Hospital-onset bloodstream infection rates after discontinuing active surveillance cultures for methicillin-resistant Staphylococcus aureus in a regional burn center. Infect Control Hosp Epidemiol 2017 Mar;38(3):371-2

El Chakhtoura NG, Saade E, Wilson BM, et al. A 17-year nationwide study of Burkholderia cepacia complex (Bcc) bloodstream infections among patients in the United States Veterans Health Administration. Clin Infect Dis 2017 (published online Jun 20)

El Moujaber G, Osman M, Rafei R, et al. Molecular mechanisms and epidemiology of resistance in Streptococcus pneumoniae in the Middle East region. J Med Microbiol 2017 (published online Jun 26)

Farmakiotis D, Kontoyiannis DP. Epidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management. Int J Antimicrob Agents 2017 (published online Jun 29)

Fernando MMPSC, Luke WANV, Miththinda JKND, et al. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern—a hospital based cross sectional study. BMC Infect Dis 2017 (published online Feb 10)

Flokas ME, Karageorgos SA, Detsis M, et al. Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis. Int J Antimicrob Agents 2017 (published online Mar 20)

Flokas ME, Karanika S, Alevizakos M, et al. Prevalence of ESBL-producing Enterobacteriaceae in pediatric bloodstream infections: a systematic review and meta-analysis. PLOS One 2017 (published online Jan 31)

Folgori L, Bielicki J, Heath PT, et al. Antimicrobial-resistant gram-negative infections in neonates: burden of disease and challenges in treatment. Curr Opin Infect Dis 2017 Jun 2017;30(3):281-8

Friedman ND, Carmeli Y, Walton AL, et al. Carbapenem-resistant Enterobacteriaceae: a strategic roadmap for infection control. Infect Control Hosp Epidemiol (published online Mar 15)

Gandra S, Trett A, Klein EY, et al. Is antimicrobial resistance a bigger problem in tertiary care hospitals than in small community hospitals in the United States? Clin Infect Dis 2017 (published online May 4)

Geladari A, Karampatakis T, Antachopoulos C, et al. Epidemiological surveillance of multidrug-resistant gram-negative bacteria in a solid organ transplantation department. Transpl Infect Dis 2017 (published online May 5)

Goto M, McDanel JS, Jones MM, et al. Antimicrobial nonsusceptibility of gram-negative bloodstream isolates, Veterans Health Administration System, United States, 2003–2013. Emerg Infect Dis 2017 (published online Oct 16)

Gurieva T, Dautzenberg MJD, Gniadkowski M, et al. The transmissibility of antibiotic-resistant Enterobacteriaceae in intensive care units. Clin Infect Dis 2017 (published online Sep 15)

Hamdy RF, Hsu AJ, Stockmann C, et al. Epidemiology of methicillin-resistant Staphylococcus aureus bacteremia in children. Pediatrics 2017 (published online May 5)

Harnvoravongchai P, Pipatthana M, Chankhamhaengdecha S, et al. Insights into drug resistance mechanisms in Clostridium difficile. Essays Biochem 2017 Mar 3;61(1):81-9

He X, Xie M, Li S, et al. Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011–2016). BMC Infect Dis 2017 (published online Sep 11)

Hook EW. Continued evolution of gonococcal resistance. Clin Infect Dis 2017 (published online May 26)

Houri H, Fallah F, Saee Y, et al. Distribution of capsular types and drug resistance patterns of invasive pediatric Streptococcus pneumoniae isolates in Teheran, Iran. Int J Infect Dis 2017 (published online Jan 25)

Islam S, Selvarangan R, Kanwar N, et al. Intestinal carriage of third-generation cephalosporin-resistant and extended-spectrum β-lactamase-producing Enterobacteriaceae in healthy US children. J Pediatric Infect Dis Soc 2017 (published online Jun 15)

Ji W, Liu H, Jin Z, et al. Disease burden and antimicrobial resistance of invasive group B streptococcus among infants in China: a protocol for a national prospective observational study. BMC Infect Dis 2017 (published online May 31)

Kanafani ZA, Fadlallah SM, Assaf S, et al. Sites of colonization in hospitalized patients with infections caused by extended-spectrum beta-lactamase organisms: a prospective cohort study. Antimicrob Resist Infect Control 2017 (published online May 15)

Karp BE, Tate H, Plumblee JR, et al. National antimicrobial resistance monitoring system: two decades of advancing public health through integrated surveillance of antimicrobial resistance. Foodborne Pathog Dis 2017 (published online Aug 9)

Kaur A, Gandra S, Gupta P, et al. Clinical outcome of dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a single-center retrospective study of 75 cases in India. Am J Infect Control 2017 (published online Aug 11)

Kavanagh KT, Abusalem S, Calderon LE. The incidence of MRSA infections in the United States: is a more comprehensive tracking system needed? Antimicrob Resist Infect Control 2017 (published online Apr 7)

Kelly AM, Mathema B, Larson EL. Carbapenem-resistant Enterobacteriaceae in the community: a scoping review. Int J Antimicrob Agents 2017 (published online Jun 21)

Kilbas I, Ciftci IH. Antimicrobial resistance of Enterococcus in Turkey: a meta-analysis of current studies. J Glob Antimicrob Resist 2017 (published online Sep 4)

Klein EY, Mojica N, Jiang W, et al. Trends in methicillin-resistant Staphylococcus aureus hospitalizations in the United States, 2010–2014. Clin Infect Dis 2017 (published online Jul 26)

Knight GM, Costelloe C, Murray KA, et al. Addressing the unknowns of antimicrobial resistance: quantifying and mapping the drivers of burden. Clin Infect Dis 2017 (published online Aug 23)

Kontoyiannis DP. Antifungal resistance: an emerging reality and a global challenge. J Infect Dis 2017 (published online Sep 5)

Lachiewicz AM, Hauck CG, Weber DJ, et al. Bacterial infections after burn injuries: impact of multidrug resistance. Clin Infect Dis 2017 (published online Oct 8)

Lee GC, Dallas SD, Wang Y, et al. Emerging multidrug resistance in community-associated Staphylococcus aureus involved in skin and soft tissue infections and nasal colonization. Clin Infect Dis 2017 (published online Jul 3)

Li YJ, Pan CZ, Fang CQ, et al. Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality. BMC Infect Dis (published online May 30)

Macesic N, Nelson B, Uhlemann AC. Colistin resistance in carbapenem-resistant Klebsiella pneumoniae: de novo or drug exposure? Clin Infect Dis 2017 (published online Jul 1)

Malcolm W, Fletcher E, Kavanagh K, et al. Risk factors for resistance and MDR in community urine isolates: population-level analysis using the NHS Scotland Infection Intelligence Platform. J Antimicrob Chemother 2017 (published online Oct 10)

Marimuthu K, Venkatachalam I, Khong WX, et al. Clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae among adult inpatients in Singapore. Clin Infect Dis 2017;64(suppl 2):S68-S75

Martens E, Demain AL. The antibiotic resistance crisis, with a focus on the United States. J Antibiot (Tokyo) 2017 (published online Mar 1)

Mascarello M, Simonetti O, Knezevich A, et al. Correlation between antibiotic consumption and resistance of bloodstream bacteria in a university hospital in north eastern Italy, 2008-2014. Infection 2017 (published online Mar 6)

Mave V, Chandanwale A, Kagal A, et al. High burden of antimicrobial resistance and mortality among adults and children with community-onset bacterial infections in India. J Infect Dis 2017 (published online Mar 3)

McCarthy MW, Denning DW, Walsh TJ. Future research priorities in fungal resistance. J Infect Dis 2017 (published online Sep 5)

McDaniel J, Schweizer M, Crabb V, et al. Incidence of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella infections in the United States: a systematic literature review. Infect Control Hosp Epidemiol 2017 (published online Jul 31)

McDonnell L, Armstrong D, Ashworth M, et al. National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries. J Antimicrob Chemother 2017 (published online Jul 25)

Moolchandani K, Sastry AS, Deepashree R, et al. Antimicrobial resistance surveillance among intensive care units of a tertiary care hospital in southern India. J Clin Diagn Res 2017 Feb;11(2):DC01-DC07

Moradigaravand D, Martin V, Peacock SJ, et al. Evolution and epidemiology of multidrug-resistant Klebsiella pneumoniae in the United Kingdom and Ireland. mBio 2017 (published online Feb 21)

Morrill HJ, Morton JB, Caffrey AR, et al. Antimicrobial resistance of Escherichia coli urinary isolates in the Veterans Affairs Healthcare System. Antimicrob Agents Chemother 2017 (published online Feb 13)

Musicha P, Cornick JE, Bar-Zeev N, et al. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998–2016): a surveillance study. Lancet Infect Dis 2017 (published online Aug 14)

Myat TO, Hannaway R, Zin KN, et al. ESBL- and carbapenemase-producing Enterobacteriaceae in patients with sepsis, Yangon, Myanmar, 2014. Emerg Infect Dis 2017 May; 23(5)

Nabarro LEB, Shankar C, Pragasam AK, et al. Clinical and bacterial risk factors for mortality in children with carbapenem-resistant Enterobacteriaceae bloodstream infections in India. Pediatric Infect Dis J 2017 Jun;36(6):e161-6

Nagelkerke MMB, Sikwewa K, Makowa D, et al. Prevalence of antimicrobial drug resistant bacteria carried by in- and outpatients attending a secondary care hospital in Zambia. BMC Res Notes 2017 (published online Aug 10)

Nisha KV, Veena SA, Rathika SD, et al. Antimicrobial susceptibility, risk factors and prevalence of bla cefotaximase, temoneira, and sulfhydryl variable genes among Escherichia coli in community-acquired pediatric urinary tract infection. J Lab Physicians 2017 Jul-Sep;9(3):156-62

Nyangacha RM, Odongo D, Oyieke F, et al. Secondary bacterial infections and antibiotic resistance among tungiasis patients in western Kenya. PLoS Negl Trop Dis 2017 (published online Sep 8)

Opintan JA, Newman MJ. Prevalence of antimicrobial resistant pathogens from blood cultures: results from a laboratory based nationwide surveillance in Ghana. Antimicrob Resist Infect Control 2017 (published online Jun 13)

Panigrahi P, Chandel DS, Hansen NI, et al. Neonatal sepsis in rural India: timing, microbiology and antibiotic resistance in a population-based prospective study in the community setting. J Perinatol 2017 (published online May 11)

Papp JR, Abrams J, Nash E, et al. Azithromycin resistance and decreased ceftriaxone susceptibility in Neisseria gonorrhoeae, Hawaii. Emerg Infect Dis 2017 (published online Mar 31)

Parajuli NP, Acharya SP, Mishra SK, et al. High burden of antimicrobial resistance among gram negative bacteria causing healthcare associated infections in a critical care unit of Nepal. Antimicrob Resist Infect Control 2017 (published online Jun 15)

Paterson DK, van Duin D. China's antibiotic resistance problems. Lancet Infect Dis 2017 (published online Jan 27)

Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 2017 (published online Jul 31)

Piddock LJV. Understanding drug resistance will improve the treatment of bacterial infections. Nat Rev Microbiol 2017 (published online Oct 12)

Piperaki ET, Syrogiannopoulos GA, Tzouvelekis LS, et al. Klebsiella pneumoniae: virulence, biofilm and antimicrobial resistance. Pediatr Infect Dis J 2017 Oct;36(10):1002-5

Pourmand A, Mazer-Amirshahi M, Jasani G, et al. Emerging trends in antibiotic resistance: implications for emergency medicine. Am J Emerg Med 2017 (published online Mar 7)

Qiao B, Wu J, Wan Q, et al. Factors influencing mortality in abdominal solid organ transplant recipients with multidrug-resistant gram-negative bacteremia. BMC Infect Dis 2017 (published online Feb 27)

Rattanaumpawan P, Boonyasiri A, Vong S, et al. Systematic review of electronic surveillance of infectious diseases with emphasis on antimicrobial resistance surveillance in resource-limited settings. Am J Infect Control 2017 (published online Oct 10)

Ravensbergen SJ, Berends M, Stienstra Y, et al. High prevalence of MRSA and ESBL among asylum seekers in the Netherlands. PLoS One 2017 (published online Apr 25)

Relhan N, Pathengay A, Schwartz SG, et al. Emerging worldwide antimicrobial resistance, antibiotic stewardship and alternative intravitreal agents for the treatment of endophthalmitis. Retina 2017 (published online Mar 23)

Remschmidt C, Behnke M, Kola A, et al. The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci—an ecologic study. Antimicrob Resist Infect Control 2017 (published online Sep 13)

Rodriguez L, Bustamante B, Huaroto L, et al. A multi-centric study of Candida bloodstream infection in Lima-Callao, Peru: species distribution, antifungal resistance and clinical outcomes. PLoS One 2017 (published online Apr 18)

Rudramurthy SM, Chakrabarti A, Paul RA, et al. Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother 2017 (published online Feb 20)

Saba CKS, Amenyona JK, Kpordze SW. Prevalence and pattern of antibiotic resistance of Staphylococcus aureus isolated from door handles and other points of contact in public hospitals in Ghana. Antimicrob Resist Infect Control 2017 (published online May 10)

Sahbudak Bal Z, Bekmezci N, Soylu M, et al. The prospective evaluation of risk factors and clinical influence of carbapenem resistance in children with gram-negative bacteria infection. Am J Infect Control 2017 (published online Oct 2)

Salomao MC, Guimaraes T, Duailibi DF, et al. Carbapenem-resistant Enterobacteriaceae in patients admitted to the emergency department: new risk factors and occurrence in patients coming directly from the community. J Hosp Infect 2017 (published online Aug 18)

Sit PS, Teh CSJ, Idris N, et al. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection and the molecular characteristics of MRSA bacteraemia over a two-year period in a tertiary teaching hospital in Malaysia. BMC Infect Dis 2017 (published online Apr 13)

Sommer MOA, Munck C, Toft-Kehler RV, et al. Prediction of antibiotic resistance: time for a new preclinical paradigm? Nat Rev Microbiol 2017 (published online Jul 31)

Stapleton PJ, Lundon DJ, McWade R, et al. Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005-2014. Ir J Med Sci 2017 (published online Jan 4)

Sugianli AK, Ginting F, Kusumawati RL, et al. Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in Indonesia. J Antimicrob Chemother 2017 (published online Jan 30)

Tadesse BT, Ashly EA, Ongarello S, et al. Antimicrobial resistance in Africa: a systematic review. BMC Infect Dis 2017 (published online Sep 11)

Teweldemedhin M, Saravanan M, Gebreyesus A, et al. Ocular bacterial infections at Quiha Ophthalmic Hospital, northern Ethiopia: an evaluation according to the risk factors and the antimicrobial susceptibility of bacterial isolates. BMC Infect Dis 2017 (published online Mar 14)

Thakur SD, Levett PN, Horsman GB, et al. High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003–15): time to consider point-of-care or molecular testing for precision treatment? J Antimicrob Chemother 2017 (published online Sep 27)

Tissera K, Lyanapathirana V, Dissanayake N, et al. Spread of resistant gram negatives in a Sri Lankan intensive care unit. BMC Infect Dis 2017 (published online Jul 11)

Tran GM, Ho-Le TP, Ha DT, et al. Patterns of antimicrobial resistance in intensive care unit patients: a study in Vietnam. BMC Infect Dis 2017 (published online Jun 15)

Tyrstrup M, Melander E, Hedin K, et al. Children with respiratory tract infections in Swedish primary care; prevalence of antibiotic resistance in common respiratory tract pathogens and relation to antibiotic consumption. BMC Infect Dis 2017 (published online Sep 4)

Valentine-King MA, Brown MB. Antibacterial resistance in Ureaplasma species and Mycoplasma hominis isolates from urine cultures in college-aged females. Antimicrob Agents Chemother 2017 Oct;61(10):e01104-17

Van Hecke O, Wang K, Lee JJ, et al. The implications of antibiotic resistance for patients’ recovery from common infections in the community: a systematic review and meta-analysis. Clin Infect Dis 2017 (published online Mar 20)

Vazquez Guillamet MC, Vazquez R, Micek ST, et al. Predicting resistance to piperacillin-tazobactam, cefepime and meropenem in septic patients with bloodstream infection due to gram-negative bacteria. Clin Infect Dis 2017 (published online Jul 10)

Venter H, Henningsen ML, Begg SL. Antimicrobial resistance in healthcare, agriculture and the environment: the biochemistry behind the headlines. Essays Biochem 2017 Mar 3;61(1):1-10

Waglechner N, Wright GD. Antibiotic resistance: it’s bad, but why isn’t it worse? BMC Biol 2017 (published online Sep 15)

Walter J, Noll I, Feig M, et al. Decline in the proportion of methicillin resistance among Staphylococcus aureus isolates from non-invasive samples and in outpatient settings, and changes in the co-resistance profiles: an analysis of data collected within the Antimicrobial Resistance Surveillance Network, Germany 2010 to 2015. BMC Infect Dis 2017 (published online Feb 23)

Wang A, Daneman N, Tan C, et al. Evaluating the relationship between hospital antibiotic use and antibiotic resistance in common nosocomial pathogens. Infect Control Hosp Epidemiol 2017 (published online Oct 26)

Wang Y, Tian GB, Zhang R, et al. Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study. Lancet Infect Dis 2017 (published online Jan 27)

Wang HP, Zhang HJ, Liu J, et al. Antimicrobial resistance of 3 types of gram-negative bacteria isolated from hospital surfaces and the hands of health care workers. Am J Infect Control 2017 (published online Aug 2)

Wernli D, Jorgensen PS, Harbarth S, et al. Antimicrobial resistance: the complex challenge of measurement to inform policy and the public. PLoS Med 2017 (published online Aug 17)

Weston EJ, Wi T, Papp J. Strengthening global surveillance for antimicrobial-resistant Neisseria gonorrhoeae through the Enhanced Gonococcal Antimicrobial Surveillance Program (EGASP). Emerg Infect Dis 2017 (published online Oct 18)

Wilson BM, El Chakhtoura NG, Patel S, et al. Carbapenem-resistant Enterobacter cloacae in patients from the US Veterans Health Administration, 2006–2015. Emerg Infect Dis 2017 (published online Apr 17)

Workneh M, Katz MJ, Lamorde M, et al. Antimicrobial resistance in sub-Saharan Africa. Open Forum Infect Dis 2017 (published online Oct 6)

Wozniak TM, Paterson D, Halton K. Review of the epidemiological data regarding antimicrobial resistance in gram-negative bacteria in Australia. Infect Dis Health 2017 (published online Aug 5)

Wushouer H, Zhang ZX, Wang JH, et al. Trends and relationship between antimicrobial resistance and antibiotic use in Xinjiang Uyghur Autonomous Region, China: based on a 3 year surveillance data, 2014-2016. J Infect Public Health 2017 (published online Oct 7)

Yang Q, Zhang H, Wang Y, et al. Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014. BMC Infect Dis 2017 (published online Mar 6)

Yarygin KS, Kovarsky BA, Bibikova TS, et al. ResistoMap—online visualization of human gut microbiota antibiotic resistome. Bioinformatics 2017 (published online Mar 14)

Yilema A, Moges F, Tadele S, et al. Isolation of enterococci, their antimicrobial susceptibility patterns and associated factors among patients attending at the University of Gondar Teaching Hospital. BMC Infect Dis 2017 (published online Apr 17)

Zheng X, Wang JF, Xu WL, et al. Clinical and molecular characteristics, risk factors and outcomes of Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in the intensive care unit. Antimicrob Resist Infect Control 2017 (published online Oct 2)

Back to top

2016

Adams DJ, Eberly MD, Goudie A, et al. Rising vancomycin-resistant Enterococcus infection in hospitalized children in the United States. Hosp Pediatr 2016 (published online Jun 1)

Akova M. Epidemiology of antimicrobial resistance in bloodstream infections. Virulence 2016 Apr 2;7(3):252-66

Alevizakos M, Gaitanidis A, Nasioudis D, et al. Colonization with vancomycin-resistant Enterococci and  risk for bloodstream infection among patients with malignancy: a systematic review and meta-analysis. Open Forum Infect Dis 2016 (published online Dec 7)

Alevizakos M, Karanika S, Detsis M, et al. Colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis. Int J Antimicrob Agents 2016 (published online Oct 6)

Aliberti S, Reyes LF, Faverio P, et al. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis 2016 (published online Sep 1)

Allison DG, Higginson P, Martin S. Antibiotic resistance awareness: a public engagement approach for all pharmacists. Int J Pharm Pract 2016 (published online Jul 22)

Al-Tawfiq JA, Laxminarayan R, Mendelson M. How should we respond to the emergence of plasmid-mediated colistin-resistance in humans and animals? Int J Infect Dis 2016 (published online Nov 31)

Alvarez-Uria G, Gandra S, Laxminarayan R. Poverty and prevalence of antimicrobial resistance in invasive isolates. Int J Infect Dis 2016 (published online Oct 4)

Angelo KM, Reynolds J, Karp BE, et al. Antimicrobial resistance among nontyphoidal Salmonella isolated from blood in the United States, 2003–2013. J Infect Dis 2016 (published online Sep 8)

Augustine MR, Testerman TL, Justo JA, et al. Clinical risk score for prediction of extended-spectrum β-lactamase–producing Enterobacteriaceae in bloodstream isolates. Infect Control Hosp Epidemiol 2016 (published online Dec 19)

Bader MS, Loeb M, Brooks AA. An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgrad Med 2016 (published online Oct 7)

Bairy LK, Nayak V, A A, et al. Advances in pharmacovigilance initiatives surrounding antimicrobial resistance — Indian perspective. Expert Opin Drug Saf 2016 (published online May 13)

Balazs I, Kenesei E, Toth-Heyn P, et al. Factors influencing antimicrobial resistance and outcome of gram-negative bloodstream infections in children. Infection 2016 Jun;44(3):309-21

Baron S, Hadjadj L, Rolain JM, et al. Molecular mechanisms of polymyxin resistance: knowns and unknowns. Int J Antimicrob Agents 2016 (published online Aug 4)

Bartoletti F, Seco BMS, dos Santos CC, et al. Polymyxin B resistance in carbapenem-resistant Klebsiella pneumoniae, Sao Paulo, Brazil. Emerg Infect Dis 2016 (published online Aug 30)

Bassetti M, Welte T, Wunderink RG. Treatment of gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair? Crit Care 2 2016 Jan 29;20:19

Batina NG, Crnich CJ, Anderson DF, et al. Models to predict prevalence and transition dynamics of methicillin-resistant Staphylococcus aureus in community nursing homes. Am J Infect Control 2016 May 1;44(5):507-14

Beier RC, Franz E, Bono JL, et al. Disinfectant and antimicrobial susceptibility profiles of the big six non-O157 Shiga toxin–producing Escherichia coli strains from food animals and humans. J Food Prot 2016 Aug;8:1355-70

Belkacem A, Jacquier H, Goubard A, et al. Molecular epidemiology and mechanisms of resistance of azithromycin-resistant Neisseria gonorrhoeae isolated in France during 2013–14. J Antimicrob Chemother 2016;71(9):2471-8

Bernasconi OJ, Kuenzli E, Pires J, et al. Travelers can import colistin-resistant Enterobacteriaceae, including those possessing the plasmid-mediated mcr-1 gene. Antimicrob Agents Chemother 2016 Aug;60(8):5080-4

Bitterman R, Geffen Y, Rabino G, et al. Rate of colonization of health care workers by carbapenem-resistant Enterobacteriaceae in an endemic hospital: a prospective study. Am J Infect Control 2016;44(9):1053-4

Bouchiat C, Curtis S, Spiliopoulou I, et al. MRSA infections among patients in the emergency department: a European multicentre study. J Antimicrob Chemother 2016 (published online Oct 17)

Bowen A, Grass J, Bicknese A, et al. Elevated risk for antimicrobial drug–resistant Shigella infection among men who have sex with men, United States, 2011–2015. Emerg Infect Dis 2016 (published online Aug 10)

Brown AC, Grass JE, Richarson LC, et al. Antimicrobial resistance in Salmonella that caused foodborne disease outbreaks: United States, 2003–2012. Epidemiol Infect 2016 (published online Dec 6)

Bryce A, Costelloe C, Hawcroft C, et al. Faecal carriage of antibiotic resistant Escherichia coli in asymptomatic children and associations with primary care antibiotic prescribing: a systematic review and meta-analysis. BMC Infect Dis 2016 (published online Jul 25)

Bryce A, Hay AD, Lane IF, et al. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. BMJ 2016 (published online Mar 15)

Carroll M, Rangaiahagari A, Musabeyezu E, et al. Five-year antimicrobial susceptibility trends among bacterial isolates from a tertiary health-care facility in Kigali, Rwanda. Am J Trop Med Hyg 2016 (published online Oct 31)

Castanheira M, Mendes RE, Jones RN, et al. Changes in the frequencies of β-lactamase genes among Enterobacteriaceae isolates in U.S. hospitals, 2012 to 2014: activity of ceftazidime-avibactam tested against β-lactamase-producing isolates. Antimicrob Agents Chemother 2016 Aug;60(8):4770-7

Castro-Sanchez E, Moore LSP, Husson F, et al. What are the factors driving antimicrobial resistance? Perspectives from a public event in London, England. BMC Infect Dis 2016 (published online Sep 2)

Cerceo E, Deitelzweig SB, Sherman BM, et al. Multidrug-resistant gram-negative bacterial infections in the hospital setting: overview, implications for clinical practice, and emerging treatment options. Microb Drug Resist 2016 (published online Feb 11)

Choi IS, Lee YJ, Wi YM, et al. Predictors of mortality in patients with extensively drug-resistant Acinetobacter baumannii pneumonia receiving colistin therapy. Int J Antimicrob Agents 2016 Aug;48(2):175-80

Chong J, Quach C, Blanchard AC, et al. Molecular epidemiology of vancomycin-intermediate heteroresistant Staphylococcus epidermidis outbreak in the neonatal intensive care unit. Antimicrob Agents Chemother 2016 (published online Jul 11)

Clock SA, Ferng YH, Tabibi S, et al. Colonization with antimicrobial-resistant gram-negative bacilli at neonatal Intensive Care Unit discharge. J Pediatric Infect Dis Soc 2016 (published online Mar 28)

Damavandi MS, Gholipour A, Latif Pour M. Prevalence of class D carbapenemases among extended-spectrum β-lactamases producing Escherichia coli isolates from educational hospitals in Shahrekord. J Clin Diagn Res 2016 May;10(5):DC01-5

Date KA, Newton AE, Medalla F, et al. Changing patterns in enteric fever incidence and increasing antibiotic resistance of enteric fever isolates in the United States, 2008–2012. Clin Infect Dis 2016 Aug;63(3):322-9

Dekker D, Wolters M, Mertens E, et al. Antibiotic resistance and clonal diversity of invasive Staphylococcus aureus in the rural Ashanti Region, Ghana. BMC Infect Dis 2016 (published online Nov 29)

de Maio Carrilho CMD, Marques de Oliveira L, Gaudereto J, et al. A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome. BMC Infect Dis 2016 (published online Nov 3)

de Smalen AW, Ghorab H, Abd El Ghany M, et al. Refugees and antimicrobial resistance: a systematic review. Travel Med Infect Dis 2016 (published online Dec 2)

Dickstein Y, Geffen Y, Andreassen S, et al. Predicting antibiotic resistance in urinary tract infection patients with prior urine cultures. Antimicrob Agents Chemother 2016 Aug;60(8):4717-21

Elbadawi LI, Borlaug G, Gundlach KM, et al. Carbapenem-resistant Enterobacteriaceae transmission in health care facilities-Wisconsin, February-May 2015. MMWR 2016 Sep 2;65(34):906-9

El Kary N, El Rassy E, Azar N, et al. Ciprofloxacin and imipenem resistance and cross-resistance in Pseudomonas aeruginosa: a single institution experience. Am J Infect Control 2016 (published online Jul 21)

Escandon-Vargas K, Reyes S, Gutierrez S, et al. The epidemiology of carbapenemases in Latin America and the Caribbean. Expert Rev Anti Infect Ther 2016 (published online Dec 3)

Faour Kassem D, Hoffmann Y, Shahar N, et al. Multidrug-resistant pathogens in hospitalized Syrian children. Emerg Infect Dis 2016 (published online Sep 12)

Fernandez J, Bert F, Nicolas-Chanoine MH. The challenges of multidrug resistance in hepatology. J Hepatol 2016 (published online Aug 17)

Flokas ME, Detsis M, Alevizakos M, et al. Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: a systematic review and meta-analysis. J Infect 2016 (published online Jul 27)

Folgori L, Bernaschi P, Piga S, et al. Healthcare-associated infections in pediatric and neonatal intensive care units: impact of underlying risk factors and antimicrobial resistance on 30-day case-fatality in Italy and Brazil. Infect Control Hosp Epidemiol 2016 (published online Aug 11)

Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect 2016 May;22(5):416-22

Fukunaga BT, Sumida WK, Taira DA, et al. Hospital-acquired methicillin-resistant Staphylococcus aureus bacteremia related to Medicare antibiotic prescriptions: a state-level analysis. Hawaii J Med Public Health 2016 Oct;75(10):303-9

Gandra S, Mojica N, Klein EY, et al. Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008-2014. Int J Infect Dis 2016 (published online Aug 10)

Ghanem Kraiem A, Zorgani A, Elahmer O, et al. Carbapenem-resistant gram-negative bacilli in Tripoli, Libya. Am J Infect Control 2016 (published online Jul 27)

Giamarellou H. Epidemiology of infections caused by polymyxin-resistant pathogens. Int J Antimicrob Agents 2016 (published online Nov 10)

Goodman KE, Simner PJ, Tamma PD, et al. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE). Expert Rev Anti Infect Ther 2016 Jan;14(1):95-108

Grundmann H, Glasner C, Albiger B, et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis 2016 (published online Nov 17)

Guillard T, Pons S, Roux D, et al. Antibiotic resistance and virulence: understanding the link and its consequences for prophylaxis and therapy. Bioessays 2016 Jul;38(7):682-93

Guo H, Qin J, Xiang J. Surveillance for and susceptibility of Acinetobacter baumannii in a large hospital and burn center in Shanghai, China, 2007-2013. Am J Infect Control 2016 (published online Aug 17)

Gutierrez-Gutierrez B, Perez-Galera S, Salamanca E, et al. A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2016 Jul;60(7):4159-69

Hammer KL, Stoessel A, Justo JA, et al. Association between chronic hemodialysis and bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae. Am J Infect Control 2016 (published online Aug 4)

Hamprecht A, Rohde AM, Behnke M, et al. Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors. J Antimicrob Chemother 2016 (published online Jun 17)

Han JH, Goldstein EJC, Wise J, et al. Epidemiology of carbapenem-resistant Klebsiella pneumoniae in a network of long-term acute care hospitals. Clin Infect Dis 2016 (published online Dec 24)

Hefzy EM, Hassuna NA. Fluoroquinolone-resistant sequence type 131 subgroups O25b and O16 among extraintestinal Escherichia coli Isolates from community-acquired urinary tract infections. Microb Drug Resist 2016 (published online May 23)

Holmes AH, Moore LS, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 2016 Jan 9;387(10014):176-87

Holubar M, Meng l, Deresinski S. Bacteremia due to methicillin-resistant Staphylococcus aureus: new therapeutic approaches. Infect Dis Clin North Am 2016 Jun;30(2):491-507

Hsu C, Tsai J, Ku M, et al. Antimicrobial resistance and diagnostic imaging in infants younger Than 2 months old hospitalized with a first febrile urinary tract infection: a population-based comparative study. Pediatr Infect Dis J 2016 Aug;35(8):840-5

Huang Z, Pan H, Zhang P, et al. Prevalence and antimicrobial resistance patterns of diarrheagenic Escherichia coli in Shanghai, China. Pediatr Infect Dis J 2016 Aug;35(8):835-9

Huebner NO, Dittman K, Henck V, et al. Epidemiology of multidrug resistant bacterial organisms and Clostridium difficile in German hospitals in 2014: results from a nationwide one-day point prevalence of 329 German hospitals. BMC Infect Dis 2016 (published online Sep 2)

Hwang AY, Gums JG. The emergence and evolution of antimicrobial resistance: impact on a global scale. Bioorg Med Chem 2016 (published online Apr 13)

Investigators of the Delhi Neonatal Infection Study (DeNIS) Collaboration. Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study. Lancet Glob Health 2016 Oct;4(10):e752-60

Irrgang A, Roschanski N, Tenhagen BA, et al. Prevalence of mcr-1 in E. coli from livestock and food in Germany, 2010–2015. PLoS One 2016 (published online Jul 25)

Jamal WY, Rotimi VO. Surveillance of antibiotic resistance among hospital- and community-acquired toxigenic Clostridium difficile isolates over 5-year period in Kuwait. PLoS One 2016 Aug 18;11(8):e0161411

Jayol A, Poirel L, Dortet L, et al. National survey of colistin resistance among carbapenemase-producing Enterobacteriaceae and outbreak caused by colistin-resistant OXA-48-producing Klebsiella pneumoniae, France, 2014. Euro Surveill 2016 Sep 15;21(37)

Judd WR, Ratliff PD, Hickson RP, et al. Clinical and economic impact of meropenem resistance in Pseudomonas aeruginosa–infected patients. Am J Infect Control 2016 (published online Jun 16)

Kabwe M, Tembo J, Chilukutu L, et al. Etiology, antibiotic resistance and risk factors for neonatal sepsis in a large referral center in Zambia. Pediatr Infect Dis J 2016 Jul;35(7):e191-98

Karam G, Chastre J, Wilcox MH, et al. Antibiotic strategies in the era of multidrug resistance. Crit Care 2016 Jun 22;20(1):136

Karanika S, Karantanos T, Arvanitis M, et al. Fecal colonization with extended-spectrum beta-lactamase–producing Enterobacteriaceae and risk factors among healthy individuals: a systematic review and metaanalysis. Clin Infect Dis 2016 Aug;63(3):310-8

Karlowsky JA, Biedenbach DJ, Bouchillon SK, et al. In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme. J Antimicrob Chemother 2016 Jan;71(1):162-9

Kline KE, Shover J, Kallen AJ, et al. Investigation of first identified mcr-1 gene in an isolate from a U.S. patient—Pennsylvania, 2016. MMWR Morb Mortal Wkly Rep 2016 (published online Sep 9)

Konca C, Tekin M, Uckardes F, et al. An overview of antibacterial resistance patterns of pediatric community-acquired urinary infections. Pediatr Int 2016 (published online Aug 20)

Laxminarayan R, Bhutta ZA. Antimicrobial resistance—a threat to neonate survival. Lancet Glob Health 2016 Oct;4(10):e676-7

Laxminarayan R, Chaudhury RR. Antibiotic resistance in India: drivers and opportunities for action. PLoS Med 2016 (published online Mar 2)

Leibovici L, Paul M, Garner P, et al. Addressing resistance to antibiotics in systematic reviews of antibiotic interventions. J Antimicrob Chemother 2016;71(9):2367-9

Leski TA, Taitt CR, Bangura U, et al. High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone. BMC Infect Dis 2016 Apr 18;16(1):167

Li YL, Tewari D, Yealy CC, et al. Surveillance for travel and domestically acquired multidrug-resistant human Shigella infections — Pennsylvania, 2006-2014. Health Secur 2016 May-Jun;14(3):143-51

Logan LK, Gandra S, Mandal S, et al. Multidrug- and carbapenem-resistant Pseudomonas aeruginosa in children, United States, 1999-2012. J Pediatric Infect Dis Soc 2016 (published online Nov 16)

Loyola S, Gutierrez LR, Horna G, et al. Extended-spectrum β-lactamase–producing Enterobacteriaceae in cell phones of health care workers from Peruvian pediatric and neonatal intensive care units. Am J Infect Control 2016 Aug 1;44(8):910-6

MacFadden DR, Fisman D, Andre J, et al. A platform for monitoring regional antimicrobial resistance, using online data sources: ResistanceOpen. J Infect Dis 2016;214(suppl 4):S393-8

Madueno A, Gonzalez Garcia J, Jose Ramos M, et al. Risk factors associated with carbapenemase-producing Klebsiella pneumoniae fecal carriage: a case–control study in a Spanish tertiary care hospital. Am J Infect Control 2016 (published online Sep 2)

Malande OO, Du Plessis A, Rip D, et al. Invasive carbapenem-resistant Enterobacteriaceae infection at a paediatric hospital: a case series. S Afr Med J 2016 Aug 18;106(9):877-82

Marston HD, Dixon DM, Knisely JM, et al. Antimicrobial resistance. JAMA 2016;316(11):1193-204

Mathlouthi N, Al-Bayssari C, El Salabi A, et al. Carbapenemases and extended-spectrum β-lactamases producing Enterobacteriaceae isolated from Tunisian and Libyan hospitals. J Infect Dev Ctries 2016 Aug 2;10(7):718-27

MacVane SH. Antimicrobial resistance in the intensive care unit: a focus on gram-negative bacterial infections. J Intensive Care Med 2016 (published online Jan 15)

McKinley L, Becerra B, Moriarty H, et al. Vancomycin-resistant Enterococcus co-colonization rates with methicillin-resistant Staphylococcus aureus and Clostridium difficile in critically ill veterans. Am J Infect Control 2016 (published online Apr 7)

McKinnell JA, Kunz DF, Moser SA, et al. Patient-level analysis of incident vancomycin-resistant enterococci colonization and antibiotic days of therapy. Epidemiol Infect 2016 Jun;144(8):1748-55

Meeker DG, Beenken KE, Mills WB, et al. Evaluation of antibiotics active against methicillin-resistant Staphylococcus aureus based on activity in an established biofilm. Antimicrob Agents Chemother 2016 (published online Jul 11)

Meletis G. Carbapenem resistance: overview of the problem and future perspectives. Ther Adv Infect Dis 2016 Feb;3(1):15-21

Miller WR, Murray BE, Rice LB, et al. Vancomycin-resistant Enterococci: therapeutic challenges in the 21st century. Infect Dis Clin North Am 2016 Jun;30(2):415-39

Mills JP, Talati NJ, Alby K, et al. The epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization and infection among long-term acute care hospital residents. Infect Control Hosp Epidemiol 2016 Jan;37(1):55-60

Mirhoseini SH, Nilkaeen M, Shamsizadeh Z, et al. Hospital air: a potential route for transmission of infections caused by β-lactam–resistant bacteria. Am J Infect Control 2016 Aug 1;44(8):898-904

Mischnik A, Baumert P, Hamprecht A, et al. Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission. Int J Antimicrob Agents 2016 (published online Nov 28)

Mladenovic-Antic S, Kocic B, Velickovic-Radovanovic R, et al. Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study. J Clin Pharm Ther 2016 Oct;41(5):532-7

Mohammed Y, Gadzama GB, Zailani SB, et al. Characterization of extended-spectrum beta-lactamase from Escherichia coli and Klebsiella species from north eastern Nigeria. J Clin Diagn Res 2016 Feb;10(2):DC07-10

Montagnani C, Prato M, Scolfaro C, et al. Carbapenem-resistant Enterobacteriaceae infections in children: an Italian retrospective multicenter study. Pediatr Infect Dis J 2016 Aug;35(8):862-8

Moremi N, Claus H, Mshana SE. Antimicrobial resistance pattern: a report of microbiological cultures at a tertiary hospital in Tanzania. BMC Infect Dis 2016 (published online Dec 13)

Morgenstern M, Erichsen C, Hackl S, et al. Antibiotic resistance of commensal Staphylococcus aureus and coagulase-negative Staphylococci in an international cohort of surgeons: a prospective point-prevalence study. PLoS One 2016 Feb 3;11(2):e0148437

Moxon CA, Paulus S. Beta-lactamases in Enterobacteriaceae infections in children. J Infect 2016 Jul 5;72(Suppl):S41-9

Mukherjee N, Sulaiman IM, Banerjee P. Characterization of methicillin-resistant Staphylococcus aureus isolates from fitness centers in the Memphis metropolitan area, Tennessee. Am J Infect Control 2016 (published online Sep 19)

Mulder M, Kiefte-de Jong JC, Goessens WHF, et al. Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population. J Antimicrob Chemother 2016 (published online Sep 21)

Mylvaganam H, Kolstad H, Breistein RI, et al. Extended spectrum cephalosporin resistance among clinical isolates of Enterobacteriaceae in West Norway during 2006-2013; a prospective surveillance study. APMIS 2016 (published online Dec 6)

Nair S, Ashton P, Doumith M, et al. WGS for surveillance of antimicrobial resistance: a pilot study to detect the prevalence and mechanism of resistance to azithromycin in a UK population of non-typhoidal Salmonella. J Antimicrob Chemother 2016 (published online Sep 1)

Ndir A, Diop A, Faye PM, et al. Epidemiology and burden of bloodstream infections caused by extended-spectrum beta-lactamase producing Enterobacteriaceae in a pediatric hospital in Senegal. PLoS One 2016 Feb 11;11(2):e0143729

Nelson RE, Schwizer ML, Perencevich EN, et al. Costs and mortality associated with multidrug-resistant healthcare-associated Acinetobacter infections. Infect Control Hosp Epidemiol 2016 (published online Jul 13)

O’Horo JC, Farrell A, Sohail MR, et al. Carbapenem-resistant Enterobacteriaceae and endoscopy: an evolving threat. Am J Infect Control 2016 (published online May 11)

Otter JA, Dyakova E, Bisnauthsing KN, et al. Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting. J Antimicrob Chemother 2016 (published online Aug 11)

Parajuli NP, Maharjan P, Joshi G, et al. Emerging perils of extended spectrum β-lactamase producing Enterobacteriaceae clinical isolates in a teaching hospital of Nepal. Biomed Res Int 2016 (published online Dec 29)

Patel SJ, Green N, Clock SA, et al. Gram-negative bacilli in infants hospitalized in the neonatal intensive care unit. J Pediatr Infect Dis Soc 2016 (published online Jun 14)

Pinhati HMS, Casulari LA, Souza ACR, et al. Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit. BMC Infect Dis 2016 (published online Aug 20)

Poramathikul K, Bodhidatta L, Chiek S, et al. Multidrug-resistant Shigella infections in patients with diarrhea, Cambodia, 2014-2015. Emerg Infect Dis 2016 (published online Jul 27)

Pournaras S, Kournaki V, Spanakis N, et al. Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance. Int J Antimicrob Agents 2016 Jul;48(1):11-8

Pullon HW, Gommans J, Thomas MG, et al. Antimicrobial resistance in New Zealand: the evidence and a call for action. N Z Med J 2016 Oct 28;129(1444):103-10

Quan J, Zhao D, Liu L, et al. High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China. J Antimicrob Chemother 2016 (published online Sep 13)

Rauber JM, Carneiro M, Arnhold GH, et al. Multidrug-resistant Staphylococcus spp and its impact on patient outcome. Am J Infect Control 2016 (published online Sep 14)

Ray MJ, Lin MY, Weinstein RA, et al. Spread of carbapenem-resistant Enterobacteriaceae among Illinois healthcare facilities: the role of patient sharing. Clin Infect Dis 2016 (published online Aug 2)

Reus Rodrigues Perez L, Rodrigues D, Dias C. Can carbapenem-resistant enterobacteriaceae susceptibility results obtained from surveillance cultures predict the susceptibility of a clinical carbapenem-resistant enterobacteriaceae? Am J Infect Control 2016 Aug 1;44(8):953-5

Reveles KR, Duhon BM, Moore RJ, et al. Epidemiology of methicillin-resistant Staphylococcus aureus diabetic foot infections in a large academic hospital: implications for antimicrobial stewardship. PLoS One 2016 Aug 24;11(8)

Reyes K, Bardossy AC, Zervos M. Vancomycin-resistant Enterococci: epidemiology, infection prevention, and control. Infect Dis Clin North Am 2016 (published online Sep 19)

Rojas LJ, Salim M, Cober E, et al. Colistin resistance in carbapenem-resistant Klebsiella pneumoniae: laboratory detection and impact on mortality. Clin Infect Dis 2016 (published Dec 10)

Rosa R, Abbo LM, Raney K, et al. Antimicrobial resistance in urinary tract infections at a large urban emergency department: factors contributing to empiric treatment failure. Am J Emerg Med 2016 (published online Nov 9)

Sader HS, Castanheira M, Farrell DJ, et al. Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011–2014). Int J Antimicrob Agents 2016 Aug;48(2):144-50

Schwarz S, Johnson AP. Transferable resistance to colistin: a new but old threat. J Antimicrob Chemother 2016 (published online Jun 24)

Schwartz-Neiderman A, Braun T, Fallach N, et al. Risk factors for carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) acquisition among contacts of newly diagnosed CP-CRE patients. Infect Control Hosp Epidemiol 2016 (published online Jul 25)

Shields RK, Potoski BA, Haidar G, et al. Clinical outcomes, drug toxicity and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections. Clin Infect Dis 2016 (published online Sep 13)

Shojaei L, Mohammadi M, Beigmohammadi MT, et al. Clinical response and outcome of pneumonia due to multi-drug resistant Acinetobacter baumannii in critically ill patients. Iran J Microbiol 2016 Oct;8(5):288-97

Spellberg B, Bonomo RA. Ceftazidime-avibactam and carbapenem-resistant Enterobacteriaceae: “We're gonna need a bigger boat.” Clin Infect Dis 2016 (published online Sep 13)

Spencer JR, Milburn EK, Chukwuma U. Correlation between antimicrobial resistance in Escherichia coli infections in hospitalized patients and rates of inpatient prescriptions for selected antimicrobial agents, Department of Defense hospitals, 2010-2014. MSMR 2016 Mar;23(3):6-10

Stewardson AJ, Allignol A, Beyersmann J, et al. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study. Euro Surveill 2016 Aug 18;21(33)

Strysko JP, Mony V, Cleveland J, et al. International travel is a risk factor for extended-spectrum β-lactamase-producing Enterobacteriaceae acquisition in children: a single center, case-case-control study in an urban U.S. hospital. Travel Med Infect Dis 2016 (published online Nov 24)

Suleyman G, Tibbetts R, Perri MB, et al. Nosocomial outbreak of a novel extended-spectrum β-Lactamase Salmonella enterica serotype Isangi among surgical patients. Infect Control Hosp Epidemiol 2016 Aug;37(8):954-61

Suwantarat N, Carroll KC. Epidemiology and molecular characterization of multidrug-resistant Gram-negative bacteria in Southeast Asia. Antimicrob Resist Infect Control 2016 May 4;5:15

Tatarelli P, Mikulska M. Multidrug-resistant bacteria in hematology patients: emerging threats. Future Microbiol 2016 Jun;11:767-80

Thung I, Aramin H, Vavinskaya V, et al. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther 2016 Feb;43(4):514-33

Toombs-Ruane LJ, Benschop J, Burgess S, et al. Multidrug resistant Enterobacteriaceae in New Zealand: a current perspective. N Z Vet J 2016 (published online Dec 7)

Toubiana J, Timsit S, Ferroni A, et al. Community-onset extended-spectrum β-lactamase-producing Enterobacteriaceae invasive infections in children in a university hospital in France. Medicine (Baltimore) 2016 Mar;95(12):e3163

Tsioutis C, Kritsotakis EI, Karageorgos S, et al. Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients. Int J Antimicrob Agents 2016 (published online Aug 12)

Turner P, Pol S, Soeng S, et al. High prevalence of antimicrobial-resistant gram-negative colonization in hospitalized Cambodian infants. Pediatr Infect Dis J 2016 Aug;35(8):856-61

Uematsu H, Yamashita K, Kunisawa S, et al. The economic burden of methicillin-resistant Staphylococcus aureus in community-onset pneumonia inpatients. Am J Infect Control 2016 (published online Jul 27)

Vading M, Kabir MH, Kalin M, et al. Frequent acquisition of low-virulence strains of ESBL-producing Escherichia coli in travellers. J Antimicrob Chemother 2016 (published online Aug 26)

van Balen J, Bottichio L, Stevenson K, et al. Understanding the introduction and circulation of environmental methicillin-resistant Staphylococcus aureus in a large academic medical center during a nonoutbreak, year-long period. Am J Infect Control 2016 Aug 1;44(8):925-30

Vasquez AM, Montero N, Laughlin M, et al. Investigation of Escherichia coli harboring the mcr-1 resistance gene—Connecticut, 2016. MMWR Morb Mortal Wkly Rep 2016 (published online Sep 9)

von Wintersdorff CJH, Wolffs PFG, van Niekerk JM, et al. Detection of the plasmid-mediated colistin-resistance gene mcr-1 in faecal metagenomes of Dutch travellers. J Antimicrob Chemother 2016 (published online Aug 26)

Watkins RR, Bonomo RA. Overview: global and local impact of antibiotic resistance. Infect Dis Clin North Am 2016 Jun;30(2):313-22

Weiner LM, Fridkin SK, Aponte-Torres Z, et al. Vital signs: preventing antibiotic-resistant infections in hospitals — United States, 2014. MMWR 2016 Mar 11;65(9):235-41

Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014. Infect Control Hosp Epidemiol 2016 (published online Aug 30)

Wong SCY, Tse H, Chen JHK, Cheng VCC, et al. Colistin- resistant Enterobacteriaceae carrying the mcr-1 gene among patients in Hong Kong. Emerg Infect Dis 2016 (published online Jul 27)

Wragg R, Harris A, Patel M, et al. Extended spectrum beta lactamase (ESBL) producing bacteria urinary tract infections and complex pediatric urology. J Pediatr Surg 2016 (published online Nov 25)

Yao H, Shen Z, Wang Y, et al. Emergence of a potent multidrug efflux pump variant that enhances Campylobacter resistance to multiple antibiotics. mBio 2016 Sep 20;7(5)

Yoon YK, Park DW, Sohn JW, et al. Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis. BMC Infect Dis 2016 (published online Jul 15)

Yu H, Qu F, Shan B, et al. Detection of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae from different hospitals in China. Antimicrob Agents Chemother 2016 Aug;60(8):5033-5

Zerr DM, Miles-Jay A, Kronman MP, et al. Previous antibiotic exposure increases risk of infection with extended spectrum beta lactamase- and AmpC-producing Escherichia coli and Klebsiella pneumoniae in pediatric patients. Antimicrob Agents Chemother 2016 May;60(7):4237-43

Zilahi G, Artigas A, Martin-Loeches I. What's new in multidrug-resistant pathogens in the ICU? Ann Intensive Care 2016 (published online Oct 6)

Zowawi HM. Antimicrobial resistance in Saudi Arabia. An urgent call for an immediate action. Saudi Med J 2016 Sep;37(9):935-40

Zurfluh K, Klupp J, Nuesch-Inderbinen M, et al. Full-length nucleotide sequences of mcr-1-harboring plasmids isolated from extended-spectrum-β-lactamase-producing Escherichia coli isolates of different origins. Antimicrob Agents Chemother 2016 Sep;60(9):5589-91

Back to top

2015

Abat C, Desboves G, Olaitan AO, et al. Increasing burden of urinary tract infections due to intrinsic colistin-resistant bacteria in hospitals in Marseille, France. Int J Antimicrob Agents 2015 Feb;45(2):144-50

Abbott IJ, Peleg AY. Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: antimicrobial resistance and therapeutic strategies. Semin Respir Crit Care Med 2015 Feb;36(1):99-110

Ahmed I, Sajed M, Sultan A, et al. The erratic antibiotic susceptibility patterns of bacterial pathogens causing urinary tract infections. EXCLI J 2015 Aug 4;14:916-25

Antonanzas F, Lozano C, Torres C. Economic features of antibiotic resistance: the case of methicillin-resistant Staphylococcus aureus. Pharmacoeconomics 2015 Apr;33(4):285-325

Arnaud I, Maugat S, Jarlier V, et al. Ongoing increasing temporal and geographical trends of the incidence of extended-spectrum beta-lactamase-producing Enterobacteriaceae infections in France, 2009 to 2013. Euro Surveill 2015 Sep;20(36):pii=30014

Asbell PA, Sanfilippo CM, Pillar CM, et al. Antibiotic resistance among ocular pathogens in the United States: five-year results from the antibiotic resistance monitoring in ocular microorganisms (ARMOR) surveillance study. JAMA Ophthalmol 2015 Dec;133(12):1445-54

Barber KE, King ST, Stover KR, et al. Therapeutic options for vancomycin-resistant enterococcal bacteremia. Expert Rev Anti Infect Ther 2015 Mar;13(3):363-77

Barfod TS, Wibroe EA, Brauner JV, et al. Changes in antimicrobial susceptibility patterns of Klebsiella pneumoniae, Escherichia coli and Staphylococcus aureus over the past decade. Dan Med J 2015 Oct;62(10):A5145

Barlam TF, Gupta K. Antibiotic resistance spreads internationally across borders. J Law Med Ethics 2015 Summer;43(Suppl 3):12-6

Beever L, Bond R, Graham PA, et al. Increasing antimicrobial resistance in clinical isolates of Staphylococcus intermedius group bacteria and emergence of MRSP in the UK. Vet Rec 2015 Feb 14;176(7):172

Bialvaei AZ, Samadi Kafil H. Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin 2015 Apr;31(4):707-21

Bielicki JA, Lundin R, Sharland M, et al. Antibiotic resistance prevalence in routine bloodstream isolates from children's hospitals varies substantially from adult surveillance data in Europe. Pediatr Infect Dis J 2015 Jul;34(7):734-41

Blair JM, Webber MA, Baylay AJ, et al. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 2015 Jan;13(1):42-51

Bowen A, Hurd J, Hoover C, et al. Importation and domestic transmission of Shigella sonnei resistant to ciprofloxacin — United States, May 2014-February 2015. MMWR 2015 Apr 3;64(12):318-20

Boyle DP, Zembower TR. Epidemiology and management of emerging drug-resistant gram-negative bacteria: extended-spectrum beta-lactamases and beyond. Urol Clin North Am 2015 Nov;42(4):493-505

Buono SA, Watson TD, Borenstein LA, et al. Stemming the tide of drug-resistant Neisseria gonorrhoeae: the need for an individualized approach to treatment. J Antimicrob Chemother 2015 Feb;70(2):374-81

Cai T, Nesi G, Mazzoli S, et al. Asymptomatic bacteriuria treatment is associated with a higher prevalence of antibiotic resistant strains in women with urinary tract infections. Clin Infect Dis 2015 Dec 1;61(11):1655-61

Calbo E, Garau J. The changing epidemiology of hospital outbreaks due to ESBL-producing Klebsiella pneumoniae: the CTX-M-15 type consolidation. Future Microbiol 2015 Jun;10(6):1063-75

Chang VS, Dhaliwal DK, Raju L, et al. Antibiotic resistance in the treatment of Staphylococcus aureus keratitis: a 20-Year Review. Cornea 2015 Jun;34(6):698-703

Ciorba V, Odone A, Veronesi L, et al. Antibiotic resistance as a major public health concern: epidemiology and economic impact. Ann Ig 2015 May-Jun;27(3):562-79

Cleveland AA, Harrison LH, Farley MM, et al. Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillance. PLoS One 2015 Mar 30;10(3):e0120452

Cole MJ, Spiteri G, Jacobsson S, et al. Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance. BMC Infect Dis 2015 Aug 11;15:321,015-1013-x

De Santis V, Gresoiu M, Corona A, et al. Bacteraemia incidence, causative organisms and resistance patterns, antibiotic strategies and outcomes in a single university hospital ICU: continuing improvement between 2000 and 2013. J Antimicrob Chemother 2015 Jan;70(1):273-8

Doi Y, Paterson DL. Carbapenemase-producing Enterobacteriaceae. Semin Respir Crit Care Med 2015 Feb;36(1):74-84

Drusano GL, Louie A, MacGowan A, et al. Suppression of emergence of resistance in pathogenic bacteria: Keeping our powder dry, part 1. Antimicrob Agents Chemother 2015 Dec 28;60(3):1183-93

Drusano GL, Hope W, MacGowan A, et al. Suppression of emergence of resistance in pathogenic bacteria: Keeping our powder dry, part 2. Antimicrob Agents Chemother 2015 Dec 28;60(3):1194-201

Dryden M, Andrasevic AT, Bassetti M, et al. Managing skin and soft-tissue infection and nosocomial pneumonia caused by MRSA: a 2014 follow-up survey. Int J Antimicrob Agents 2015 Apr 24;45 Suppl 1:S1-14

Fanella S, Embree J. Pediatric Staphylococcus aureus Infections: impact of methicillin resistance at a Canadian center. South Med J 2015 May;108(5):254-7

Ferjani S, Saidani M, Amine FS, et al. A comparative study of antimicrobial resistance rates and phylogenetic groups of community-acquired versus hospital-acquired invasive Escherichia coli. Med Mal Infect 2015 Apr;45(4):133-8

Ferri M, Ranucci E, Romagnoli P, et al. Antimicrobial resistance: a global emerging threat to public health systems. Crit Rev Food Sci Nutr 2015 Oct 13:0

Fridkin SK, Cleveland AA, See I, et al. Emerging Infections Program as surveillance for antimicrobial drug resistance. Emerg Infect Dis 2015 Sep;21(9):1578-81

Garner MJ, Carson C, Lingohr EJ, et al. An assessment of antimicrobial resistant disease threats in Canada. PLoS One 2015 Apr 23;10(4):e0125155

Gentry CA, Williams RJ 2nd. Trends in susceptibility rates and extended-spectrum beta-lactamase production of Klebsiella pneumoniae in bloodstream infections across the United States Veterans Affairs Healthcare System. Microb Drug Resist 2015 Dec;21(6):590-9

George CE, Norman G, Ramana GV, et al. Treatment of uncomplicated symptomatic urinary tract infections: resistance patterns and misuse of antibiotics. J Family Med Prim Care 2015 Jul-Sep;4(3):416-21

Gharbi M, Moore LS, Gilchrist M, et al. Forecasting carbapenem resistance from antimicrobial consumption surveillance: lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit. Int J Antimicrob Agents 2015 Aug;46(2):150-6

Gibble AM, Gross AE, Huang AM. Examining the clinical effectiveness of non-carbapenem beta-lactams for the treatment of extended-spectrum beta-lactamase-producing Enterobacteriaceae. Antibiotics (Basel) 2015 Dec 15;4(4):653-66

Goldsmith CE, Hara Y, Sato T, et al. Comparison of antibiotic susceptibility in viridans group streptococci in low and high antibiotic-prescribing General Practices. J Clin Pharm Ther 2015 Apr;40(2):204-7

Guidry CA, Davies SW, Metzger R, et al. Whence resistance? Surg Infect (Larchmt) 2015 Dec;16(6):716-20

Guiral E, Saez-Lopez E, Bosch J, et al. Antimicrobial resistance and virulence characterization among Escherichia coli clinical isolates causing severe obstetric infections in pregnant women. J Clin Microbiol 2015 May;53(5):1745-7

Harris P, Paterson D, Rogers B. Facing the challenge of multidrug-resistant gram-negative bacilli in Australia. Med J Aust 2015 Mar 16;202(5):243-7

Heil EL, Lowery AV, Thom KA, et al. Treatment of multidrug-resistant Pseudomonas aeruginosa using extended infusion antimicrobial regimens. Pharmacotherapy 2015 Jan;35(1):54-8

Holmes NE, Tong SY, Davis JS, et al. Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond. Semin Respir Crit Care Med 2015 Feb;36(1):17-30

Holt KE, Wertheim H, Zadoks RN, et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci 2015 Jul 7;112(27):E3574-81

Ironmonger D, Edeghere O, Bains A, et al. Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years. J Antimicrob Chemother 2015 Jun;70(6):1744-50

Jean SS, Lee WS, Lam C, et al. Carbapenemase-producing Gram-negative bacteria: current epidemics, antimicrobial susceptibility and treatment options. Future Microbiol 2015 Mar;10(3):407-25

Johnson AP. Surveillance of antibiotic resistance. Philos Trans R Soc Lond B Biol Sci 2015 Jun 5;370(1670):20140080

Joseph NM, Bhanupriya B, Shewade DG, et al. Relationship between antimicrobial consumption and the incidence of antimicrobial resistance in Escherichia coli and Klebsiella pneumoniae isolates. J Clin Diagn Res 2015 Feb;9(2):DC08-12

Karlowsky JA, Biedenbach DJ, Bouchillon SK, et al. In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme. J Antimicrob Chemother 2015 Jan;71(1):162-9

Lai CC, Chu CC, Cheng A, et al. Correlation between antimicrobial consumption and incidence of health-care-associated infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 2000 to 2010. J Microbiol Immunol Infect 2015 Aug;48(4):431-6

Lesho EP, Clifford RJ, Chukwuma U, et al. Carbapenem-resistant Enterobacteriaceae and the correlation between carbapenem and fluoroquinolone usage and resistance in the US military health system. Diagn Microbiol Infect Dis 2015 Feb;81(2):119-25

Lindsay JA. Transmission of antimicrobial resistance in resource-poor healthcare. Trends Microbiol 2015 Feb;23(2):69-70

Lob SH, Kazmierczak KM, Badal RE, et al. Trends in susceptibility of Escherichia coli from intra-abdominal i

Antimicrobial Use

Recently Added
2017
2016

2015
2014
2013
2012
2011
2010
2000-2009 

Recently Added

Baghban A, Juthani-Mehta M. Antimicrobial use at the end of life. Infect Dis Clin 2017 Dec;31(4):639-47

Grigoryan L, Zoorob R, Shah J, et al. Antibiotic prescribing for uncomplicated acute bronchitis Is highest in younger adults. Antibiotics (Basel) 2017 (published online Oct 27)

Sanchez GV, Shapiro DJ, Hersh AL, et al. Outpatient macrolide antibiotic prescribing in the United States, 2008-2011. Open Forum Infect Dis 2017 (published online Oct 8)

Timbrook TT, Caffrey AR, Ovalle A, et al. Assessments of opportunities to improve antibiotic prescribing in an emergency department: a period prevalence survey. Infect Dis Ther 2017 (published online Oct 19)

Zhang Y, Yuan Q, Yi X, et al. Trends in antimicrobial prescription for inpatients in Changsha, China, 2003 to 2014. Iran J Public Health 2017 Sep;46(9):1223-30

Back to top 

2017

Alhomoud F, Aljamea Z, Almahasnah R, et al. Self-medication and self-prescription with antibiotics in the Middle East—do they really happen? A systemic review of the prevalence, possible reasons and outcomes. Int J Infect Dis 2017 (published online Jan 19)

Al-Jumaili AA, Hussein AH, Al-Rekabi MD, et al. Antimicrobial utilization in an Iraqi province: a comprehensive evaluation of antibiotic source and cost. Int J Pharm Pract 2017 (published online Jan 18)

Antachopoulos C, Iosifidis E. Colistin use in neonates and children with infections due to carbapenem-resistant bacteria. Pediatric Infect Dis J 2017 Sep;36(9):905-7

Atif M, Azeem M, Saqib A, et al. Investigation of antimicrobial use at a tertiary care hospital in Southern Punjab, Pakistan using WHO methodology. Antimicrob Resist Infect Control 2017 (published online Apr 28)

Babich T, Zusman O, Elbaz M, et al. Empirical antibiotic treatment does not improve outcomes in catheter-associated UTI: prospective cohort study. Clin Infect Dis 2017 (published online Aug 2)

Baghban A, Juthani-Mehta M. Antimicrobial use at the end of life. Infect Dis Clin 2017 Dec;31(4):639-47

Barlam TF, Morgan JR, Kaplan WA, et al. Disproportionate exposure to antibiotics in children at risk for invasive pneumococcal disease: potential for emerging resistance and opportunity for antibiotic stewardship. J Pediatric Infect Dis Soc 2017 (published online Sep 7)

Barnes SL, Rock C, Harris AD, et al. The impact of reducing antibiotics on the transmission of multidrug-resistant organisms. Infect Control Hosp Epidemiol 2017 (published online Mar 8)

Bathoorn E, Groenhof F, Hendrix R, et al. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care. Int J Chron Obstruct Pulmon Dis 2017 (published online Jan 13)

Bernatz JT, Safdar N, Hetzel S, et al. Antibiotic overuse is a major risk factor for Clostridium difficile infection in surgical patients. Infect Control Hosp Epidemiol 2017 (published online Jul 31)

Berrevoets MA, Ten Oever J, Sprong T, et al. Monitoring, documenting and reporting the quality of antibiotic use in the Netherlands: a pilot study to establish a national antimicrobial stewardship registry. BMC Infect Dis 2017 (published online Aug 15)

Boyd SE, Prockter Moore LS, Gilchrist M, et al. Obtaining antibiotics online from within the UK: a cross-sectional study. J Antimicrob Chemother 2017 (published online Feb 17)

Broom A, Broom J, Kirby E, et al. Antibiotic optimisation in ‘the bush’: Local know-how and core-periphery relations. Health Place 2017 (published online Sep 23)

Brownridge DJ, Zaidi ST. Retrospective audit of antimicrobial prescribing practices for acute exacerbations of chronic obstructive pulmonary diseases in a large regional hospital. J Clin Pharm Ther 2017 (published online Mar 1)

Bundy DG, Richardson TE, Hall M. Association of guideline-adherent antibiotic treatment with readmission of children with sickle cell disease hospitalized with acute chest syndrome. JAMA Pediatr 2017 (published online Sep 11)

Cai Y, Venkatachalam I, Tee NW, et al. Prevalence of healthcare-associated infections and antimicrobial use among adult inpatients in Singapore acute-care hospitals: results from the first national point prevalence survey. Clin Infect Dis 2017 May;64(suppl 2):S61-S67

Cantarero-Arevalo L, Pavelics Hallas M, Kaae S. Parental knowledge of antibiotic use in children with respiratory infections: a systematic review. Int J Pharm Pract 2017 (published online Jan 18)

Celestin AR, Odom SR, Angelidou K, et al. Novel method suggests global superiority of short-duration antibiotics for intra-abdominal infections. Clin Infect Dis 2017 (published online Aug 28)

Charani E, Ahmad R, Tarrant C, et al. Opportunities for system level improvement in antibiotic use across the surgical pathway. Int J Infect Dis 2017 Jul;60:29-34

Chiotos K, Ross RK, Han JH, et al. Use of carbapenems, polymyxins, and tigecycline in United States children's hospitals, 2010-2014. Open Forum Infect Dis 2017 (published online Mar 9)

Courtenay M, Gillespie D, Lim R. Patterns of dispensed non-medical prescriber prescriptions for antibiotics in primary care across England: a retrospective analysis. J Antimicrob Chemother 2017 (published online Jul 17)

Courtenay M, Rowbotham S, Lim R, et al. Antibiotics for acute respiratory tract infections: a mixed-methods study of patient experiences of non-medical prescriber management. BMJ Open 2017 (published online Mar 15)

Coxeter PD, Del Mar C, Hoffmann TC. Parents’ expectations and experiences of antibiotics for acute respiratory infections in primary care. Ann Fam Med 2017;15(2):149-54

Cunha BA, Cunha CB, Lam B, et al. Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications. Eur J Clin Microbiol Infect Dis 2017 (published online Feb 2)

Cunha CB, Cunha BA. Antimicrobial therapy for legionnaire's disease: antibiotic stewardship implications. Infect Dis Clin North Am 2017 Mar;31(1):179-91

Cunha BA, Gian J, Klein NC. Severe adenoviral pneumonia in an immunocompetent host with persistent fevers treated with multiple empiric antibiotics for presumed bacterial co-infection: an antibiotic stewardship perspective on de-escalation derailed. J Clin Med 2017 (published online Apr 4)

David CM, O’Neal KS, Miller MJ, et al. A literacy-sensitive approach to improving antibiotic understanding in a community-based setting. Int J Pharm Pract 2017 (published online Jan 18)

Deelen JWR, Visser CE, Prins JM, et al. Antimicrobial prophylaxis outside the operating theatre, an audit in a university hospital. BMC Infect Dis 2017 (published online Apr 21)

Delaney F, Jackson A. An audit of empiric antibiotic choice in the inpatient management of community-acquired pneumonia. Ir Med J 2017 Apr 10;110(4):545

Demore B, Le Govic D, Thilly N, et al. Reliability of self-reported recent antibiotic use among the general population: a cross-sectional study. Clin Microbiol Infect 2017 (published online Jan 18)

Doan T, Arzika AM, Ray KJ, et al. Gut microbial diversity in antibiotic-naive children after systemic antibiotic exposure: a randomized controlled trial. Clin Infect Dis 2017 (published online Apr 11)

Dona D, Mozzo E, Mardegan V, et al. Antibiotics prescriptions in the neonatal intensive care unit: how to overcome everyday challenges. Am J Perinatol 2017 (published online Apr 10)

Duong VT, Tuyen HT, Minh PV, et al. No clinical benefit of empirical antimicrobial therapy for pediatric diarrhea in a high usage, high resistance setting. Clin Infect Dis 2017 (published online Sep 26)

Duffy E, Ritchie S, Metcalfe S, et al. Antibacterials dispensed in the community comprise 85%-95% of total human antibacterial consumption. J Clin Pharm Ther 2017 (published online Aug 18)

Durkin MJ, Hsueh K, Sallah YH, et al. An evaluation of dental antibiotic prescribing practices in the United States. J Am Dent Assoc 2017 (published online Sep 16)

Edelstein M, Agbebiyi A, Ashiru-Oredope D, et al. Trends and patterns in antibiotic prescribing among out-of-hours primary care providers in England, 2010-14. J Antimicrob Chemother 2017 (published online Sep 18)

Elango S, Szymczak JE, Bennett IM, et al. Changing antibiotic prescribing in a primary care network: the role of readiness to change and group dynamics in success. Am J Med Qual 2017 (published online Jul 20)

Esaiassen E, Widding Fjalstad J, Juvet LC, et al. Antibiotic exposure in neonates and early adverse outcomes: a systematic review and meta-analysis. J Antimicrob Chemother 2017 (published online Mar 24)

Feinstein M, Escandon-Vargas K, Reyes, S, et al. Improved outcomes when antibiotic prescribing guidelines are followed by healthcare providers: a Colombian example to encourage adherence in hospital settings. Infect Control Hosp Epidemiol 2017 (published online Apr 3)

Fisher D, Michaels J, Hase R, et al. Outpatient parenteral antibiotic therapy (OPAT) in Asia: missing an opportunity. J Antimicrob Chemother 2017 (published online Jan 10)

Fleming-Dutra KE, Demirjian A, Bartoces M, et al. Variations in antibiotic and azithromycin prescribing for children by geography and specialty—United States, 2013. Pediatr Infect Dis J 2017 (published online Jul 19)

Fowler LH, Lee S. Antibiotic trends amid multidrug-resistant gram-negative infections in intensive care units. Crit Care Nurs Clin North Am 2017 Mar;29(1):111-8

Gebrekirstos NH, Workneh BD, Gebregiorgis YS, et al. Non-prescribed antimicrobial use and associated factors among customers in drug retail outlet in central zone of Tigray, northern Ethiopia: a cross-sectional study. Antimicrob Resist Infect Control 2017 (published online Jun 26)

Giacomini JL, Fortaleza CMCB. Use of parenteral antimicrobials in very small hospitals in inner Brazil: patterns, determinants and opportunities for interventions in developing countries. J Hosp Infect 2017 (published online Apr 14)

Glenn IC, Bruns NE, Soldes OS, et al. Prospective observational study to assess the need for postoperative antibiotics following surgical incision and drainage of skin and soft tissue abscess in pediatric patients. J Pediatr Sug 2017 (published online Aug 20)

Glinz D, Reyes SL, Saccilotto R, et al. Quality of antibiotic prescribing of Swiss primary care physicians with high prescription rates: a nationwide survey. J Antimicrob Chemother 2017 (published online Aug 24)

Goldman JL, Ross RK, Lee BR, et al. Variability in antifungal and antiviral use in hospitalized children. Infect Control Hosp Epidemiol 2017 (published online Mar 15)

Gradel KO, Jensen US, Schonheyder HC, et al. Impact of appropriate empirical antibiotic treatment on recurrence and mortality in patients with bacteraemia: a population-based cohort study. BMC Infect Dis 2017 (published online Feb 6)

Greenhouse I, Babushkin F, Finn T, et al. Long term outcomes of inappropriate antibiotic therapy for upper urinary tract infections caused by extended-spectrum beta-lactamase producing Enterobacteriaceae: a retrospective cohort study. Diagn Microbiol Infect Dis 2017 (published online Jul 28)

Grigoryan L, Zoorob R, Shah J, et al. Antibiotic prescribing for uncomplicated acute bronchitis Is highest in younger adults. Antibiotics (Basel) 2017 (published online Oct 27)

Gutierrez-Gutierrez B, Salamanca E, de Cueto M, et al. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. The Lancet Infect Dis 2017 (published online Apr 22)

Handy LK, Bryan M, Gerber JS, et al. Variability in antibiotic prescribing for community-acquired pneumonia. Pediatrics 2017 (published online Mar 7)

Harris PNA, Pezzani MD, Gutierrez-Gutierrez B, et al. Geographical variation in therapy for bloodstream infections due to multidrug-resistant enterobacteriaceae: a post hoc analysis of the INCREMENT study. Int J Antimicrob Agents 2017 (published online Aug 3)

Hawking MKD, Lecky DM, Lundgren PD, et al. Attitudes and behaviours of adolescents towards antibiotics and self-care for respiratory tract infections: a qualitative study. BMJ Open 2017 (published online Jun 6)

Hiensch R, Poeran J, Saunders-Hao P, et al. Impact of an electronic sepsis initiative on antibiotic use and health care facility–onset Clostridium difficile infection rates. Am J Infect Control 2017 (published online Jun 8)

Hopkins H, Bruxvoort KJ, Cairns ME, et al. Impact of introduction of rapid diagnostic tests for malaria on antibiotic prescribing: analysis of observational and randomised studies in public and private healthcare settings. BMJ 2017 (published online Mar 29)

Ivanovska V, Hek K, Mantel-Teeuwisse AK, et al. Age-specific antibiotic prescribing and adherence to guidelines in pediatric patients in primary care. Pediatr Infect Dis J 2017 (published online Aug 28)

Jaaskelainen IH, Hagberg L, Schyman T, et al. A potential benefit from infectious disease specialist and stationary ward in rational antibiotic therapy of complicated skin and skin structure infections. Infect Dis (Lond) 2017 (published online Aug 8)

Jalil MHA, Hammour KA, Alsous M, et al. Noncompliance with surgical antimicrobial prophylaxis guidelines: a Jordanian experience in cesarean deliveries. Am J Infect Control 2017 (published online Aug 8)

Jamhour A, El-Kheir A, Salameh P, et al. Antibiotic knowledge and self-medication practices in a developing country: a cross-sectional study. Am J Infect Control 2017 (published online Jan 12)

Jones BE, Samore MH. Antibiotic overuse: clinicians are the solution. Ann Intern Med 2017 (published online May 9)

Jones T. Overutilization of antibiotics in children with diarrhea: first do no harm. Clin Infect Dis 2017 (published online Sep 26)

Katchanov J, Kreuels B, Maurer FP, et al. Risk factors for excessively prolonged meropenem use in the intensive care setting: a case-control study. BMC Infect Dis 2017 (published online Feb 8)

Khalifeh MM, Moore ND, Salameh PR. Self-medication misuse in the Middle East: a systematic literature review. Pharmacol Res Perspect 2017 (published online Jun 18)

Kioka MJ, DiGiovine B, Rezik M, et al. Anaerobic antibiotic usage for pneumonia in the medical intensive care unit. Respirology 2017 (published online Jul 4)

King ST, Barber KE, Parham JJ, et al. Shifts in antimicrobial consumption and infection rates before and during a piperacillin-tazobactam shortage. J Glob Antimicrob Resist 2017 (published online Jul 31)

Kinlaw AC, Sturmer T, Lund JL, et al. Trends in antibiotic use by birth season and birth year. Pediatrics 2017 (published online Aug 10)

Klein EY, Martinez EM, May L, et al. Categorical risk perception drives variability in antibiotic prescribing in the emergency department: a mixed methods observational study. J Gen Intern Med 2017 (published online Jun 20)

Kraus EM, Pelzl S, Szecsenyi J, et al. Antibiotic prescribing for acute lower respiratory tract infections (LRTI)—guideline adherence in the German primary care setting: an analysis of routine data. PLoS One 2017 (published online Mar 28)

Landstedt K, Sharma A, Johansson F, et al. Antibiotic prescriptions for inpatients having non-bacterial diagnosis at medicine departments of two private sector hospitals in Madhya Pradesh, India: a cross-sectional study. BMJ Open 2017 (published online Apr 8)

Liao JM, Schapira MS, Navathe AS, et al. The effect of emphasizing patient, societal, and institutional harms of inappropriate antibiotic prescribing on physician support of financial penalties: a randomized trial. Ann Intern Med 2017 (published online Jun 20)

Lipsky MJ, Sayegh C, Theofanides MC, et al. Preoperative antibiotics prior to bladder biopsy: are they necessary? Urology 2017 (published online Aug 29)

Little P, Stuart B, Smith S, et al. Antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3C) study. BMJ 2017 (published online May 22)

MacGeorge EL, Caldes EP, Smith RA, et al. Reducing unwarranted antibiotic use for pediatric acute otitis media: the influence of physicians' explanation and instruction on parent compliance with ‘watchful waiting.’ J Appl Commun Res 2017 (published online May 30)

Marzec NS, Nelson C, Waldron PR, et al. Serious bacterial infections acquired during treatment of patients given a diagnosis of chronic lyme disease—United States. MMWR Morb Mortal Wkly Rep 2017 (published online Jun 16)

Mascarello M, Simonetti O, Knezevich A, et al. Correlation between antibiotic consumption and resistance of bloodstream bacteria in a university hospital in north eastern Italy, 2008-2014. Infection 2017 (published online Mar 6)

Matsitse TB, Helberg E, Meyer JC, et al. Compliance to the primary health care treatment guidelines and the essential medicines list in the management of sexually transmitted infections in correctional centres in South Africa: findings and implications. Expert Rev Anti Infect Ther 2017 (published online Sep 19)

Micallef C, Chaudhry NT, Holmes AH, et al. Secondary use of data from hospital electronic prescribing and pharmacy systems to support the quality and safety of antimicrobial use: a systematic review. J Antimicrob Chemother 2017 (published online Mar 22)

Moghnieh RA, Abdallah DI, Fawaz IA, et al. Prescription patterns for tigecycline in severely ill patients for  non-FDA approved indications in a developing country: a compromised outcome. Front Microbiol 2017 (published online Mar 27)

Moore M, Stuart B, Hobbs FDR, et al. Symptom response to antibiotic prescribing strategies in acute sore throat in adults: the DESCARTE prospective cohort study in UK general practice. Br J Gen Pract 2017 (published online Aug 14)

Nakwatumbah S, Kibuule D, Godman B, et al. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia's national referral hospital: a pilot study and the implications. Expert Rev Anti Infect Ther 2017 (published online Apr 20)

Oliver SJ, Cush J, Ward JE. Community-based prescribing for impetigo in remote Australia: an opportunity for antimicrobial stewardship. Front Public Health 2017 (published online Jul 12)

Olsen MA, Nickel KB, Fraser VJ, et al. Prevalence and predictors of postdischarge antibiotic use following mastectomy. Infect Control Hosp Epidemiol 2017 (published online Jul 3)

Om C, Daily F, Vlieghe E, et al. Pervasive antibiotic misuse in the Cambodian community: antibiotic-seeking behaviour with unrestricted access. Antimicrob Resist Infect Control 2017 (published online Mar 24)

Palacios-Baena ZR, Gutierrez-Gutierrez B, Calbo E, et al. Empiric therapy with carbapenem-sparing regimens for bloodstream infections due to extended-spectrum β-lactamase–producing Enterobacteriaceae: results from the INCREMENT cohort. Clin Infect Dis 2017 (published online Aug 19)

Papoutsi C, Mattack K, Pearson M, et al. Social and professional influences on antimicrobial prescribing for doctors-in-training: a realist review. J Antimicrob Chemother 2017 (published online Jul 9)

Parente DM, Timbrook TT, Caffrey AR, et al. Inappropriate prescribing in outpatient healthcare: an evaluation of respiratory infection visits among veterans in teaching versus non-teaching primary care clinics. Antimicrob Resist Infect Control 2017 (published online Mar 29)

Park J, Han E, Lee SO, et al. Antibiotic use in South Korea from 2007 to 2014: a health insurance database-generated time series analysis. PLoS One 2017 (published online May 17)

Park JS, Tennant M, Walsh LJ, et al. Is there a consensus on antibiotic usage for dental implant placement in healthy patients? Aust Dent J 2017 (published online May 25)

Peterson LR, Samia NI, Skinner AM, et al. Antimicrobial stewardship lessons from mupirocin use and resistance in MRSA. Open Forum Infect Dis 2017 (published online May 4)

Pouwels KB, Van Kleef E, Vansteelandt S, et al. Does appropriate empiric antibiotic therapy modify ICU-acquired Enterobacteriaceae bacteraemia mortality and discharge? J Hosp Infect 2017 (published online Mar 18)

Pruetpongpun N, Khawcharoenporn T, Damronglerd P, et al. Inappropriate empirical treatment of uncomplicated cystitis in Thai women: lessons learned. Clin Infect Dis 2017 May;64(suppl 2):S115-S118

Ramos GE. Systemic antimicrobial prophylaxis in burn patients: a systematic review. J Hosp Infect 2017 (published online Jun 16)

Ravi N, Laha A, Hmar L, et al. Exploring the prescribing behaviours and the mind of antibiotic prescribers is critical for a successful antibiotic stewardship programme: results of a survey from eastern India. Indian J Med Microbiol 2017 Apr-Jun;35(2):299-301

Roberts RM, Bartoces M, Thompson SE, et al. Antibiotic prescribing by general dentists in the United States, 2013. J Am Dent Assoc 2017 (published online Jan 23)

Safa L, Afif N, Zied H, et al. Proper use of antibiotics: situation of linezolid at the intensive care unit of the Tunisian Military Hospital. Pan Afr Med J 2016 (published online Nov 28)

Salim AMA, Elgizoli B. Exploring the reasons why pharmacists dispense antibiotics without prescriptions in Khartoum state, Sudan. Int J Pharm Pract 2017 Feb;25(1):59-65

Sanchez GV, Shapiro DJ, Hersh AL, et al. Outpatient macrolide antibiotic prescribing in the United States, 2008-2011. Open Forum Infect Dis 2017 (published online Oct 8)

Sekikubo M, Hedman K, Mirembe F, et al. Antibiotic overconsumption in pregnant women with urinary tract symptoms in Uganda. Clin Infect Dis 2017 (published online Jun 30)

Shah KJ, Cherabuddi K, Shultz J, et al. Ampicillin for the treatment of complicated urinary tract infections caused by vancomycin resistant enterococcus spp (VRE): a single-center university hospital experience. Int J Antimicrob Agents 2017 (published online Jun 27)

Shah N, Joshi A, Ganguly B. Impact of antibiotic stewardship program on prescribing pattern of antimicrobials in patients of medical intensive care unit. J Clin Diagn Res 2017 (published online Jul 1)

Shahid A, Iftikhar F, Arshad MK, et al. Knowledge and attitude of physicians about antimicrobial resistance and their prescribing practices in Services hospital, Lahore, Pakistan. J Pak Med Assoc 2017 Jun;67(6):968

Shallcross L, Beckley N, Rait G, et al. Antibiotic prescribing frequency amongst patients in primary care: a cohort study using electronic health records. J Antimicrob Chemother 2017 (published online Feb 21)

Sharma P, Finley R, Weese S, et al. Antibiotic prescriptions for outpatient acute rhinosinusitis in Canada, 2007-2013. PLoS One 2017 (published Jul 27)

Shekhawat NS, Shtein RM, Blachley TS, et al. Antibiotic prescription fills for acute conjunctivitis among enrollees in a large United States managed care network. Ophthalmology 2017 (published online Jun 14)

Shukla PJ, Behnam-Terneus M, Cunill-De Sautu B, et al. Antibiotic use by pediatric residents: identifying opportunities and strategies for antimicrobial stewardship. Hosp Pediatr 2017 (published online Aug 16)

Silverman M, Povitz M, Sontrop JM, et al. Antibiotic prescribing for nonbacterial acute upper respiratory infections in elderly persons. Ann Intern Med 2017 (published online May 9)

Spivak ES, Burk M, Zhang R, et al. Management of bacteriuria in Veterans Affairs hospitals. Clin Infect Dis 2017 (published online May 20)

Tamma PD, Avdic E, Li DX, et al. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 2017 (published online Jun 12)

Tashiro M, Fushimi K, Kawano K, et al. Comparison of efficacy of antimicrobial agents among hospitalized patients with Mycoplasma pneumoniae pneumonia in Japan during large epidemics of macrolide-resistant M. pneumoniae infections: a nationwide observational study. Clin Infect Dis 2017 (published online Aug 16)

Thiessen K, Lloyd AE, Miller MJ, et al. Assessing guideline-concordant prescribing for community-acquired pneumonia. Int J Clin Pharm 2017 (published online May 29)

Timbrook TT, Caffrey AR, Ovalle A, et al. Assessments of opportunities to improve antibiotic prescribing in an emergency department: a period prevalence survey. Infect Dis Ther 2017 (published online Oct 19)

Tomczyk S, Jain S, Bramley AM, et al. Antibiotic prescribing for adults hospitalized in the etiology of pneumonia in the community study. Open Forum Infect Dis (published online Jun 20)

Torjesen I. Immediate antibiotics for uncomplicated RTIs do not reduce risk of admission and death, study finds. BMJ 2017 (published online May 23)

Verghese VP, Veeraraghavan B, Jayaraman R, et al. Increasing incidence of penicillin- and cefotaxime-resistant Streptococcus pneumoniae causing meningitis in India: time for revision of treatment guidelines? Indian J Med Microbiol 2017 Apr-Jun;35(2):228-36

Veve MP, Davis SL, Williams AM, et al. Considerations for antibiotic prophylaxis in head and neck cancer surgery. Oral Oncol 2017 (published online Sep 21)

Ville AP, Heyman MB, Medrano R, et al. Early antibiotic exposure and risk of childhood obesity in Latinos. Child Obes 2017 (published online Feb 6)

Walls T, Stark E, Pattemore P, et al. Missed opportunities for antimicrobial stewardship in pre-school children admitted to hospital with lower respiratory tract infection. J Paediatr Child Health 2017 (published online Mar 23)

Wang J, Harbarth S, Pittet D, et al. Burden of healthcare-associated infections in China—results of the 2015-point prevalence survey in Dong Guan City. J Hosp Infect 2017 (published online Feb 16)

Wang X, Peng D, Wang W, et al. Massive misuse of antibiotics by university students in all regions of China: implications for national policy. Int J Antimicrob Agents 2017 (published online Jun 28)

Wilson APR. Sparing carbapenem usage. J Antimicrob Chemother 2017 (published online Jun 15)

Wong S, Santullo P, Hirani SP, et al. Use of antibiotics and the prevalence of antibiotic-associated diarrhoea in patients with spinal cord injuries: an international, multicentre centre study. J Hosp Infect 2017 (published online Jun 21)

Wong S, Santullo P, O’Driscoll J, et al. Use of antibiotic and prevalence of antibiotic-associated diarrhoea in-patients with spinal cord injuries: a UK national spinal injury centre experience. Spinal Cord 2017 (published online Jan 31)

Worth LJ, Spelman T, Holt SG, et al. Epidemiology of infections and antimicrobial use in Australian haemodialysis outpatients: findings from a Victorian surveillance network, 2008-2015. J Hosp Infect 2017 (published online May 30)

Ye D, Chang J, Yang C, et al. How does the general public view antibiotic use in China? Result from a cross-sectional survey. Int J Clin Pharm 2017 (published online May 2)

Yusuf E, Versporten A, Goossens H. Is there any difference in quality of prescribing between antibacterials and antifungals? Results from the first global point prevalence study (Global PPS) of antimicrobial consumption and resistance from 53 countries. J Antimicrob Chemother 2017 (published online Jul 21)

Zembower TR, Maxwell KM, Nadler RB, et al. Evaluation of targeted antimicrobial prophylaxis for transrectal ultrasound guided prostate biopsy: a prospective cohort trial. BMC Infect Dis 2017 (published online Jun 7)

Zeng L, Hu D, Choonara I, et al. A prospective study of the use of antibiotics in the emergency department of a Chinese university hospital. Int J Pharm Pract 2017 (published online Jan 18)

Zhang Y, Yuan Q, Yi X, et al. Trends in antimicrobial prescription for inpatients in Changsha, China, 2003 to 2014. Iran J Public Health 2017 Sep;46(9):1223-30

Zhao SR, Griffin MR, Patterson BL, et al. Risk factors for outpatient use of antibiotics in children with acute respiratory illnesses. South Med J 2017 Mar;110(3):172-80

Back to top 

2016

Abou-Shaaban M, Ali AA, Rao PG, et al. Drug utilization review of cephalosporins in a secondary care hospital in United Arab Emirates. Int J Clin Pharm 2016 (published online Nov 5)

Al-Yamani A, Khamis F, Al-Zakwani I, et al. Patterns of antimicrobial prescribing in a tertiary care hospital in Oman. Oman Med p 2016 Jan;31(1):35-9

Arizpe A, Reveles KR, Aitken SL. Regional variation in antibiotic prescribing among medicare part D enrollees, 2013. BMC Infect Dis 2016 (published online Dec 9)

Baggs J, Fridkin SK, Pollack LA, et al. Estimating national trends in inpatient antibiotic use among US hospitals From 2006 to 2012. JAMA Intern Med 2016 (published online Sep 19)

Bailly S, Maubon D, Fournier P, et al. Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - trends over 10 years. J Infect 2016 Jan;72(1):103-11

Barlam TF, Soria-Saucedo R, Cabral HJ, et al. Unnecessary antibiotics for acute respiratory tract infections: association with care setting and patient demographics. Open Forum Infect Dis 2016 Jan;3(1):ofw045 

Battle SE, Bookstaver PB, Justo JA, et al. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in gram-negative bloodstream infections: stratification by prognosis. J Antimicrob Chemother 2016 (published online Sep 28)

Batzing-Feigenbaum J, Schulz M, Schulz M, et al. Outpatient antibiotic prescription: a population-based study on regional age-related use of cephalosporins and fluoroquinolones in Germany. Dtsch Arztebl Int 2016 Jul 1;113(26):454-9

Baysari MT, Lehnbom EC, Li L, et al. The effectiveness of information technology to improve antimicrobial prescribing in hospitals: a systematic review and meta-analysis. Int J Med Inform 2016 Aug;92:15-34

Bradley SF. Principles of antimicrobial therapy in older adults. Clin Geriatr Med 2016 Aug;32(3):443-57

Broom A, Gibson AF, Broom J, et al. Optimizing antibiotic usage in hospitals: a qualitative study of the perspectives of hospital managers. J Hosp Infect 2016 (published online Aug 31)

Burnham JP, Burnham CAD, Warren DK, et al. Impact of time to appropriate therapy on mortality in patients with vancomycin intermediate Staphylococcus aureus infection. Antimicrob Agents Chemother 2016 (published online Jul 11)

Cai T, Mazzoli S, Lanzafame P, et al. Asymptomatic bacteriuria in clinical urological practice: preoperative control of bacteriuria and management of recurrent UTI. Pathogens 2016 (published online Jan 5)

Castel C, de La Blanchardiere A, Michon J, et al. Study on daptomycin use and implementation of an antimicrobial stewardship program. Int J Clin Pharm 2016 Apr;38(2):421-8

Chaintarli K, Ingle SM, Bhattacharya A, et al. Impact of a United Kingdom-wide campaign to tackle antimicrobial resistance on self-reported knowledge and behaviour change. BMC Public Health 2016 May 12;16(1):393

Chang J, Ye D, Lv B, et al. Sale of antibiotics without a prescription at community pharmacies in urban China: a multicentre cross-sectional survey. J Antimicrob Chemother 2017 (published online Jan 6)

Charmillon A, Novy E, Agrinier N, et al. The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for beta-lactam administration and therapeutic drug monitoring among critically ill patients in France. Clin Microbiol Infect 2016 (published online May 1)

Cordoba G, Caballero L, Sandholdt H, et al. Antibiotic prescriptions for suspected respiratory tract infection in primary care in South America. J Antimicrob Chemother 2016 (published online Sep 13)

Cotta MO, Chen C, Tacey M, et al. What are the similarities and differences in antimicrobial prescribing between Australian public and private hospitals? Intern Med J 2016 (published online Aug 12)

de Bie S, Kaguelidou F, Verhamme KMC, et al. Using prescription patterns in primary care to derive new quality indicators for childhood community antibiotic prescribing. Pediatr Infect Dis J 2016 Dec;35(12):1317-23

De Luca M, Dona D, Montagnani C, et al. Antibiotic prescriptions and prophylaxis in Italian children. Is it time to change? Data from the ARPEC project. PLoS One 2016 May 16;11(5):e0154662

Del Rosso JQ, Webster GF, Rosen T, et al. Status report from the scientific panel on antibiotic use in dermatology of the American Acne and Rosacea Society: part 1: antibiotic prescribing patterns, sources of antibiotic exposure, antibiotic consumption and emergence of antibiotic resistance, impact of alterations in antibiotic prescribing, and clinical sequelae of antibiotic use. J Clin Aesthet Dermatol 2016 Apr;9(4):18-24

Dyar OJ, Beovic B, Vlahovic-Palcevski V, et al. on behalf of ESGAP (the ESCMID [European Society of Clinical Microbiology and Infectious Diseases] Study Group for Antibiotic Policies). How can we improve antibiotic prescribing in primary care? Expert Rev Anti Infect Ther 2016 Apr;14(4):403-13

Eke-Usim AC, Rogers MA, Gibson KE, et al. Constitutional symptoms trigger diagnostic testing before antibiotic prescribing in high-risk nursing home residents. J Am Geriatr Soc 2016 (published online Sep 22)

El Sakka N, Gould IM. Role of old antimicrobial agents in the management of urinary tract infection. Expert Rev Clin Pharmacol 2016 Aug;9(8):1047-56

Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011. JAMA 2016 May 3;315(17):1864-73

Fleming-Dutra KE, Mangione-Smith R, Hicks LA. How to prescribe fewer unnecessary antibiotics: talking points that work with patients and their families. Am Fam Physician 2016 Aug 1;94(3):200-2

Frenk SM, Kit BK, Lukacs SL, et al. Trends in the use of prescription antibiotics: NHANES 1999-2012. J Antimicrob Chemother 2016 Jan;71(1):251-6

Fukunaga BT, Sumida WK, Taira DA, et al. Hospital-acquired methicillin-resistant Staphylococcus aureus bacteremia related to Medicare antibiotic prescriptions: a state-level analysis. Hawaii J Med Public Health 2016 Oct;75(10):303-9

Gamal Hashem N, Hidayat L, Berkowitz L, et al. Management of skin and soft-tissue infections at a community teaching hospital using a severity-of-illness tool. J Antimicrob Chemother 2016 (published online Aug 3)

Gauld NJ, Zeng IS, Ikram RB, et al. Antibiotic treatment of women with uncomplicated cystitis before and after allowing pharmacist-supply of trimethoprim. Int J Clin Pharm 2016 (published Dec 23)

Gharbi M, Doerholt K, Vergnano S, et al. Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK. BMJ Open 2016 Nov 3;6(11)

Ghazi IM, Nicolau DP, Nailor MD, et al. Antibiotic utilization and opportunities for stewardship among hospitalized patients with Influenza respiratory tract infection. Infect Control Hosp Epidemiol 2016 May;37(5):583-9 

Gillon J, Xu M, Slaughter J, et al. Vancomycin use: room for improvement among hospitalized children. J Pharm Pract 2016 (published online Apr 4)

Grenet J, Davido B, Bouchand F, et al. Evaluating antibiotic therapies prescribed to adult patients in the emergency department. Med Mal Infect 2016 Jun;46(4):207-14

Hahn AW, Jain R, Spach DH. New approaches to antibiotic use and review of recently approved antimicrobial agents. Med Clin North Am 2016 Jul;100(4):911-26

Harris AM, Hicks LA, Qaseem A. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American college of physicians and the centers for disease control and prevention. Ann Intern Med 2016 Mar 15;164(6):425-34

Hayward GN, Fisher RFR, Spence GT, et al. Increase in antibiotic prescriptions in out-of-hours primary care in contrast to in-hours primary care prescriptions: service evaluation in a population of 600 000 patients. J Antimicrob Chemother 2016;71(9):2612-9

Heid C, Knobloch MJ, Schulz LT, et al. Use of the health belief model to study patient perceptions of antimicrobial stewardship in the acute care setting. Infect Control Hosp Epidemiol 2016 May;37(5):576-82

Hersh AL, Fleming-Dutra KE, Shapiro DJ, et al. Frequency of first-line antibiotic selection among US ambulatory care visits for otitis media, sinusitis, and pharyngitis. JAMA Intern Med 2016 (published online Oct 24)

Hoberman A, Paradis JL, Rockette HE, et al. Shortened antimicrobial treatment for acute otitis media in young children. New Engl J Med 2016 (published online Dec 22)

Holt S, Thompson-Brazill KA, Sparks ER, et al. Treating central catheter-associated bacteremia due to methicillin-resistant Staphylococcus aureus: beyond vancomycin. Crit Care Nurse 2016 Aug;36(4):46-57

Hu Y, Walley J, Chou R, et al. Interventions to reduce childhood antibiotic prescribing for upper respiratory infections: systematic review and meta-analysis. J Epidemiol Community Health 2016 Jun 20. pii: jech-2015-206543

Jelic M, Adler AL, Miles-Jay A, et al. Use of antibiotics reserved for resistant gram-negative infections at freestanding U.S. children’s hospitals from 2004 to 2014. Infect Control Hosp Epidemiol 2016 Aug;37(8):967-70

Johansson EW, Selling KE, Nsona H, et al. Integrated paediatric fever management and antibiotic over-treatment in Malawi health facilities: data mining a national facility census. Malar J 2016 Aug 4;15(1):396

Johnson AP, Muller-Pedbody B, Budd E, et al. Improving feedback of surveillance data on antimicrobial consumption, resistance and stewardship in England: putting the data at your Fingertips. J Antimicrob Chemother 2016 (published online Dec 20)

Johnston SL, Szigeti M, Cross M, et al. Azithromycin for acute exacerbations of asthma: the AZALEA randomized clinical trial. JAMA Intern Med 2016 (published online Sep 19)

Jose J, Devassykutty D. Paediatric prescription analysis in a primary health care institution. J Clin Diagn Res 2016 Nov;10(11)

Kelesidis T, Braykov N, Uslan DZ, et al. Indications and types of antibiotic agents used in 6 acute care hospitals, 2009-2010: a pragmatic retrospective observational study. Infect Control Hosp Epidemiol 2016 Jan;37(1):70-9

Kobayashi M, Shapiro DJ, Hersh AL, et al. Outpatient antibiotic prescribing practices for uncomplicated urinary tract infection in women in the United States, 2002-2011. Open Forum Infect Dis 2016 Aug 2;3(3)

Kranz J, Helbig S, Mandraka F, et al. The revival of old antibiotics for treatment of uncomplicated urinary tract infections in the era of antibiotic stewardship. Curr Opin Urol 2016 (published online Nov 21)

Lewis A, Czeisler BM, Lord AS. Prolonged prophylactic antibiotics with neurosurgical drains and devices: Are we using them? Do we need them? Am J Infect Control 2016 (published online Oct 6)

Lindenauer PK, Stefan MS, Feemster LC, et al. Use of antibiotics among patients hospitalized for exacerbations of asthma. Jama Intern Med 2016 (published online Jul 25)

Malekpour M, Bridgham K, Neuhaus N, et al. Utility of prophylactic antibiotics in nonoperative facial fractures. J Craniofac Surg 2016 (published online Jul 8)

Maltezou HC, Adamis G, Tsonou P, et al. Consumption of antibiotics for community-acquired infections by adults in Greece: A cross-sectional study. Am J Infect Control 2016 (published online Jul 13)

Marc C, Vrignaud B, Levieux K, et al. Inappropriate prescription of antibiotics in pediatric practice: analysis of the prescriptions in primary care. J Child Health Care 2016 (published online Apr 18)

Marra F, George D, Chong M, et al. Antibiotic prescribing by dentists has increased: why? J Am Dent Assoc 2016 May;147(5):320-7

McDonald ML, Buckley J. Antimicrobial practice patterns for urethroplasty: opportunity for improved stewardship. Urology 2016 (published online Apr 29)

McKay R, Mah A, Law M, et al. Systematic review of factors associated with antibiotic prescribing for respiratory tract infections. Antimicrob Agents Chemother 2016 May;60(7):4106-18

Mehta N, Schilder A, Fragaszy E, et al. Antibiotic prescribing in patients with self-reported sore throat. J Antimicrob Chemother 2016 (published online Dec 20)

Micallef C, McLeod M, Castro-Sanchez E, et al. An evidence-based antimicrobial stewardship smartphone app for hospital outpatients: survey-based needs assessment among patients. JMIR Mhealth UHealth 2016 Jul 6;4(3):e83

Mohareb AM, Dugas AF, Hsieh YH. Changing epidemiology and management of infectious diseases in US EDs. Am J Emerg Med 2016 (published online Mar 11)

Morgan DJ, Dhruva SS, Wright SM, et al. 2016 update on medical overuse: a systematic review. JAMA Intern Med 2016 (published online Sep 19)

Mothes A, Leotard S, Nicolle I, et al. Community-acquired pneumonia and positive urinary antigen tests: Factors associated with targeted antibiotic therapy. Med Mal Infect 2016 (published online Jul 1)

Mueller T, Ostergren PO. The correlation between regulatory conditions and antibiotic consumption within the WHO European Region. Health Policy 2016 (published online Jul 12)

Ness V, Price L, Currie K, et al. Influences on independent nurse prescribers' antimicrobial prescribing behaviour: a systematic review. J Clin Nurse 2016 May;25(9-10):1206-17

Om C, Daily F, Vlieghe E, et al. “If it’s a broad spectrum, it can shoot better”: inappropriate antibiotic prescribing in Cambodia. Antimicrob Resist Infect Control 2016 (published online Dec 20)

Oza A, Donohue F, Johnson H, et al. Risk-adjusted antibiotic consumption in 34 public acute hospitals in Ireland, 2006 to 2014. Euro Surveill 2016 Aug 11;21(32)

Padget M, Guillemot D, Delarocque-Astagneau E. Measuring antibiotic consumption in low-income countries: a systematic review and integrative approach. Antimicrob Agents Chemother 2016 Jul;48(1):27-32

Padget M, Tamarelle J, Herindrainy P, et al. A community survey of antibiotic consumption among children in Madagascar and Senegal: the importance of healthcare access and care quality. J Antimicrob Chemother 2016 (published online Nov 8)

Parker HM, Mattick K. The determinants of antimicrobial prescribing among hospital doctors in England: a framework to inform tailored stewardship interventions. Br J Clin Pharmacol 2016 (published online Apr 1)

Pulcini C, Mohrs S, Beovic B, et al. Forgotten antibiotics: a follow-up inventory study in Europe, the USA, Canada and Australia. Int J Antimicrob Agents 2016 (published online Nov 16)

Qaseem A. Appropriate use of therapeutic interventions to foster high-value care. Ann Intern Med 2016 (published online Dec 6)

Ren N, Zhou P, Wen X, et al. Point prevalence survey of antimicrobial use in Chinese hospitals in 2012. Am J Infect Control 2016 Mar 1;44(3):332-9

Riedle BN, Polgreen LA, Cavanaugh JE, et al. Phantom prescribing: examining the frequency of antimicrobial prescriptions without a patient visit. Infect Control Hosp Epidemiol 2016 (published online Dec 13)

Roberts RM, Hicks LA, Bartoces M. Variation in US outpatient antibiotic prescribing quality measures according to health plan and geography. Am J Manag Care 2016 Aug;22(8):519-23

Roche M, Bornet C, Monges P, et al. Misuse of antibiotics reserved for hospital settings in outpatients: a prospective clinical audit in a university hospital in Southern France. Int J Antimicrob Agents 2016 (published online Apr 25)

Ryves R, Eyles C, Moore M, et al. Understanding the delayed prescribing of antibiotics for respiratory tract infection in primary care: a qualitative analysis. BMJ Open 2016 (published online Nov 18)

Sader HS, Castanheira M, Flamm RK, et al. Antimicrobial activities of ceftazidime-avibactam and comparator agents against gram-negative organisms isolated from patients with urinary tract infections in U.S. medical centers, 2012 to 2014. Antimicrob Agents Chemother 2016 Jul;60(7):4355-60

Sakabe D, de Sa Del Fiol F. Profile of infections and antimicrobial treatment among burn-injury patients. Am J Infect Control 2016 (published online Jun 17)

Sanchez GV, Hersh AL, Shapiro DJ, et al. Outpatient antibiotic prescribing among United States nurse practitioners and physician assistants. Open Forum Infect Dis 2016 Aug 10;3(3)

Santa-Ana-Tellez Y, Mantel-Teeuwisse AK, Leufkens HG, et al. Effects of over-the-counter sales restriction of antibiotics on substitution with medicines for symptoms relief of cold in Mexico and Brazil: time series analysis. Health Policy Plan 2016 (published online May 26)

Scarpato SJ, Timko DR, Cluzet VC, et al. An evaluation of antibiotic prescribing practices upon hospital discharge. Infect Control Hosp Epidemiol 2016 (published online Nov 28)

Schroder W, Sommer H, Gladstone BP, et al. Gender differences in antibiotic prescribing in the community: a systematic review and meta-analysis. J Antimicrob Chemother 2016 (published online Apr 3)

Schulz L, Hoffman RJ, Pothof J, et al. Top ten myths regarding the diagnosis and treatment of urinary tract infections. J Emerg Med 2016 Jul;51(1):25-30

Shallcross LJ, Freemantle N, Nisar S, et al. A cross-sectional study of blood cultures and antibiotic use in patients admitted from the emergency department: missed opportunities for antimicrobial stewardship. BMC Infect Dis 2016 Apr 18;16(1):166

Sharma S, Bowman C, Alladin-Karan B, et al. Antibiotic prescribing patterns in the pediatric emergency department at Georgetown Public Hospital Corporation: a retrospective chart review. BMC Infect Dis 2016 Apr 19;16(1):170

Spivak ES, Cosgrove SE, Srinivasan A. Measuring appropriate antimicrobial use: attempts at opening the black box. Clin Infect Dis 2016 (published online Sep 28)

Stenehjem E, Hersh AL, Sheng X, et al. Antibiotic use in small community hospitals. Clin Infect Dis 2016 (published online Sep 30)

Suda KJ, Robers RM, Hunkler RJ, et al. Antibiotic prescriptions in the community by type of provider in the United States, 2005-2010. J Am Pharm Assoc 2016 (published online Oct 8)

Tan C, Vermeulen M, Wang X, et al. Variability in antibiotic use across Ontario acute care hospitals. J Antimicrob Chemother 2016 (published online Nov 17)

Teixeira Rodrigues A, Ferreira M, Pineiro-Lamas M, et al. Determinants of physician antibiotic prescribing behavior: a 3 year cohort study in Portugal. Curr Med Res Opin 2016 May;32(5):949-57

Teixeira Rodrigues A, Ferreira M, Roque F, et al. Physicians' attitudes and knowledge concerning antibiotic prescription and resistance: questionnaire development and reliability. BMC Infect Dis 2016 Jan 8;16:7

Thompson ND, LaPlace L, Epstein L, et al. Prevalence of antimicrobial use and opportunities to improve prescribing practices in U.S. nursing homes. J Am Med Dir 2016 (published online Oct 14)

Thompson A, O’Sullivan P, Banham E, et al. Assessing the uptake and effectiveness of a quick reference guide to antibiotic prescribing in Australian general practice. Aust J Prim Health 2016 (published online Jul 8)

Turnidge JD, Thursky K, Chen CS, et al. Antimicrobial use in Australian hospitals: how much and how appropriate? Med J Aust 2016 Nov 21;205(10):S16-20

Tyrstrup M, Beckman A, Molstad S, et al. Reduction in antibiotic prescribing for respiratory tract infections in Swedish primary care—a retrospective study of electronic patient records. BMC Infect Dis 2016 (published online Nov 25)

Uno S, Hase R, Kobayashi M, et al. Short-course antimicrobial treatment for acute cholangitis with gram-negative bacillary bacteremia. Int J Infect Dis 2016 (published online Dec 24)

van den Bosch CMA, Hulscher MEJL, Akkermans RP, et al. Appropriate antibiotic use reduces length of hospital stay. J Antimicrob Chemother 2016 (published online Dec 20)

Van Duin D, Bonoma RA. Ceftazidime/avibactam and ceftolozane/tazobactam: second-generation β-lactam/β-lactamase inhibitor combinations. Clin Infect Dis 2016 Jul 15;63(2):234-41

Versporten A, Bielicki J, Drapier N, et al.; ARPEC project group. The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. J Antimicrob Chemother 2016 Apr;71(4):1106-17

Voigt J, Mosier M, Darouiche R. Antibiotics and antiseptics for preventing infection in people receiving revision total hip and knee prostheses: a systematic review of randomized controlled trials. BMC Infect Dis 2016 (published online Dec 12)

Wang YY, Du P, Huang F, et al. Antimicrobial prescribing patterns in a large tertiary hospital in Shanghai, China. Int J Antimicrob Agents 2016 (published online Oct 14)

Watson JR, Sanchez PJ, Spencer JD, et al. Urinary tract infection and antimicrobial stewardship in the emergency department. Pediatr Emerg Care 2016 (published online Feb 6)

Yoon D, Koo HL, Choe PG, et al. The purpose and appropriateness of carbapenem use in a single university hospital, 2009-2013. Expert Rev Clin Pharmacol 2016 Jun;9(6):863-5 

Zhao M, Liang L, Ji, L, et al. Similar efficacy and safety of daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bloodstream infections: a meta-analysis. Antimicrob Agents Chemother 2016 (published online Jul 19)

Zhou WJ, Luo ZN, Tang CM, et al. Is there an improvement of antibiotic use in China? Evidence from the usage analysis of combination antibiotic therapy for type I incisions in 244 hospitals. J Huazhong Univ Sci Technolog Med Sci 2016 Oct;36(5):772-9

Zoorob R, Grigoryan L, Nash S, et al. Non-prescription antimicrobial use in a primary care population in the United States: evidence for action. Antimicrob Agents Chemother 2016 (published online Jul 11)

Zusman O, Altunin S, Koppel F, et al. Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis. J Antimicrob Chemother 2016 (published online Sep 13)

Zycinska K, Chmielewska M, Lenartowicz B, et al. Antibiotic treatment of hospitalized patients with pneumonia complicated by Clostridium difficile infection. Adv Exp Med Biol 2016 (published online Sep 13)

Back to top

2015

Akhloufi H, Streefkerk RH, Melles DC, et al. Point prevalence of appropriate antimicrobial therapy in a Dutch university hospital. Eur J Clin Microbiol Infect Dis 2015 Aug;34(8):1631-7

Alfandari S, Robert J, Pean Y, et al. Antibiotic use and good practice in 314 French hospitals: the 2010 SPA2 prevalence study. Med Mal Infect 2015 Nov-Dec;45(11-12):475-80

Alsan M, Morden NE, Gottlieb JD, et al. Antibiotic use in cold and flu season and prescribing quality: a retrospective cohort study. Med Care 2015 Dec;53(12):1066-71

Barlam TF, Morgan JR, Wetzler LM, et al. Antibiotics for respiratory tract infections: a comparison of prescribing in an outpatient setting. Infect Control Hosp Epidemiol 2015 Feb;36(2):153-9

Batard E, Lecadet N, Goffinet N, et al. High variability among emergency departments in 3rd-generation cephalosporins and fluoroquinolones use for community-acquired pneumonia. Infection 2015 Dec;43(6):681-9

Batard E, Vibet MA, Lemarchand C, et al. Use of broad-spectrum antibiotics in French EDs: different trends for third-generation cephalosporins and fluoroquinolones. Eur J Emerg Med 2015 Sep 29

Cooke J, Stephens P, Ashiru-Oredope D,et al. Longitudinal trends and cross-sectional analysis of English national hospital antibacterial use over 5 years (2008-13): working towards hospital prescribing quality measures. J Antimicrob Chemother 2015 Jan;70(1):279-85

Coon ER, Maloney CG, Shen MW. Antibiotic and diagnostic discordance between ED physicians and hospitalists for pediatric respiratory illness. Hosp Pediatr 2015 Mar;5(3):111-8

Courtenay M, Carter S, Rowbotham S, et al. Antibiotic prescribing in primary care: the need for interprofessional collaboration. J Interprof Care 2015;29(4):404-5

Coxeter P, Del Mar CB, McGregor L, et al. Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care. Cochrane Database Syst Rev 2015 Nov 12;(11):CD010907. doi(11):CD010907

Dallas A, Magin P, Morgan S, et al. Antibiotic prescribing for respiratory infections: a cross-sectional analysis of the ReCEnT study exploring the habits of early-career doctors in primary care. Fam Pract 2015 Feb;32(1):49-55

Dalton BR, MacTavish SJ, Bresee LC,et al. Antimicrobial use over a four-year period using days of therapy measurement at a Canadian pediatric acute care hospital. Can J Infect Dis Med Microbiol 2015 Sep-Oct;26(5):253-8

Demirjian A, Sanchez GV, Finkelstein JA, et al. Getting smart about antibiotics. (CDC Grand Rounds) MMWR 2015 Aug 21;64(32):871-3

Filice GA, Drekonja DM, Thurn JR, et al. Diagnostic errors that lead to inappropriate antimicrobial use. Infect Control Hosp Epidemiol 2015 Aug;36(8):949-56

Francois Watkins LK, Sanchez GV, Albert AP, et al. Knowledge and attitudes regarding antibiotic use among adult consumers, adult Hispanic consumers, and health care providers — United States, 2012-2013. MMWR 2015 Jul 24;64(28):767-70

Gerber JS, Prasad PA, Russell Localio A, et al. Variation in antibiotic prescribing across a pediatric primary care network. J Pediatric Infect Dis Soc 2015 Dec;4(4):297-304

Gonzalez-Gonzalez C, Lopez-Vazquez P, Vazquez-Lago JM, et al. Effect of physicians' attitudes and knowledge on the quality of antibiotic prescription: a cohort study. PLoS One 2015 Oct 28;10(10):e0141820

Gualano MR, Gili R, Scaioli G, et al. General population's knowledge and attitudes about antibiotics: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf 2015 Jan;24(1):2-10

Guo W, He Q, Wang Z, et al. Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China. Am J Infect Control 2015 Apr 1;43(4):358-64

Hamilton KW, Gerber JS, Moehring R, et al. Point-of-prescription interventions to improve antimicrobial stewardship. Clin Infect Dis 2015 Apr 15;60(8):1252-8

Hamouda K, Oezkur M, Sinha B, et al. Different duration strategies of perioperative antibiotic prophylaxis in adult patients undergoing cardiac surgery: an observational study. J Cardiothorac Surg 2015 Feb 26;10:25,015-0225-x

Hartley S, Valley S, Kuhn L, et al. Overtreatment of asymptomatic bacteriuria: identifying targets for improvement. Infect Control Hosp Epidemiol 2015 Apr;36(4):470-3

Hassali MA, Kamil TK, Md Yusof FA, et al. General practitioners' knowledge, attitude and prescribing of antibiotics for upper respiratory tract infections in Selangor, Malaysia: findings and implications. Expert Rev Anti Infect Ther 2015 Apr;13(4):511-20

Havey TC, Hull MW, Romney MG, et al. Retrospective cohort study of inappropriate piperacillin-tazobactam use for lower respiratory tract and skin and soft tissue infections: opportunities for antimicrobial stewardship. Am J Infect Control 2015 (published online Jul 6)

Hellman J, Grape M, Ternhag A. Antibiotic consumption among a Swedish cohort of children born in 2006. Acta Paediatr 2015 Oct;104(10):1035-8

Hersh AL, Gerber JS, Hicks LA, et al. Lessons learned in antibiotic stewardship: fluoroquinolone use in pediatrics. J Pediatric Infect Dis Soc 2015 Mar;4(1):57-9

Hicks LA, Bartoces MG, Roberts RM, et al. US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. Clin Infect Dis 2015 May 1;60(9):1308-16

James R, Upjohn L, Cotta M, et al. Measuring antimicrobial prescribing quality in Australian hospitals: development and evaluation of a national antimicrobial prescribing survey tool. J Antimicrob Chemother 2015;70(6):1912-8

Janowski AB, Michaels MG, Martin JM, et al. Piperacillin-tazobactam usage at a tertiary pediatric hospital: an antimicrobial stewardship review. J Pediatric Infect Dis Soc 2015 Jul 13

Jones BE, Sauer B, Jones MM, et al. Variation in outpatient antibiotic prescribing for acute respiratory infections in the veteran population: a cross-sectional study. Ann Intern Med 2015 Jul 21;163(2):73-80

Klein EY, Makowsky M, Orlando M, et al. Influence of provider and urgent care density across different socioeconomic strata on outpatient antibiotic prescribing in the USA. J Antimicrob Chemother 2015 May;70(5):1580-7

Kourlaba G, Kourkouni E, Spyridis N, et al. Antibiotic prescribing and expenditures in outpatient paediatrics in Greece, 2010-13. J Antimicrob Chemother 2015 Aug;70(8):2405-8

Kronman MP, Hersh AL, Gerber JS, et al. Identifying antimicrobial stewardship targets for pediatric surgical patients. J Pediatric Infect Dis Soc 2015 Dec;4(4):e100-8

Larru B, Sulieman SE, Localio R, et al. Frontline clinician knowledge of antimicrobial prescribing in an academic tertiary children's hospital: a point prevalence study. J Pediatric Infect Dis Soc 2015 (published online May 11)

Le Doare K, Barker CI, Irwin A, et al. Improving antibiotic prescribing for children in the resource-poor setting. Br J Clin Pharmacol 2015 Mar;79(3):446-55

Lee C, Walker SA, Daneman N, et al. Point prevalence survey of antimicrobial utilization in a Canadian tertiary-care teaching hospital. J Epidemiol Glob Health 2015 Jun;5(2):143-50

Lee MJ, Kim M, Kim NH, et al. Why is asymptomatic bacteriuria overtreated? A tertiary care institutional survey of resident physicians. BMC Infect Dis 2015 Jul 26;15:289,015-1044-3

Lefebure A, Papy E, Rioux C, et al. Audit of carbapenem prescriptions comparing 2 assessment periods. Med Mal Infect 2015 Jul;45(7):273-8

Lucas PJ, Cabral C, Hay AD, et al. A systematic review of parent and clinician views and perceptions that influence prescribing decisions in relation to acute childhood infections in primary care. Scand J Prim Health Care 2015 Mar;33(1):11-20

Malo S, Bjerrum L, Feja C, et al. Compliance with recommendations on outpatient antibiotic prescribing for respiratory tract infections: the case of Spain. Basic Clin Pharmacol Toxicol 2015 Apr;116(4):337-42

Mangione-Smith R, Zhou C, Robinson JD, et al. Communication practices and antibiotic use for acute respiratory tract infections in children. Ann Fam Med 2015 May-Jun;13(3):221-7

Md Rezal RS, Hassali MA, Alrasheedy AA, et al. Physicians' knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature. Expert Rev Anti Infect Ther 2015 May;13(5):665-80

Mueller K, McCammon C, Skrupky L, et al. Vancomycin use in patients discharged from the emergency department: a retrospective observational cohort study. J Emerg Med 2015 Jul;49(1):50-7

Ness V, Malcolm W, McGivern G, et al. Growth in nurse prescribing of antibiotics: the Scottish experience 2007-13. J Antimicrob Chemother 2015 Dec;70(12):3384-9

Osowicki J, Gwee A, Noronha J, et al. Australia-wide point prevalence survey of antimicrobial prescribing in neonatal units: how much and how good? Pediatr Infect Dis J 2015 Aug;34(8):e185-90

Pulcini C, Wencker F, Frimodt-Moller N, et al. European survey on principles of prudent antibiotic prescribing teaching in undergraduate students. Clin Microbiol Infect 2015 Apr;21(4):354-61

Raman G, Avendano E, Berger S, et al. Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis. BMC Infect Dis 2015 Sep 30;15:395

Reddy SC, Jacob JT, Varkey JB, et al. Antibiotic use in US hospitals: quantification, quality measures and stewardship. Expert Rev Anti Infect Ther. 2015 Jul;13(7):843-54

Roque F, Soares S, Breitenfeld L, et al. Influence of community pharmacists attitudes on antibiotic dispensing behavior: a cross-sectional study in Portugal. Clin Ther 2015 Jan 1;37(1):168-77

Ross RK, Hersh AL, Kronman MP, et al. Cost of antimicrobial therapy across US children's hospitals. Infect Control Hosp Epidemiol 2015 Oct;36(10):1242-4

Saleh EA, Schroeder DR, Hanson AC, et al. Guideline-concordant antibiotic prescribing for pediatric outpatients with otitis media, community-acquired pneumonia, and skin and soft tissue infections in a large multispecialty healthcare system. Clin Res Infect Dis 2015 Jan 10;2(1):1010

Sanchez GV, Fleming-Dutra KE, Hicks LA. Minimizing antibiotic misuse through evidence-based management of outpatient acute respiratory infections. Antimicrob Agents Chemother 2015 Oct;59(10):6673

Shawyer AC, Hatchell AC, Pemberton J, et al. Compliance with published recommendations for postoperative antibiotic management of children with appendicitis: a chart audit. J Pediatr Surg 2015 May;50(5):783-5

Skodvin B, Aase K, Charani E, et al. An antimicrobial stewardship program initiative: a qualitative study on prescribing practices among hospital doctors. Antimicrob Resist Infect Control 2015 Jun 4;4:24

Taylor G, Gravel D, Saxinger L, et al. Prevalence of antimicrobial use in a network of Canadian hospitals in 2002 and 2009. Can J Infect Dis Med Microbiol 2015 Mar-Apr;26(2):85-9

Vanbeek J, Hoffman WW, Huntington MK. Comparison of content and format for upper respiratory illness antibiotic prescribing guideline developed by two Midwestern organizations. S D Med 2015 Jul;68(7):304-7

van Spreuwel PC, Blok H, Langelaar MF, et al. Identifying targets for quality improvement in hospital antibiotic prescribing. Neth J Med 2015 May;73(4):161-8

Vellinga A, Galvin S, Duane S, et al. Intervention to improve the quality of antimicrobial prescribing for urinary tract infection: a cluster randomized trial. CMAJ 2015 (published online Nov 16)

Vora NM, Kubin CJ, Furuya EY. Appropriateness of gram-negative agent use at a tertiary care hospital in the setting of significant antimicrobial resistance. Open Forum Infect Dis 2015 Feb 19;2(1):ofv009

Williams DJ, Edwards KM, Self WH, et al. Antibiotic choice for children hospitalized with pneumonia and adherence to national guidelines. Pediatrics 2015 Jul;136(1):44-52

Yogo N, Haas MK, Knepper BC, et al. Antibiotic prescribing at the transition from hospitalization to discharge: a target for antibiotic stewardship. Infect Control Hosp Epidemiol 2015 Apr;36(4):474-8

Back to top

2014

Adler N, Weber H, Gunadasa I, et al. Adherence to therapeutic guidelines for patients with community-acquired pneumonia in Australian hospitals. Clin Med Insights Circ Respir Pulm Med 2014 Sep 14;8:17-20

Charani E, Castro Sanchez E, Holmes A. The role of behavior change in antimicrobial stewardship. Infect Dis Clin North Am 2014 Jun;28(2):169-75

Chaves NJ, Cheng AC, Runnegar N, et al. Analysis of knowledge and attitude surveys to identify barriers and enablers of appropriate antimicrobial prescribing in three Australian tertiary hospitals. Intern Med J 2014 Jun;44(6):568-74

Cooke J, Stephens P, Ashiru-Oredope D. Antibacterial usage in English NHS hospitals as part of a national antimicrobial stewardship programme. Public Health 2014 Aug;128(8):693-7

Covvey JR, Johnson BF, Elliott V, et al. An association between socioeconomic deprivation and primary care antibiotic prescribing in Scotland. J Antimicrob Chemother 2014 Mar;69(3):835-41

Dooling KL, Kandeel A, Hicks LA, et al. Understanding antibiotic use in Minya District, Egypt: physician and pharmacist prescribing and the factors influencing their practices. Antibiotics (Basel) 2014 Jun 20;3(2):233-43

Dooling KL, Shapiro DJ, Van Beneden C, et al. Overprescribing and inappropriate antibiotic selection for children with pharyngitis in the United States, 1997-2010. JAMA Pedatr 2014 Nov;168(11):1073-4

Dreno B, Thiboutot D, Gollnick H, et al. Antibiotic stewardship in dermatology: limiting antibiotic use in acne. Eur J Dermatol 2014 May-Jun;24(3):330-4

Dull RB, Friedman SK, Risoldi ZM, et al. Antimicrobial treatment of asymptomatic bacteriuria in noncatheterized adults: a systematic review. Pharmacotherapy 2014 Sep;34(9):941-60

Dyar OJ, Pulcini C, Howard P, et al. European medical students: a first multicentre study of knowledge, attitudes and perceptions of antibiotic prescribing and antibiotic resistance. J Antimicrob Chemother 2014 Mar;69(3):842-6

Fleming A, Bradly, C, Cullinan S, et al. Antibiotic prescribing in long-term care facilities: a qualitative, multidisciplinary investigation. BMJ Open 2014 Nov 5;4(11):e006442

Fleming-Dutra KE, Shapiro DJ, Hicks LA, et al. Race, otitis media, and antibiotic selection. Pediatrics 2014 Dec;134(6):1059-66

Fridkin S, Baggs J, Fagan R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR 2014 Mar 7;63(9):194-200

Glass Kaastra SK, Finley R, Hutchinson J, et al. Longitudinal surveillance of outpatient quinolone antimicrobial use in Canada. Can J Infect Dis Med Microbiol 2014 Mar;25(2):99-102

Glass Kaastra SK, Finley R, Hutchinson J, et al. Provincial and temporal variation in macrolide and lincosamide antimicrobial use by outpatients in Canada, 1995 to 2010. Can J Infect Dis Med Microbiol 2014 Mar;25(2):103-6

Glass Kaastra SK, Finley R, Hutchinson J, et al. Variation in outpatient oral antimicrobial use patterns among Canadian provinces, 2000 to 2010. Can J Infect Dis Med Microbiol 2014 Mar;25(2):95-8

Goff DA, Bauer KA, Mangino, JE. Bad bugs need old drugs: a stewardship program's evaluation of minocycline for multidrug-resistant Acinetobacter baumannii infections. Clin Infect Dis 2014 Dec 1;59(Suppl 6):S381-7

Goffinet N, Lecadet N, Cousin M, et al. Increasing use of third-generation cephalosporins for pneumonia in the emergency department: may some prescriptions be avoided? Eur J Clin Microbiol Infect Dis 2014 Jul;33(7):1095-9

Henard S, Boussat S, Demore B, et al. Comparison of hospital databases on antibiotic consumption in France, for a single management tool. Med Mal Infect 2014 Jul;44(7):308-14

Here HW. Should antibiotics be given prior to outpatient cystoscopy? A plea to urologists to practice antibiotic stewardship. Eur Urol 2014 Apr;65(4):839-42

Hopkins CJ. Inpatient antibiotic consumption in a regional secondary hospital in New Zealand. Intern Med J 2014 Feb;44(2):185-90

Johnson TM, Hawkes J. Awareness of antibiotic prescribing and resistance in primary dental care. Prim Dent J 2014 Nov;3(4):44-7

Justo JA, Gauthier TP, Scheetz MH, et al. Knowledge and attitudes of doctor of pharmacy students regarding the appropriate use of antimicrobials. Clin Infect Dis 2014 Oct 15;59(Suppl 3):S162-9

Kandeel A, El Shoubary W, Hicks LA, et al. Patient attitudes and beliefs and provider practices regarding antibiotic use for acute respiratory tract infections in Minya, Egypt. Antibiotics (Basel) 2014 Nov 14;3(4):632-44

Kronman MP, Zhou C, Mangione Smith R. Bacterial prevalence and antimicrobial prescribing trends for acute respiratory tract infections. Pediatrics 2014 Oct;134(4):e956-65

Laxminarayan R, Van Boeckel TP. The value of tracking antibiotic consumption. Lancet Infect Dis 2014 May;14(5):360-1

Leyenaar JK, Lagu T, Shieh MS, et al. Variation in resource utilization for the management of uncomplicated community-acquired pneumonia across community and children's hospitals. J Pediatr 2014 Sep;165(3):585-91

May L, Gudger G, Armstrong P, et al. Multisite exploration of clinical decision making for antibiotic use by emergency medicine providers using quantitative and qualitative methods. Infect Control Hosp Epidemiol 2014 Sep;35(9):1114-25

McLaughlin MM, Pentoney Z, Skoglund E, et al. Projections for antiinfective drug shortages and time to actual resolution. Am J Health Syst Pharm 2014 Dec 1;71(23):2074-8

Pallin DJ, Camargo CA Jr, Schuur JD. Skin infections and antibiotic stewardship: analysis of emergency department prescribing practices, 2007-2010. West J Emerg Med 2014 May;15(3):282-9

Pogue JM, Neelakanta A, Mynatt RP, et al. Carbapenem-resistance in gram-negative bacilli and intravenous minocycline: an antimicrobial stewardship approach at the Detroit Medical Center. Clin Infect Dis 2014 Dec 1;59(Suppl 6):S388-93

Pulcini C, Botelho-Nevers E, Dyar OJ, et al. The impact of infectious disease specialists on antibiotic prescribing in hospitals. Clin Microbiol Infect 2014 Oct;20(10):963-72

Raman G, Avendano E, Berger S, et al. Initial inappropriate antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis. Value Health 2014 Nov;17(7):A667

Sanchez GV, Hicks LA. Acute sinusitis and pharyngitis as inappropriate indications for antibiotic use. Antimicrob Agents Chemother 2014 Jun;58(6):3572

Sanchez GV, Roberts RM, Albert AP, et al. Effects of knowledge, attitudes, and practices of primary care providers on antibiotic selection, United States. Emerg Infect Dis 2014 Dec;20(12):2041-7

Schultz L, Lowe TJ, Srinivasan A, et al. Economic impact of redundant antimicrobial therapy in US hospitals. Infect Control Hosp Epidemiol 2014 Oct;35(10):1229-35

Shapiro DJ, Hicks LA, Pavia AT, et al. Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. J Antimicrob Chemother 2014 Jan;69(1):234-40

Short E, Esterly J, Postelnick M, et al. Disposition of linezolid or daptomycin in Enterococcal bloodstream infections according to vancomycin resistant Enterococcus colonization. Antimicrob Resist Infect Control 2014 Dec 1;3(1):37

Siddiqui NU, Qamar FN, Jurair H, et al. Multi-drug resistant gram negative infections and use of intravenous polymyxin B in critically ill children of developing country: retrospective cohort study. BMC Infect Dis 2014 Nov 28;14:626

Suda KJ, Hicks LA, Roberts RM, et al. Trends and seasonal variation in outpatient antibiotic prescription rates in the United States, 2006 to 2010. Antimicrob Agents Chemother 2014 May;58(5):2763-6

Talaat M, Saied T, Kandeel A, et al. A point prevalence zurvey of antibiotic use in 18 hospitals in Egypt. Antibiotics (Basel) 2014 Sep 10;3(3):450-60

Valerio M, Rodriguez Gonzalez CG, Munoz P, et al. Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed. J Antimicrob Chemother 2014 Jul;69(7):1993-9

Van Boeckel TP, Gandra S, Ashok A, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 2014 Aug;14(8):742-50

Wortham JM, Shapiro DJ, Hersh AL, et al. Burden of ambulatory visits and antibiotic prescribing patterns for adults with community-acquired pneumonia in the United States, 1998 through 2009. JAMA Intern Med 2014 Sep;174(9):1520-2

Wright AJ, Marra F, Chong M, et al. Increased moxifloxacin utilization associated with an unrestricted addition to a drug reimbursement formulary: a population-based analysis. Can J Infect Dis Med Microbiol 2014 Spring;25(1):27-31

Back to top

2013

Akar A, et al. Appropriateness and safety of outpatient parenteral antimicrobial therapy in children: opportunities for pediatric antimicrobial stewardship. Clin Pediatr (Phila) 2013 Nov 6. [Epub ahead of print]

Al-Tawfiq JA, et al. The pattern and impact of infectious diseases consultation on antimicrobial prescription. J Glob Infect Dis 2013 Apr;5(2):45-8

Ambroggio L, et al. Quality improvement methods increase appropriate antibiotic prescribing for childhood pneumonia. Pediatrics 2013 May;131(5):e1623-31

Barr DA, et al. Outpatient parenteral antimicrobial therapy (OPAT) and the general physician. Clin Med 2013 Oct;13(5):495-9

Bartlett JG. How important are anaerobic bacteria in aspiration pneumonia: when should they be treated and what is optimal therapy. Infect Dis Clin North Am 2013 Mar;27(1):149-55

Cairns KA, et al. Prescribing trends before and after implementation of an antimicrobial stewardship program. Med J Aust 2013;198:262-6

Calbo E, et al. A review of the factors influencing antimicrobial prescribing. Enferm Infecc Microbiol Clin 2013 Sep;31(Suppl 4):12-5

Casapao AM, et al. Multicenter study of high-dose daptomycin for treatment of enterococcal infections. Antimicrob Agents Chemother 2013 Sep; 57(9):4190-6

Charani E, et al. Understanding the determinants of antimicrobial prescribing within hospitals: the role of "prescribing etiquette." Clin Infect Dis 2013 Jul;57(2):188-96

Dyar OJ, et al. Knowledge, attitudes, and beliefs of French medical students about antibiotic prescribing and resistance. Med Mal Infect 2013 Oct;43(10):423-30

Evans CT, et al. Antibiotic prescribing trends in the emergency department for veterans with spinal cord injury and disorder 2002-2007. J Spinal Cord Med 2013 Sep;36(5):492-8

Gerber JS, et al. Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial. JAMA 2013 Jun 12;309(22):2345-52

Graber CJ, et al. Unnecessary antimicrobial use in the context of Clostridium difficile infection: a call to arms for the Veterans Affairs Antimicrobial Stewardship Task Force. Infect Control Hosp Epidemiol 2013 Jun;34(6):651-3

Hurley HJ, et al. Avoidable antibiotic exposure for uncomplicated skin and soft tissue infections in the ambulatory care setting. Am J Med 2013 Dec;126(12):1099-106

Lai A, et al. Outpatient parenteral antimicrobial therapy at large veterans administration medical center. Am J Manag Care 2013 Sep;19(9):e317-24

Li S, et al. Are physicians’ prescribing decisions sensitive to drug prices? Evidence from a free-antibiotics program. Health Econ 2015 Feb;24(2):158-74

Lopez-Medrano F, et al. How to assist clinicians in improving antimicrobial prescribing: tools and interventions provided by stewardship programs. Enferm Infecc Microbiol Clin 2013 Sep;31(Suppl 4):38-44

Madigan T, et al. Characteristics and outcomes of outpatient parenteral antimicrobial therapy at an academic children's hospital. Pediatr Infect Dis J 2013 Apr;32(4):346-9

Peron EP, et al. Another setting for stewardship: high rate of unnecessary antimicrobial use in a veterans affairs long-term care facility. J Am Geriatr Soc 2013 Feb;61(2):289-90

Pulcini C, et al. Drug-specific quality indicators assessing outpatient antibiotic use among French general practitioners. Eur J Public Health 2013 Apr;23(2):262-4

Retamar P, et al. Evaluating the quality of antimicrobial prescribing: is standardisation possible? Enferm Infecc Microbiol Clin 2013 Sep;31(Suppl 4):25-30

Rimawi RH, et al. Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome. Crit Care Med 2013 Sep;41(9):2099-107

Schweizer ML, et al. Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections. Antimicrob Resist Infect Control 2013 Oct 15;2(1):28

Wertheim H, et al. Global survey of polymyxin use: a call for international guidelines. J Glob Antimicrob Resist 2013 Sep;1(3):131-134

Back to top

2012

Ashiru-Oredope D, et al. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus. J Antimicrob Chemother 2012;67(Suppl 1):i51-63

Barr DA, et al. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years. Int J Antimicrob Agents 2012 May;39(5):407-13

Cano EL, et al. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Clin Ther 2012;34:149-57

Fairlie T, et al. National trends in visit rates and antibiotic prescribing for adults with acute sinusitis. Arch Intern Med 2012 Oct 22;172(19):1513-4

Huttner B, et al. Double trouble: how big a problem is redundant anaerobic antibiotic coverage in Veterans Affairs medical centres? J Antimicrob Chemother 2012;67:1537-9

Roberts RM, et al. Appropriate antibiotic use: family physicians have the power of the pen. Am Fam Physician 2012 Nov 1;86(9):810

Suda KJ, et al. A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009. J Antimicrob Chemother 2013 Mar;68(3):715-8

Back to top

2011

Aldeyab MA, et al. A point prevalence survey of antibiotic prescriptions: benchmarking and patterns of use. Br J Clin Pharmacol 2011;71:293-6

Etienne P, et al. Antimicrobial stewardship program and quality of antibiotic prescriptions. Med Mal Infect 2011;41:608-12

Hicks LA, et al. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. Clin Infect Dis 2011 Oct;53(7):631-9

Kiyatkin DE, et al. Improving utilization of antimicrobial drugs among physician assistants in the ED. JAAPA 2011;24:44, 47-8, 50-1

Leekha S, et al. General principles of antimicrobial therapy. Mayo Clin Proc 2011;86:156-67

Montravers P,et al. Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units. Crit Care 2011;15:R17

Ozgenc O, et al. Evaluation of the therapeutic use of antibiotics in Aegean Region hospitals of Turkey: a multicentric study. Indian J Med Microbiol 2011;29:124-9

Parienti JJ, et al. Hospital-wide modification of fluoroquinolone policy and methicillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis. J Hosp Infect 2011;78:118- 22

Polk RE, et al. Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals. Clin Infect Dis 2011;53:1100-10

Schwartz DN, et al. Deriving measures of intensive care unit antimicrobial use from computerized pharmacy data: methods, validation, and overcoming barriers. Infect Control Hosp Epidemiol 2011 May;32(5):472-80

Seyler L, et al. Recommended beta-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. Crit Care 2011;15:R137

Back to top

2010

Bhavnani SM, et al. Daptomycin exposure and the probability of elevations in the creatinine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis. Clin Infect Dis 2010;50:1568-74

Bjerrum L, et al. Health alliance for prudent prescribing, yield and use of antimicrobial drugs in the treatment of respiratory tract infections (HAPPY AUDIT). BMC Fam Pract 2010;11:29

Di Pentima MC, Chan S. Impact of antimicrobial stewardship program on vancomycin use in a pediatric teaching hospital. Pediatr Infect Dis J 2010;29:707-11

Dryden M, et al. A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice. Clin Microbiol Infect 2010 Mar;16 Suppl 1:3-30

Frei CR, et al. Guideline-concordant antibiotic use and survival among patients with community- acquired pneumonia admitted to the intensive care unit. Clin Ther 2010;32:293-9

McNulty CA, Francis NA. Optimizing antibiotic prescribing in primary care settings in the UK: findings of a BSAC multi-disciplinary workshop 2009. J Antimicrob Chemother 2010;65:2278-84

Back to top

2000-2009

Bassetti M, Righi E, Viscoli C. Pseudomonas aeruginosa serious infections: mono or combination antimicrobial therapy? Curr Med Chem 2008;15(5):517-22

Bouza E, Munoz P. Monotherapy versus combination therapy for bacterial infections. Med Clin North Am 2000 Nov;84(6):1357-89

Davey P, Brown E, Fenelon L, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2005 Oct 19;4

Elphick HE, Tan A. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. Cochrane Database Syst Rev 2001 (published online Jan 22)

Hecker MT, Aron DC, Patel NP, et al. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 2003 Apr 28;163(8):972-8

Klibanov OM, Raasch RH, Rublein JC. Single versus combined antibiotic therapy for gram-negative infections. Ann Pharmacother 2004 Feb;38(2):332-7

Lan CK, Hsueh PR, Wong WW, et al. Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase-producing organisms. J Microbiol Immunol Infect 2003 Sep;36(3):182-6

Leibovici L, Paul M. Aminoglycoside/beta-lactam combinations in clinical practice. J Antimicrob Chemother 2007 Nov;60(5):911-2

Lister PD, Wolter DJ. Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa. Clin Infect Dis 2005 Feb 15;40(Suppl 2):S105-14

Lister PD, Wolter DJ, Wickman PA, et al. Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs. J Antimicrob Chemother 2006 May;57(5):999-1003

Mamdani M, McNeely D, Evans G, et al. Impact of a fluoroquinolone restriction policy in an elderly population. Am J Med 2007 Oct;120(10):893-900

Pakyz AL, MacDougall C, Oinonen M, et al. Trends in antibacterial use in US academic health centers: 2002 to 2006. Arch Intern Med 2008 Nov 10;168(20):2254-60

Paterson DL. The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. Clin Infect Dis 2006 Jan 15;42(Suppl 2):S90-5

Safdar N, Handelsman J, Maki DG. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 2004 Aug;4(8):519-27

Sobieszczyk ME, Furuya EY, Hay CM, et al. Combination therapy with polymyxin B for the treatment of multidrug-resistant gram-negative respiratory tract infections. J Antimicrob Chemother 2004 Aug;54(2):566-9

Back to top

Stewardship: Guidance, Consensus

Recently Added
2017
2016

2015
2014
2013
2012
2011
2000-2009 

Recently Added

Barwell ND, Devers MC, Kennon B, et al. Diabetic foot infection: antibiotic therapy and good practice recommendations. Int J Clin Pract 2017 (published online Sep 11)

Chiappini E, Bortone B, Doria M, et al. What not to do in acute otitis media: the top five recommendations proposed by the Italian Society of Preventive and Social Pediatrics. Expert Rev Anti Infect Ther 2017 (published online Sep 18)

Dresser LD, Bell CM, Steinberg M, et al. Use of a structured panel process to define antimicrobial prescribing appropriateness in critical care. J Antimicrob Chemother 2017 (published online Sep 26)

Heinz WJ, Buchheidt D, Christopeit M, et al. Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 2017 (published online Aug 30)

Meng L, Mui E, Holubar MK, et al. Comprehensive guidance for antibiotic dosing in obese adults. Pharmacotherapy 2017 (published online Sep 4)

Back to top 

2017

Barwell ND, Devers MC, Kennon B, et al. Diabetic foot infection: antibiotic therapy and good practice recommendations. Int J Clin Pract 2017 (published online Sep 11)

Berrios-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg 2017 (published online May 3)

Chiappini E, Bortone B, Doria M, et al. What not to do in acute otitis media: the top five recommendations proposed by the Italian Society of Preventive and Social Pediatrics. Expert Rev Anti Infect Ther 2017 (published online Sep 18)

Dresser LD, Bell CM, Steinberg M, et al. Use of a structured panel process to define antimicrobial prescribing appropriateness in critical care. J Antimicrob Chemother 2017 (published online Sep 26)

Heinz WJ, Buchheidt D, Christopeit M, et al. Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 2017 (published online Aug 30)

Ko BS, Chen WT, Kung HC, et al. 2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan. J Microbiol Immunol Infect 2017 (published online Aug 4)

Lehmann C, Berner R, Bogner JR, et al. The "Choosing Wisely" initiative in infectious diseases. Infection 2017 (published online Mar 13)

Meng L, Mui E, Holubar MK, et al. Comprehensive guidance for antibiotic dosing in obese adults. Pharmacotherapy 2017 (published online Sep 4)

Nichols K, Stoffella S, Meyers R, et al. Pediatric antimicrobial stewardship programs. J Pediatr Pharmacol Ther 2017 Jan-Feb;22(1):77-80

Patel I, Wungjiranirun M, Theethira T, et al. Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality. J Antimicrob Chemother 2017 Feb;72(2):574-81

Pont LG, Morgan TK, Williamson M, et al. Validity of prescribing indicators for assessing quality of antibiotic use in Australian general practice. Int J Pharm Pract 2017 Feb;25(1):66-74

Septimus EJ, Coopersmith CM, Whittle J, et al. Sepsis national hospital inpatient quality measure (SEP-1): multi-stakeholder work group recommendations for appropriate antibiotics for the treatment of sepsis. Clin Infect Dis 2017 (published online Jul 14)

Wintenberger C, Guery B, Bonnet E, et al. Proposal for shorter antibiotic therapies. Med Mal Infect 2017 (published online Mar 6)

Back to top 

2016

Allegranzi B, Bischoff P, de Jonge S, et al. New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis 2016 (published online Nov 2)

Allegranzi B, Zayed B, Bischoff P, et al. New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis 2016 (published online Nov 2)

Ban KA, Minei JP, Laronga C, et al. American College of Surgeons and Surgical Infection Society: surgical site infection guidelines, 2016 update. J Am Coll Surg 2016 (published online Nov 30)

Barlam TF, Cosgrove SE, Abbo LM, et al. Executive summary: implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016 May 15;62(10):1197-202

Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016 May 15;62(10):e51-77

Baugh CW, Wang TJ, Caterino JM, et al. ED management of patients with febrile neutropenia: guideline concordant or overly aggressive? Acad Emerg Med 2016 (published online Sep 9)

Chinese XDR Consensus Working GroupLaboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement. Clin Microbiol Infect 2016 Mar;22(Suppl 1):S15-25

Collignon PC, Conly JM, Andremont A, et al. World Health Organization ranking of antimicrobials according to their importance in human medicine: a critical step for developing risk management strategies to control antimicrobial resistance from food animal production. Clin Infect Dis 2016 (published online Jul 20)

de With K, Allerberger F, Amann S, et al. Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases. Infection 2016 Jun;44(3):395-439

Huang LL, Van Schooneveld TC, Huang RD, et al. Guideline-concordant versus discordant antimicrobial therapy in patients with community-onset complicated intra-abdominal infections. Infect Control Hosp Epidemiol 2016 Jul;37(7):855-8

Levy Hara G, Kanj SS, Pagani L, et al. Ten key points for the appropriate use of antibiotics in hospitalised patients: a consensus from the Antimicrobial Stewardship and Resistance Working Groups of the International Society of Chemotherapy. Int J Antimicrob Agents 2016 (published online Jul 25)

Lipsky BA, Dryden M, Gottrup F, et al. Antimicrobial stewardship in wound care: a position paper from the British Society for Antimicrobial Chemotherapy and European Wound Management Association. J Antimicrob Chemother 2016 (published online Jul 25)

McAnaw SE, Hesseling AC, Seddon JA, et al. Pediatric multidrug resistant tuberculosis clinical trials: challenges and opportunities. Int J Infec Dis 2016 (published online Dec 9)

McMullan BJ, Andresen D, Blyth CC, et al. Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines. Lancet Infect Dis 2016 Aug;16(8):e139-52

Moehring RW, Anderson DJ, Cochran RL, et al. Expert consensus on metrics to assess the impact of patient-level antimicrobial stewardship interventions in acute care settings. Clin Infect Dis 2016 (published online Dec 7)

Pulcini C, ESGAP AMOXDOSE Working Group. Amoxicillin dosing recommendations are very different in European countries: a cross-sectional survey. Clin Microbiol Infect 2016 (published online Nov 23)

Sanchez GV, Fleming-Dutra KE, Roberts RM, et al. Core elements of outpatient antibiotic stewardship. MMWR Recomm Rep 2016 Nov 11;65(6):1-12

Sartelli M, Weber DG, Ruppe E, et al. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg 2016 Jul 15;11:33

Watson R. EU to launch new antimicrobial resistance action plan. BMJ 2016 (published online Nov 23)

Zaffar S, Fletcher P. An audit of the paediatric empiric anti-infective guidelines and anti-infective drug dose table for children. Arch Dis Child 2016 Sep;101(9):e2

Zatorski C, Zocchi M, Cosgrove SE, et al. A single center observational study on emergency department clinician non-adherence to clinical practice guidelines for treatment of uncomplicated urinary tract infections. BMC Infect Dis 2016 (published online Nov 4)

Back to top

2015

Miyazaki T, Kohno S. Current recommendations and importance of antifungal stewardship for the management of invasive candidiasis. Expert Rev Anti Infect Ther 2015;13(9):1171-83

Patel S, Abrahamson E, Goldring S, et al. Good practice recommendations for paediatric outpatient parenteral antibiotic therapy (p-OPAT) in the UK: a consensus statement. J Antimicrob Chemother 2015 Feb;70(2):360-73

Back to top

2014

Ashiru-Oredope D, Cookson B, Fry C, et al. Developing the first national antimicrobial prescribing and stewardship competences. J Antimicrob Chemother 2014 Nov;69(11):2886-8

Chang CC, Ananda Rajah M, Belcastro A, et al. Consensus guidelines for implementation of quality processes to prevent invasive fungal disease and enhanced surveillance measures during hospital building works, 2014. Intern Med J 2014 Dec;44(12b):1389-97

Cosgrove SE, Hermsen ED, Rybak MJ, et al. Guidance for the knowledge and skills required for antimicrobial stewardship leaders. Infect Control Hosp Epidemiol 2014 Dec;35(12):1444-51

Couch KA, Geide T. ASHP therapeutic position statement on strategies for identifying and preventing pneumococcal resistance. Am J Health Syst Pharm 2014 Mar 1;71(5):417-24

Fridkin SK, Srinivasan A. Implementing a strategy for monitoring inpatient antimicrobial use among hospitals in the United States. Clin Infect Dis 2014 Feb;58(3):401-6

Mehta Y, Gupta A, Todi S, et al. Guidelines for prevention of hospital acquired infections. Indian J Crit Care Med 2014 Mar;18(3):149-63

Pollack LA, Srinivasan A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis 2014 Oct 15;59(Suppl 3):S97-100

Septimus E, Yokoe DS, Weinstein RA, et al. Maintaining the momentum of change: the role of the 2014 updates to the compendium in preventing healthcare-associated infections. Infect Control Hosp Epidemiol 2014 Sep;35(Suppl 2):S6-9

Thern J, de With K, Strauss R, et al. Selection of hospital antimicrobial prescribing quality indicators: a consensus among German antibiotic stewardship (ABS) networkers. Infection 2014 Apr;42(2):351-62

Yokoe DS, Anderson DJ, Berenholtz SM, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol 2014 Sep;35(Suppl 2):S21-31

Back to top

2013

Bratzler DW, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 2013 Feb;14(1):73-156

Hersh AL, et al. Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics 2013 Dec;132(6):1146-54

Holmes AH, et al. The Chennai Declaration: India's landmark national commitment to antibiotic stewardship demonstrates that 'truth alone triumphs.' J Antimicrob Chemother 2013 Jul;68(7):1453-4

Back to top

2012

Chapman AL, et al. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother 2012 May;67(5):1053-62

FDA. The judicious use of medically important antimicrobial drugs in food-producing animals. Guidance for industry (#209).  Apr 13, 2012 [See also: FDA. New animal drugs and new animal drug combination products administered in or on medicated feed or drinking water of food-producing animals: recommendations for drug sponsors for voluntarily aligning product use conditions with GFI #209. December 2013]

FDA. Safety and innovation act. Accessed July 2016.

IDSA/SHEA/PIDS. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol 2012 Apr;33(4):322-7

Patient Centered Outcomes Research Institute. Draft national priorities for research and research agenda, version 1. Jan 23, 2012

Back to top

2011

IDSA. Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis 2011;52:S397-S428

McIntosh KA, et al. A quality improvement initiative to improve adherence to national guidelines for empiric management of community-acquired pneumonia in emergency departments. Int J Qual Health Care 2011;23:142-50

Back to top

2000-2009

Bedouch P, Labarere J, Chirpaz E, et al. Compliance with guidelines on antibiotic prophylaxis in total hip replacement surgery: results of a retrospective study of 416 patients in a teaching hospital. Infect Control Hosp Epidemiol 2004 Apr;25(4):302-7

Dellit TH, Owens RC, McGowan JE Jr., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007 Jan 15;44(2):159-77

Drew RH, White R, MacDougall C, et al. Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Pharmacotherapy 2009 May;29(5):593-607

Hagaman JT, Yurkowski P, Trott A, et al. Getting physicians to make "the switch": the role of clinical guidelines in the management of community-acquired pneumonia. Am J Med Qual 2005 Jan-Feb;20(1):15-21

Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy 2009 Nov;29(11):1275-9

Spellberg B, Guidos R, Gilbert D, et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008 Jan 15;46(2):155-64

Taur Y, Smith MA. Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection. Clin Infect Dis 2007 Mar 15;44(6):769-74

Back to top

Stewardship: Health Policy

Recently Added
2017
2016

2015
2014
2013
2012
2011
2010
2000-2009 

Recently Added

Castro-Sanchez E, Gilchrist MJ, McEwan J, et al. Antimicrobial stewardship: widening the collaborative approach. J Antimicrob Steward 2017;1(1):29-37

Del Mar CB, Scott AM, Glasziou PP, et al. Reducing antibiotic prescribing in Australian general practice: time for a national strategy. Med J Aust 2017 (published online Oct 23)

Giubilini A. Antimicrobial resistance and antimicrobial stewardship programmes: benefiting the patient or the population? J Med Ethics 2017 Oct;43(10):653-4

Littmann J, Rid A, Buyx A. Tackling anti-microbial resistance: ethical framework for rational antibiotic use. Eur J Public Health 2017 (published online Oct 5)

Maranon G. Antibiotic resistance and good stewardship. J Calif Dent Assoc 2017 May;45(5):244-52

Micallef C, Ashiru-Oredope D, Hansraj S, et al. An investigation of antifungal stewardship programmes in England. J Med Microbiol 2017 (published online Oct 25)

Osthoff M, Belicki J, Widmer AF, et al. Evaluation of existing and desired antimicrobial stewardship activities and strategies in Swiss hospitals. Swiss Med Wkly 2017 (published online Oct 24)

Rizzo K, Kealey M, Epson E. Antimicrobial stewardship practices reported by California hospitals following new legislative requirements: analysis of National Healthcare Safety Network annual survey data, 2014-2015. Infect Control Hosp Epidemiol 2017 (published online Oct 30)

Silverberg SL, Zannella VE, Countryman D, et al. A review of antimicrobial stewardship training in medical education. Int J Med Educ 2017 (published online Oct 12)

Smith RA, MacGeorge EL, Hackman NM, et al. Campaign preparation for complex initiatives: a person-centered approach to audience segmentation of parents' antibiotic stewardship. Health Commun 2017 (published online Oct 25)

Xiao M, Cheng JW, Kudinha T, et al. National antimicrobial stewardship and fluoroquinolone-resistant Clostridium difficile in China. Infect Drug Resist 2017 (published online Oct 13)

Back to top

2017

Adeniji F. Global analysis of strategies to tackle antimicrobial resistance. Int J Pharm Pract 2017 (published online May 22)

Allison DG, Higginson P, Martin S. Antibiotic resistance awareness: a public engagement approach for all pharmacists. Int J Pharm Pract 2017 Feb;25(1):93-6

Anderson DJ, Jenkins TC, Evans SR, et al. The role of stewardship in addressing antibacterial resistance: stewardship and infection control committee of the Antibacterial Resistance Leadership Group. Clin Infect Dis 2017 (published online Mar 2)

Araujo da Silva AR, Albernaz de Almeida Dias DC, Marques AF, et al. The role of antimicrobial stewardship programmes in children: a systematic review. J Hosp Infect 2017 (published online Aug 11)

Baclet N, Ficheur G, Alfandari S, et al. Explicit definitions of potentially inappropriate prescriptions of antibiotics in older patients: a compilation derived from a systematic review. Int J Antimicrob Agents 2017 (published online Aug 10)

Bashir A, Gray J. Fight antibiotic resistance—it’s in your hands to improve antibiotic stewardship. J Hosp Infect 2017 (published online Mar 9)

Bassetti M, Kollef MH, Poulakou G. Principles of antimicrobial stewardship for bacterial and fungal infections in ICU. Intensive Care Med 2017 (published online Sep 12)

Baummer-Carr A, Nicolau DP. The challenges of patient satisfaction: influencing factors and the patient-provider relationship in the United States. Expert Rev Anti Infect Ther 2017 (published online Sep 12)

Beerlage-de Jong N, Van Gemert-Pijnen L, Wentzel J, et al. Technology to support integrated antimicrobial stewardship programs: a user centered and stakeholder driven development approach. Infect Dis Rep 2017 (published online Mar 30)

Bennie M, Malcolm W, Marwick CA, et al. Building a national infection intelligence platform to improve antimicrobial stewardship and drive better patient outcomes: the Scottish experience. J Antimicrob Chemother 2017 (published online Jul 10)

Birgand G, Troughton R, Moore LSP, et al. Blogging in infectious diseases and clinical microbiology: assessment of ‘blogosphere’ content. Infect Control Hosp Epidemiol 2017 (published online May 18)

Bosley H, Henshall C, Appleton JV, et al. A systematic review to explore influences on parental attitudes towards antibiotic prescribing in children. J Clin Nurs 2017 (published online Sep 14)

Brink A, Schoeman J, Muntingh G. Undergraduate antibiotic stewardship training: Are we leaving our future prescribers 'flapping in the wind'? S Afr Med J 2017 Apr 25;107(5):357-8

Broom J. How do hospital respiratory clinicians perceive antimicrobial stewardship? A qualitative study highlighting barriers to AMS in respiratory medicine. J Hosp Med 2017 (published online May 5)

Broom JK, Broom AF, Kirby ER, et al. Clinical and social barriers to antimicrobial stewardship in pulmonary medicine: a qualitative study. Am J Infect Control 2017 (published online Apr 3)

Broom A, Kirby E, Gibson AF, et al. Myth, manners, and medical ritual: defensive medicine and the fetish of antibiotics. Qual Health Res 2017 (published online Jul 24)

Bush LM, Kaye D. Antimicrobial utilization: job of a steward or time for a pilot? Clin Infect Dis 2017 (published online Jun 7)

Cadavid CD, Sakamoto SD, Terashita DM, et al. Bedside registered nurse roles in antimicrobial stewardship: a survey of acute-care hospitals in Los Angeles County. Infect Control Hosp Epidemiol 2017 (published online Aug 14)

Caronia L, Saglietti M. Struggles over antibiotics: physicians' stance-taking toward a nonconforming policy in an intensive care unit. Qual Health Res 2017 (published online Aug 15)

Castro-Sanchez E, Gilchrist MJ, McEwan J, et al. Antimicrobial stewardship: widening the collaborative approach. J Antimicrob Steward 2017;1(1):29-37

Chambers HF, Cross HR, Evans SR, et al. The Antibacterial Resistance Leadership Group: progress report and work in progress. Clin Infect Dis 2017 (published online Mar 2)

Charani E, Tarrant C, Moorthy K, et al. Understanding antibiotic decision making in surgery—a qualitative analysis. Clin Microbiol Infect 2017 (published online Mar 21)

Collins A, Broeseker A, Cunningham J, et al. A longitudinal online interprofessional education experience involving family nurse practitioner students and pharmacy students. J Interprof Care 2017 (published online Jan 31)

Cox JA, Vlieghe E, Mendelson M, et al. Antibiotic stewardship in low-and middle-income countries: 'same, but different'? Clin Microbiol Infect 2017 (published online Jul 13)

Cross HR, Harris A, Arias RM, et al. Transforming concepts into clinical trials and creating a multisite network: the leadership and operations center of the antibacterial resistance leadership group. Clin Infect Dis 2017 (published Mar 2)

Davis M, Whittaker A, Lindgren M, et al. Understanding media publics and the antimicrobial resistance crisis. Glob Public Health 2017 (published online Jun 8)

Del Mar CB, Scott AM, Glasziou PP, et al. Reducing antibiotic prescribing in Australian general practice: time for a national strategy. Med J Aust 2017 (published online Oct 23)

Demore B, Mangin L, Tebano G, et al. Public knowledge and behaviours concerning antibiotic use and resistance in France: a cross-sectional survey. Infection 2017 (published online Apr 12)

Dik JWH, Friedrich AW, Nathwani D, et al. Combating the complex global challenge of antimicrobial resistance: what can antimicrobial stewardship contribute? Infect Dis Rep 2017 (published online Mar 30)

Dik JWH, Sinha B. Challenges for a sustainable financial foundation for antimicrobial stewardship. Infect Dis Rep 2017 (published online Mar 30)

Dobson EL, Klepser ME, Pogue JM, et al. Outpatient antibiotic stewardship: interventions and opportunities. J Am Pharm Assoc 2017 (published online May 16)

Doernberg SB, Chambers HF. Antimicrobial stewardship approaches in the intensive care unit. Infect Dis Clin 2017 (published online Jul 5)

Durojaiye OC, Bell H, Andrews D, et al. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service. Int J Antimicrob Agents 2017 (published online Jun 30)

Dutta SS. India launches strategy to curb antimicrobial resistance. BMJ 2017 (published online Apr 26)

Dyar OJ, Huttner B, Schouten J, et al. What is antimicrobial stewardship? Clin Microbiol Infect 2017 (published online Sep 4)

Dyar OJ, Tebano G, Pulcini C, et al. Managing responsible antimicrobial use: perspectives across the healthcare system. Clin Microbiol Infect 2017 (published online Apr 19)

Edmiston CE, Leaper D, Spencer M, et al. Considering a new domain for antimicrobial stewardship: topical antibiotics in the open surgical wound. Am J Infect Control 2017 (published online Jun 5)

Fabre V, Cosgrove SE. A coordinated and sustained response to the threat of antibiotic resistance is critical: lessons learned from Israel. Clin Infect Dis 2017 (published online Jul 18)

Fantoni M, Murri R, Cauda R. Antibiotic stewardship from toolkit to local implementation: the 'gutta cavat lapidem' strategy. Future Microbiol 2017 (published online Jul 26)

Fathi I, Sameh O, Abu-Ollo M, et al. Knowledge, attitudes, and beliefs regarding antimicrobial therapy and resistance among physicians in Alexandria University teaching hospitals and the associated prescription habits. Microb Drug Resist 2017 Jan;23(1):71-8

Gardiner SJ, Pryer JA, Duffy EJ. Survey of antimicrobial stewardship practices in public hospitals in New Zealand district health boards. N Z Med J 2017 Jul 7;130(1458):27-41

Giubilini A. Antimicrobial resistance and antimicrobial stewardship programmes: benefiting the patient or the population? J Med Ethics 2017 Oct;43(10):653-4

Goff DA, File TM. The risk of prescribing antibiotics “just-in-case” there is infection. Semin Colon Rectal Surg 2017 (published online Sep 22)

Goff DA, Kullar R, Bauer KA, et al. Eight habits of highly effective antimicrobial stewardship programs to meet the Joint Commission standards for hospitals. Clin Infect Dis 2017 (published online Feb 14)

Goff DA, Mendelson M. Antibiotic stewardship hits a home run for patients. Lancet Infect Dis 2017 (published online Jun 16)

Greub G. Management: from antibiotic stewardship to clinical microbiology. Clin Microbiol Infect 2017 (published online Jun 15)

Hersh AL, Fleming-Dutra KE. Vaccines and outpatient antibiotic stewardship. Pediatrics 2017 (published online Aug 14)

Hom J, Kumar A, Evans KH, et al. A high value care curriculum for interns: a description of curricular design, implementation and housestaff feedback. Postgrad Med J 2017 (published online Jun 29)

Hulscher MEJL, Prins JM. Antibiotic stewardship: does it work in hospital practice? A review of the evidence base. Clin Microbiol Infect 2017 (published online Jul 24)

Inoue H, Minghui R. Antimicrobial resistance: translating political commitment into national action. Bull World Health Organ 2017;95:242

Jenkins A, Hills T, Santillo M, et al. Extended stability of antimicrobial agents in administration devices. J Antimicrob Chemother 2017 (published online Jan 10)

Kelly AA, Jones MM, Echevarria KL, et al. A report of the efforts of the Veterans Health Administration national antimicrobial stewardship initiative. Infect Control Hosp Epidemiol 2017 (published Jan 25)

Kesten JM, Bhattacharya A, Ashiru-Oredope D, et al. The Antibiotic Guardian campaign: a qualitative evaluation of an online pledge-based system focused on making better use of antibiotics. BMC Public Health 2017 (published online Jul 11)

Khan Y, Boschmans SA, McCartney J, et al. Undergraduate antimicrobial stewardship training for pharmacy students: creating a foundation for containment of antimicrobial resistance in South Africa. S Afr Med J 2017 (published online Aug 25)

King A, Cresswell KM, Coleman JJ, et al. Investigating the ways in which health information technology can promote antimicrobial stewardship: a conceptual overview. J R Soc Med 2017 (published online Jul  21)

Klepser ME, Dobson EL, Pogue JM, et al. A call to action for outpatient antibiotic stewardship. J Am Pharm Assoc 2017 (published online May 9)

Kollef MH, Bassetti M, Francois B, et al. The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. Intensive Care Med 2017 (published online Feb 4)

Laake AM, Bernabe G, Peterson J, et al. Internal medicine resident perspectives regarding broad-spectrum antibiotic usage. Open Forum Infect Dis 2017 (published online Apr 4)

Lautenbach E. Infectious diseases careers in healthcare epidemiology and antimicrobial stewardship. J Infect Dis 2017 Sep 15;216(suppl 5):S620-1

Lavrentieva A. Antibiotic stewardship in burn patients: From theory to reality and vice versa. Burns 2017 (published online Feb 4)

Lawrence MJ. Antibiotic stewardship: why we must play our part. Int J Pharm Pract 2017 Feb;25(1):3-4

Lebentrau S, Gilfrich C, Vetterlein MW, et al. Impact of the medical specialty on knowledge regarding multidrug-resistant organisms and strategies toward antimicrobial stewardship. Int Urol Nephrol 2017 (published online Apr 21)

Littmann J, Rid A, Buyx A. Tackling anti-microbial resistance: ethical framework for rational antibiotic use. Eur J Public Health 2017 (published online Oct 5)

Long MJ, LaPlant BN, McCormick JC. Antimicrobial stewardship in the Federal Bureau of Prisons: approaches from the national and local levels. J Am Pharm Assoc 2017 (published online Jan 12)

Maranon G. Antibiotic resistance and good stewardship. J Calif Dent Assoc 2017 May;45(5):244-52

Martin CM. Antibiotic stewardship: new frontier, familiar journey. Consult Pharm 2017 Mar 1;32(3):134-9

May M, Obermaier R, Novotny A, et al. Face to face with multi-resistant pathogens: an urgent call to action for modern surgeons to pioneer in antibiotic stewardship. Surg Infect (Larchmt) 2017 (published online May 3)

McCulloh RJ, Norton LE, Goldman JL. Extending antimicrobial stewardship to all hospitalized children: the time is now. Hosp Pediatr 2017 (published online Aug 16)

McQuillen DP, MacIntyre AT. The value that infectious diseases physicians bring to the healthcare system. J Infect Dis 2017 Sep 15;216(suppl 5):S588-93

Mehrotra P, Gupta K, Strymish J, et al. Implementation of infection prevention and antimicrobial stewardship in cardiac electrophysiology laboratories: results from the SHEA research network. Infect Control Hosp Epidemiol 2017 (published online Jan 20)

Mendelson M, Balasegaram M, Jinks T, et al. Antibiotic resistance has a language problem. Nature 2017 (published online May 3)

Micallef C, Ashiru-Oredope D, Hansraj S, et al. An investigation of antifungal stewardship programmes in England. J Med Microbiol 2017 (published online Oct 25)

M’ikanatha NM, Yealy C, Warrington AM, et al. Use of an annual art competition to promote Web site traffic and engage children in antimicrobial stewardship in Pennsylvania. Am J Infect Control 2017 (published online Sep 8)

Mistry RD, Newland JG, Gerber JS, et al. Current state of antimicrobial stewardship in children's hospital emergency departments. Infect Control Hosp Epidemiol 2017 (published online Feb 8)

Moiemen NS, ISBI Guideline Committee. Antibiotic stewardship in burns patients: ISBI guidelines. Burns 2017 (published online Jun 17)

Monsees E, Goldman J, Popejoy L. Staff nurses as antimicrobial stewards: an integrative literature review. Am J Infect Control 2017 (published online Aug 1)

Morel CM, Edwards SE, Harbarth S. Preserving the 'commons': addressing the sustainable use of antibiotics through an economic lens. Clin Microbiol Infect 2017 (published online Aug 12)

Morgan DJ, Malani P, Diekema DJ. Diagnostic stewardship—leveraging the laboratory to improve antimicrobial use. JAMA 2017 (published online Jul 31)

Morley GL, Wacogne ID. UK recommendations for combating antimicrobial resistance: a review of 'antimicrobial stewardship: systems and processes for effective antimicrobial medicine use' (NICE guideline NG15, 2015) and related guidance. Arch Dis Child Educ Pract Ed 2017 (published online Aug 9)

Morris A. Antibiotic stewardship in a remote health region: signs of success. Can J Rural Med 2017;22(1):33-4

Mostaghim M, Snelling T, McMullan B, et al. Nurses are underutilised in antimicrobial stewardship—results of a multisite survey in paediatric and adult hospitals. Infection, Disease & Health 2017 (published online May 24)

Murray BE, Jezek A. The Antibacterial Resistance Leadership Group: first steps. Clin Infect Dis 2017 (published online Mar 2)

Nasr Z, Paravattil B, Wilby KJ. The impact of antimicrobial stewardship strategies on antibiotic appropriateness and prescribing behaviours in selected countries in the Middle East: a systematic review. East Mediterr Health J 2017 Aug 20;23(6):430-40

Nathwani D, Guise T, Gilchrist M. e-learning for global antimicrobial stewardship. Lancet Infect Dis 2017 Jun;17(6):579

Newland JG, Gerber JS, Kronman MP, et al. Sharing antimicrobial reports for pediatric stewardship (SHARPS): a quality improvement collaborative. J Pediatric Infect Dis Soc 2017 (published online Apr 4)

Nunez-Nunez M, Navarro MD, Palomo V, et al. The methodology of surveillance for antimicrobial resistance and healthcare-associated infections in Europe (SUSPIRE): a systematic review of publicly available information. Clin Microbiol Infect 2017 (published online Jul 24)

Oczkowski S. Antimicrobial stewardship programmes: bedside rationing by another name? J Med Ethics 2017 (published online Mar 15)

Olans RD, Olans RN, Witt DJ. Good nursing Is good antibiotic stewardship. Am J Nurs 2017 Aug;117(8):58-63

Ortiz-Martinez Y. Antibiotic prescribing and resistance: knowledge among Latin American medical students during the World Antibiotic Awareness Week 2016. J Hosp Infect 2017 (published online Mar 31)

Osthoff M, Belicki J, Widmer AF, et al. Evaluation of existing and desired antimicrobial stewardship activities and strategies in Swiss hospitals. Swiss Med Wkly 2017 (published online Oct 24)

Patel PK. Applying the horizontal and vertical paradigm to antimicrobial stewardship. Infect Control Hosp Epidemiol 2017 (published online Apr 19)

Patel PK, Srinivasan A. Moving antibiotic stewardship from theory to practice. J Hosp Med 2017 May;12(5):382-3

Pereira NR, Castro-Sanchez E, Nathwani D. How can multi-professional education support better stewardship? Infect Dis Rep 2017 Mar 30;9(1):6917

Perez MF, Metersky ML, Kalil AC. How to translate the new hospital-acquired and ventilator-associated pneumonia guideline to the bedside. Curr Opin Crit Care 2017 Oct;23(5):355-363.

Phuong NTK, Hoang TT, Van PH, et al. Encouraging rational antibiotic use in childhood pneumonia: a focus on Vietnam and the Western Pacific Region. Pneumonia 2017 (published online Apr 25)

Pires D, de Kraker MEA, Tartari E, et al. ‘Fight antibiotic resistance—it’s in your hands’: call from the World Health Organization for 5th May 2017. Clin Infect Dis 2017 (published online May 4)

Plachouras D, Hopkins S. Antimicrobial stewardship: we know it works; time to make sure it is in place everywhere. Cochrane Database Syst Rev 2017 (published online Feb 9)

Poteete C, Scaletta J. Antimicrobial stewardship in Kansas: results from a statewide survey. Am J Infect Control 2017 Jan 1;45(1):42-5

Powell N, Davidson I, Yelling P, et al. Developing a local antimicrobial resistance action plan: the Cornwall One Health Antimicrobial Resistance Group. J Antimicrob Chemother 2017 (published online Jun 7)

Pulcini C. Antibiotic stewardship: update and perspectives. Clin Microbiol Infect 2017 (published online Sep 4)

Pulcini C, Morel CM, Tacconelli E, et al. Human resources estimates and funding for antibiotic stewardship teams are urgently needed. Clin Microbiol Infect 2017 (published online Jul 24)

Pulcini C, Tebano G, Mutters NT, et al. Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey. Int J Antimicrob Agents 2017 (published online Jan 10)

Pulia MS, Redwood R, Sharp B. Antimicrobial stewardship in the management of sepsis. Emerg Med Clin North Am 2017 Feb;35(1):199-217

Ramasethu J, Kawakita T. Antibiotic stewardship in perinatal and neonatal care. Semin Fetal Neonatal Med 2017 (published online Jul 20)

Rizzo K, Kealey M, Epson E. Antimicrobial stewardship practices reported by California hospitals following new legislative requirements: analysis of National Healthcare Safety Network annual survey data, 2014-2015. Infect Control Hosp Epidemiol 2017 (published online Oct 30)

Roberts CD, Leaper DJ, Assadian O. The role of topical antiseptic agents within antimicrobial stewardship strategies for prevention and treatment of surgical site and chronic open wound infection. Adv Wound Care (New Rochelle) 2017 Feb 1;6(2):63-71

Robilotti E, Holubar M, Nahrgang S. Educating front-line clinicians about antimicrobial resistance. Lancet Infect Dis 2017 Mar;17(3):257-8

Rocha-Pereira N, Castro Sanchez E, Nathwani D. How can multi-professional education support better stewardship? Infect Dis Rep 2017 (published online Mar 30)

Safdari R, GhaziSaeedi M, Masoumi-Asl H, et al. A national framework for an antimicrobial resistance surveillance system within Iranian healthcare facilities: towards a global surveillance system. J Glob Antimicrob Resist 2017 (published online Jul 6)

Sartelli M. Labricciosa FM, Barbadoro P, et al. The Global Alliance for Infections in Surgery: defining a model for antimicrobial stewardship—results from an international cross-sectional survey. World J Emerg Surg 2017 (published online Aug 1)

Schafer J. The role of payers in antibiotic stewardship: facilitating transitions of care for patients with active infection. J Clin Path 2017 Mar;3(2)

Schellack N, Benjamin D, Brink A, et al. A situational analysis of current antimicrobial governance, regulation and utilisation in South Africa. Int J Infect Dis 2017 (published online Sep 8)

Sean VXF, Ong RYL, Lim ASY, et al. Impact of a carbapenem antimicrobial stewardship program on patient outcomes. Antimicrob Agents Chemother 2017 (published online Jul 17)

Sedrak A, Anpalahan M, Luetsch K. Enablers and barriers to the use of antibiotic guidelines in the assessment and treatment of community-acquired pneumonia—a qualitative study of clinicians' perspectives. Int J Clin Pract 2017 (published online May 19)

Sexton DJ, Moehring RW. Implementation of antimicrobial stewardship programs in small community hospitals: recognizing the barriers and meeting the challenge. Clin Infect Dis 2017 (published online May 2)

Silverberg SL, Zannella VE, Countryman D, et al. A review of antimicrobial stewardship training in medical education. Int J Med Educ 2017 (published online Oct 12)

Smith RA, MacGeorge EL, Hackman NM, et al. Campaign preparation for complex initiatives: a person-centered approach to audience segmentation of parents' antibiotic stewardship. Health Commun 2017 (published online Oct 25)

Sopirala MM. Does CDC's ventilator associated event definition unintentionally contradict its antimicrobial stewardship initiative? Clin Infect Dis 2017 (published online Jun 7)

Smith EA, Gold HS, Mahoney MV, et al. Nasal methicillin-resistant Staphylococcus aureus screening in patients with pneumonia: a powerful antimicrobial stewardship tool. Am J Infect Control 2017 (published online Aug 22)

Spellberg B. Preserving the health of the public and our specialty. Clin Infect Dis 2017 (published online Jun 29)

Srinivasan A. Antibiotic stewardship: why we must, how we can. Cleve Clin J Med 2017 Sep;84(9):673-9

Srinivasan A, Davidson LE. Improving patient safety through antibiotic stewardship: the Veterans Health Administration leads the way, again. Infect Control Hosp Epidemiol 2017 (published online Apr 19)

Stenehjem E, Hyun DY, Septimus E, et al. Antibiotic stewardship in small hospitals: barriers and potential solutions. Clin Infect Dis 2017 (published online May 2)

Szymczak JE, Klieger SB, Miller M, et al. What parents think about the risks and benefits of antibiotics for their child’s acute respiratory tract infection. J Pediatric Infect Dis Soc 2017 (published online Sep 14)

Tarchini G, Liau KH, Solomkin JS. Antimicrobial stewardship in surgery: challenges and opportunities. Clin Infect Dis 2017 May;64(suppl 2): S112-S114

Tartari E, Pires D, Pittet D. Clean Your Hands 5th May 2017: 'Fight antibiotic resistance—it's in your hands.' Antimicrob Resist Infect Control (published online May 5)

Thompson CA. Delay of antimicrobial stewardship CoP shouldn't delay pharmacists. Am J Health Syst Pharm 2017 Feb 15;74(4):186-7

Traynor K. Antimicrobial stewardship faces hurdles in primary care. Am J Health Syst Pharm 2017 Oct 1;74(19):1516-8

Tsay S, Kallen A, Jackson BR, et al. Approach to the investigation and management of patients with Candida auris, an emerging multidrug-resistant yeast. Clin Infect Dis 2017 (published online Aug 17)

Wasserman S, Potgieter S, Shoul E, et al. South African medical students’ perceptions and knowledge about antibiotic resistance and appropriate prescribing: are we providing adequate training to future prescribers? S Afr Med J 2017 May;107(5):405-10

Wattal C, Javeri Y, Goel N, et al. Convergence of minds: for better patient outcome in intensive care unit infections. Indian J Crit Care Med 2017 Mar;21(3):154-9

Weier N, Thursky K, Zaidi STR. Antimicrobial knowledge and confidence amongst final year medical students in Australia. PLoS One 2017 (published online Aug 3)

Wernli D, Jorgensen PS, Morel CM, et al. Mapping global policy discourse on antimicrobial resistance. BMJ Global Health 2017 (published online Jul 13)

Williams DJ, Hall M, Gerber JS, et al. Impact of a national guideline on antibiotic selection for hospitalized pneumonia. Pediatrics 2017 (published online Mar 6)

Xiao M, Cheng JW, Kudinha T, et al. National antimicrobial stewardship and fluoroquinolone-resistant Clostridium difficile in China. Infect Drug Resist 2017 (published online Oct 13)

Back to top

2016

Agrawal S, Barnes R, Bruggemann RJ, et al. The role of the multidisciplinary team in antifungal stewardship. J Antimicrob Chemother 2016;71(suppl 2):ii37-42

Akrami K, Sweeney DA, Malhotra A. Antibiotic stewardship in the intensive care unit: tools for de-escalation from the American Thoracic Society Meeting 2016. J Thorac Dis 2016 Jul;8(Suppl 7):S533-5

Ardal C, Outterson K, Hoffman SJ, et al. International cooperation to improve access to and sustain effectiveness of antimicrobials. Lancet 2016 Jan 16;387(10015):296-307

Ashiru-Oredope D, Budd EL, Bhattacharya A, et al.; English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR). Implementation of antimicrobial stewardship interventions recommended by national toolkits in primary and secondary healthcare sectors in England: TARGET and Start Smart Then Focus. J Antimicrob Chemother 2016 May;71(5):1408-14

Bailey C, Tully MP, Pampaka M, et al. Rasch analysis of the Antimicrobial Self-Assessment Toolkit for National Health Service (NHS) Trusts (ASAT v17). J Antimicrob Chemother 2016 (published online Oct 25)

Bassetti M, Peghin M, Timsit JF. The current treatment landscape: candidiasis. J Antimicrob Chemother 2016;71(suppl 2):ii13-22

Brink A, Van de Bergh D, Mendelson M, et al. Passing the baton to pharmacists and nurses: New models of antibiotic stewardship for South Africa? S Afr Med J 2016 Sep 6;106(10):947-8

Brogan DM, Mossialos E. A critical analysis of the review on antimicrobial resistance report and the infectious disease financing facility. Global Health 2016 Mar 22;12:8

Broom A, Broom J, Kirby E, et al. Nurses as antibiotic brokers: institutionalized praxis in the hospital. Qual Health Res 2016 (published online Nov 30)

Broom A, Plage S, Broom J, et al. A qualitative study of hospital pharmacists and antibiotic governance: negotiating interprofessional responsibilities, expertise and resource constraints. BMC Health Serv Res 2016 Feb 6;16:43

Bryson DJ, Morris DL, Shivji FS, et al. Antibiotic prophylaxis in orthopaedic surgery: difficult decisions in an era of evolving antibiotic resistance. Bone Joint J 2016 Aug;98-B(8):1014-9

Bui C, Zhu E, Donnelley MA, et al. Antimicrobial stewardship programs that target only high-cost, broad-spectrum antimicrobials miss opportunities to reduce Clostridium difficile infections. Am J Infect Control 2016 Dec 1;44(12):1684-6

Cantey JB, Vora N, Sunkara M. Prevalence, Characteristics, and Perception of Nursery Antibiotic Stewardship Coverage in the United States. J Ped Infect Dis 2016 (published online Jul 15)

Castro-Sanchez E, Drumright LN, Gharbi M, et al. Mapping antimicrobial stewardship in undergraduate medical, dental, pharmacy, nursing and veterinary education in the United Kingdom. PLoS One 2016 Feb;11(2):e0150056

Chuenchom N, Thamlikitkul V, Chaiwarith R, et al. Perception, attitude, and knowledge regarding antimicrobial resistance, appropriate antimicrobial use, and infection control among future medical practitioners: a multicenter study. Infect Control Hosp Epidemiol 2016 May;37(5):603-5

Chou AF, Graber CJ, Jones M, et al. Characteristics of antimicrobial stewardship programs at Veterans Affairs hospitals: results of a nationwide survey. Infect Control Hosp Epidemiol 2016 Jun;37(6):647-54

Cross ELA, Tolfree R, Kipping R. Systematic review of public-targeted communication interventions to improve antibiotic use. J Antimicrob Chemother 2016 (published online Dec 20)

Cunha CB, D’Agata EM. Implementing an antimicrobial stewardship program in out-patient dialysis units. Curr Opin Nephrol Hypertens 2016 (published online Sep 14)

Dar OA, Hasan R, Schlundt J, et al. Exploring the evidence base for national and regional policy interventions to combat resistance. Lancet 2016 Jan 16;387(10015):285-95

Dyar OJ, Obua C, Chandy S, et al. Using antibiotics responsibly: are we there yet? Future Microbiol 2016 (published online Aug 9)

Erku DA. Antimicrobial stewardship: a cross-sectional survey assessing the perceptions and practices of community pharmacists in Ethiopia. Interdiscip Perspect Infect Dis 2016 (published online Nov 22)

Essack SY, Desta AT, Abotsi RE, et al. Antimicrobial resistance in the WHO African region: current status and roadmap for action. J Public Health (Oxf) 2016 (published online Mar 3)

Fakih MG, Guharoy R, Hendrich A, et al. Health systems can play a pivotal role in supporting antimicrobial stewardship. Clin Infect Dis 2016 (published online Aug 30)

Fluent MT, Jacobsen PL, Hicks LA, et al. Considerations for responsible antibiotic use in dentistry. J Am Dent Assoc 2016 (published online Jun 11)

Gillon SA, Wyncoll D. In a financially driven quest for antibiotic stewardship, does intensive care hold the key? Expert Rev Anti Infect Ther 2016 (published online Nov 11)

Goff DA, File TM Jr. The evolving role of antimicrobial stewardship in management of multidrug resistant infections. Infect Dis Clin North Am 2016 Jun;30(2):539-51

Goff DA, Kullar R, Goldstein EJC, et al. A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail. Lancet Infect Dis 2016 (published online Nov 17)

Goo RA, Chu CH, Yoneda MK, et al. The Daniel K. Inouye College of Pharmacy scripts: the development of antimicrobial stewardship programs in Hawai'i. Hawaii J Med Public Health 2016 Jul;75(7):208-11

Hamdy RF, Zaoutis TE, Seo SK. Antifungal stewardship considerations for adults and pediatrics. Virulence 2016 (published online Sep 2)

Hogan KA, Gazarin M, Lapenskie J. Development and implementation of an antimicrobial stewardship program in a rural hospital. Can J Hosp Pharm 2016 (published online Oct 31)

Holloway KA, Rosella L, Henry D. The impact of WHO essential medicines policies on inappropriate use of antibiotics. PLoS One 2016 Mar 22;11(3):e0152020

Huttner B, Pulcini C, Schouten J. "De-constructing de-escalation". Clin Microbiol Infect 2016 (published online Sep 29)

Jacobs DM, Kuper K, Septimus E, et al. Assessment of antimicrobial stewardship activities in a large metropolitan area. J Pharm Pract 2016 Jun;29(3):188-93

Joseph A, Mahida N. Antimicrobial stewardship in secondary care: what are we trying to achieve? J Hosp Infect 2016 Aug;93(4):393-4

Kampf G. Acquired resistance to chlorhexidine—is it time to establish an 'antiseptic stewardship' initiative? J Hosp Infect 2016 (published online Aug 26)

Karanika S, Paudel S, Grigoras C, et al. Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs. Antimicrob Agents Chemother 2016 Aug;60(8):4840-52

Kim B, Kim J, Kim SW, et al. A survey of antimicrobial stewardship programs in Korea, 2015. J Korean Med Sci 2016 Oct;31(10):1553-9

Kostyanev T, Bonten MJ, O'Brien S, et al. The innovative medicines initiative's new drugs for bad bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance. J Antimicrob Chemother 2016 Feb;71(2):290-5

Launay E, Levieux K, Levy C, et al. Compliance with the current recommendations for prescribing antibiotics for paediatric community-acquired pneumonia is improving: data from a prospective study in a French network. BMC Pediatr 2016 Aug 12;16(1):126

Laxminarayan R, Matsoso P, Pant S, et al. Access to effective antimicrobials: a worldwide challenge. Lancet 2016 Jan 9;387(10014):168-75

Laxminarayan R, Sridhar D, Blaser M, et al. Achieving global targets for antimicrobial resistance. Science 2016 (published Aug 18)

Lebentrau S, Vetterlein MW, May M. The urologist's role in antibiotic stewardship: results from the MR2 study. Eur Urol 2016 (published online Dec 28)

Lee KB, Ramirez JA, Collins R, et al. Antimicrobial stewardship practices in Virginia. Am J Infect Control 2016 (published online Dec 26)

Leeds IL, Fabrizio A, Cosgrove SE, et al. Treating wisely: the surgeon's role in antibiotic stewardship. Ann Surg 2016 (published online Oct 4)

Lortholary O, Fernandez-Ruiz M, Perfect JR. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis). J Antimicrob Chemother 2016;71(suppl 2):ii31-6

Maertens JA, Blennow O, Duarte RF, et al. The current management landscape: aspergillosis. J Antimicrob Chemother 2016;71(suppl 2):ii23-9

Manning ML, Pfeiffer J, Larson EL. Combating antibiotic resistance: The role of nursing in antibiotic stewardship. Am J Infect Control 2016 (published online Aug 31)

Markley JD, Pakyz A, Bernard S, et al. A survey to optimize the design of an antimicrobial stewardship smartphone app at an academic medical center. Am J Infect Control 2016 (published online Nov 9)

Martin CM. Implementing an antimicrobial stewardship program. Consult Pharm 2016;31(10)532-9

Mauffrey V, Kivits J, Pulcini C, et al. Perception of acceptable antibiotic stewardship strategies in outpatient settings. Med Mal Infect 2016 (published online Jul 27)

Mayor S. Improving outcomes in the management of Gram-negative bacterial infections in the face of growing antimicrobial resistance. Future Microbiol 2016 (published online Sep 29)

McGowan JE Jr. The 2016 Garrod Lecture: The role of the healthcare epidemiologist in antimicrobial chemotherapy-a view from the USA. J Antimicrob Chemother 2016 Sep;71(9):2370-8

Mendelson M, Dar OA, Hoffman SJ, et al. A global antimicrobial conservation fund for low- and middle-income countries. Int J Infect Dis 2016 (published online Sep 16)

Mendelson M, Rottingen JA, Gopinathan U, et al. Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries. Lancet 2016 Jan 9;387(10014):188-98

Morgan DJ, Croft LD, Deloney V, et al. Choosing wisely in healthcare epidemiology and antimicrobial stewardship. Infect Control Hosp Epidemiol 2016 Mar;37(7):755-60

Munoz P, Bouza E. The current treatment landscape: the need for antifungal stewardship programmes. J Antimicrob Chemother 2016;71(suppl 2):ii5-12

Olans RN, Olans RD, DeMaria A Jr. The critical role of the staff nurse in antimicrobial stewardship — unrecognized, but already there. Clin Infect Dis 2016 Jan 1;62(1):84-9

Outterson K, McDonnell A. Funding antibiotic innovation with vouchers: recommendations on how to strengthen a flawed incentive policy. Health Aff (Millwood) 2016 May 1;35(5):784-90

Padayatchi N, Mahomed S, Loveday M, et al. Antibiotic stewardship for drug resistant tuberculosis. Expert Opin Pharmacother 2016 (published online Aug 23)

Pakyz AL, Harpe SE. Takin' it to the streets: antimicrobial stewardship in the outpatient setting. J Am Pharm Assoc (2003) 2016 Nov-Dec;56(6):608-9

Pammett RT, Ridgewell A. Development of an antimicrobial stewardship program in a rural and remote health authority. Can J Hosp Pharm 2016 Jul-Aug;69(4):333-4

Pisano J, Pettit N, Bartlett A, et al. Social media as a tool for antimicrobial stewardship. Am J Infect Control 2016 Nov 1;44(11):1231-6

Pollack LA, Plachouras D, Sinkowitz-Cochran R, et al. A concise set of structure and process indicators to assess and compare antimicrobial stewardship programs among EU and US hospitals: results from a multinational expert panel. Infect Control Hosp Epidemiol 2016 Oct;37(10):1201-11

Pollack LA, van Santen KL, Weiner LM, et al. Antibiotic stewardship programs in U.S. acute care hospitals: findings from the 2014 National Healthcare Safety Network (NHSN) Annual Hospital Survey. Clin Infect Dis 2016 (published online May 19)

Premanandh J, Samara BS, Mazen AN. Race against antimicrobial resistance requires coordinated action — an overview. Front Microbiol 2016 Feb;6:1536

Principi N, Esposito S. Antimicrobial stewardship in paediatrics. BMC Infect Dis 2016 Aug 18;16(1):424

Queenan K, Hasler B, Rushton J. A One Health approach to antimicrobial resistance surveillance: is there a business case for it? Int J Antimicrob Agents 2016 Oct;48(4):422-7

Rawson TM, Butters TP, Moore LS, et al. Exploring the coverage of antimicrobial stewardship across UK clinical postgraduate training curricula. J Antimicrob Chemother 2016 (published online Jul 17)

Rawson TM, Charani E, Prockter Moore LS, et al. Mapping the decision pathways of acute infection management in secondary care among UK medical physicians: a qualitative study. BMC Med 2016 (published online Dec 12)

Rawson TM, Moore LS, Gilchrist MJ, et al. Antimicrobial stewardship: are we failing in cross-specialty clinical engagement? J Antimicrob Chemother 2016 Feb;71(2):554-9

Rawson TM, Moore LSP, Gill D, et al. Promoting medical student engagement with antimicrobial stewardship through involvement in undergraduate research. J Infect 2016 (published online Aug 30)

Safdar N, Sengupta S, Musuuza JS, et al. Status of the prevention of multidrug-resistant organisms in international settings: a survey of the Society for Healthcare Epidemiology of America research network. Infect Control Hosp Epidemiol 2016 (published online Nov 7)

Sartelli M, Duane TM, Catena F, et al. Antimicrobial stewardship: a call to action for surgeons. Surg Infect (Larchmt) 2016 (published online Nov 9)

Schellack N, Pretorius R, Messina AP. ‘Esprit de corps’: towards collaborative integration of pharmacists and nurses into antimicrobial stewardship programmes in South Africa. S Afr Med J 2017 (published online Sep 23)

Stewardship: Interventions

(Pre-authorization and/or prospective audit with feedback, education, facility-specific guidelines for common infectious disease syndromes, interventions for patients with specific infectious disease syndromes, CDI risk reduction, prescriber-led review [eg, antibiotic stop orders, antibiotic timeouts], computerized clinical support systems, antibiotic cycling)

Recently Added
2017
2016

2015
2014
2013
2012
2011
2010
2000-2009 

Recently Added

Chavada R, Walker HN, Tong D, et al. Changes in antimicrobial prescribing behavior after the introduction of the antimicrobial stewardship program: a pre- and post-intervention survey. Infect Dis Rep 2017 (published online Oct 2)

Deckx L, Anthierens S, Magin PJ, et al. Focus on early-career GPs: qualitative evaluation of a multi-faceted educational intervention to improve antibiotic prescribing. Fam Pract 2017 (published online Jul 17)

Eljaaly K, Elarabi S, Alshehri S, et al. Impact of requiring re-authorization of restricted antibiotics on day 3 of therapy. J Antimicrob Chemother 2017 (published online Oct 25)

McIsaac MJ, Moineddin R, Gagyor I, et al. External validation study of a clinical decision aid to reduce unnecessary antibiotic prescriptions in women with acute cystitis. BMC Fam Pract 2017 (published online Oct 2)

Molayi A, Kirk A, Markley J, et al. Description of a restriction program for gram-positive antimicrobial agents at an academic medical center. Am J Infect Control 2017 (published online Oct 12)

Murri R, Taccari F, Spanu T, et al. A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections. Eur J Clin Microbiol Infect Dis 2017 (published online Oct 19)

So M, Husain S, Nakamachi Y, et al. Implementing antimicrobial stewardship-oriented guidelines using a change management approach: the example of febrile neutropenia. J Antimicrob Steward 2017;1(1): 38-48

Zhou Y, Lynch JB, Pottinger PS, et al. University of Washington tele-antimicrobial stewardship program (UW-TASP/ECHO): collaboration across Washington state to improve antimicrobial use. Open Forum Infect Dis 2017 (published online Oct 4)

Back to top

2017

Abdallah M, Badawi M, Faisal Amirah M et al. Impact of carbapenem restriction on the antimicrobial susceptibility pattern of Pseudomonas aeruginosa isolates in the ICU. J Antimicrob Chemother 2017 (published online Aug 4)

Al Mohajer M, Matthias KR, Nix DE. Improving the knowledge of students and physicians regarding appropriate use of antibiotics for respiratory infections through an online educational module. Am J Infect Control 2017 Jan 1;45(1):e15-7

Al-Tawfiq JA, Alawami AH. A multifaceted approach to decrease inappropriate antibiotic use in a pediatric outpatient clinic. Ann Thorac Med 2017 Jan-Mar;12(1):51-4

Barlow G, Patterson J, Stultz J, et al. Associations between antimicrobial stewardship program elements and Clostridium difficile infection performance. Am J Infect Control 2017 (published online Jul 28)

Baur D, Gladstone BP, Burkert F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis 2017 (published online Jun 16)

Beerlage-de Jong N, Wentzel J, Hendrix R, et al. The value of participatory development to support antimicrobial stewardship with a clinical decision support system. Am J Infect Control 2017 (published online Jan 12)

Bond SE, Boutlis CS, Yeo WW, et al. Impact of an antimicrobial stewardship intervention on appropriateness of prescribing for community-acquired pneumonia in an Australian regional hospital. Intern Med J 2017 May;47(5):582-5

Bookstaver PB, Nimmich EB, Smith III TJ, et al. Cumulative effect of an antimicrobial stewardship and rapid diagnostic testing bundle on early streamlining of antimicrobial therapy in gram-negative bloodstream infections. Antimicrob Agents Chemother 2017 (published online Jun 19)

Boyles TH, Naicker V, Rawoot N, et al. Sustained reduction in antibiotic consumption in a South African public sector hospital: four-year outcomes from the Groote Schuur Hospital antibiotic stewardship programme. S Afr Med J 2017;107(2)

Buehrle K, Pisano J, Han Z, et al. Guideline compliance and clinical outcomes among patients with Staphylococcus aureus bacteremia with infectious diseases consultation in addition to antimicrobial stewardship-directed review. Am J Infect Control 2017 (published online Apr 18)

Burston J, Adhikari S, Hayen A, et al. A role for antimicrobial stewardship in clinical sepsis pathways: a prospective interventional study. Infect Control Hosp Epidemiol 2017 (published online Jul 11)

Campbell TJ, Decloe M, Gill S, et al. Every antibiotic, every day: maximizing the impact of prospective audit and feedback on total antibiotic use. PLoS One 2017 (published online May 31)

Chang YY, Chen HP, Lin CW, et al. Implementation and outcomes of an antimicrobial stewardship program: effectiveness of education. J Chin Med Assoc 2017 (published online Apr 12)

Charani E, Gharbi M, Moore LSP, et al. Effect of adding a mobile health intervention to a multimodal antimicrobial stewardship programme across three teaching hospitals: an interrupted time series study. J Antimicrob Chemother 2017 (published online Feb 28)

Chavada R, Walker HN, Tong D, et al. Changes in antimicrobial prescribing behavior after the introduction of the antimicrobial stewardship program: a pre- and post-intervention survey. Infect Dis Rep 2017 (published online Oct 2)

Cheung A, Karmali G, Noble S, et al. Antimicrobial stewardship initiative in treatment of urinary tract infections at a rehabilitation and complex continuing care hospital. Can J Hosp Pharm 2017 (published online Apr 28)

Chung P, Scandlyn J, Dayan PS, et al. Working at the intersection of context, culture, and technology: provider perspectives on antimicrobial stewardship in the emergency department using electronic health record clinical decision support. Am J Infect Control 2017 (published online Jul 12)

Conway EL, Sellick JA, Horey A, et al. Decreased mortality in patients prescribed vancomycin after implementation of antimicrobial stewardship program. Am J Infect Control 2017 (published online Jul 21)

Dassner AM, Girotto JE. Evaluation of a second-sign process for antimicrobial prior authorization. J Pediatric Infect Dis Soc 2017 (published online Apr 12)

Davey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2017 (published online Feb 9)

Davido B, Bouchand F, Dinh A, et al. Reinforcement of an antimicrobial stewardship task force aims at a better use of antibiotics of last resort: the COLITIFOS study. Int J Antimicrob Agents 2017 (published online Jul 8)

Deckx L, Anthierens S, Magin PJ, et al. Focus on early-career GPs: qualitative evaluation of a multi-faceted educational intervention to improve antibiotic prescribing. Fam Pract 2017 (published online Jul 17)

del Arco A, Olalla J, de la Torre J, et al. Results of an early intervention programme for patients with bacteraemia: analysis of prognostic factors and mortality. BMC Infect Dis 2017 (published online May 22)

Dingle KE, Didelot X, Quan TP, et al. Effects of control interventions on Clostridium difficile infection in England: an observational study. Lancet Infect Dis 2017 (published online Jan 24)

Dinh A, Duran C, Davido B, et al. Impact of an antimicrobial stewardship program to optimize antimicrobial use for outpatients at emergency department. J Hosp Infect 2017 (published online Jul 8)

Dumkow LE, Beuschel TS, Brandt KL. Expanding antimicrobial stewardship to urgent care centers through a pharmacist-led culture follow-up program. Infect Dis Ther 2017 (published online Aug 29)

Eljaaly K, Elarabi S, Alshehri S, et al. Impact of requiring re-authorization of restricted antibiotics on day 3 of therapy. J Antimicrob Chemother 2017 (published online Oct 25)

Farber J, Illiger S, Berger F, et al. Management of a cluster of Clostridium difficile infections among patients with osteoarticular infections. Antimicrob Resist Infect Control 2017 (published online Feb 15)

Foolad F, Nagel JL, Eschenauer G, et al. Disease-based antimicrobial stewardship: a review of active and passive approaches to patient management. J Antimicrob Chemother 2017 (published online Aug 17)

Freeman T, Eschenauer G, Patel T, et al. Evaluating the need for antibiotic stewardship prospective audit and feedback on weekends. Infect Control Hosp Epidemiol 2017 (published online Aug 22)

Giacobbe DR, Del Bono V, Mikulska M, et al. Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in northern Italy. Infection 2017 (published online Aug 30)

Gibbons JA, Smith HL, Kumar SC, et al. Antimicrobial stewardship in the treatment of skin and soft tissue infections. Am J Infect Control 2017 (published online Jul 18)

Goff DA, Karam GH, Haines ST. Impact of a national antimicrobial stewardship mentoring program: insights and lessons learned. Am J Health Syst Pharm 2017 (published online Jan 12)

Goodlet KJ, Nailor MD. Necessity of carbapenem use when prescribed per infectious diseases specialists. Diagn Microbiol Infect Dis 2017 (published online Feb 27)

Hersh AL, Olson J, Stockman C, et al. Impact of antimicrobial stewardship for pediatric outpatient parenteral antibiotic therapy. J Pediatric Infect Dis Soc 2017 (published online May 26)

Horikoshi Y, Suwa J, Higuchi H, et al. Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality. Int J Infect Dis 2017 (published online Sep 20)

Hoshina T, Yamamoto N, Ogawa M, et al. The efficacy of the direct clinical intervention for infectious diseases by a pediatric infectious disease specialist in the pediatric ward of a tertiary medical facility without a pediatric antimicrobial stewardship program. Eur J Clin Microbiol Infect Dis 2017 (published online Mar 10)

Housman E, Livings SE, Knee A, et al. Improving management of hospitalized adults with uncomplicated cellulitis or cutaneous abscess. Open Forum Infect Dis 2017 (published online Jun 20)

Hughes J, Huo X, Falk L, et al. Benefits and unintended consequences of antimicrobial de-escalation: implications for stewardship programs. PLoS One 2017 (published online Feb 9)

Jeffs L, Law MP, Zahradnik M, et al. Engaging nurses in optimizing antimicrobial use in ICUs: a qualitative study. J Nurs Care Qual 2017 (published online Aug 24)

Jones JM, Leedahl ND, Losing A, et al. A pilot study for antimicrobial stewardship post-discharge. J Pharm Pract 2017 (published online Jan 1)

Kallel H, Abboud P, Nkouka S, et al. Effectiveness of post-prescription antibiotic stewardship to reduce carbapenems consumption: a quantitative study. J Hosp Infect 2017 (published online Aug 10)

Kaufman AJ, McCready J, Powis J. Impact of a multifaceted antimicrobial stewardship program: a front-line ownership driven quality improvement project in a large urban emergency department. CJEM. 2017 (published online Apr 12)

Kreitmeyr K, von Both U, Pecar A, et al. Pediatric antibiotic stewardship: successful interventions to reduce broad-spectrum antibiotic use on general pediatric wards. Infection 2017 (published online Apr 10)

Kuzniewicz MW, Puopolo KM, Fischer A, et al. A quantitative, risk-based approach to the management of neonatal early-onset sepsis. JAMA Pediatr 2017 (published online Feb 20)

Lambl BB, Kaufman N, Kurowski J, et al. Does electronic stewardship work? J Am Med Inform Assoc 2017 (published online Mar 21)

Lee BJ, Rao SN, Wang SK, et al. Implementation of a cefazolin-based stewardship pathway for methicillin-susceptible Staphylococcus aureus bloodstream infections paired with infectious diseases consultation. Int J Antimicrob Agents 2017 (published online Mar 6)

Li Z, Cheng B, Zhang K, et al. Pharmacist-driven antimicrobial stewardship in intensive care units in east China: a multicenter prospective cohort study. Am J Infect Control 2017 (published online Jun 5)

Libertin CR, Watson SH, Tillett WL, et al. Dramatic effects of a new antimicrobial stewardship program in a rural community hospital. Am J Infect Control 2017 (published online May 16)

Lighter-Fisher J, Desai S, Stachel A, et al. Implementing an inpatient pediatric prospective audit and feedback antimicrobial stewardship program within a larger medical center. Hosp Pediatr 2017 (published online Aug 16)

Lockwood AR, Bolton NS, Winton MD, et al. Formalization of an antimicrobial stewardship program in a small community hospital. Am J Health Syst Pharm 2017 Sep 1;74(17 Suppl 3):S52-S60

Losier M, Ramsey TD, Wilby KJ, et al. A systematic review of antimicrobial stewardship interventions in the emergency department. Ann Pharmacother 2017 (published online May 1)

Lowe CF, Payne M, Puddicombe D, et al. Antimicrobial stewardship for hospitalized patients with viral respiratory tract infections. Am J Infect Control 2017 (published online May 16)

Lucas M, Germain JM, Remy E, et al. Reassessment of antibiotic therapy in hospitals. Med Mal Infect 2017 (published online May 24)

Lukaszewicz Bushen J, Mehta JM, Hamilton KW, et al. Impact of two different antimicrobial stewardship methods on frequency of streamlining antimicrobial agents in patients with bacteremia. Infect Control Hosp Epidemiol 2017 Jan;38(1):89-95

MacDougall C, Schwartz BS, Kim L, et al. An interprofessional curriculum on antimicrobial stewardship improves knowledge and attitudes toward appropriate antimicrobial use and collaboration. Open Forum Infect Dis 2017 (published online Jan 31)

McCoy D, Sebti R, Kuyumijian AG. An evaluation of selected indications and appropriateness of ampicillin/sulbactam, an unrestricted antimicrobial, at a single center. P T 2017 Mar;42(3):189-94

McIntyre MT, Naik L, Bell CM, et al. The development and assessment of a physician-specific antibiotic usage and spectrum feedback tool. Open Forum Infect Dis 2017 (published online Jun 17)

McIsaac MJ, Moineddin R, Gagyor I, et al. External validation study of a clinical decision aid to reduce unnecessary antibiotic prescriptions in women with acute cystitis. BMC Fam Pract 2017 (published online Oct 2)

Messacar K, Campbell K, Pearce K, et al. A handshake from antimicrobial stewardship opens doors for infectious disease consultations. Clin Infect Dis 2017 (published online Feb 10)

Molayi A, Kirk A, Markley J, et al. Description of a restriction program for gram-positive antimicrobial agents at an academic medical center. Am J Infect Control 2017 (published online Oct 12)

Mukhopadhyay A, Maliapen M, Ong V, et al. Community-acquired pneumonia case validation in an anonymized electronic medical record–linked expert system. Clin Infect Dis 2017 May;64(suppl 2):S141-S144

Murri R, Taccari F, Spanu T, et al. A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections. Eur J Clin Microbiol Infect Dis 2017 (published online Oct 19)

Mutters NT, De Angelis G, Restuccia G, et al. Use of evidence-based recommendations in an antibiotic care bundle for the intensive care unit. Int J Antimicrob Agents 2017 (published online Jul 10)

Ng TM, Phang VY, Young B, et al. Clinical impact of non-antibiotic recommendations by a multi-disciplinary antimicrobial stewardship team. Int J Antimicrob Agents 2017 (published online Jun 15)

Nori P, Madaline T, Munjal I, et al. Developing interactive antimicrobial stewardship and infection prevention curricula for diverse learners: a tailored approach. Open Forum Infect Dis 2017 (published online Jul 21)

Ohashi K, Matsuoka T, Shinoda Y, et al. Effectiveness of a computer-facilitated, pharmacist-driven antimicrobial stewardship program for infection management. Yakugaku Zasshi 2017;137(5):643-50

Patros C, Sabol M, Paniagua A, et al. Implementation and evaluation of an algorithm-based order set for the outpatient treatment of urinary tract infections in the spinal cord injury population in a VA Medical Center. J Spinal Cord Med 2017 (published online Jun 2)

Pitiriga V, Vrioni G, Saroglou G, et al. The impact of antibiotic stewardship programs in combating quinolone resistance: a systematic review and recommendations for more efficient interventions. Adv Ther 2017 (published online Mar 16)

Polinski JM, Harmon SL, Henderson KJ, et al. Antibiotic stewardship in the retail clinic setting: implementation in 1100 clinics nationwide. Healthc (Amst) 2017 (published online Jul 5)

Rattanaumpawan P, Chuenchom N, Thamlikitkul V, et al. Individual feedback to reduce inappropriate antimicrobial prescriptions for treating acute upper respiratory tract infections in an outpatient setting of a Thai university hospital. J Glob Antimicrob Resist 2017 (published online Sep 5)

Rawson TM, Moore LSP, Tivey AM, et al. Behaviour change interventions to influence antimicrobial prescribing: a cross-sectional analysis of reports from UK state-of-the-art scientific conferences. Antimicrob Resist Infect Control 2017 (published online Jan 13)

Rizan C, Phee J, Boardman C, et al. General surgeon's antibiotic stewardship: climbing the Rogers diffusion of innovation curve. Int J Surg 2017 (published online Feb 20)

Rogers PM, Demonchy E, Risso K, et al. Medical table: A major tool for antimicrobial stewardship policy. Med Mal Infect 2017 (published online Apr 27)

Ruiz J, Ramirez P, Gordon M, et al. Antimicrobial stewardship programme in critical care medicine: a prospective interventional study. Med Intensiva 2017 (published online Sep 4)

Saha D, Patel J, Buckingham D, et al. Urine culture follow-up and antimicrobial stewardship in a pediatric urgent care network. Pediatrics 2017 (published online Mar 16)

Saliba-Gustafsson EA, Borg MA, Rosales-Klintz S, et al. Maltese Antibiotic Stewardship Programme in the Community (MASPIC): protocol of a prospective quasiexperimental social marketing intervention. BMJ Open 2017 (published online Sep 24)

Schmitt C, Lacerda RA, Turrini RNT, et al. Improving compliance with surgical antibiotic prophylaxis guidelines: a multicenter evaluation. Am J Infect Control 2017 (published online Jun 16)

Schwartz DN, McConeghy KW, Lyles RD, et al. Computer-assisted antimicrobial recommendations for optimal therapy: analysis of prescribing errors in an antimicrobial stewardship trial. Infect Control Hosp Epidemiol 2017 (published online Jun 2)

Shah KB, Rimawi RH, Mazer MA, et al. Can a collaborative subspecialty antimicrobial stewardship intervention have lasting effects? Infection 2017 (published online Jul 19)

Siegfried J, Merchan C, Scipione MR, et al. Role of postgraduate year 2 pharmacy residents in providing weekend antimicrobial stewardship coverage in an academic medical center. Am J Health Syst Pharm 2017 Mar 15;74(6):417-23

Sikkens JJ, van Agtmael MA, Peters EJG, et al. Behavioral approach to appropriate antimicrobial prescribing in hospitals: the Dutch unique method for antimicrobial stewardship (DUMAS) participatory intervention study. JAMA Intern Med 2017 (published online May 1)

So M, Husain S, Nakamachi Y, et al. Implementing antimicrobial stewardship-oriented guidelines using a change management approach: the example of febrile neutropenia. J Antimicrob Steward 2017;1(1): 38-48

Sobolewski K, Costello J, Miller L. Development of antibiotic stewardship practices targeting urinary tract infections in a hospital with consultant-based infectious disease services. P T 2017 Aug;42(8):527-32

Swe Swe-Han K, Mlisana KP, Pillay M. Analysis of clinical and microbiological data on Acinetobacter baumannii strains assist the preauthorization of antibiotics at the patient level for an effective antibiotic stewardship program. J Infect Public Health 2017 (published online Feb 22)

Trupka T, Fisher K, Micek ST, et al. Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study. Crit Care 2017 (published online Jul 15)

Turner RB, Valcarlos E, Loeffler AM, et al. Impact of an antimicrobial stewardship program on antibiotic use at a nonfreestanding children's hospital. J Pediatric Infect Dis Soc 2017 Sep;6(3):e36-e40

Tuon FF, Gasparetto J, Wollmann LC, et al. Mobile health application to assist doctors in antibiotic prescription—an approach for antibiotic stewardship. Braz J Infect Dis 2017 (published online Sep 20)

van Daalen FV, Lagerburg A, de Kort J, et al. Implementation of an antibiotic checklist increased appropriate antibiotic use in the hospital on Aruba. Int J Infect Dis 2017 (published online Mar 24)

Viale P, Tedeschi S, Scudeller L, et al. Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department. Clin Infect Dis 2017 (published online Jun 12)

Walsh TL, Bremmer DN, Moffa MA, et al. Effect of antimicrobial stewardship program guidance on the management of uncomplicated skin and soft tissue infections in hospitalized adults. Mayo Clin Proc 2017 (published online Jun 21)

Wenzler E, Goff DA, Humphries R, et al. Anticipating the unpredictable: a review of antimicrobial stewardship and Acinetobacter infections. Infect Dis Ther 2017 (published online Mar 4)

Wenzler E, Wang F, Goff D, et al. An automated, pharmacist-driven initiative improves quality of care for Staphylococcus aureus bacteremia. Clin Infect Dis 2017 (published online Apr 4)

Yamada T, Kagami K, Imai S, et al. Improved clinical outcomes in patients with positive blood culture by proactive intervention of antimicrobial use-impact of antimicrobial stewardship program implementation on clinical practice.Yakugaku Zasshi 2017;137(7):917-25

Yeung EYH, Alexander M. Use of junior doctor-led peer education to improve antibiotic stewardship. Br J Clin Pharmacol 2017 (published online Aug 11)

Yogo N, Shihadeh K, Young H, et al. Intervention to reduce broad-spectrum antibiotics and treatment durations prescribed at the time of hospital discharge: a novel stewardship approach. Infect Control Hosp Epidemiol 2017 (published online Mar 6)

Zhang HH, Du Y, Liu W, et al. Effectiveness of antibiotic use management in Tianjin (2011-2013): a quasi-experimental study. Med Sci Monit 2017 Feb 9;23:725-31

Zhou Y, Lynch JB, Pottinger PS, et al. University of Washington tele-antimicrobial stewardship program (UW-TASP/ECHO): collaboration across Washington state to improve antimicrobial use. Open Forum Infect Dis 2017 (published online Oct 4)

Back to top

2016

Alawi MM, Darwesh, BM. A stepwise introduction of a successful antimicrobial stewardship program. Experience from a tertiary care university hospital in Western, Saudi Arabia. Saudi Med J 2016 Dec;37(12):1341-9

Avent ML, Hansen MP, Gilks C, et al. General practitioner antimicrobial stewardship programme study (GAPS): protocol for a cluster randomised controlled trial. BMC Fam Pract 2016 Apr 21;17:48

Beaudoin M, Kabanza F, Nault V, et al. Evaluation of a machine learning capability for a clinical decision support system to enhance antimicrobial stewardship programs. Artif Intell Med 2016 Mar;68:29-36

Beaulac K, Corcione S, Epstein L, et al. Antimicrobial stewardship in a long-term acute care hospital using offsite electronic medical record audit. Infect Control Hosp Epidemiol 2016 Apr;37(4):433-9

Bhalla N, Hussein N, Atari M, et al. Introducing an antibiotic stewardship program in a humanitarian surgical hospital. Am J Infect Control 2016 (published online May 17)

Boel J, Andreasen V, Jarlov JO, et al. Impact of antibiotic restriction on resistance levels of Escherichia coli: a controlled interrupted time series study of a hospital-wide antibiotic stewardship programme. J Antimicrob Chemother 2016 Jul;71(7):2047-51

Bond SE, Boutlis CS, Jansen SG, et al. Discontinuation of peri-operative gentamicin use for indwelling urinary catheter manipulation in orthopaedic surgery. ANZ J Surg 2016 (published online Jun 3)

Bond SE, Boutlis CS, Yeo WW, et al. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting. J Hosp Infect 2016 (published online Dec 18)

Borde JP, Nussbaum S, Hauser S, et al. Implementing an intensified antibiotic stewardship programme targeting daptomycin use in orthopaedic surgery: a cost-benefit analysis from the hospital perspective. Infection 2016 Jun;44(3):301-7

Bouchand F, Dinh A, Roux AL, et al. Implementation of a simple innovative organisation for post-prescription antibiotic review based on computerized tools with shared access. J Hosp Infect 2016 (published online Nov 26)

Brigg Turner R, Valcarlos E, Loeffler AM, et al. Impact of an antimicrobial stewardship program on antibiotic use at a nonfreestanding children's hospital. J Pediatric Infect Dis Soc 2016 (published online Oct 21)

Brink AJ, Messina AP, Feldman C, et al. Antimicrobial stewardship across 47 South African hospitals: an implementation study. Lancet Infect Dis 2016 (published online Jun 13)

Brink AJ, Messina AP, Feldman C, et al. From guidelines to practice: a pharmacist-driven prospective audit and feedback improvement model for peri-operative antibiotic prophylaxis in 34 South African hospitals. J Antimicrob Chemother 2016 (published online Dec 19)

Broom J, Broom A, Plage S, et al. Barriers to uptake of antimicrobial advice in a UK hospital: a qualitative study. J Hosp Infect 2016 (published online Mar 26)

Brumley PE, Malani AN, Kabara JJ, et al. Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection. J Antimicrob Chemother 2016 Mar;71(3):836-40

Cai Y, Shek PY, Teo I, et al. A multidisciplinary antimicrobial stewardship programme safely decreases the duration of broad-spectrum antibiotic prescription in Singaporean adult renal patients. Int J Antimicrob Agents 2016 Jan;47(1):91-6

Cai T, Verze P, Brugnolli A, et al. Adherence to European Association of Urology guidelines on prophylactic antibiotics: an important step in antimicrobial stewardship. Eur Urol 2016 Feb;69(2):276-83

Cairns KA, Bortz HD, Le A, et al. ICU antimicrobial stewardship (AMS) rounds: the daily activities of an AMS service. Int J Antimicrob Agents 2016 (published online Sep 7)

Cairns KA, Doyle JS, Trevillyan JM, et al. The impact of a multidisciplinary antimicrobial stewardship team on the timeliness of antimicrobial therapy in patients with positive blood cultures: a randomized controlled trial. J Antimicrob Chemother 2016 (published online Aug 2)

Cao H, Phe K, Laine GA, et al. An institutional review of antimicrobial stewardship interventions. J Glob Antimicrob Resist 2016 May 4;6:75-7

Carbo JF, Ruh CA, Kurtzhalts KE, et al. Male veterans with complicated urinary tract infections: Influence of a patient-centered antimicrobial stewardship program. Am J Infect Control 2016 (published online Jul 4)

Chen IL, Lee CH, Su LH, et al. Effects of implementation of an online comprehensive antimicrobial-stewardship program in ICUs: a longitudinal study. J Microbiol Immunol Infect 2016 (published online Jul 29)

Cheng CY, Lee CY, Wu MW, et al. Prospective antimicrobial audit and feedback did not decrease case fatality: experiences from a hospital in northern Taiwan. J Infect Dev Ctries 2016 Apr 28;10(4):395-9

Cheon S, Kim MJ, Yun SJ, et al. Controlling endemic multidrug-resistant Acinetobacter baumannii in intensive care units using antimicrobial stewardship and infection control. Korean J Intern Med 2016 Mar;31(2):367-74

Chow AL, Ang A, Chow CZ, et al. Implementation hurdles of an interactive, integrated, point-of-care computerised decision support system for hospital antibiotic prescription. Int J Antimicrob Agents 2016 Feb;47(2):132-9

Collins CD, Kabara JJ, Michienzi SM, et al. Impact of an antimicrobial stewardship care bundle to improve the management of patients with suspected or confirmed urinary tract infection. Infect Control Hosp Epidemiol 2016 (published online Aug 30)

Cresswell K, Mozaffar H, Shah S, et al. A systematic assessment of review to promoting the appropriate use of antibiotics through hospital electronic prescribing systems. Int J Pharm Pract 2016 (published online May 20)

Dassner AM, Nicolau DP, Girotto JE. Management of pneumonia in the pediatric critical care unit: an area for antimicrobial stewardship. Curr Pediatr Rev 2016 (published online Dec 4)

DiDiodato G, McArthur L. Evaluating the effectiveness of an antimicrobial stewardship program on reducing the incidence rate of healthcare-associated Clostridium difficile infection: a non-randomized, stepped wedge, single-site, observational study. PLoS One 2016 Jun 16;11(6):e0157671

DiDiodato G, McArthur L, Beyene J, et al. Evaluating the impact of an antimicrobial stewardship program on the length of stay of immune-competent adult patients admitted to a hospital ward with a diagnosis of community-acquired pneumonia: a quasi-experimental study. Am J Infect Control 2016 May 1;44(5):e73-9

Elouafkaoui P, Young L, Newlands R, et al. An audit and feedback intervention for reducing antibiotic prescribing in general dental practice: the RAPiD cluster randomised controlled trial. PLOS Medicine 2016 (published online Aug 30)

Fleming D, Ali KF, Matelski J, et al. When antimicrobial stewardship isn't watching: the educational impact of critical care prospective audit and feedback. Open Forum Infect Dis 2016 May 30;3(3):ofw115

Ford PA, Anthone JM, Destache CJ, et al. Education and communication in an interprofessional antimicrobial stewardship program. J Am Osteopath Assoc 2016 Sep 1;116(9):588-93

Frenette C, Sperlea D, Tesolin J, et al. Influence of a 5-year serial infection control and antibiotic stewardship intervention on cardiac surgical site infections. Am J Infect Control 2016 (published online Apr 25)

Garcia-Martinez L, Gracia-Ahulfinger I, Machuca I. Impact of the PROVAUR stewardship programme on linezolid resistance in a tertiary university hospital: a before-and-after interventional study. J Antimicrob Chemother 2016 (published online May 30)

Giry M, Pulcini C, Rabaud C, et al. Acceptability of antibiotic stewardship measures in primary care. Med Mal Infect 2016 (published online Apr 4)

Goldstein EJ, Goff DA, Reeve W, et al. Approaches to modifying the behavior of clinicians who are noncompliant with antimicrobial stewardship program guidelines. Clin Infect Dis 2016 (published online Apr 20)

Gong S, Qiu X, Song Y, et al. Effect of financially punished audit and feedback in a pediatric setting in China, within an antimicrobial stewardship program, and as part of an international accreditation process. Front Public Health 2016 May;4:99

Graber CJ, Jones MM, Glassman PA, et al. Taking an antibiotic time-out: utilization and usability of a self-stewardship time-out program for renewal of vancomycin and piperacillin-tazobactam. Hosp Pharm 2015 Dec;50(11):1011-24

Grigoryan L, Naik AD, Horwitz D, et al. Survey finds improvement in cognitive biases that drive overtreatment of asymptomatic bacteriuria after a successful antimicrobial stewardship intervention. Am J Infect Control 2016 (published online Jul 7)

Guanche Garcell H, Villanueva Arias A, Pancorbo Sandoval C, et al. Impact of a focused antimicrobial stewardship program in adherence to antibiotic prophylaxis and antimicrobial consumption in appendectomies. J Infect Public Health 2016 (published online Jul 19)

Guerri-Fernandez R, Villar-Garcia J, Herrera-Fernandez S, et al. An antimicrobial stewardship program reduces antimicrobial therapy duration and hospital stay in surgical wards. Rev Esp Quimioter 2016 Jun;29(3):119-22

Haas MK, Dalton K, Knepper BC, et al. Effects of a syndrome-specific antibiotic stewardship intervention for inpatient community-acquired pneumonia. Open Forum Infect Dis 2016 Sep;3(4)

Hallsworth M, Chadborn T, Sallis A, et al. Provision of social norm feedback to high prescribers of antibiotics in general practice: a pragmatic national randomised controlled trial. Lancet 2016 Apr 23;387(10029):1743-52

Hammond DA, Hughes CA, Painter JT, et al. Impact of targeted educational interventions on Clostridium difficile infection treatment in critically ill adults. Hosp Pharm 2016 Dec;51(11):901-6

Hand KS, Cumming D, Hopkins S, et al. Electronic prescribing system design priorities for antimicrobial stewardship: a cross-sectional survey of 142 UK infection specialists. J Antimicrob Chemother 2016 (published online Dec 20)

Hartley SE, Kuhn L, Valley S, et al. Evaluating a hospitalist-based intervention to decrease unnecessary antimicrobial use in patients with asymptomatic bacteriuria. Infect Control Hosp Epidemiol 2016 Sep;37(9):1044-51

Hay AD, Redmond NM, Turnbull S, et al. Development and internal validation of a clinical rule to improve antibiotic use in children presenting to primary care with acute respiratory tract infection and cough: a prognostic cohort study. Lancet Respir Med 2016 (published online Sep 1)

Heath B, Bernhardt J, Michalski TJ, et al. Results of a Veterans Affairs employee education program on antimicrobial stewardship for older adults. Am J Infect Control 2016 Mar 1;44(3):349-51

Hemkens LG, Saccilotto R, Reyes SL, et al. Personalized prescription feedback using routinely collected data to reduce antibiotic use in primary care: a randomized clinical trial. JAMA Intern Med 2016 (published online Dec 27)

Hoffmann C, Zak M, Avery L, et al. Treatment modalities and antimicrobial stewardship initiatives in the management of intra-abdominal infections. Antibiotics (Basel) 2016 Mar;5(1):11

Hogli JU, Garcia BH, Skjold F, et al. An audit and feedback intervention study increased adherence to antibiotic prescribing guidelines at a Norwegian hospital. BMC Infect Dis 2016 Feb 27;16(1):96

Horikoshi Y, Higuchi H, Suwa J, et al. Impact of computerized pre-authorization of broad spectrum antibiotics in Pseudomonas aeruginosa at a children's hospital in Japan. J Infect Chemother 2016 Aug;22(8):532-5

Hsueh K, Reyes M, Krekel T, et al. Effective antibiotic conservation by emergency antimicrobial stewardship during a drug shortage. Infect Control Hosp Epidemiol 2016 (published online Dec 5)

Huang SF, Chang JS, Sheu CC, et al. An antibiotic decision-making tool for patients with pneumonia admitted to a medical intensive care unit. Int J Antimicrob Agents 2016 Sep;48(3):286-91

Huh K, Chung DR, Park HJ, et al. Impact of monitoring surgical prophylactic antibiotics and a computerized decision support system on antimicrobial use and antimicrobial resistance. Am J Infect Control 2016 (published online Mar 11)

Hurst AL, Child J, Pearce K, et al. Handshake stewardship: a highly effective rounding-based antimicrobial optimization service. Pediatr Infect Dis J 2016 (published online May 31)

Ironmonger D, Edeghere O, Gossain S, et al. Use of antimicrobial resistance information and prescribing guidance for management of urinary tract infections: survey of general practitioners in the West Midlands. BMC Infect Dis 2016 May 24;16(1):226

Issa N, Pedeboscq S, Le Quellec F, et al. Proper use of carbapenems: role of the infectious disease specialist. Med Mal Infect 2016 Feb;46(1):10-3 

Jaszczur GR, Adams KK, Cabie M, et al. Formulary stewardship as a novel training method for postgraduate pharmacy practice residents. Hosp Pharm 2016 Dec;51(11):869-76

Jones M, Butler J, Graber CJ, et al. Think twice: a cognitive perspective of an antibiotic timeout intervention to improve antibiotic use. J Biomed Inform 2016 (published online Jun 17)

Kandel CE, Gill S, McCready J, et al. Reducing co-administration of proton pump inhibitors and antibiotics using a computerized order entry alert and prospective audit and feedback. BMC Infect Dis 2016 (published online Jul 22)

Kim M, Song KH, Kim CJ, et al. Electronic alerts with automated consultations promote appropriate antimicrobial prescriptions. PLoS One 2016 Aug 17;11(8)

Knox MC, Edye M. Educational antimicrobial stewardship intervention ineffective in changing surgical prophylactic antibiotic prescribing. Surg Infect (Larchmt) 2016 Apr;17(2):224-8

Kurtzhalts KE, Sellick JA Jr, Ruh CA, et al. Impact of antimicrobial stewardship on outcomes in hospitalized veterans with pneumonia. Clin Ther 2016 Jul;38(7):1750-8

Ladenheim D, Cramp E, Patel N. Are current electronic prescribing systems facilitating antimicrobial stewardship in acute National Health Service Hospital Trusts in the East of England? J Hosp Infect 2016 (published Jul 30)

Lai CC, Shi ZY, Chen YH, et al. Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health care-associated infections: A multicenter comparison. J Microbiol Immunol Infect 2016 Feb;49(1):74-82

Lawes T, Lopez-Lozano JM, Nebot CA, et al. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis. Lancet Infect Dis 2016 (published online Nov 4)

Lee KR, Bagga B, Arnold SR. Reduction of broad-spectrum antimicrobial use in a tertiary children's hospital post antimicrobial stewardship program guideline implementation. Pediatr Crit Care Med 2016 Mar;17(3):187-93

Lee BR, Goldman JL, Yu D, et al. Clinical impact of an antibiotic stewardship program at a children's hospital. Infect Dis Ther 2016 (published online Dec 2)

Li DX, Ferrada MA, Avdic E, et al. Sustained impact of an antibiotic stewardship intervention for community-acquired pneumonia. Infect Control and Hosp Epidemiol 2016 (published online Aug 8)

Livorsi DJ, Heintz B, Jacob JT, et al. Audit and feedback processes among antimicrobial stewardship programs: a survey of the society for healthcare epidemiology of America research network. Infect Control Hosp Epidemiol 2016 Jun;37(6):704-6

Lui P, Ohl C, Johnson J, et al. Frequency of empiric antibiotic de-escalation in an acute care hospital with an established antimicrobial stewardship program. BMC Infect Dis 2016 (published online Dec 12)

Ma X, Xie J, Yang Y, et al. Antimicrobial stewardship of Chinese ministry of health reduces multidrug-resistant organism isolates in critically ill patients: a pre-post study from a single center. BMC Infect Dis 2016 (published online Nov 25)

Mack MR, Rohde JM, Jacobsen D, et al. Engaging hospitalists in antimicrobial stewardship: lessons from a multihospital collaborative. J Hosp Med 2016 (published online Apr 30)

Maeda M, Takuma T, Seki H, et al. Effect of interventions by an antimicrobial stewardship team on clinical course and economic outcome in patients with bloodstream infection. J Infect Chemother 2016 Feb;22(2):90-5

Meeker D, Linder JA, Fox CR, et al. Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial. JAMA 2016 Feb 9;315(6):562-70

Micallef C, Kildonaviciute K, Castro-Sanchez E, et al. Patient and public understanding and knowledge of antimicrobial resistance and stewardship in a UK hospital: should public campaigns change focus? J Antimicrob Chemother 2016 (published online Sep 21)

Molloy L, McGrath E, Thomas R, et al. Acceptance of pharmacist-driven antimicrobial stewardship recommendations with differing levels of physician involvement in a children's hospital. Clin Pediatr (Phila) 2016 (published online Nov 20)

Morrill HJ, Caffrey AR, Gaitanis MM, et al. Impact of a prospective audit and feedback antimicrobial stewardship program at a veterans affairs medical center: a six-point assessment. PLoS One 2016 Mar;11(3):e0150795

Nault V, Pepin J, Beaudoin M, et al. Sustained impact of a computer-assisted antimicrobial stewardship intervention on antimicrobial use and length of stay. J Antimicrob Chemother 2016 (published online Dec 20)

Nguyen-Ha PT, Howrie D, Crowley K, et al. A quality assessment of a collaborative model of a pediatric antimicrobial stewardship program. Pediatrics 2016 Apr;137(4):e20150316

Ni Riain U, Tierney M, Doyle C, et al. Targeted de-escalation rounds may effectively and safely reduce meropenem use. Ir J Med Sci 2016 (published online Sep 29)

Panesar P, Jones A, Aldous A, et al. Attitudes and behaviours to antimicrobial prescribing following Introduction of a smartphone App. PLoS One 2016 Apr 25;11(4):e0154202

Pano-Pardo JR, Schuffelmann-Gutierrez C, Escosa-Garcia L, et al. Opportunities to improve antimicrobial use in paediatric intensive care units: a nationwide survey in Spain. Clin Microbiol Infect 2016 Feb;22(2):171-7

Ritchie ND, Irvine SC, Alieen H, et al. Restrictive antibiotic stewardship associated with reduced hospital mortality in gram-negative infection. QJM 2016 (published online Aug 13)

Ross RK, Beus JM, Metjian TA, et al. Safety of automatic end dates for antimicrobial orders to facilitate stewardship. Infect Control Hosp Epidemiol 2016 May 13:1-5

Salahuddin N, Amer L, Joseph M, et al. Determinants of deescalation failure in critically ill patients with sepsis: a prospective cohort study. Crit Care Res Pract 2016 (published online Jul 14)

Sarg M, Waldrop GE, Beier MA, et al. Impact of changes in urine culture ordering practice on antimicrobial utilization in Intensive Care Units at an academic medical center. Infect Control Hosp Epidemiol 2016 Apr;37(4):448-54

Sartelli M, Labricciosa FM, Scoccia L, et al. Non-restrictive antimicrobial stewardship program in a general and emergency surgery unit. Surg Infect (Larchmt) 2016 (published online May )

Shafiq N, Praveen Kumar M, Gautam V, et al. Antibiotic stewardship in a tertiary care hospital of a developing country: establishment of a system and its application in a unit-GASP Initiative. Infection 2016 (published online Jun 20)

Sikkens JJ, van Agtmael MA, Peters EJ, et al. Assessment of appropriate antimicrobial prescribing: do experts agree? J Antimicrob Chemother 2016 (published online Jun 10)

Sing DY, Boo YL, Mukhlis R, et al. Antimicrobial stewardship program in a Malaysian district hospital: first year experience. Pak J Med Sci 2016 Jul-Aug;32(4):999-1004

Tagashira Y, Horiuchi M, Tokuda Y, et al. Antimicrobial stewardship for carbapenem use at a Japanese tertiary care center: An interrupted time series analysis on the impact of infectious disease consultation, prospective audit, and feedback. Am J Infect Control 2016 Jun 1;44(6):708-10

Tamma PD, Avdic E, Keenan JF, et al. What is the more effective antibiotic stewardship intervention: pre-prescription authorization or post-prescription review with feedback? Clin Infect Dis 2016 (published online Dec 7)

Tedeschi S, Trapani F, Gianella M, et al. An antimicrobial stewardship program based on systematic infectious disease consultation in a rehabilitation facility. Infect Control Hosp Epidemiol 2016 (published online Oct 17)

Thompson A, O’Sullivan P, Banham E, et al. Assessing the uptake and effectiveness of a quick reference guide to antibiotic prescribing in Australian general practice. Aust J Prim Health 2016 (published online Jul 8)

Van Hollebeke M, Chapuis C, Bernard S, et al. Compliance with carbapenem guidelines in a university hospital. Med Mal Infect 2016 Mar;46(2):72-8

Vicente M, Al Nahedh M, Parsad S, et al. Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia. J Oncol Pharm Pract 2016 (published online Sep 8)

Warren S, Garcia M, Hankins C. Impact of neonatal early-onset sepsis calculator on antibiotic use within two tertiary healthcare centers. J Perinatol 2016 (published online Dec 22)

Weddle G, Goldman J, Myers A, et al. Impact of an educational intervention to improve antibiotic prescribing for nurse practitioners in a pediatric urgent care center. J Pediatr Health Care 2016 (published online Aug 23)

Wentzel J, van Drie-Pierik R, Nijdam L, et al. Antibiotic information application offers nurses quick support. Am J Infect Control 2016 Jun 1;44(6):677-84

Willis ZI, Gillon J, Xu M, et al. Reducing antimicrobial use in an academic pediatric institution: evaluation of the effectiveness of a prospective audit with real-time feedback. J Ped Infect Dis 2016 (published online Oct 7)

Winchester CC, Chisholm A, Price D. A practical tool for primary care antimicrobial stewardship in children. Lancet Respir Med 2016 (published online Sep 1)

Yeo JM. Antimicrobial stewardship: improving antibiotic prescribing practice in a respiratory ward. BMJ Qual Improv Rep 2016 Jul;5(1)

Zhang X, Rowan N, Pflugeisen BM, et al. Urine culture guided antibiotic interventions: a pharmacist driven antimicrobial stewardship effort in the emergency department. Am J Emerg Med 2016 (published online Dec 15)

Back to top

2015

Anthierens S, Tonkin-Crine S, Cals JW, et al. Clinicians' views and experiences of interventions to enhance the quality of antibiotic prescribing for acute respiratory tract infections. J Gen Intern Med 2015 Apr;30(4):408-16

Arena F, Scolletta S, Marchetti L, et al. Impact of a clinical microbiology-intensive care consulting program in a cardiothoracic intensive care unit. Am J Infect Control 2015 (published online Jun 3)

Bessesen MT, Ma A, Clegg D, et al. Antimicrobial stewardship programs: comparison of a program with infectious diseases pharmacist support to a program with a geographic pharmacist staffing model. Hosp Pharm 2015 Jun;50(6):477-83

Borde JP, Kern WV, Hug M, et al. Implementation of an intensified antibiotic stewardship programme targeting third-generation cephalosporin and fluoroquinolone use in an emergency medicine department. Emerg Med J 2015 Jul;32(7):509-15

Borde JP, Litterst S, Ruhnke M, et al. Implementing an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a 200-bed community hospital in Germany. Infection 2015 Feb;43(1):45-50

Carreno JJ, Kenney RM, Bloome M, et al. Evaluation of pharmacy generalists performing antimicrobial stewardship services. Am J Health Syst Pharm 2015 Aug 1;72(15):1298-303

Chan S, Hossain J, Di Pentima MC. Implications and impact of prior authorization policy on vancomycin use at a tertiary pediatric teaching hospital. Pediatr Infect Dis J 2015 May;34(5):506-8

Chow AL, Ang A, Chow CZ, et al. Implementation hurdles of an interactive, integrated, point-of-care computerised decision support system for hospital antibiotic prescription. Int J Antimicrob Agents 2015 (published online Dec 28)

Chow A, Lye DC, Arah OA. Psychosocial determinants of physicians' acceptance of recommendations by antibiotic computerised decision support systems: a mixed methods study. Int J Antimicrob Agents 2015 Mar;45(3):295-304

Cook PP, Gooch M. Long-term effects of an antimicrobial stewardship programme at a tertiary-care teaching hospital. Int J Antimicrob Agents 2015 Mar;45(3):262-7

Cotta MO, Robertson MS, Marshall C, et al. Implementing antimicrobial stewardship in the Australian private hospital system: a qualitative study. Aust Health Rev 2015 Jun;39(3):315-22

Daneman N, Guttmann A, Wang X, et al. The association of hospital prevention processes and patient risk factors with the risk of Clostridium difficile infection: a population-based cohort study. BMJ Qual Saf 2015 Jul;24(7):435-43

Day SR, Smith D, Harris K, et al. An infectious diseases physician-led antimicrobial stewardship program at a small community hospital associated with improved susceptibility patterns and cost-savings after the first year. Open Forum Infect Dis 2015 May 12;2(2):ofv064

DiDiodato G, McArthur L, Beyene J, et al. Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study. Trials 2015 Aug 14;16:355

Dik JW, Hendrix R, Friedrich AW, et al. Cost-minimization model of a multidisciplinary antibiotic stewardship team based on a successful implementation on a urology ward of an academic hospital. PLoS One 2015 May 8;10(5):e0126106

Dik JW, Hendrix R, Lo-Ten-Foe JR, et al. Automatic day-2 intervention by a multidisciplinary antimicrobial stewardship-team leads to multiple positive effects. Front Microbiol 2015 Jun 3;6:546

Evans RS, Olson JA, Stenehjem E, et al. Use of computer decision support in an antimicrobial stewardship program (ASP). Appl Clin Inform 2015 Mar 3;6(1):120-35

Gauthier TP, Sherman EM, Unger NR. An elective course on antimicrobial stewardship. Am J Pharm Educ 2015 Dec 25;79(10):157

Goldman JL, Lee BR, Hersh AL, et al. Clinical diagnoses and antimicrobials predictive of pediatric antimicrobial stewardship recommendations: a program evaluation. Infect Control Hosp Epidemiol 2015 Jun;36(6):673-80

Hall AB, Montero J, Cobian J, et al. The effects of an electronic order set on vancomycin dosing in the ED. Am J Emerg Med 2015 Jan;33(1):92-4

Hamilton KW, Gerber JS, Moehring R, et al. Point-of-prescription interventions to improve antimicrobial stewardship. Clin Infect Dis 2015 Apr 15;60(8):1252-8

Hernandez-Santiago V, Marwick CA, Patton A, et al. Time series analysis of the impact of an intervention in Tayside, Scotland to reduce primary care broad-spectrum antimicrobial use. J Antimicrob Chemother 2015 Aug;70(8):2397-404

Hingorani R, Mahmood M, Alweis R. Improving antibiotic adherence in treatment of acute upper respiratory infections: a quality improvement process. J Community Hosp Intern Med Perspect 2015 Jun 15;5(3):27472

Kamata K, Suzuki H, Kanemoto K, et al. Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia. J Infect Chemother 2015 Aug;21(8):596-603

Kram JJ, Borlaug G, Safdar N, et al. Development and distribution of educational materials for carbapenem-resistant Enterobacteriaceae among acute and long-term care facilities. WMJ 2015 Apr;114(2):48-51

Lai CC, Shi ZY, Chen YH, et al. Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health care-associated infections: a multicenter comparison. J Microbiol Immunol Infect 2015 (published online Nov 12)

Lawes T, Lopez-Lozano JM, Nebot CA, et al. Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated methicillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study. Lancet Infect Dis 2015 Dec;15(12):1438-49

Lawes T, Lopez-Lozano JM, Nebot C, et al. Turning the tide or riding the waves? Impacts of antibiotic stewardship and infection control on MRSA strain dynamics in a Scottish region over 16 years: non-linear time series analysis. BMJ Open 2015 Mar 26;5(3):e006596

Llewelyn MJ, Hand K, Hopkins S, et al. Antibiotic policies in acute English NHS trusts: implementation of 'Start Smart-Then Focus' and relationship with Clostridium difficile infection rates. J Antimicrob Chemother 2015 Apr;70(4):1230-5

Lesprit P, de Pontfarcy A, Esposito-Farese M, et al. Postprescription review improves in-hospital antibiotic use: a multicenter randomized controlled trial. Clin Microbiol Infect 2015 Feb;21(2):180.e1,180.e7

Liew YX, Lee W, Tay D, et al. Prospective audit and feedback in antimicrobial stewardship: is there value in early reviewing within 48 h of antibiotic prescription? Int J Antimicrob Agents 2015 Feb;45(2):168-73

McCulloh RJ, Queen MA, Lee B, et al. Clinical impact of an antimicrobial stewardship program on pediatric hospitalist practice, a 5-year retrospective analysis. Hosp Pediatr 2015 Oct;5(10):520-7

Mertz D, Brooks A, Irfan N, et al. Antimicrobial stewardship in the intensive care setting--a review and critical appraisal of the literature. Swiss Med Wkly 2015 Dec 21;145:w14220

Messina AP, van den Bergh D, Goff DA. Antimicrobial stewardship with pharmacist intervention improves timeliness of antimicrobials across thirty-three hospitals in South Africa. Infect Dis Ther 2015 Sep;4(Suppl 1):5-14

Micallef C, Aliyu SH, Santos R, et al. Introduction of an antifungal stewardship programme targeting high-cost antifungals at a tertiary hospital in Cambridge, England. J Antimicrob Chemother 2015;70(6):1908-11

Morquin D, Ologeanu-Taddei R, Koumar Y, et al. Implementing a tele-expertise system to optimise the antibiotic use and stewardship: the case of the Montpellier University Hospital (France). Stud Health Technol Inform 2015;210:296-300

Murni IK, Duke T, Kinney S, et al. Reducing hospital-acquired infections and improving the rational use of antibiotics in a developing country: an effectiveness study. Arch Dis Child 2015 May;100(5):454-9

Nguyen CT, Gandhi T, Chenoweth C, et al. Impact of an antimicrobial stewardship-led intervention for Staphylococcus aureus bacteraemia: a quasi-experimental study. J Antimicrob Chemother 2015 Dec;70(12):3390-6

Nilholm H, Holmstrand L, Ahl J, et al. An audit-based, infectious disease specialist-guided antimicrobial stewardship program profoundly reduced antibiotic use without negatively affecting patient outcomes. Open Forum Infect Dis 2015 Mar 23;2(2):ofv042

Okumura LM, Silva MM, Veroneze I. Effects of a bundled antimicrobial stewardship program on mortality: a cohort study. Braz J Infect Dis 2015 May-Jun;19(3):246-52

Percival KM, Valenti KM, Schmittling SE, et al. Impact of an antimicrobial stewardship intervention on urinary tract infection treatment in the ED. Am J Emerg Med 2015 Sep;33(9):1129-33

Popovski Z, Mercuri M, Main C, et al. Multifaceted intervention to optimize antibiotic use for intra-abdominal infections. J Antimicrob Chemother 2015 Apr;70(4):1226-9

Powell N, Franklin BD, Jacklin A, et al. Omitted doses as an unintended consequence of a hospital restricted antibacterial system: a retrospective observational study. J Antimicrob Chemother 2015 Dec;70(12):3379-83

Rocha-Pereira N, Lafferty N, Nathwani D. Educating healthcare professionals in antimicrobial stewardship: can online-learning solutions help? J Antimicrob Chemother 2015 Dec;70(12):3175-7

Roberts E, Dawoud DM, Hughes DA, et al. Evaluation of a consultant audit and feedback programme to improve the quality of antimicrobial prescribing in acute medical admissions. Int J Pharm Pract 2015 Oct;23(5):333-9

Saied T, Hafez SF, Kandeel A, et al. Antimicrobial stewardship to optimize the use of antimicrobials for surgical prophylaxis in Egypt: a multicenter pilot intervention study. Am J Infect Control 2015 Nov 1;43(11):e67-71

Sarma JB, Marshall B, Cleeve V, et al. Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: Interrupted time-series analysis. J Hosp Infect 2015 Sep;91(1):74-80

Sneddon J, Gilchrist M, Wickens H. Development of an expert professional curriculum for antimicrobial pharmacists in the UK. J Antimicrob Chemother 2015 May;70(5):1277-80

Song YJ, Kim M, Huh S, et al. Impact of an antimicrobial stewardship on unnecessary double anaerobic coverage prescription. Infect Chemother 2015 Jun;47(2):111-6

Taggart LR, Leung E, Muller MP, et al. Differential outcome of an antimicrobial stewardship audit and feedback program in two intensive care units: a controlled interrupted time series study. BMC Infect Dis 2015 Oct 29;15:480

Teng CB, Ng TM, Tan MW, et al. Safety and effectiveness of improving carbapenem use via prospective review and feedback in a multidisciplinary antimicrobial stewardship programme. Ann Acad Med Singapore 2015 Jan;44(1):19-25

Trautner BW, Grigoryan L, Petersen NJ, et al. Effectiveness of an antimicrobial stewardship approach for urinary catheter-associated asymptomatic bacteriuria. JAMA Intern Med 2015 Jul;175(7):1120-7

Velez RP, Becker KL, Davidson P, et al. A quality improvement intervention to address provider behaviour as it relates to utilisation of CA-MRSA guidelines. J Clin Nurs 2015 Feb;24(3-4):556-62

Waters CD. Pharmacist-driven antimicrobial stewardship program in an institution without infectious diseases physician support. Am J Health Syst Pharm 2015 Mar 15;72(6):466-8

Wattal C, Goel N, Khanna S, et al. Impact of informational feedback to clinicians on antibiotic-prescribing rates in a tertiary care hospital in Delhi. Indian J Med Microbiol 2015 Apr-Jun;33(2):255-9

Wood ZH, Nicolsen NC, Allen N, et al. Remote antimicrobial stewardship in community hospitals. Antibiotics (Basel) 2015 Nov 13;4(4):605-16

Zhou Y, Ma LY, Zhao X, et al. Impact of pharmacist intervention on antibiotic use and prophylactic antibiotic use in urology clean operations. J Clin Pharm Ther 2015 Aug;40(4):404-8

Back to top

2014

Aldeyab MA, Scott MG, Kearney MP, et al. Impact of an enhanced antibiotic stewardship on reducing methicillin-resistant Staphylococcus aureus in primary and secondary healthcare settings. Epidemiol Infect 2014 Mar;142(3):494-500

Alfandari S, Berthon C, Coiteaux V. Antifungal stewardship: implementation in a French teaching hospital. Med Mal Infect 2014 Apr;44(4):154-8

Asakura T, Ikeda M, Nakamura A, et al. Efficacy of empirical therapy with non-carbapenems for urinary tract infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae. Int J Infect Dis 2014 Dec;29:91-5

Benson JM. Incorporating pharmacy student activities into an antimicrobial stewardship program in a long-term acute care hospital. Am J Health Syst Pharm 2014 Feb 1;71(3):227-30

Borde JP, Batin N, Rieg S. Adherence to an antibiotic stewardship bundle targeting Staphylococcus aureus blood stream infections at a 200-bed community hospital. Infection 2014 Aug;42(4):713-9

Borde JP, Kaier K, Steib Bauert M, et al. Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center. BMC Infect Dis 2014 Apr 15;14:201

Buyle FM, Wallaert M, Beck N, et al. Implementation of a multidisciplinary infectious diseases team in a tertiary hospital within an antimicrobial stewardship program. Acta Clin Belg 2014 Oct;69(5):320-6

Chaves NJ, Ingram RJ, MacIsaac CM, et al. Sticking to minimum standards: implementing antibiotic stewardship in intensive care. Intern Med J 2014 Dec;44(12a):1180-7

Cisneros JM, Neth O, Gil Navarro MV, et al. Global impact of an educational antimicrobial stewardship programme on prescribing practice in a tertiary hospital centre. Clin Microbiol Infect 2014 Jan;20(1):82-8

Conant MM, Erdman SM, Osterholzer D. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases. J Antimicrob Chemother 2014 Jun;69(6):1695-700

De Bus L, Saerens L, Gadeyne B, et al. Development of antibiotic treatment algorithms based on local ecology and respiratory surveillance cultures to restrict the use of broad-spectrum antimicrobial drugs in the treatment of hospital-acquired pneumonia in the intensive care unit: a retrospective analysis. Crit Care 2014 Jul 14;18(4):R152

Demonchy E, Dufour JC, Gaudart J, et al. Impact of a computerized decision support system on compliance with guidelines on antibiotics prescribed for urinary tract infections in emergency departments: a multicentre prospective before-and-after controlled interventional study. J Antimicrob Chemother 2014 Oct;69(10):2857-63

Durnkow LE, Kenney RM, MacDonald NC, et al. Impact of a multidisciplinary culture follow-up program of antimicrobial therapy in the emergency department. Infect Dis Ther 2014 Jun;3(1):45-53

Elemraid MA, Rushton SP, Thomas MF, et al. Changing clinical practice: management of paediatric community-acquired pneumonia. J Eval Clin pract 2014 Feb;20(1):94-9

Forrest GN, Van Schooneveld TC, Kullar R, et al. Use of electronic health records and clinical decision support systems for antimicrobial stewardship. Clin Infect Dis 2014 Oct 15;59(Suppl 3):S122-33

Hadjiphilippou S, Odogwu SE, Jeyaratnam D. Promoting antimicrobial stewardship: using video tools for junior doctors' induction. Br J Hosp Med (Lond) 2014 Feb;75(2):106-8

Halpape K, Sulz L, Schuster B, et al. Audit and feedback-focused approach to evidence-based care in treating patients with pneumonia in hospital (AFFECT study). Can J Hosp Pharm 2014 Jan;67(1):17-27

Hecker MT, Fox CJ, Son AH, et al. Effect of a stewardship intervention on adherence to uncomplicated cystitis and pyelonephritis guidelines in an emergency department setting. PLoS One 2014 Feb 3;9(2):e87899

Hou D, Wang Q, Jiang C, et al. Evaluation of the short-term effects of antimicrobial stewardship in the intensive care unit at a tertiary hospital in China. PLoS One 2014 Jul 7;9(7):e101447

Kelley D, Aaronson P, Poon E, et al. Evaluation of an antimicrobial stewardship approach to minimize overuse of antibiotics in patients with asymptomatic bacteriuria. Infect Control Hosp Epidemiol 2014 Feb;35(2):193-5

Knudsen JD, Andersen SE, Bispebjerg Intervention Group. A multidisciplinary intervention to reduce infections of ESBL- and AmpC-producing, gram-negative bacteria at a university hospital. PLoS One 2014 Jan 23;9(1):e86457

Kullar R, Goff DA. Transformation of antimicrobial stewardship programs through technology and informatics. Infect Dis Clin North Am 2014 Jun;28(2):291-300

Lee TC, Frenette C, Jayaraman D, et al. Antibiotic self-stewardship: trainee-led structured antibiotic time-outs to improve antimicrobial use. Ann Intern Med 2014 Nov 18;161(10 Suppl):S53-8

Mehta JM, Haynes K, Wileyto EP, et al. Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship. Infect Control Hosp Epidemiol 2014 Sep;35(9):1092-9

Meng P, Fehre K, Rappelsberger A, et al. Mobile display of information about aggregated antibiotic resistance in the hospital setting supported by near field communication. Stud Health Technol Inform 2014;200:88-92

Morquin D, Koumar Y, Ologeanu Taddei R, et al. Integrating electronic medical records to improve antimicrobial stewardship at the Montpellier Hospital in France. World Hosp Health Serv 2014;50(2):35-9

Morrill HJ, Gaitanis MM, LaPlante KL. Antimicrobial stewardship program prompts increased and earlier infectious diseases consultation. Antimicrob Resist Infect Control 2014 Apr 17;3:12

Nachtigall I, Tafelski S, Deja M, et al. Long-term effect of computer-assisted decision support for antibiotic treatment in critically ill patients: a prospective 'before/after' cohort study. BMJ Open 2014 Dec 22;4(12):e005370

Ohl CA, Luther VP. Health care provider education as a tool to enhance antibiotic stewardship practices. Infect Dis Clin North Am 2014 Jun;28(2):177-93

Ostrowsky B, Ruiz R, Brown S, et al. Lessons learned from implementing Clostridium difficile-focused antibiotic stewardship interventions. Infect Control Hosp Epidemiol 2014 Oct;35(Suppl 3):S86-95

Ou Y, Jing BQ, Guo FF, et al. Audits of the quality of perioperative antibiotic prophylaxis in Shandong Province, China, 2006 to 2011. Am J Infect Control 2014 May;42(5):516-20

Palmay L, Elligsen M, Walker SA, et al. Hospital-wide rollout of antimicrobial stewardship: a stepped-wedge randomized trial. Clin Infect Dis 2014 Sep 15;59(6):867-74

Pasquale TR, Trienski TL, Olexia DE, et al. Impact of an antimicrobial stewardship program on patients with acute bacterial skin and skin structure infections. Am J Health Syst Pharm 2014 Jul 1;71(13):1136-9

Pogue JM, Mynatt RP, Marchaim D, et al. Automated alerts coupled with antimicrobial stewardship intervention lead to decreases in length of stay in patients with gram-negative bacteremia. Infect Control Hosp Epidemiol 2014 Feb;35(2):132-8

Pogue JM, Potoski BA, Postelnick M, et al. Bringing the "power" to Cerner's PowerChart for antimicrobial stewardship. Clin Infect Dis 2014 Aug 1;59(3):416-24

Ramos A, Benitez Gutierrez L, Asensio A, et al. Antimicrobial stewardship in patients recently transferred to a ward from the ICU. Rev Esp Quimioter 2014 Mar;27(1):46-50

Reed EE, West JE, Keating EA, et al. Improving the management of candidemia through antimicrobial stewardship interventions. Diagn Microbiol Infect Dis 2014 Feb;78(2):157-61

Rodriguez L, Jung, HS, Goulet JA, et al. Evidence-based protocol for prophylactic antibiotics in open fractures: improved antibiotic stewardship with no increase in infection rates. J Trauma Acute Care Surg 2014 Sep;77(3):400-7

Seah XF, Ong YL, Tan SW, et al. Impact of an antimicrobial stewardship program on the use of carbapenems in a tertiary women's and children's hospital, Singapore. Pharmacotherapy 2014 Nov;34(11):1141-50

Smith T, Philmon CL, Johnson GD, et al. Antimicrobial stewardship in a community hospital: attacking the more difficult problems. Hosp Pharm 2014 Oct;49(9):839-46

Song P, Li W, Zhou Q. An outpatient antibacterial stewardship intervention during the journey to JCI accreditation. BMC Pharmacol Toxicol 2014 Feb 26;15:8

Spellberg B. Antibiotic judo: working gently with prescriber psychology to overcome inappropriate use. JAMA Intern Med 2014 Mar;174(3):432-3

Szymczak JE, Feemster KA, Zaoutis TE, et al. Pediatrician perceptions of an outpatient antimicrobial stewardship intervention. Infect Control Hosp Epidemiol 2014 Oct;35(Suppl 3):S69-78

Van Buul LW, Sikkens JJ, van Agtmael MA, et al. Participatory action research in antimicrobial stewardship: a novel approach to improving antimicrobial prescribing in hospitals and long-term care facilities. J Antimicrob Chemother 2014 Jul;69(7):1734-41

Van Dujin PJ, Bonten MJ. Antibiotic rotation strategies to reduce antimicrobial resistance in gram-negative bacteria in European intensive care units: study protocol for a cluster-randomized crossover controlled trial. Trials 2014 Jul 10;15:277

Van Limburg M, Sinha B, Lo Ten Foe JR, et al. Evaluation of early implementations of antibiotic stewardship program initiatives in nine Dutch hospitals. Antimicrob Resist Infect Control 2014 Oct 23;3(1):33

Venugopal V, Lehmann CU, Diener West M. Longitudinal evaluation of a World Wide Web-based antimicrobial stewardship program: assessing factors associated with approval patterns and trends over time. Am J Infect Control 2014 Feb;42(2):100-5

Wagner B, Filice GA, Drekonja D, et al. Antimicrobial stewardship programs in inpatient hospital settings: a systematic review. Infect Control Hosp Epidemiol 2014 Oct;35(10):1209-28

Wentzel J, van Velsen L, van Limburg M, et al. Participatory eHealth development to support nurses in antimicrobial stewardship. BMC Med Inform Decis Mak 2014 Jun 5;14:45

Yoon YK, Yang KS, Lee SE, et al. Effects of Group 1 versus Group 2 carbapenems on the susceptibility of Acinetobacter baumannii to carbapenems: a before and after intervention study of carbapenem-use stewardship. PLoS One 2014 Jun 9;9(6):e99101

Back to top

2013

Ambroggio L, et al. Quality improvement methods increase appropriate antibiotic prescribing for childhood pneumonia. Pediatrics 2013 May;131(5):e1623-31

Amer MR, et al. Antimicrobial stewardship program implementation in a medical intensive care unit at a tertiary care hospital in Saudi Arabia. Ann Saudi Med 2013 Nov-Dec;33(6):547-54

Andersen SE, et al. A managed multidisciplinary programme on multi-resistant Klebsiella pneumoniae in a Danish university hospital. BMJ Qual Saf 2013 Nov;22(11):907-15

Baysari MT, et al. Audit and feedback of antibiotic use: utilising electronic prescription data. Appl Clin Inform 2013 Dec 11;4(4):583-95

Cairns KA, et al. Prescribing trends before and after implementation of an antimicrobial stewardship program. Med J Aust 2013;198:262-6

Camargo LF. The "de-escalation concept" and antibiotic de-escalation: a missed opportunity? Shock 2013;39(7 suppl 1):29-31

Chong Y, et al. Antibiotic rotation for febrile neutropenic patients with haematological malignancies: clinical significance of antibiotic heterogeneity. PLoS One 2013;8:e54190

Chung GW, et al. Antimicrobial stewardship: a review of prospective audit and feedback systems and an objective evaluation of outcomes. Virulence 2013;4:151-7

Davey P, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst 2013;4:CD003543

Delory T, et al. Impact of a program combining pre-authorization requirement and post-prescription review of carbapenems: an interrupted time-series analysis. Eur J Clin Microbiol Infect Dis 2013 Dec;32(12):1599-604

Embi PJ, et al. Computerized provider documentation: findings and implications of a multisite study of clinicians and administrators. J Am Med Inform Assoc 2013 Jul-Aug;20(4):718-26

Filice GA, et al. Use of a computer decision support system and antimicrobial therapy appropriateness. Infect Control Hosp Epidemiol 2013;34:558-65

Forrest CB, et al. Improving adherence to otitis media guidelines with clinical decision support and physician feedback. Pediatrics 2013;131:e1071-81

Gerber JS, et al. Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial. JAMA 2013 Jun 12;309(22):2345-52

Gonzales R, et al. A cluster randomized trial of decision support strategies for reducing antibiotic use in acute bronchitis. JAMA Intern Med 2013;173:267-73

Jardin CG, et al. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy. J Hosp Infect 2013 Sep;85(1):28-32

Jury LA, et al. A Clostridium difficile infection (CDI) stewardship initiative improves adherence to practice guidelines for management of CDI. Infect Control Hosp Epidemiol 2013 Nov;34(11):1222-4

Kim YC, et al. Trend of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in an institution with a high rate of MRSA after the reinforcement of antibiotic stewardship and hand hygiene. Am J Infect Control 2013 May;41(5):e39-43

Kullar R, et al. The EPIC challenge of optimizing antimicrobial stewardship: the role of electronic medical records and technology. Clin Infect Dis 2013 Oct;57(7):1005-13

Lin YS, et al. Impact of an antimicrobial stewardship program with multidisciplinary cooperation in a community public teaching hospital in Taiwan. Am J Infect Control 2013 Nov;41(11):1069-72

Mondain V, et al. A 6-year antifungal stewardship programme in a teaching hospital. Infection 2013 Jun;41(3):621-8

Mondain V, et al. An antibiotic stewardship program in a French teaching hospital. Med Mal Infect 2013;43:17-21.

Ostrowsky B, et al. Antimicrobial stewardship and automated pharmacy technology improve antibiotic appropriateness for community-acquired pneumonia. Infect Control Hosp Epidemiol 2013;34:566-72

Ramírez E, et al. Improving linezolid use decreases the incidence of resistance among Gram-positive microorganisms. Int J Antimicrob Agents 2013;41:174-8

Reed EE, et al. Impact of formulary restriction with prior authorization by an antimicrobial stewardship program. Virulence 2013;4:158-62

Rimawi RH, et al. Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome. Crit Care Med 2013 Sep;41(9):2099-107

Webber EC, et al. Conversion of a single-facility pediatric antimicrobial stewardship program to multi- facility application with computerized provider order entry and clinical decision support. Appl Clin Inform 2013 Nov 27;4(4):556-68

Weston A, et al. The impact of a Massachusetts state-sponsored educational program on antimicrobial stewardship in acute care hospitals. Infect Control Hosp Epidemiol 2013 Apr;34(4):437-9

Back to top

2012

Aldeyab MA, et al. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother 2012;67:2988-96

Ash JS, et al. Standard practices for computerized clinical decision support in community hospitals: a national survey. J Am Med Inform Assoc 2012;19:980-7

Baker SN, et al. Pharmacist-managed antimicrobial stewardship program for patients discharged from the emergency department. J Pharm Pract 2012 Apr;25(2):190-4

Cooley TW, et al. Implementation of computerized prescriber order entry in four academic medical centers. Am J Health Syst Pharm 2012;69:2166-73

Cosgrove SE, et al. Evaluation of post-prescription review and feedback as a method of promoting rational antimicrobial use: a multicenter intervention. Infect Control Hosp Epidemiol 2012;33:374-80

Diaz Granados CA. Prospective audit for antimicrobial stewardship in intensive care: impact on resistance and clinical outcomes. Am J Infect Control 2012;40:526-9

Dryden M, et al. Antibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial management. J Antimicrob Chemother 2012;67:2289-96

Elligsen M, et al. Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients: a controlled interrupted time series analysis. Infect Control Hosp Epidemiol 2012 Apr;33(4):354-61

Elligsen M, et al. Prospective audit and feedback of antimicrobial stewardship in critical care: program implementation, experience, and challenges. Can J Hosp Pharm 2012;65:31-6

Evans RS,et al. Clinical use of an enterprise data warehouse. AMIA Annu Symp Proc 2012;2012:189-98

Goff DA. iPhones, iPads, and medical applications for antimicrobial stewardship. Pharmacotherapy 2012;32:657-61

Hashino S, et al. Clinical impact of cycling the administration of antibiotics for febrile neutropenia in Japanese patients with hematological malignancy. Eur J Clin Microbiol Infect Dis 2012;31:173-8

Heenen S, et al. Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often? Crit Care Med 2012;40:1404-9

Hermsen ED, et al. Implementation of a clinical decision support system for antimicrobial stewardship. Infect Control Hosp Epidemiol 2012 Apr;33(4):412-5

Johnston T, et al. Audit of Staphylococcus aureus bacteraemia management in NHS Tayside and comparison with European Antibiotic Strategies study group international quality standards. J Antimicrob Chemother 2012 Sep;67(9):2304-6

Katsios CM, et al. An antimicrobial stewardship program improves antimicrobial treatment by culture site and the quality of antimicrobial prescribing in critically ill patients. Crit Care 2012;16:R216

Kaye KS. Antimicrobial de-escalation strategies in hospitalized patients with pneumonia, intra- abdominal infections, and bacteremia. J Hosp Med 2012;7:S13-21

Kellie SM. Antimicrobial stewardship on the frontier: a pilot study of training using an electronic learning network. Infect Control Hosp Epidemiol 2012 Nov;33(11):1181-3

Lewis GJ, et al. Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital’s intensive care and intermediate care units. Infect Control Hosp Epidemiol 2012 Apr;33(4):368-73

Litvin CB, et al. Adoption of a clinical decision support system to promote judicious use of antibiotics for acute respiratory infections in primary care. Int J Med Inform 2012;81:521-6

Montravers P, et al. De-escalation: in drug we trust. Crit Care Med 2012;40:1645-6

Newman RE, et al. Impact of a guideline on management of children hospitalized with community- acquired pneumonia. Pediatrics 2012;129:e597-604

Pate PG, et al. Implementation of an antimicrobial stewardship program at a 60-bed long-term acute care hospital. Infect Control Hosp Epidemiol 2012 Apr;33(4):405-8

Patel SJ, et al. Development of an antimicrobial stewardship intervention using a model of actionable feedback. Interdiscip Perspect Infect Dis 2012;2012:150367

Patel J, et al. Effective use of a clinical decision-support system to advance antimicrobial stewardship. Am J Health Syst Pharm 2012;69:1543-4

Po JL, et al. The impact of an infectious diseases specialist-directed computerized physician order entry antimicrobial stewardship program targeting linezolid use. Infect Control Hosp Epidemiol 2012 Apr;33(4):434-5

Potasman I, et al. Impact of a computerized integrated antibiotic authorization system. Isr Med Assoc J 2012;14:415-9

Rauniar GP, et al. Effectiveness of an educational feedback intervention on drug prescribing in dental practice. Kathmandu Univ Med J (KUMJ) 2012;10:30-5

Rodrigues JF, et al. A computer-assisted prescription system to improve antibacterial surgical prophylaxis. Infect Control Hosp Epidemiol 2012;33:435-7

Rolston KV, et al. Antimicrobial de-escalation in cancer patients. Infection 2012;40:223-4

Sarraf-Yazdi S, et al. A 9-year retrospective review of antibiotic cycling in a surgical intensive care unit. J Surg Res 2012;176:e73-8

Shrestha NK, et al. Contribution of infectious disease consultation toward the care of inpatients being considered for community-based parenteral anti-infective therapy. J Hosp Med 2012;7:365-9

Smith MJ, et al. Effectiveness of antimicrobial guidelines for community-acquired pneumonia in children. Pediatrics 2012;129:e1326-33

Storey DF, et al. Implementation of an antimicrobial stewardship program on the medical surgical service of a 100-bed community hospital. Antimicrob Resist Infect Control 2012;1:32

Teo J, et al. The effect of a whole-system approach in an antimicrobial stewardship programme at the Singapore General Hospital. Eur J Clin Microbiol Infect Dis 2012;31:947-55

Vines C, Dean NC. Technology implementation impacting the outcomes of patients with CAP. Semin Respir Crit Care Med 2012;33:292-7

Wang HY, et al. Effectiveness of an integrated CPOE decision-supporting system with clinical pharmacist monitoring practice in preventing antibiotic dosing errors. Int J Clin Pharmacol Ther 2012;50:375-82

Wilde AM, et al. Inappropriate antibiotic use due to decreased compliance with a ventilator-associated pneumonia computerized clinical pathway: implications for continuing education and prospective feedback. Pharmacotherapy 2012 Aug;32(8):755-63

Yam P, et al. Implementation of an antimicrobial stewardship program in a rural hospital. Am J Health Syst Pharm 2012;69:1142-8

Yeo CL, et al. Prospective audit and feedback on antibiotic prescription in an adult hematology-oncology unit in Singapore. Eur J Clin Microbiol Infect Dis 2012 Apr;31(4):583-90

Zaidi ST, Marriott JL. Barriers and facilitators to adoption of a web-based antibiotic decision support system. South Med Rev 2012;5:42-50

Back to top

2011

Best JT, et al. Implementation of an evidence-based order set to impact initial antibiotic time intervals in adult febrile neutropenia. Oncol Nurs Forum 2011;38:661-8

Bjerrum L, et al. Health Alliance for prudent antibiotic prescribing in patients with respiratory tract infections (HAPPY AUDIT)‒impact of a non-randomised multifaceted intervention programme. BMC Fam Pract 2011;12:52

Chan YY, et al. Implementation and outcomes of a hospital-wide computerised antimicrobial stewardship programme in a large medical centre in Taiwan. Int J Antimicrob Agents 2011;38:486-92

Dunn K, et al. Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study. Int J Clin Pharm 2011;33:208-14

Enoch DA, et al. Outcome for Gram-negative bacteraemia when following restrictive empirical antibiotic guidelines. QJM 2011;104:411-9

Ewig S. Nosocomial pneumonia: de-escalation is what matters. Lancet Infect Dis 2011;11:155-7

Haynes K, et al. Effectiveness of an information technology intervention to improve prophylactic antibacterial use in the postoperative period. J Am Med Inform Assoc 2011;18:164-8

Heintz BH, et al. Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center. Ann Pharmacother 2011 Nov;45(11):1329-37

Kazemi A, et al. The effect of computerized physician order entry and decision support system on medication errors in the neonatal ward: experiences from an Iranian teaching hospital. J Med Syst 2011;35:25-37

Kouyos RD, et al. Informed switching strongly decreases the prevalence of antibiotic resistance in hospital wards. PLoS Comput Biol 2011;7:e1001094

Landis Lewis Z, et al. The feasibility of automating audit and feedback for ART guideline adherence in Malawi. J Am Med Inform Assoc 2011;18:868-74

Lima AL, et al. Carbapenem stewardship: positive impact on hospital ecology. Braz J Infect Dis 2011;15:1-5

Mansouri MD, et al. Impact of an antibiotic restriction program on antibiotic utilization in the treatment of community-acquired pneumonia in a Veterans Affairs Medical Center. Infection 2011;39:53-8

Masterton RG. Antibiotic de-escalation. Crit Care Clin 2011;27:149-62

McKinley BA, et al. Computer protocol facilitates evidence-based care of sepsis in the surgical intensive care unit. J Trauma 2011;70:1153-66; discussion 1166-7

Medina Presentado JC, et al. Ceftriaxone and ciprofloxacin restriction in an intensive care unit: less incidence of Acinetobacter spp. and improved susceptibility of Pseudomonas aeruginosa. Rev Panam Salud Publica 2011;30:603-9

Niederman MS, Soulountsi V. De-escalation therapy: is it valuable for the management of ventilator- associated pneumonia? Clin Chest Med 2011;32:517-34

Oliveira PR, et al. Impact of restriction of cefepime use on the antimicrobial susceptibility of gram- negative bacilli related to healthcare-associated infections in an orthopedic hospital. Infect Drug Resist 2011;4:149-54

Ribner BS, et al. A web-based program to ensure compliance of medical staff providers with mandated health care facility requirements. Am J Infect Control 2011;39:511-4

Shime N, et al. De-escalation of antimicrobials in the treatment of bacteraemia due to antibiotic- sensitive pathogens in immunocompetent patients. Infection 2011;39:319-25

Skrlin J, et al. Impact of ceftriaxone de-restriction on the occurrence of ESBL-positive bacterial strains and antibiotic consumption. J Chemother 2011;23:341-4

Talpaert MJ, et al. Impact of guidelines and enhanced antibiotic stewardship on reducing broad- spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother 2011;66:2168-74

Trautner BW, et al. A hospital-site controlled intervention using audit and feedback to implement guidelines concerning inappropriate treatment of catheter-associated asymptomatic bacteriuria. Implement Sci 2011;6:41

Wald HL, Kramer AM. Feasibility of audit and feedback to reduce postoperative urinary catheter duration. J Hosp Med 2011;6:183-9

Westphal JF, et al. Enhanced physician adherence to antibiotic use guidelines through increased availability of guidelines at the time of drug ordering in hospital setting. Pharmacoepidemiol Drug Saf 2011;20:162-8

Back to top

2010

Apisarnthanarak A,et al. Impact of education and an antifungal stewardship program for candidiasis at a Thai tertiary care center. Infect Control Hosp Epidemiol 2010;31:722-7

Beardmore RE, Pena-Miller R. Antibiotic cycling versus mixing: the difficulty of using mathematical models to definitively quantify their relative merits. Math Biosci Eng 2010;7:923-33

Beardmore RE, Pena-Miller R. Rotating antibiotics selects optimally against antibiotic resistance, in theory. Math Biosci Eng 2010;7:527-52

Braxton CC, et al. Improving antibiotic stewardship: order set implementation to improve prophylactic antimicrobial prescribing in the outpatient surgical setting. J Ambul Care Manage 2010;33:131-40

Cooke J, et al. Antimicrobial stewardship: an evidence-based, antimicrobial self-assessment toolkit (ASAT) for acute hospitals. J Antimicrob Chemother 2010;65:2669-73

Enne VI. Reducing antimicrobial resistance in the community by restricting prescribing: can it be done? J Antimicrob Chemother 2010;65:179-82

Fowkes CT, et al. Audit of physicians' adherence to a preprinted order set for community-acquired pneumonia. Can J Hosp Pharm 2010;63:289-94

Helmons PJ, et al. Using a clinical decision support system to determine the quality of antimicrobial dosing in intensive care patients with renal insufficiency. Qual Saf Health Care 2010;19:22-6

Hibbard ML, et al. Empiric, broad-spectrum antibiotic therapy with an aggressive de-escalation strategy does not induce gram-negative pathogen resistance in ventilator-associated pneumonia. Surg Infect (Larchmt) 2010;11:427-32

Laible BR, et al. Implementation of a pharmacist-led antimicrobial management team in a community teaching hospital: use of pharmacy residents and pharmacy students in a prospective audit and feedback approach. J Pharm Pract 2010;23:531-5

Morel J, et al. De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit. Crit Care 2010;14:R225

Rattanaumpawan P, et al. Effectiveness of drug use evaluation and antibiotic authorization on patients' clinical outcomes, antibiotic consumption, and antibiotic expenditures. Am J Infect Control 2010;38:38-43

Schlueter M, et al. Practice patterns for antibiotic de-escalation in culture-negative healthcare-associated pneumonia. Infection 2010;38:357-62

Winters BD, et al. Impact of a restrictive antimicrobial policy on the process and timing of antimicrobial administration. J Hosp Med 2010;5:E41-5

Yong MK, et al. Improved susceptibility of Gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system. J Antimicrob Chemother 2010;65:1062-9

Back to top

 

2000-2009

Agwu AL, Lee CK, Jain SK, et al. A World Wide Web-based antimicrobial stewardship program improves efficiency, communication, and user satisfaction and reduces cost in a tertiary care pediatric medical center. Clin Infect Dis 2008 Sep 15;47(6):747-53

Arnold FW, McDonald LC, Smith RS, et al. Improving antimicrobial use in the hospital setting by providing usage feedback to prescribing physicians. Infect Control Hosp Epidemiol 2006 Apr;27(4):378-82

Bantar C, Sartori B, Vesco E, et al. A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 2003 Jul 15;37(2):180-6

Barenfanger J, Short MA, Groesch AA. Improved antimicrobial interventions have benefits. J Clin Microbiol 2001 Aug;39(8):2823-8

Bassetti M, Di Biagio A, Rebesco B, et al. The effect of formulary restriction in the use of antibiotics in an Italian hospital. Eur J Clin Pharmacol 2001 Sep;57(6-7):529-34

Bassett M, Di Biagio A, Rebesco B, et al. Impact of an antimicrobial formulary and restriction policy in the largest hospital in Italy. Int J Antimicrob Agents 2000 Nov;16(3):295-9

Bedouch P, Labarere J, Chirpaz E, et al. Compliance with guidelines on antibiotic prophylaxis in total hip replacement surgery: results of a retrospective study of 416 patients in a teaching hospital. Infect Control Hosp Epidemiol 2004 Apr;25(4):302-7

Bolon MK, Arnold AD, Feldman HA, et al. An antibiotic order form intervention does not improve or reduce vancomycin use. Pediatr Infect Dis J 2005 Dec;24(12):1053-8

Buising KL, Thursky KA, Robertson MB, et al. Electronic antibiotic stewardship--reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting. J Antimicrob Chemother 2008 Sep;62(3):608-16

Camins BC, King MD, Wells JB, et al. Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial. Infect Control Hosp Epidemiol 2009 Oct;30(10):931-8

Cheng VC, To KK, Li IW, et al. Antimicrobial stewardship program directed at broad-spectrum intravenous antibiotics prescription in a tertiary hospital. Eur J Clin Microbiol Infect Dis 2009 Dec;28(12):1447-56

Cosgrove SE, Patel A, Song X, et al. Impact of different methods of feedback to clinicians after post prescription antimicrobial review based on the Centers For Disease Control and Prevention's 12 Steps to Prevent Antimicrobial Resistance Among Hospitalized Adults. Infect Control Hosp Epidemiol 2007 Jun;28(6):641-6

Crowley RK, Fitzpatrick F, Solanki D, et al. Vancomycin administration: the impact of multidisciplinary interventions. J Clin Pathol 2007 Oct;60(10):1155-9

Davydov L, Ebert SC, Restino M, et al. Prospective evaluation of the treatment and outcome of community-acquired pneumonia according to the Pneumonia Severity Index in VHA hospitals. Diagn Microbiol Infect Dis 2006 Apr;54(4):267-75

Di Pentima MC, Chan S, Eppes SC, et al. Antimicrobial prescription errors in hospitalized children: role of antimicrobial stewardship program in detection and intervention. Clin Pediatr (Phila) 2009 Jun;48(5):505-12

Fowler S, Webber A, Cooper BS, et al. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. J Antimicrob Chemother 2007 May;59(5):990-5

Francetic I, Kalenic S, Huic M, et al. Impact of aminoglycoside cycling in six tertiary intensive care units: prospective longitudinal interventional study. Croat Med J 2008 Apr;49(2):207-14

Freedman K, Kolluri B, Neudecker L. Antimicrobial stewardship stabilizes resistance patterns in a behavioral health setting. Conn Med 2007 Sep;71(8):457-60

Gerding DN. Antimicrobial cycling: lessons learned from the aminoglycoside experience. Infect Control Hosp Epidemiol 2000 Jan;21(1 Suppl):S12-7

Gruson D, Hilbert G, Vargas F, et al. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of gram-negative bacilli responsible for ventilator-associated pneumonia. Crit Care Med 2003 Jul;31(7):1908-14

Hagaman JT, Yurkowski P, Trott A, et al. Getting physicians to make "the switch": the role of clinical guidelines in the management of community-acquired pneumonia. Am J Med Qual 2005 Jan-Feb;20(1):15-21

Hermsen ED, Smith Shull S, Puumala SE, et al. Improvement in prescribing habits and economic outcomes associated with the introduction of a standardized approach for surgical antimicrobial prophylaxis. Infect Control Hosp Epidemiol 2008 May;29(5):457-61

Hodges BM, White RL. Antimicrobial cycling: the future or a fad? Ann Pharmacother 2001 Oct;35(10):1224-32

Ibrahim EH, Ward S, Sherman G, et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001 Jun;29(6):1109-15

Kahan NR, Chinitz DP, Waitman DA, et al. When gatekeepers meet the sentinel: the impact of a prior authorization requirement for cefuroxime on the prescribing behaviour of community-based physicians. Br J Clin Pharmacol 2006 Mar;61(3):341-4

Kollef MH. Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit? Clin Infect Dis 2006 Sep 1;43(Suppl 2):S82-8

Kollef MH. Is there a role for antibiotic cycling in the intensive care unit? Crit Care Med 2001 Apr;29(4 Suppl):N135-42

LaRosa LA, Fishman NO, Lautenbach E, et al. Evaluation of antimicrobial therapy orders circumventing an antimicrobial stewardship program: investigating the strategy of “stealth dosing.” Infect Control Hosp Epidemiol 2007 May;28(5):551-6

Lautenbach E, LaRosa LA, Marr AM, et al. Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis 2003 Feb 15;36(4):440-6

Lipworth AD, Hyle EP, Fishman NO, et al. Limiting the emergence of extended-spectrum beta-lactamase-producing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions. Infect Control Hosp Epidemiol 2006 Mar;27(3):279-86

Martin C, Ofotokun I, Rapp R, et al. Results of an antimicrobial control program at a university hospital. Am J Health Syst Pharm 2005 Apr 1;62(7):732-8

Martinez JA, Nicolas JM, Marco F, et al. Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units. Crit Care Med 2006 Feb;34(2):329-36

McGowan JE Jr. Strategies for study of the role of cycling on antimicrobial use and resistance. Infect Control Hosp Epidemiol 2000 Jan;21(1 Suppl):S36-43

McGregor JC, Weekes E, Forrest GN, et al. Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial. J Am Med Inform Assoc 2006 Jul-Aug;13(4):378-84

Merz LR, Warren DK, Kollef MH, et al. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Chest 2006 Dec;130(6):1672-8

Ng CK, Wu TC, Chan WM, et al. Clinical and economic impact of an antibiotics stewardship programme in a regional hospital in Hong Kong. Qual Saf Health Care 2008 Oct;17(5):387-92

Pakyz AL, Oinonen M, Polk RE. Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009 May;53(5):1983-6

Paul M, Andreassen S, Tacconelli E, et al. Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial. J Antimicrob Chemother 2006 Dec;58(6):1238-45

Pestotnik SL. Expert clinical decision support systems to enhance antimicrobial stewardship programs: insights from the society of infectious diseases pharmacists. Pharmacotherapy 2005 Aug;25(8):1116-25

Philmon C, Smith T, Williamson S, et al. Controlling use of antimicrobials in a community teaching hospital. Infect Control Hosp Epidemiol 2006 Mar;27(3):239-44

Pulver LK, Tett SE, Coombes J. The Queensland experience of participation in a national drug use evaluation project, Community-Acquired Pneumonia Towards Improving Outcomes Nationally (CAPTION). BMC Pulm Med 2009 Aug 3;9:38

Regal RE, DePestel DD, VandenBussche HL. The effect of an antimicrobial restriction program on Pseudomonas aeruginosa resistance to beta-lactams in a large teaching hospital. Pharmacotherapy 2003 May;23(5):618-24

Samore MH, Bateman K, Alder SC, et al. Clinical decision support and appropriateness of antimicrobial prescribing: a randomized trial. JAMA 2005 Nov 9;294(18):2305-14

Schwartz DN, Wu US, Lyles RD, et al. Lost in translation? Reliability of assessing inpatient antimicrobial appropriateness with use of computerized case vignettes. Infect Control Hosp Epidemiol 2009 Feb;30(2):163-71

Sharma R, Loomis W, Brown RB. Impact of mandatory inpatient infectious disease consultation on outpatient parenteral antibiotic therapy. Am J Med Sci 2005 Aug;330(2):60-4

Siddiqui S, Hussein K, Manasia R, et al. Impact of antibiotic restriction on broad spectrum antibiotic usage in the ICU of a developing country. J Pak Med Assoc 2007 Oct;57(10):484-7

Sintchenko V, Coiera E, Gilbert GL. Decision support systems for antibiotic prescribing. Curr Opin Infect Dis 2008 Dec;21(6):573-9

Sintchenko V, Coiera E, Iredell JR, et al. Comparative impact of guidelines, clinical data, and decision support on prescribing decisions: an interactive web experiment with simulated cases. J Am Med Inform Assoc 2004 Jan-Feb;11(1):71-7

Smeets HM, Kuyvenhoven MM, Akkerman AE, et al. Intervention with educational outreach at large scale to reduce antibiotics for respiratory tract infections: a controlled before and after study. Fam Pract 2009 Jun;26(3):183-7

Steinman MA, Ranji SR, Shojania KG, et al. Improving antibiotic selection: a systematic review and quantitative analysis of quality improvement strategies. Med Care 2006 Jul;44(7):617-28

Thursky K. Use of computerized decision support systems to improve antibiotic prescribing. Expert Rev Anti Infect Ther 2006 Jun;4(3):491-507

Warren DK, Hill HA, Merz LR, et al. Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients. Crit Care Med 2004 Dec;32(12):2450-6

Weinstein RA, Fridkin SK. Routine cycling of antimicrobial agents as an infection-control measure. Clin Infect Dis 2003 Jun 1;36(11):1438-44

Wong-Beringer A, Nguyen LH, Lee M, et al. An antimicrobial stewardship program with a focus on reducing fluoroquinolone overuse. Pharmacotherapy 2009 Jun;29(6):736-43

Back to top

Stewardship: Optimizing Drug Use

(Pharmacokinetic monitoring, dosing strategies for broad spectrum beta-lactam antibiotics, increasing use of oral antibiotics, allergy assessments, reducing antibiotic duration)

Recently Added
2017
2016

2015
2014
2013
2012
2011
2010
2000-2009 

Recently Added

Blumenthal KG, Ryan EE, Li Y, et al. The impact of a reported penicillin allergy on surgical site infection risk. Clin Infect Dis 2017 (published online Oct 9)

Chotiprasitsakul D, Han JH, Cosgrove SE, et al. Comparing the outcomes of adults with Enterobacteriaceae bacteremia receiving short-course versus prolonged-course antibiotic therapy in a multicenter, propensity score–matched cohort. Clin Infect Dis 2017 (published online Oct 8)

Gustinetti G, Cangemi G, Bandettini R, et al. Pharmacokinetic/pharmacodynamic parameters for treatment optimization of infection due to antibiotic resistant bacteria: a summary for practical purposes in children and adults. J Chemother 2017 (published online Oct 13)

Kendall RE, Hanson AP, Crank CW, et al. Impact of fosfomycin tromethamine on the treatment of multi-drug resistant urinary tract infections. J Antimicrob Steward 2017;1(1):4-11

Krishna MT, Huissoon AP, Li M, et al. Enhancing antibiotic stewardship by tackling 'spurious' penicillin allergy. Clin Exp Allergy 2017 (published online Oct 13)

Triffault-Fillit C, Ferry T, Perpoint T, et al. Outpatient parenteral antibiotic therapy: evaluation of practices and limits of use in rural areas in France. Med Mal Infect 2017 (published online Oct 16)

Back to top

2017

Abdelraouf K, Linder KE, Nailor MD, et al. Predicting and preventing antimicrobial resistance utilizing pharmacodynamics: part II gram-negative bacteria. Expert Opin Drug Metab Toxicol 2017 (published online May 19)

Allison MG, Heil EL, Hayes BD. Appropriate antibiotic therapy. Emerg Med Clin North Am 2017 Feb;35(1):25-42

Al-Tawil K, Babu A, Loeffler M, et al. Second generation cephalosporin antibiotic prophylaxis and Clostridium difficile infection in hip and knee arthroplasty. Ann R Coll Surg Engl 2017 May;99(5):351-4

Berrevoets MAH, Pot JLW, Houterman AE, et al. An electronic trigger tool to optimise intravenous to oral antibiotic switch: a controlled, interrupted time series study. Antimicrob Resist Infect Control 2017 (published online Aug 15)

Blot M, Pivot D, Bourredjem A, et al. Effectiveness of and obstacles to antibiotic streamlining to amoxicillin monotherapy in bacteremic pneumococcal pneumonia. Int J Antimicrob Agents 2017 (published online Jul 8)

Blumenthal KG, Ryan EE, Li Y, et al. The impact of a reported penicillin allergy on surgical site infection risk. Clin Infect Dis 2017 (published online Oct 9)

Blumenthal KG, Shenoy ES, Wolfson AR, et al. Addressing inpatient beta-lactam allergies: a multihospital implementation. J Allergy Clin Immunol Pract 2017 May-Jun;5(3):616-25

Blumenthal KG, Wickner PG, Hurwitz S, et al. Tackling inpatient penicillin allergies: tools for antimicrobial stewardship. J Allergy Clin Immunol 2017 (published online Feb 27)

Bulik CC, Bader JC, Zhang L, et al. PK-PD Compass: bringing infectious diseases pharmacometrics to the patient's bedside. J Pharmcokinet Pharmacodyn 2017 (published online Mar 28)

Chao Y, Reuter C, Kociolek LK, et al. Optimizing empiric therapy for gram-negative bloodstream infections in children. J Hosp Infect 2017 (published online Sep 23)

Chen JR, Khan DA. Evaluation of penicillin allergy in the hospitalized patient: opportunities for antimicrobial stewardship. Curr Allergy Asthma Rep 2017 Jun;17(6):40

Chotiprasitsakul D, Han JH, Cosgrove SE, et al. Comparing the outcomes of adults with Enterobacteriaceae bacteremia receiving short-course versus prolonged-course antibiotic therapy in a multicenter, propensity score–matched cohort. Clin Infect Dis 2017 (published online Oct 8)

Corona A, Cattaneo D. Dosing colistin properly: let’s save “our last resort old drug!” Clin Infect Dis 2017 (published online Jul 13)

Cunha BA, Baron J, Cunha CB. Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations. Eur J Clin Microbiol Infect Dis 2017 (published online Aug 17)

Daniel Markley J, Bernard S, Bearman G, et al. De-escalating antibiotic use in the inpatient setting: strategies, controversies, and challenges. Curr Infect Dis Rep 2017 Apr;19(4):17

Demore B, Humbert P, Boschetti E, et al. Evaluation of effects of an operational multidisciplinary team on antibiotic use in the medium to long term at a French university hospital. Int J Clin Pharm 2017 (published online Jul 29)

Desai SH, Kaplan MS, Chen Q, et al. Morbidity in pregnant women associated with unverified penicillin allergies, antibiotic use, and group B Streptococcus infections. Perm J 2017 (published online Jan 6)

Economou CJP, Wong G, McWhinney B, et al. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy. Int J Antimicrob Agents 2017 (published online Mar 21)

Grupper M, Nicolau DP. Obesity and skin and soft tissue infections: how to optimize antimicrobial usage for prevention and treatment? Curr Opin Infect Dis 2017 (published online Jan 23)

Gugkaeva Z, Crago JS, Yasnogorodsky M. Next step in antibiotic stewardship: pharmacist-provided penicillin allergy testing. J Clin Pharm Ther 2017 (published online May 14)

Gustinetti G, Cangemi G, Bandettini R, et al. Pharmacokinetic/pharmacodynamic parameters for treatment optimization of infection due to antibiotic resistant bacteria: a summary for practical purposes in children and adults. J Chemother 2017 (published online Oct 13)

Gutierrez-Pizarraya A, Leone M, Garnacho-Montero J, et al. Collaborative approach of individual participant data of prospective studies of de-escalation in non-immunosuppressed critically ill patients with sepsis. Expert Rev Clin Pharmacol 2017 (published online Mar 2)

Huang PY, Shie SS, Ye JJ, et al. Acquisition and clearance of multidrug resistant Acinetobacter baumannii on healthy young adults concurrently burned in a dust explosion in Taiwan: the implication for antimicrobial stewardship. BMC Infect Dis 2017 (published online Aug 30)

Jones BM, Bland CM. Penicillin skin testing as an antimicrobial stewardship initiative. Am J Health Syst Pharm 2017 Feb 15;74(4):232-7

Kaziani K, Sotiriou A, Dimopoulos G. Duration of pneumonia therapy and the role of biomarkers. Curr Opin Infect Dis 2017 (published online Jan 12)

Kendall RE, Hanson AP, Crank CW, et al. Impact of fosfomycin tromethamine on the treatment of multi-drug resistant urinary tract infections. J Antimicrob Steward 2017;1(1):4-11

Kim SW. Antimicrobial stewardship with intravenous to oral conversion and future directions of antimicrobial stewardship. Infect Chemother 2017 (published online Mar 22)

Koseck K, Steinberg A, Caliendo G, et al. Comparison of the rates of Clostridium difficile and bacteremia after delaying fluoroquinolone prophylaxis from day 0 to day +3 post autologous stem cell transplantation. Transpl Infect Dis 2017 (published online Apr 29)

Krishna MT, Huissoon AP, Li M, et al. Enhancing antibiotic stewardship by tackling 'spurious' penicillin allergy. Clin Exp Allergy 2017 (published online Oct 13)

Lauerman M, Kolesnik O, Sethuraman K, et al. Less is more? Antibiotic duration and outcomes in fournier's gangrene. J Trauma Acute Care Surg 2017 (published online May 22)

Lee CC, Wang JL, Lee CH, et al. Clinical benefits of antimicrobial de-escalation in adults with community-onset monomicrobial Escherichia coli, Klebsiella species and Proteus mirabilis bacteremia. Int J Antimicrob Agents 2017 (published online Jul 8)

Leis JA, Palmay L, Ho G, et al. Point-of-care beta-lactam allergy skin testing by antimicrobial stewardship programs: a pragmatic multicenter prospective evaluation. Clin Infect Dis 2017 (published online Jun 1)

Llewelyn MJ, Fitzpatrick JM, Darwin E, et al. The antibiotic course has had its day. BMJ 2017 (published online Jul 26)

Lopez-Cortes LE, Rosso-Fernandez C, Nunez-Nunez M, et al. Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial. BMJ Open 2017 (published online Jun 9)

MacFadden DR, Daneman N, Coburn B. Optimizing empiric antibiotic selection in sepsis—turning probabilities into practice. Clin Infect Dis 2017 (published online Aug 25)

Macy E, Shu YH. The effect of penicillin allergy testing on future health care utilization: a matched cohort study. J Allergy Clin Immunol Pract 2017 (published online Mar 30)

McDanel DL, Azar AE, Dowden AM, et al. Screening for beta-lactam allergy in joint arthroplasty patients to improve surgical prophylaxis practice. J Arthroplasty 2017 (published online Jan 17)

McNeil J, Chase MD, Kaplan SL, et al. The influence of the route of antibiotic administration, methicillin susceptibility, vancomycin duration and serum trough concentration on outcomes of pediatric Staphylococcus aureus bacteremic osteoarticular infection. Pediatric Infect Dis J 2017 Jun;36(6):572-7

Moreno E, Laffond E, Munoz-Bellido FJ, et al. Using beta-lactam antibiotics in patients with a history of beta-lactam allergy: current concepts. Pol Arch Intern Med 2017 (published online Jul 19)

Narayanan PP, Jeffres MN. Feasibility, benefits, and limitations of a penicillin allergy skin testing service. Ann Pharmacother 2017 (published online Feb 1)

Nelson AN, Justo JA, Bookstaver PB, et al. Optimal duration of antimicrobial therapy for uncomplicated gram-negative bloodstream infections. Infection 2017 (published online May 6)

Park SM, Kim HS, Jeong YM, et al. Impact of intervention by an antimicrobial stewardship team on conversion from intravenous to oral fluoroquinolones. Infect Chemother 2017 (published online Mar 13)

Paruk F, Sime FB, Lipman J, et al. Dosing antibiotic prophylaxis during cardiopulmonary bypass—a higher level of complexity? A structured review. Int J Antimicrob Agents 2017 (published online Feb 27)

Perez LRR, Narvaez GA. Understanding the β-lactam/inhibitor of β-lactamase combinations: reassessment for better antimicrobial stewardship. Infect Control Hosp Epidemiol 2017 (published online Jun 1)

Pitiriga V, Dimitroulia E, Saroglou G, et al. The challenge of curbing aminoglycoside resistance: can antimicrobial stewardship programs play a critical role? Expert Rev Anti Infect Ther 2017 (published online Sep 20)

Radetsky M. Hostage to history: the duration of antimicrobial treatment for acute Streptococcal pharyngitis. Pediatric Infect Dis J 2017 May;36(5):507-12

Rattanaumpawan P, Werarak P, Jitmuang A, et al. Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial. BMC Infect Dis (published online Mar 1)

Rawson TM, Sharma S, Georgiou P, et al. Towards a minimally invasive device for beta-lactam monitoring in humans. Electrophys Comm 2017 (published online Jul 13)

Roberts JA, Kumar A, Lipman J. Right dose, right now: customized drug dosing in the critically ill. Crit Care Med 2017 Feb;45(2):331-6

Sacco KA, Bates A, Brigham TJ, et al. Clinical outcomes following inpatient penicillin allergy testing: a systematic review and meta-analysis. Allergy 2017 (published online Mar 29)

Su T, Broekhuizen BDL, Verheij TJM, et al. The impact of penicillin allergy labels on antibiotic and health care use in primary care: a retrospective cohort study. Clin Transl Allergy 2017 (published online Jun 7)

Triffault-Fillit C, Ferry T, Perpoint T, et al. Outpatient parenteral antibiotic therapy: evaluation of practices and limits of use in rural areas in France. Med Mal Infect 2017 (published online Oct 16)

Trubiano JA, Stone CA, Lindsay Grayson M, et al. The 3 Cs of antibiotic allergy—classification, cross-reactivity, and collaboration. J Allergy Clin Immunol Pract 2017 (published online Aug 23)

Trubiano JA, Thursky KA, Stewardson AJ, et al. Impact of an integrated antibiotic allergy testing program on antimicrobial stewardship: a multicenter evaluation. Clin Infect Dis 2017 (published online May 18)

Turner RB, Lalikian K, Fry M, et al. Impact of rapid identification of Staphylococcus aureus bloodstream infection without antimicrobial stewardship intervention on antibiotic optimization and clinical outcomes. Diagn Microbiol Infect Dis 2017 (published online Jul 8)

Vaisman A, McCready J, Hicks S, et al. Optimizing preoperative prophylaxis in patients with reported β-lactam allergy: a novel extension of antimicrobial stewardship. J Antimicrob Chemother 2017 (published online Jun 10)

Wada KJ, Calhoun KH. US antibiotic stewardship and penicillin allergy. Curr Opin Otolaryngol Head Neck Surg 2017 (published online Apr 19)

Xu M, Doan Q. Outpatient parenteral antimicrobial therapy and judicious use of pediatric emergency resources. Pediatr Emerg Care 2017 (published online Jul 11)

Yogo N, Shihadeh K, Young H, et al. Intervention to reduce broad-spectrum antibiotics and treatment durations prescribed at the time of hospital discharge: a novel stewardship approach. Infect Control Hosp Epidemiol 2017 (published online Mar 6)

Back to top

2016

Akhloufi H, Hulscher M, Melles DC, et al. Development of operationalized intravenous to oral antibiotic switch criteria. J Antimicrob Chemother 2016 (published online Dec 20)

Allison MG, Heil EL, Hayes BD. Appropriate antibiotic therapy. Emerg Med Clin North Am 2017 Feb;35(1):25-42

Ashfaq A, Zhu A, Iyengar A, et al. Impact of an institutional antimicrobial stewardship program on bacteriology of surgical site infections in cardiac surgery. J Card Surg 2016 Jun;31(6):367-72

Bairy LK, Nayak V, A A, et al. Advances in pharmacovigilance initiatives surrounding antimicrobial resistance — Indian perspective. Expert Opin Drug Saf 2016 May 13:1-8

Bassetti M, Welte T, Wunderink RG. Treatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair? Crit Care 2016 Jan 29;20:19

Broom, J, Broom A, Adams K, et al. What prevents the intravenous to oral antibiotic switch? A qualitative study of hospital doctors' accounts of what influences their clinical practice. J Antimicrob Chemother 2016;71(8):2295-9

Buckel WR, Stenehjem E, Sorensen J, et al. Broad- versus narrow-spectrum oral antibiotic transition and outcomes in healthcare-associated pneumonia. Ann Am Thorac Soc 2016 (published online Oct 3)

Bushen JL, Mehta JM, Hamilton KW, et al. Impact of two different antimicrobial stewardship methods on frequency of streamlining antimicrobial agents in patients with bacteremia. Infect Control Hosp Epidemiol 2016 (published online Nov 9)

Carbo JF, Ruh CA, Kurtzhalts KE, et al. Male veterans with complicated urinary tract infections: Influence of a patient-centered antimicrobial stewardship program. Am J Infect Control 2016 (published online Jul 4)

Corcione S, Baietto L, Malvasio V, et al. Pharmacokinetics of colistin methanesulfonate (CMS) in burn patients. J Antimicrob Chemother 2016 (published online Sep 2)

Crandon JL, Luyt CE, Aubry A, et al. Pharmacodynamics of carbapenems for the treatment of Pseudomonas aeruginosa ventilator-associated pneumonia: associations with clinical outcome and recurrence. J Antimicrob Chemother 2016;71(9):2534-7

Creemers-Schild D, Kroon FP, Kuijper EJ, et al. Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim–sulfamethoxazole: lessons from an observational cohort study. Infection 2016 Jun;44(3):291-9

Cristallini S, Hites M, Kabtouri H, et al. New regimen for continuous infusion of vancomycin in critically ill patients. Antimicrob Agents Chemother 2016 Aug;60(8):4750-6

Cunha BA, Baron J, Cunha CB. Once daily high dose tigecycline—pharmacokinetic/pharmacodynamic based dosing for optimal clinical effectiveness: dosing matters, revisited. Expert Rev Anti Infect Ther 2016 (published online Dec 3)

Davis LC, Covey RB, Weston JS, et al. Pharmacist-driven antimicrobial optimization in the emergency department. Am J Health Syst Pharm 2016 Mar 1;73(5 Suppl 1):S49-56

De Bus L, Denys W, Catteeuw J, et al. Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study. Intensive Care Med 2016 Jun;42(6):1029-39

Erickson CM, Sue PK, Steward K, et al. Sequential parenteral to oral clindamycin dosing in pediatric musculoskeletal infection: a retrospective review of 30mg/kg/day vs 40mg/kg/day. Pediatr Infect Dis J 2016 (published online Jun 10)

Estep PM, Ferreira JA, Dupree LH, et al. Impact of an antimicrobial stewardship initiative to evaluate beta-lactam allergy in patients ordered aztreonam. Am J Health Syst Pharm 2016 Mar 1;73(5 Suppl 1):S8-13

Gagetti P, Pasteran F, Martinez MP, et al. Modeling meropenem treatment, alone and in combination with daptomycin, for KPC-producing Klebsiella pneumoniae strains with unusually low carbapenem MICs. Antimicrob Agents Chemother 2016 Aug;60(8):5047-50

Germovsek E, Kent A, Metsvaht T, et al. Development and evaluation of a gentamicin pharmacokinetic model that facilitates opportunistic gentamicin therapeutic drug monitoring in neonates and infants. Antimicrob Agents Chemother 2016 Aug;60(8):4869-77

Grupper M, Kuti JL, Nicolau DP. Continuous and prolonged intravenous β-lactam dosing: implications for the clinical laboratory. Clin Microbiol Rev 2016 Oct;29(4):759-72

He JC, Golob JF, Brajcich BC, et al. Benefit of TeamSTEPPS rounding improvement project on infection-related monitoring. Surg Infect (Larchmt) 2016 (published online Aug 11)

Hirano R, Sakamoto Y, Kitazawa J, et al. Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience. Infect Drug Resist 2016 Oct 14;9:243-52

Hsieh CC, Lee CH, Hong MY, et al. Propensity score-matched analysis comparing the therapeutic efficacies of cefazolin and extended-spectrum cephalosporins as appropriate empirical therapy in adults with community-onset Escherichia coli, Klebsiella spp. and Proteus mirabilis bacteraemia. Int J Antimicrob Chemother 2016 (published online Oct 26)

Karageorgos SA, Miligkos M, Dakoutrou M, et al. Clinical effectiveness, safety profile, and pharmacokinetics of daptomycin in pediatric patients: a systematic review. J Ped Infect Dis 2016 (published online Aug 24)

Klompas M, Li L, Menchaca JT, et al. Ultra short course antibiotics for patients with suspected ventilator-associated pneumonia but minimal and stable ventilator settings. Clin Infect Dis 2016 (published online Dec 29)

Kongthavonsakul K, Lucksiri A, Eakanunkul S, et al. Pharmacokinetics and pharmacodynamics of meropenem in children with severe infection. Int J Antimicrob Agents 2016 Aug;48(2):151-7

Kutob LF, Justo JA, Bookstaver PB, et al. Effectiveness of oral antibiotics for definitive therapy of gram-negative bloodstream infections. Int J Antimicrob Agents 2016 (published online Aug 20)

Lee YT, Chiang MC, Kuo SC, et al. Carbapenem breakpoints for Acinetobacter baumannii group: supporting clinical outcome data from patients with bacteremia. PLoS One 2016 (published online Sep 19)

Macy E, Khan DA, Castells MC, et al. Penicillin allergy testing, a key component of antibiotic stewardship. Clin Infect Dis 2016 (published online Dec 7)

McMullan BJ, Andresen D, Blyth CC, et al. Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines. Lancet Infect Dis 2016 Aug;16(8):e139-52

Monogue ML, Kuti JL, Nicolau DP. Optimizing antibiotic dosing strategies for the treatment of Gram-negative infections in the era of resistance. Expert Rev Clin Pharmacol 2016 Jan 16;9(3):459-76

Nathwani D, Dryden M, Garau J. Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe. Int J Antimicrob Agents 2016 Aug;48(2):127-36

Nguyen-Ha PT, Howrie D, Crowley K, et al. A quality assessment of a collaborative model of a pediatric antimicrobial stewardship program. Pediatrics 2016 Apr;137(4):e20150316

Niwa T, Watanabe T, Goto T, et al. Daily review of antimicrobial use facilitates the early optimization of antimicrobial therapy and improves clinical outcomes of patients with bloodstream infections. Biol Pharm Bull 2016 May 1;39(5):721-7

Niwa T, Watanabe T, Suzuki K, et al. Early optimization of antimicrobial therapy improves clinical outcomes of patients administered agents targeting methicillin-resistant Staphylococcus aureus. J Clin Pharm Ther 2016 Feb;41(1):19-25

Paul M, Dickstein Y, Raz-Pasteur A. Antibiotic de-escalation for bloodstream infections and pneumonia: systematic review and meta-analysis. Clin Microbiol Infect 2016 (published online Jun 6)

Pea F, Della Siega P, Cojutti P, et al. Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? Int J Antimicrob Agents 2016 (published online Dec 8)

Rattan R, Allen CJ, Sawyer RG, et al. Patients with risk factors for complications do not require longer antimicrobial therapy for complicated intra-abdominal infection. Am Surg 2016 Sep;82(9):860-6

Ritchie ND, Irvine SC, Alieen H, et al. Restrictive antibiotic stewardship associated with reduced hospital mortality in gram-negative infection. QJM 2016 (published online Aug 13)

Swearingen SM, White C, Weidert S, et al. A multidimensional antimicrobial stewardship intervention targeting aztreonam use in patients with a reported penicillin allergy. Int J Clin Pharm 2016 Apr;38(2):213-7

Tabah A, Cotta MO, Garnacho-Montero J, et al.; Working Group for Antimicrobial Use in the ICU. A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit. Clin Infect Dis 2016 Apr 15;62(8):1009-17

Trubiano JA, Chen C, Cheng AC, et al.; National Antimicrobial Prescribing Survey (NAPS). Antimicrobial allergy 'labels' drive inappropriate antimicrobial prescribing: lessons for stewardship. J Antimicrob Chemother 2016 Jun;71(6):1715-22

Ungphakorn W, Tangden T, Sandegren L, et al. A pharmacokinetic–pharmacodynamic model characterizing the emergence of resistant Escherichia coli subpopulations during ertapenem exposure. J Antimicrob Chemother 2016;71(9):2521-33

Uranga A, Espana PP, Bilbao A, et al. Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial. Jama Intern Med 2016 (published online Jul 25)

Veve MP, Wagner JL, Kenney RM, et al. Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum beta-lactamase urinary tract infections. Int J Antimicrob Agents 2016 Jul;48(1):56-60

Viasus D, Simonetti AF, Garcia-Vidal C, et al. Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia. J Antimicrob Chemother 2016 (published online Oct 20)

Wilbaux M, Fuchs A, Samardzic J, et al. Pharmacometric approaches to personalize use of primarily renally eliminated antibiotics in preterm and term neonates. J Clin Pharmacol 2016 Aug;56(8):909-35

Zilahi G, McMahon MA, Povoa P, et al. Duration of antibiotic therapy in the intensive care unit. J Thorac Dis 2016 Dec;8(12):3774-80

Back to top

2015

Abdul-Aziz MH, Lipman J, Mouton JW, et al. Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development. Semin Respir Crit Care Med 2015 Feb;36(1):136-53

Aliberti S, Giuliani F, Ramirez J, et al. How to choose the duration of antibiotic therapy in patients with pneumonia. Curr Opin Infect Dis 2015 Apr;28(2):177-84

Arena F, Scolletta S, Marchetti L, et al. Impact of a clinical microbiology-intensive care consulting program in a cardiothoracic intensive care unit. Am J Infect Control 2015 (published online Jun 3)

Barber KE, Werth BJ, Rybak MJ. The combination of ceftaroline plus daptomycin allows for therapeutic de-escalation and daptomycin sparing against MRSA. J Antimicrob Chemother 2015 Feb;70(2):505-9

Barrett J, Edgeworth J, Wyncoll D. Shortening the course of antibiotic treatment in the intensive care unit. Expert Rev Anti Infect Ther 2015 Apr;13(4):463-71

Bassetti M, De Waele JJ, Eggimann P, et al. Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med 2015 May;41(5):776-95

Beique L, Zvonar R. Addressing concerns about changing the route of antimicrobial administration from intravenous to oral in adult inpatients. Can J Hosp Pharm 2015 Jul-Aug;68(4):318-26

del Arco A, Tortajada B, de la Torre J, et al. The impact of an antimicrobial stewardship programme on the use of antimicrobials and the evolution of drug resistance. Eur J Clin Microbiol Infect Dis 2015 Feb;34(2):247-51

Fantoni M, Murri R, Scoppettuolo G, et al. Resource-saving advice from an infectious diseases specialist team in a large university hospital: an exportable model? Future Microbiol 2015;10(1):15-20

Furtado GH, Cardinal L, Macedo RS, et al. Pharmacokinetic/pharmacodynamic target attainment of intravenous beta-lactam regimens against gram-negative bacteria isolated in a Brazilian teaching hospital. Rev Soc Bras Med Trop 2015 Sep-Oct;48(5):539-45

Gilchrist M, Seaton RA. Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists. J Antimicrob Chemother 2015 Apr;70(4):965-70

Goldman JL, Lee BR, Hersh AL, et al. Clinical diagnoses and antimicrobials predictive of pediatric antimicrobial stewardship recommendations: a program evaluation. Infect Control Hosp Epidemiol 2015 Jun;36(6):673-80

Knackstedt ED, Stockmann C, Davis CR, et al. Outpatient parenteral antimicrobial therapy in pediatrics: an opportunity to expand antimicrobial stewardship. Infect Control Hosp Epidemiol 2015 Feb;36(2):222-4

Lawson W, Nathwani D, Eckmann C, et al. Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistance Staphylococcus aureus. Clin Microbiol Infect 2015 Sep;21(Suppl 2):S40-6

Lesprit P, de Pontfarcy A, Esposito-Farese M, et al. Postprescription review improves in-hospital antibiotic use: a multicenter randomized controlled trial. Clin Microbiol Infect 2015 Feb;21(2):180.e1-7

Lew KY, Ng TM, Tan M, et al. Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting. J Antimicrob Chemother 2015 Apr;70(4):1219-25

Loo LW, Liew YX, Lee W, et al. Impact of antimicrobial stewardship program (ASP) on outcomes in patients with acute bacterial skin and skin structure infections (ABSSSIs) in an acute-tertiary care hospital. Infect Dis Ther 2015 Sep;4(Suppl 1):15-25

Nathwani D, Lawson W, Dryden M, et al. Implementing criteria-based early switch/early discharge programmes: a European perspective. Clin Microbiol Infect 2015 Sep;21(Suppl 2):S47-55

Nguyen CT, Gandhi T, Chenoweth C, et al. Impact of an antimicrobial stewardship-led intervention for Staphylococcus aureus bacteraemia: a quasi-experimental study. J Antimicrob Chemother 2015 Dec;70(12):3390-6

Niwa T, Watanabe T, Suzuki K, et al. Early optimization of antimicrobial therapy improves clinical outcomes of patients administered agents targeting methicillin-resistant Staphylococcus aureus. J Clin Pharm Ther 2015 (published online Dec 18)

Singh S, Zhang YZ, Chalkley S, et al. A three-point time series study of antibiotic usage on an intensive care unit, following an antibiotic stewardship programme, after an outbreak of multi-resistant Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 2015 Sep;34(9):1893-900

Spivak ES, Kendall B, Orlando P, et al. Evaluation of outpatient parenteral antimicrobial therapy at a Veterans Affairs hospital. Infect Control Hosp Epidemiol 2015 Sep;36(9):1103-5

Tabah A, Cotta MO, Garnacho-Montero J, et al. A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit. Clin Infect Dis 2015 (published online Dec 23)

Thompson C, Zahradnik M, Brown A, et al. The use of an IV to PO clinical intervention form to improve antibiotic administration in a community based hospital. BMJ Qual Improv Rep 2015 Jan 29;4(1):u200786.w2247

Weiss E, Zahar JR, Lesprit P, et al. Elaboration of a consensual definition of de-escalation allowing a ranking of beta-lactams. Clin Microbiol Infect 2015 Jul;21(7):649.e1-10

Back to top

2014

Ahmad F, Pogue JM, Marchaim D, et al. Evaluation of the potential impact of a carbapenem de-escalation program in an academic healthcare system. J Infect Public Health 2014 Feb;7(1):50-3

Bartlett JM, Siola PL. Implementation and first-year results of an antimicrobial stewardship program at a community hospital. Am J Health Syst Pharm 2014 Jun 1;71(11):943-9

Blanchette LM, Kuti JL, Nicolau DP, et al. Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing Enterobacteriaceae. Scand J Infect Dis 2014 Nov;46(11):803

Braykov NP, Morgon DJ, Schweizer ML, et al. Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study. Lancet Infect Dis 2014 Dec;14(12):1220-7

Buyle RM, Wallaert M, Beck N, et al. Implementation of a multidisciplinary infectious diseases team in a tertiary hospital within an antimicrobial stewardship program. Acta Clin Belg 2014 Oct;69(5):320-6

Cotta MO, Roberts JA, Tabah A, et al. Antimicrobial stewardship of beta-lactams in intensive care units. Expert Rev Anti Infect Ther 2014 May;12(5):581-95

Eckmann C, Lawson W, Nathwani D, et al. Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria. Int J Antimicrob Agents 2014 Jul;44(1):56-64

El Houfi A, Javed N, Nathwani D, et al. Early switch/early discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates. Value Health 2014 Nov;17(7):A683

Fagan M, Lindbaek M, Reiso H, et al. A simple intervention to reduce inappropriate ciprofloxacin prescribing in the emergency department. Scand J Infect Dis 2014 Jul;46(7):481-5

Guillard P, de La Blanchardiere A, Cattoir V, et al. Antimicrobial stewardship and linezolid. Int J Clin Pharm 2014 Oct;36(5):1059-68

Landry E, Sulz L, Bell A, et al. Urinary tract infections: leading initiatives in selecting empiric outpatient treatment (UTILISE). Can J Hosp Pharm 2014 Mar;67(2):116-25

MacVane SH, Kuti JL, Nicolau DP. Clinical pharmacodynamics of antipseudomonal cephalosporins in patients with ventilator-associated pneumonia. Antimicrob Agents Chemother 2014 Mar;58(3):1359-64

MacVane SH, Kuti JL, Nicolau DP. Prolonging beta-lactam infusion: a review of the rationale and evidence, and guidance for implementation. Int J Antimicrob Agents 2014 Feb;43(2):105-13

Maddox ML, DeBoer EC, Hammerquist RJ. Administration of extended infusion piperacillin-tazobactam with the use of smart pump technology. Hosp Pharm 2014 May;49(5):444-8

Nathwani D, Eckmann C, Lawson W, et al. Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections. Clin Microbiol Infect 2014 Oct;20(10):993-1000.

Pinzone MR, Cacopardo B, Abbo, L, et al. Duration of antimicrobial therapy in community acquired pneumonia: less is more. Sci World J 2014 Jan 21;2014:759138

Sakoulas G, Moise PA, Casapao AM, et al. Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline. Clin Ther 2014 Oct 1;36(10):1317-33

Shrayteh ZM, Rahal MK, Malaeb DN. Practice of switch from intravenous to oral antibiotics. Springerplus 2014 Dec 9;3:717

So W, Kuti JL, Nicolau DP. Population pharmacokinetics of cefazolin in serum and tissue for patients with complicated skin and soft tissue infections (cSSTI). Infect Dis Ther 2014 Dec;3(2):269-79

Vitrat V, Hautefeuille S, Janssen C, et al. Optimizing antimicrobial therapy in critically ill patients. Infect Drug Resist 2014 Oct 20;7:261-71

Wang HY, Chiu CH, Huang CT, et al. Blood culture-guided de-escalation of empirical antimicrobial regimen for critical patients in an online antimicrobial stewardship programme. Int J Antimicrob Agents 2014 Dec;44(6):520-7

Back to top

2013

Ampe E, et al. Implementation of a protocol for administration of vancomycin by continuous infusion: pharmacokinetic, pharmacodynamic and toxicological aspects. Int J Antimicrob Agents 2013;41:439- 46

Arnold HM, et al. Prolonged infusion antibiotics for suspected Gram-negative infections in the ICU: a before-after study. Ann Pharmacother 2013; 47:170-80

Bauer KA, et al. Extended-infusion cefepime reduces mortality in patients with Pseudomonas aeruginosa infections. Antimicrob Agents Chemother 2013 Jul;57(7):2907-12

Bhalodi AA, et al. Pharmacokinetics of doripenem in infected patients treated within and outside the intensive care unit. Ann Pharmacother. 2013 May;47(5):617-27

Bhalodi AA, et al. Pharmacokinetics of intravenous linezolid in moderately to morbidly obese adults. Antimicrob Agents Chemother 2013 Mar;57(3):1144-9

Bhalodi AA, et al. Tissue pharmacokinetics of cefazolin in patients with lower limb infections. Antimicrob Agents Chemother 2013 Nov;57(11):5679-83

Boyce JM, et al. A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia. Antimicrob Agents Chemother 2013;57:1163-8

Butterfield JM, et al. Daptomycin pharmacokinetics and pharmacodynamics in a pooled sample of patients receiving thrice-weekly hemodialysis. Antimicrob Agents Chemother 2013;57:864-72

Carlier M, et al. Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used? Crit Care 2013;17:R84

Covajes C, et al. Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy. Int J Antimicrob Agents 2013;41:261-6

Davis SL, et al. Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals. Pharmacotherapy 2013 Dec;33(12):1256-63

De Waele JJ, et al. Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion. Int J Antimicrob Agents 2013;41:434-8

Durante-Mangoni E, et al. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. Clin Infect Dis 2013 Aug;57(3):349-58

Falagas ME, et al. Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis. Clin Infect Dis 2013;56:272-82

Falcone M, et al. Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary? J Infect Chemother 2013 Aug;19(4):732-9

Fernandez-Hidalgo N, et al. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis. Clin Infect Dis 2013;56:1261-8

Fissell WH. Antimicrobial dosing in acute renal replacement. Adv Chronic Kidney Dis 2013;20:85-93

Goff DA, et al. When pharmacodynamics trump costs: an antimicrobial stewardship program's approach to selecting optimal antimicrobial agents. Clin Ther 2013 Jun;35(6):766-71

Golenia BS, et al. Evaluation of a vancomycin dosing nomogram based on the Modification of Diet in Renal Disease equation in intensive care unit patients. J Crit Care 2013 Oct;28(5):710-6

Haeseker M, et al. The ciprofloxacin target AUC: MIC ratio is not reached in hospitalized patients with the recommended dosing regimens. Br J Clin Pharmacol 2013;75:180-5

Hermsen ED, et al. Failure of a pharmacist-initiated antimicrobial step-down protocol to impact physician prescribing behaviour or patient outcomes: a quasi-experimental, cross-over study. J Hosp Admin 2013;2:62-70

Kiratisin P, et al. Pharmacodynamic profiling of doripenem, imipenem and meropenem against prevalent Gram-negative organisms in the Asia-Pacific region. Int J Antimicrob Agents 2013 Jan;41(1):47-51

Kullar R, et al. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia. Pharmacotherapy 2013;33:3-10

Montoya M, et al. Antimicrobial selection and its impact on the incidence of clostridium difficile- associated diarrhea. J Pharm Pract 2013 Oct;26(5):483-7

Murray KP, et al. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration ≥ 1 mg/L: a matched cohort study. Clin Infect Dis 2013;56:1562-9

Paciullo CA, et al. Vancomycin clearance in high-volume venovenous hemofiltration. Ann Pharmacother 2013;47:e14

Preiswerk B, et al. Experience with daptomycin daily dosing in ICU patients undergoing continuous renal replacement therapy. Infection 2013;41:553-7

Raman K, et al. Early antibiotic discontinuation in patients with clinically suspected ventilator-associated pneumonia and negative quantitative bronchoscopy cultures. Crit Care Med 2013 Jul;41(7):1656-63

Sallach-Ruma R, et al. Evaluation of outcomes of intravenous to oral antimicrobial conversion initiatives: a literature review. Expert Rev Clin Pharmacol 2013 Nov;6(6):703-29

Saugel B, et al. Continuous intravenous administration of vancomycin in medical intensive care unit patients. J Crit Care 2013;28:9-13

Schulz L, et al. The use of best practice alerts with the development of an antimicrobial stewardship navigator to promote antibiotic de-escalation in the electronic medical record. Infect Control Hosp Epidemiol 2013 Dec;34(12):1259-65

Silva BN, et al. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev 2013;3:CD007934

Takahashi Y, et al. Preferable timing of therapeutic drug monitoring in patients with impaired renal function treated with once-daily administration of vancomycin. J Infect Chemother 2013 Aug;19(4):709-16

Udy AA, et al. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients? Int J Antimicrob Agents 2013;41:564-8

Vandecasteele SJ, et al. The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties. J Antimicrob Chemother 2013;68:743-8

Zelenitsky S, et al. Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock. Int J Antimicrob Agents 2013;41:255-60

Zhao W, et al. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring. Arch Dis Child 2013;98:449-53

Back to top

2012

Avdic E, et al. Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia. Clin Infect Dis 2012;54:1581-7

Bhalodi AA, et al. Pharmacokinetics of intravenous linezolid in moderately to morbidly obese adults. Antimicrob Agents Chemother 2013 Mar;57(3):1144-9

Buyle FM, et al. Prospective multicentre feasibility study of a quality of care indicator for intravenous to oral switch therapy with highly bioavailable antibiotics. J Antimicrob Chemother 2012;67:2043-6

Deresinski S. Methicillin-resistant Staphylococcus aureus and vancomycin: minimum inhibitory concentration matters. Clin Infect Dis 2012 Mar;54(6):772-4

Duszynska W, et al. Continuous infusion of piperacillin/tazobactam in ventilator-associated pneumonia: a pilot study on efficacy and costs. Int J Antimicrob Agents 2012;39:153-8

El Nekidy WS, et al. Factors influencing vancomycin loading dose for hospitalized hemodialysis patients: prospective observational cohort study. Can J Hosp Pharm 2012;65:436-42

Frazee EN, et al. Effect of continuous venovenous hemofiltration dose on achievement of adequate vancomycin trough concentrations. Antimicrob Agents Chemother 2012;56:6181-5

Geli P, et al. “One-size-fits-all”? Optimizing treatment duration for bacterial infections. PLoS One 2012;7(1):e29838

Georges B, et al. Ceftazidime dosage regimen in intensive care unit patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations. Br J Clin Pharmacol 2012;73:588-96

George JM, et al. Prolonged infusions of beta-lactam antibiotics: implication for antimicrobial stewardship. Pharmacotherapy 2012;32:707-21

Jamal JA, et al. Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy, and extracorporeal membrane oxygenation. Curr Opin Crit Care 2012;18:460-71

Jones M, et al. Parenteral to oral conversion of fluoroquinolones: low-hanging fruit for antimicrobial stewardship programs? Infect Control Hosp Epidemiol 2012 Apr;33(4):362-7

Lee GC, et al. Outcomes of extended-infusion piperacillin-tazobactam: a retrospective analysis of critically ill patients. Clin Ther 2012;34:2297-300

Lee SL, et al. Clinicians' knowledge, beliefs and acceptance of intravenous-to-oral antibiotic switching, Hospital Pulau Pinang. Med J Malaysia 2012;67:190-8

Lodise TP, et al. Telavancin pharmacokinetics and pharmacodynamics in patients with complicated skin and skin structure infections and various degrees of renal function. Antimicrob Agents Chemother 2012;56:2062-6

McKamy S, et al. Evaluation of a pediatric continuous-infusion vancomycin therapy guideline. Am J Health Syst Pharm 2012;69:2066-71

Minne L, et al. Five years of therapeutic drug monitoring in the intensive care did not change vancomycin prescription behaviour: perceived needs for decision support. Minerva Anestesiol 2012;78:684-92

Nicolau DP, et al. Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence. Int J Antimicrob Agents 2012 Jan;39(1):11-5

Nichols KR, et al. System-wide implementation of the use of an extended-infusion piperacillin/tazobactam dosing strategy: feasibility of utilization from a children's hospital perspective. Clin Ther 2012;34:1459-65

Pea F, et al. Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe Gram-negative infections: a pharmacokinetics/pharmacodynamics-based approach. Antimicrob Agents Chemother 2012;56:6343- 8

Piper GL, Kaplan LJ. Antibiotic heterogeneity optimizes antimicrobial prescription and enables resistant pathogen control in the intensive care unit. Surg Infect (Larchmt) 2012;13:194-202

Reynolds DC, et al. Performance of a vancomycin dosage regimen developed for obese patients. Am J Health Syst Pharm 2012;69:944-50

Roberts JA, et al. How to optimise antimicrobial prescriptions in the intensive care unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics. Int J Antimicrob Agents 2012;39:187-92

Silva DC, et al. Vancomycin serum concentrations in pediatric oncologic/hematologic intensive care patients. Braz J Infect Dis 2012;16:361-5

Sinnollareddy MG, et al. Beta-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review. Clin Exp Pharmacol Physiol 2012;39:489- 96

Soto Guerrero Y, et al. Evaluation of a vancomycin dosing regimen for patients on high flux hemodialysis: an observational study. Bol Asoc Med P R 2012;104:10-4

Tamma PD, et al. Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev 2012;25:450-70

Teo J, et al. The effect of a whole-system approach in an antimicrobial stewardship programme at the Singapore General Hospital. Eur J Clin Microbiol Infect Dis 2012;31:947-55

Tran TT, et al. Evaluation of a daptomycin dose-optimization protocol. Am J Health Syst Pharm 2012;69:979-84

Troger U, et al. Decreased meropenem levels in intensive care unit patients with augmented renal clearance: benefit of therapeutic drug monitoring. Int J Antimicrob Agents 2012;40:370-2

Walker MC, et al. Continuous and extended infusions of beta-lactam antibiotics in the pediatric population. Ann Pharmacother 2012;46:1537-46

Wilson FP, Berns JS. Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD). Clin Nephrol 2012;77:329-31

Wilson FP, et al. Low cefepime concentrations during high blood and dialysate flow continuous venovenous hemodialysis. Antimicrob Agents Chemother 2012;56:2178-80

Yen YH, et al. Clinical and economic impact of a pharmacist-managed I.V.-to-P.O. conversion service for levofloxacin in Taiwan. Int J Clin Pharmacol Ther 2012;50:136-41

Yoshizawa K, et al. Optimisation of imipenem regimens in patients with impaired renal function by pharmacokinetic-pharmacodynamic target attainment analysis of plasma and urinary concentration data. Int J Antimicrob Agents 2012;40:427-33

Zelenitsky SA, et al. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis. Clin Infect Dis 2012;55:527-33

Back to top

2011

Abuhasna S, Al Jundi AH. Therapeutic drug monitoring of vancomycin in an obese patient with renal insufficiency. J Anaesthesiol Clin Pharmacol 2011;27:531-3

Aubron C, et al. Evaluation of the accuracy of a pharmacokinetic dosing program in predicting serum vancomycin concentrations in critically ill patients. Ann Pharmacother 2011;45:1193-8

Bosso JA, et al. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob Agents Chemother 2011;55:5475-9

Cardone KE, et al. Pharmacokinetics and pharmacodynamics of intravenous daptomycin during continuous ambulatory peritoneal dialysis. Clin J Am Soc Nephrol 2011;6:1081-8

Cheatham SC, et al. Steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patients. Int J Antimicrob Agents 2011;37:46-50

Cook AM, et al. Pharmacokinetics of intravenous levofloxacin administered at 750 milligrams in obese adults. Antimicrob Agents Chemother 2011;55:3240-3

Chung J, et al. Optimal dose of vancomycin for treating methicillin-resistant Staphylococcus aureus pneumonia in critically ill patients. Anaesth Intensive Care 2011;39:1030-7

Cirillo I, et al. Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenem. Antimicrob Agents Chemother 2011;55:1187-93

Conil JM, et al. Tobramycin disposition in ICU patients receiving a once daily regimen: population approach and dosage simulations. Br J Clin Pharmacol 2011;71:61-71

Connor MJ Jr, et al. Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis. Antimicrob Agents Chemother 2011;55:557-60

Crandon JL, et al. Optimization of meropenem dosage in the critically ill population based on renal function. Intensive Care Med 2011 Apr;37(4):632-8

Crandon, JL, et al. Pharmacodynamic approaches to optimizing beta-lactam therapy. Crit Care Clin 2011 Jan;27(1):77-93

Drusano GL, Louie A. Optimization of aminoglycoside therapy. Antimicrob Agents Chemother 2011;55:2528-31

Dunn K, et al. Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study. Int J Clin Pharm 2011;33:208-14

Frymoyer A, et al. Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations. Pharmacotherapy 2011;31:871-6

Giachetto GA, et al. Vancomycin pharmacokinetic-pharmacodynamic parameters to optimize dosage administration in critically ill children. Pediatr Crit Care Med 2011;12:e250-4

Garonzik SM et al. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother 2011;55:3284-94

Heil EL, et al. Validation of doripenem dosing in patients with end-stage renal disease receiving hemodialysis. Ann Pharmacother 2011 Nov; 45(11):1455-6

Housman ST, et al. Optimizing antibiotic pharmacodynamics in hospital-acquired and ventilator-acquired bacterial pneumonia. Clin Chest Med 2011 Sep;32(3):439-50

Jain R, et al. Implications of obesity for drug therapy: limitations and challenges. Clin Pharmacol Ther 2011;90:77-89

Kaufman SE, et al. Rationale and evidence for extended infusion of piperacillin-tazobactam. Am J Health Syst Pharm 2011;68:1521-6

Keel RA, et al. Pharmacodynamic evaluation of i.v. antimicrobials against Psedomonas aeruginosa samples collected from U.S. hospitals. Am J Health Syst Pharm 2011 Sep 1;68(17):1619-25

Keel, RA. Pharmacodynamic profiling of antimicrobials against gram-negative respiratory isolates from Canadian hospitals. Can J Infect Dis Med Microbiol 2011 Winter;22(4):132-6

Keel RA, et al. Pharmacokinetics of intravenous and oral linezolid in adults with cystic fibrosis. Antimicrob Agents Chemother 2011 Jul;55(7):3393-8

Khachman D, et al. Optimizing ciprofloxacin dosing in intensive care unit patients through the use of population pharmacokinetic-pharmacodynamic analysis and Monte Carlo simulations. J Antimicrob Chemother 2011;66:1798-809

Kullar R, et al. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines. Pharmacotherapy 2011;31:441-8

Kumar A. Optimizing antimicrobial therapy in sepsis and septic shock. Crit Care Nurs Clin North Am 2011;23:79-97

Lodise TP, Butterfield J. Use of pharmacodynamic principles to inform beta-lactam dosing: "S" does not always mean success. J Hosp Med 2011;6:S16-23

Lodise TP, Drusano GL. Pharmacokinetics and pharmacodynamics: optimal antimicrobial therapy in the intensive care unit. Crit Care Clin 2011;27:1-18

Lomaestro BM. Vancomycin dosing and monitoring 2 years after the guidelines. Expert Rev Anti Infect Ther 2011;9:657-67

Mehta SA, Phillips MS. Combination therapy for septic shock: considerations for antibiotic stewardship. Crit Care Med 2011;39:608-9

McKenzie C. Antibiotic dosing in critical illness. J Antimicrob Chemother 2011;66(Suppl 2):ii25-ii32

Nadeau MC, Kuti EL. Clinical and economic impact of intravenous to oral conversion therapy programs. Conn Med 2011;75:25-9

Nicolau DP, et al. Bronchopulmonary pharmacokinetic and pharmacodynamics profiles of levofloxacin 750 mg once daily in adults undergoing treatment for actue exacerbation of chronic bronchitis. Pulm Pharmacol Ther 2012 Feb;25(1):94-8

Nielsen EI, et al. Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization. Antimicrob Agents Chemother 2011;55:4619-30

Nyman HA, et al. Comparative evaluation of the Cockcroft-Gault equation and the modification of diet in renal disease (MDRD) study equation for drug dosing: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy 2011;31:1130- 44

Ohata Y, et al. Optimal dosage regimen of meropenem for pediatric patients based on pharmacokinetic/pharmacodynamic considerations. Drug Metab Pharmacokinet 2011;26:523-31

Patel N, et al. Use of pharmacokinetic and pharmacodynamic principles to determine optimal administration of daptomycin in patients receiving standardized thrice-weekly hemodialysis. Antimicrob Agents Chemother 2011;55:1677-83

Rattanaumpawan P, et al. Impact of antimicrobial stewardship programme changes on unnecessary double anaerobic coverage therapy. J Antimicrob Chemother 2011;66:2655-8

Roberts JA, et al. Vancomycin dosing in critically ill patients: robust methods for improved continuous- infusion regimens. Antimicrob Agents Chemother 2011;55:2704-9

Roberts JA. Using PK/PD to optimize antibiotic dosing for critically ill patients. Curr Pharm Biotechnol 2011;12:2070-9

Rotschafer J, et al. Optimal use of fluoroquinolones in the intensive care setting. Crit Care Clin 2011 Jan;27(1):95-106

Ulldemolins M, et al. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients. Clin Pharmacokinet 2011;50:99-110

Varghese JM, et al. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock. Crit Care Clin 2011;27:19-34

Vilay AM, et al. Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis. Crit Care Med 2011;39:19-25

Yamamoto T, et al. Proposal of a pharmacokinetically optimized dosage regimen of antibiotics in patients receiving continuous hemodiafiltration. Antimicrob Agents Chemother 2011;55:5804-12

Yost RJ, et al. The retrospective cohort of extended-infusion piperacillin-tazobactam (RECEIPT) study: a multicenter study. Pharmacotherapy 2011;31:767-75

Back to top

2010

Bal AM, et al. Antibiotic heterogeneity: from concept to practice. Ann N Y Acad Sci 2010;1213:81-91

Bazan JA, et al. Peramivir pharmacokinetics in two critically ill adults with 2009 H1N1 influenza A concurrently receiving continuous renal replacement therapy. Pharmacotherapy 2010 Oct;30(10):1016-20

Bulitta JB, et al. Population pharmacokinetic comparison and pharmacodynamics breakpoints of ceftazidime in cystic fibrosis patients and healthy volunteers. Antimicrob Agents Chemother 2010;54:1275-82

Burkhardt O, et al. Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations. Int J Antimicrob Agents 2010;35:96-7

Chapuis TM, et al. Prospective monitoring of cefepime in intensive care unit adult patients. Crit Care 2010;14:R51

Decker BS, et al. Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis. Clin J Am Soc Nephrol 2010;5:1981-7

Delattre IK, et al. Empirical models for dosage optimization of four beta-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin. Clin Biochem 2010;43:589-98

Giuliano C, et al. Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections. Expert Rev Anti Infect Ther 2010;8:95-106

Gomes Silva BN, et al. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev 2010;(12):CD007934

Helmons PJ,et al. Using a clinical decision support system to determine the quality of antimicrobial dosing in intensive care patients with renal insufficiency. Qual Saf Health Care 2010;19:22-6

Hermsen ED, et al. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections. Expert Opin Drug Saf 2010;9:9-14

Imberti C, et al. Steady-state pharmacokinetics and BAL concentration of colistin in critically ill patients after IV colistin methanesulfonate administration. Chest 2010;138:1333-9

Kielstein JT, et al. Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis--a pharmacokinetic study. Nephrol Dial Transplant 2010;25:1537-41

Koomanachai P, et al. Pharmacodynamic modeling of intravenous antibiotics against gram-negative bacteria collected in the United States. Clin Ther 2010 Apr;32(4):766-79

Kumar A, et al. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med 2010;38:1773-85

Legal M, Wan M. Influence of age on frequency of vancomycin dosing. Can J Hosp Pharm 2010;63:13-9

Logman JF, et al. Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections. Curr Med Res Opin 2010 Jul;26(7):1565-78

Marques-Minana MR, et al. Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline. Br J Clin Pharmacol 2010;70:713-20

Nicasio AM, et al. Length of stay and hospital costs associated with a pharmacodynamics-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia. Pharmacotherapy 2010 May;30(5):453-62

Panais R, et al. A protocolized approach to vancomycin dosing in conventional hemodialysis. J Nephrol 2010;23:569-74

Patel N, et al. Determination of antibiotic dosage adjustments in patients with renal impairment: elements for success. J Antimicrob Chemother 2010;65:2285-90

Patel N, et al. Identification of optimal renal dosage adjustments for traditional and extended-infusion piperacillin-tazobactam dosing regimens in hospitalized patients. Antimicrob Agents Chemother 2010;54:460-5

Revilla N, et al. Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation. Br J Clin Pharmacol 2010;70:201-12

Roberts JA, et al. First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis. Int J Antimicrob Agents 2010;35:156-63

Samtani MN, et al. Pharmacokinetic-pharmacodynamic-model-guided doripenem dosing in critically ill patients. Antimicrob Agents Chemother 2010;54:2360-2364

Shaw PA. Combination versus monotherapy for septic shock patients. Crit Care Med 2010;38:1905-6

van de Vijsel LM, et al. Initial vancomycin dosing recommendations for critically ill patients undergoing continuous venovenous hemodialysis. Can J Hosp Pharm 2010;63:196-206

Xamplas RC, et al. Implementation of an extended-infusion piperacillin-tazobactam program at an urban teaching hospital. Am J Health Syst Pharm 2010;67:622-8

Back to top

 

2000-2009

Adembri C, Fallani S, Cassetta MI, et al. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion. Int J Antimicrob Agents 2009 Feb;31(2):122-9

Adibe OO, Barnaby K, Dobies J, et al. Postoperative antibiotic therapy for children with perforated appendicitis: long course of intravenous antibiotics versus early conversion to an oral regimen. Am J Surg 2008 Feb;195(2):141-3

Athanassa Z, Makris G, Dimopoulos G, et al. Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis. Drugs 2008;68(17):2469-81

Ballock RT, Newton PO, Evans SJ, et al. A comparison of early versus late conversion from intravenous to oral therapy in the treatment of septic arthritis. J Pediatr Orthop 2009 Sep;29(6):636-42

Bearden DT, Rodvold KA. Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics. Clin Pharmacokinet 2000 May;38(5):415-26

Bergen PJ, Li J, Nation RL, et al. Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model. J Antimicrob Chemother 2008 Mar;61(3):636-42

Boselli E, Breilh D, Reimmele T, et al. Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia. Crit Care Med 2005 Jul;33(7):1529-33

Brink AJ, Richards GA, Schillack V, et al. Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis. Int J Antimicrob Agents 2009 May;33(5):432-6

Burkhardt O, Kumar V, Katterwe D, et al. Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration. J Antimicrob Chemother 2007 Feb;59(2):277-84

Castro-Guardiola A, Viejo-Rodriguez AL, Soler-Simon S, et al. Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial. Am J Med 2001 Oct 1;111(5):367-74

Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003 Nov 19;290(19):2588-98

Chen M, Nafziger AN, Drusano GL, et al. Comparative pharmacokinetics and pharmacodynamic target attainment of ertapenem in normal-weight, obese, and extremely obese adults. Antimicrob Agents Chemother 2006 Apr;50(4):1222-7

Choi G, Gomersall CD, Tian Q, et al. Principles of antibacterial dosing in continuous renal replacement therapy. Blood Purif 2010;30(3):195-212

Cohn SM, Lipsett PA, Buchman TG, et al. Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Ann Surg 2000 Aug;232(2):254-62

Conort O, Gabardi S, Didier MP, et al. Intravenous to oral conversion of fluoroquinolones: knowledge versus clinical practice patterns. Pharm World Sci 2002 Apr;24(2):67-70

Craig WA. Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. Infect Dis Clin North Am 2003 Sep;17(3):479-501

Czock D, Markert C, Hartman B, et al. Pharmacokinetics and pharmacodynamics of antimicrobial drugs. Expert Opin Drug Metab Toxicol 2009 May;5(5):475-87

Davis SL, Delgado G Jr, McKinnon PS. Pharmacoeconomic considerations associated with the use of intravenous-to-oral moxifloxacin for community-acquired pneumonia. Clin Infect Dis 2005 Jul 15;41 Suppl 2:S136-43

del Mar Fernandez de Gatta Garcia M, Revilla N, Calvo MV, et al. Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients. Intensive Care Med 2007 Feb;33(2):279-85

Drusano GL, Ambrose PG, Bhavnani SM, et al. Back to the future: using aminoglycosides again and how to dose them optimally. Clin Infect Dis 2007 Sep 15;45(6):753-60

Dvorchik B, Arbeit RD, Chung J, et al. Population pharmacokinetics of daptomycin. Antimicrob Agents Chemother 2004 Aug;48(8):2799-807

Fernandez de Gatta Mdel M, Santos Buelga D, Sanchez Navarro A, et al. Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokinetic/pharmacodynamic analysis. Clin Pharmacokinet 2009;48(4):273-80

Fischer MA, Solomon DH, Teich JM, et al. Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized patients. Arch Intern Med 2003 Nov 24;163(21):2585-9

Glemaud I. Use of a physician order entry system to identify opportunities for intravenous to oral levofloxacin conversion. Am J Health Syst Pharm 2000 Nov 15;57 Suppl 3:S14-6

Gunderson BW, Ross GH, Ibrahim KH, et al. What do we really know about antibiotic pharmacodynamics? Pharmacotherapy 2001 Nov;21(11 Pt 2):302S-318S

Hagaman JT, Yurkowski P, Trott A, et al. Getting physicians to make "the switch": the role of clinical guidelines in the management of community-acquired pneumonia. Am J Med Qual 2005 Jan-Feb;20(1):15-21

Halley HJ. Approaches to drug therapy, formulary, and pathway management in a large community hospital. Am J Health Syst Pharm 2000 Nov 15;57(Suppl 3):S17-21

Halm EA, Switzer GE, Mittman BS, et al. What factors influence physicians' decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia? J Gen Intern Med 2001 Sep;16(9):599-605

Hanes SD, Wood GC, Herring V, et al. Intermittent and continuous ceftazidime infusion for critically ill trauma patients. Am J Surg 2000 Jun;179(6):436-40

Heintz BH, Matzke GR, Dager WE. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis. Pharmacotherapy 2009 May;29(5):562-77

Hermsen ED, Maiefski M, Florescu MC, et al. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials. Pharmacotherapy 2009 Jun;29(6):649-55

Ho BP, Lau TT, Balen RM, et al. The impact of a pharmacist-managed dosage form conversion service on ciprofloxacin usage at a major Canadian teaching hospital: a pre- and post-intervention study. BMC Health Serv Res 2005 Jun 29;5:48

Ikawa K, Morikawa N, Uehara S, et al. Pharmacokinetic-pharmacodynamic target attainment analysis of doripenem in infected patients. Int J Antimicrob Agents 2009 Mar;33(3):276-9

Isla A, Rodriguez-Gascon A, Troconiz IF, et al. Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy. Clin Pharmacokinet 2008;47(3):173-80

Kuti JL, Le TN, Nightingale CH, et al. Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from i.v. to oral. Am J Health Syst Pharm 2002 Nov 15;59(22):2209-15

Langgartner J, Vasold A, Gluck T, et al. Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy. Intensive Care Med 2008 Jun;34(6):1091-6

Levison ME, Levison JH. Pharmacokinetics and pharmacodynamics of antibacterial agents. Infect Dis Clin North Am 2009 Dec;23(4):791-815

Li J, Rayner CR, Nation RL, et al. Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration. Antimicrob Agents Chemother 2005 Nov;48(11):4814-5

Lodise TP Jr, Lomaestro B, Drusano GL. Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. Clin Infect Dis 2007 Feb 1;44(3):357-63

Lodise TP, Patel N, Lomaestro BM, et al. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis 2009 Aug 15;49(4):507-14

Lodise TP Jr, Pypstra R, Khan JB, et al. Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjects. Antimicrob Agents Chemother 2007 Jul;51(7):2378-87

Marra CA, Frighetto L, Quaia CB, et al. A new ciprofloxacin stepdown program in the treatment of high-risk febrile neutropenia: a clinical and economic analysis. Pharmacotherapy 2000 Aug;20(8):931-40

Martinez MJ, Freire A, Castro I, et al. Clinical and economic impact of a pharmacist-intervention to promote sequential intravenous to oral clindamycin conversion. Pharm World Sci 2000 Apr;22(2):53-8

Meagher AK, Forrest A, Rayner CR, et al. Population pharmacokinetics of linezolid in patients treated in a compassionate-use program. Antimicrob Agents Chemother 2003 Feb;47(2):548-53

Meyer B, Kornek GV, Nikfardjam M, et al. Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltration. J Antimicrob Chemother 2005 Jul;56(1):172-9

Mohr JF 3rd, Ostrosky-Zeichner L, Wainright DJ, et al. Pharmacokinetic evaluation of single-dose intravenous daptomycin in patients with thermal burn injury. Antimicrob Agents Chemother 2008 May;52(5):1891-3

Markou N, Markantonis SL, Dimitrakis E, et al. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study. Clin Ther 2008 Jan;30(1):143-51

Moise-Broder PA, Forrest A, Birmingham MC, et al. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet 2004;43(13):925-42

Moranville MP, Jennings HR. Implications of using modification of diet in renal disease versusCockcroft-Gault equations for renal dosing adjustments. Am J Health Syst Pharm 2009 Jan 15;66(2):154-61

Newman D, Scheetz MH, Adeyami OA, et al. Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individual. Ann Pharmacother 2007 Oct;41(10):1734-9

Niu SC, Deng ST, Lee MH, et al. Modified vancomycin dosing protocol for treatment of diabetic foot infections. Am J Health Syst Pharm 2008 Sep 15;65(18):1740-3

Pai MP, Bearden DT. Antimicrobial dosing considerations in obese adult patients. Pharmacotherapy 2007 Aug;27(8):1081-91

Pai MP, Mercier RC, Allen SE. Using vancomycin concentrations for dosing daptomycin in a morbidly obese patient with renal insufficiency. Ann Pharmacother 2006 Mar;40(3):553-8

Pea F, Viale P, Pavan F, et al. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy. Clin Pharmacokinet 2007;46(12):997-1038

Plachouras D, Karvanen M, Friberg LE, et al. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob Agents Chemother 2009 Aug;53(8):3430-6

Pujal M, Soy D, Codina C, et al. Are higher vancomycin doses needed in ventricle-external shunted patients? Pharm World Sci 2006 Aug;28(4):215-21

Ramirez JA. Managing antiinfective therapy of community-acquired pneumonia in the hospital setting: focus on switch therapy. Pharmacotherapy 2001 Jul;21(7 Pt 2):79S-82S

Ramirez JA, Bordon J. Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia. Arch Intern Med 2001 Mar 26;161(6):848-50

Rea RS, Capitano B, Bies R, et al. Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit 2008 Dec;30(6):674-81

Roberts JA, Lipman J. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis. Clin Pharmacokinet 2006;45(8):755-73

Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009 Mar;37(3):840-51

Roos JF, Lipman J, Kirkpatrick CM. Population pharmacokinetics and pharmacodynamics of cefpirome in critically ill patients against Gram-negative bacteria. Intensive Care Med 2007 May;33(5):781-8

Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy 2009 Nov;29(11):1275-9

Sanchez Navarro A, Colino Gandarillas CI, Alvarez Lerma F, et al. Pharmacokinetics and pharmacodynamics of levofloxacin in intensive care patients. Clin Pharmacokinet 2005;44(6):627-35

Sarria JC, Angulo-Pernett F, Kimbrough RC, et al. Use of intravenous polymyxin B during continuous venovenous hemodialysis. Eur J Clin Microbiol Infect Dis 2004 Apr;23(4):340-1

Tam VH, Louie A, Lomaestro BM, et al. Integration of population pharmacokinetics, a pharmacodynamic target, and microbiologic surveillance data to generate a rational empiric dosing strategy for cefepime against Pseudomonas aeruginosa. Pharmacotherapy 2003 Mar;23(3):291-5

Tam VH, McKinnon PS, Akins RL, et al. Pharmacokinetics and pharmacodynamics of cefepime in patients with various degrees of renal function. Antimicrob Agents Chemother 2003 Jun;47(6):1853-61

Thomson AH, Staatz CE, Tobin CM, et al. Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations. J Antimicrob Chemother 2009 May;63(5):1050-7

Van Wart SA, Andes DR, Ambrose PG, et al. Pharmacokinetic-pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patients. Diagn Microbiol Infect Dis 2009 Apr;63(4):409-14

Wallace AW, Jones M, Bertino JS Jr. Evaluation of four once-daily aminoglycoside dosing nomograms. Pharmacotherapy 2002 Sep;22(9):1077-83

Wong-Beringer A, Nguyen LH, Lee M, et al. An antimicrobial stewardship program with a focus on reducing fluoroquinolone overuse. Pharmacotherapy 2009 Jun;29(6):736-43

Wong-Beringer A, Nguyen KH, Razeghi J. Implementing a program for switching from i.v. to oral antimicrobial therapy. Am J Health Syst Pharm 2001 Jun 15;58(12):1146-9

Yeh RF, Jain R, Palmer HR. 49th ICAAC annual meeting: optimization of anti-infective use in the clinical setting. Expert Rev Anti Infect Ther 2009 Dec;7(10):1167-72

Zahar JR, Rioux C, Girou E, et al. Inappropriate prescribing of aminoglycosides: risk factors and impact of an antibiotic control team. J Antimicrob Chemother 2006 Sep;58(3):651-6

Zavascki AP, Goldani LZ, Cao G, et al. Pharmacokinetics of intravenous polymyxin B in critically ill patients. Clin Infect Dis 2008 Nov 15;47(10):1298-304

Zhang J, Zhang Y, Shi Y, et al. Population pharmacokinetic and pharmacodynamic modeling of norvancomycin. Eur J Clin Microbiol Infect Dis 2008 Apr;27(4):275-84

Back to top

Stewardship: Microbiology

(Use of antibiograms, reporting of antibiotic susceptibility testing, use of rapid viral testing, use of rapid diagnostic testing in addition to cultures, procalcitonin [PCT testing], use of nonculture-based fungal markers in patients with hematologic malignancy)

Recently Added
2017
2016

2015
2014
2013
2012
2011
2010
2000-2009 

Recently Added

Andrews D, Chetty Y, Cooper BS, et al. Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use. BMC Infect Dis 2017 (published online Oct 10)

Belknap A, Grosser DS, Hale DA, et al. Clinical uptake of antimicrobial stewardship recommendations following Nanosphere Verigene blood culture gram-negative reporting. Proc (Bayl Univ Med Cent) 2017 Oct;30(4):395-9

Broyles MR. Impact of procalcitonin (PCT)-guided antibiotic management on antibiotic exposure and outcomes: real world evidence. Open Forum Infect Dis 2017 (published online Oct 3)

Burnham CAD, Leeds J, Nordmann P, et al. Diagnosing antimicrobial resistance. Nat Rev Microbiol 2017 (published online Oct 12)

Guarascio AJ, Brickett LM, Porter TJ, et al. Development of a statewide antibiogram to assess regional trends in antibiotic-resistant ESKAPE organisms. J Pharm Pract 2017 (published online Oct 10)

Keitel K, Kagoro F, Samaka J, et al. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): a randomized, controlled non-inferiority trial. PLoS Med 2017 (published online Oct 23)

Khalid Saeed D, Hasan R, Naim M, et al. Readiness for antimicrobial resistance (AMR) surveillance in Pakistan: a model for laboratory strengthening. Antimicrob Resist Infect Control 2017 (published online Sep 29)

Ibrahim WH, Mushtaq K, Raza T, et al. Effects of procalcitonin-guided treatment on antibiotic use and need for mechanical ventilation in patients with acute asthma exacerbation: meta-analysis of randomized controlled trials. Int J Infect Dis 2017 (published online Oct 13)

Schuetz P, Wirz Y, Sager R, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis 2017 (published online Oct 13)

Schuetz P, Wirz Y, Sager R, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 2017 (published online Oct 13)

Self WH, Rosen J, Sharp SC, et al. Diagnostic accuracy of FebriDx: a rapid test to detect immune responses to viral and bacterial upper respiratory infections. J Clin Med 2017 (published online Oct 7)

Wilson NM, Alangaden G, Tibbetts RJ, et al. T2 magnetic resonance assay improves timely management of candidemia. J Antimicrob Steward 2017;1(1):12-8

Back to top

2017

Andrews D, Chetty Y, Cooper BS, et al. Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use. BMC Infect Dis 2017 (published online Oct 10)

Arroyo MA, Denys GA. Parallel evaluation of the MALDI Sepsityper and Verigene BC-GN assays for rapid identification of gram-negative bacilli from positive blood cultures. J Clin Microbiol 2017 (published online Jun 21)

Avdic E, Wang R, Li DX, et al. Sustained impact of a rapid microarray-based assay with antimicrobial stewardship interventions on optimizing therapy in patients with gram-positive bacteraemia. J Antimicrob Chemother 2017 (published online Aug 21)

Beganovic M, Costello M, Wieczorkiewicz SM. MALDI-TOF alone versus MALDI-TOF combined with real-time antimicrobial stewardship interventions on time to optimal antimicrobial therapy in patients with positive blood cultures. J Clin Microbiol 2017 (published online Feb 22)

Belknap A, Grosser DS, Hale DA, et al. Clinical uptake of antimicrobial stewardship recommendations following Nanosphere Verigene blood culture gram-negative reporting. Proc (Bayl Univ Med Cent) 2017 Oct;30(4):395-9

Blatt SP, Yultyev A, Huang M, et al. Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia. Am J Infect Control 2017 (published online Aug 30)

Bourdellon L, Thilly N, Fougnot S, et al. Impact of selective reporting of antibiotic susceptibility test results on the appropriateness of antibiotics chosen by French general practitioners in urinary tract infections: a randomised controlled case-vignette study. Int J Antimicrob Agents 2017 (published online May 31)

Brendish NJ, Malachira AK, Armstrong L, et al. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med 2017 (published online Apr 6)

Broyles MR. Impact of procalcitonin (PCT)-guided antibiotic management on antibiotic exposure and outcomes: real world evidence. Open Forum Infect Dis 2017 (published online Oct 3)

Burnham CAD, Leeds J, Nordmann P, et al. Diagnosing antimicrobial resistance. Nat Rev Microbiol 2017 (published online Oct 12)

Cabral L, Afreixo V, Santos F, et al. Procalcitonin for the early diagnosis of sepsis in burn patients: a retrospective study. Burns 2017 (published online Apr 25)

Chu DC, Mehta AB, Walkey AJ. Practice patterns and outcomes associated with procalcitonin use in critically ill patients with sepsis. Clin Infect Dis 2017 (published online Feb 24)

Davenport M, Mach KE, Shortliffe LM, et al. New and developing diagnostic technologies for urinary tract infections. Nat Rev Urol 2017 (published online Mar 1)

Denning DW, Perlin DS, Muldoon EG, et al. Delivering on antimicrobial resistance agenda not possible without improving fungal diagnostic capabilities. Emerg Infect Dis 2017 Feb 15;23(2)

Diekema DJ. Rising stakes for healthcare-associated infection prevention: implications for the clinical microbiology laboratory. J Clin Microbiol 2017 (published online Jan 25)

Donner LM, Campbell WS, Lyden E, et al. Assessment of rapid blood culture identification results interpretation and antibiotic prescribing practices. J Clin Microbiol 2017 (published online Mar 1)

Douglas IS. Pulmonary infections in critical/intensive care—rapid diagnosis and optimizing antimicrobial usage. Curr Opin Pulm Med 2017 (published online Mar 2)

Drum BE, Collinsworth K, Arnold BD, et al. Hospital-onset bloodstream infection rates after discontinuing active surveillance cultures for methicillin-resistant Staphylococcus aureus in a regional burn center. Infect Control Hosp Epidemiol 2017 Mar;38(3):371-2

Dryden M, Sitjar A, Gunning Z, et al. Can rapid negative exclusion of blood cultures by a molecular method, enzyme template generation and amplification technique (Cognitor® Minus), aid antimicrobial stewardship? Int J Pharm Pract 2017 (published online Aug 18)

Eby JC, Richey MM, Platts-Mills JA, et al. A healthcare improvement intervention combining nucleic acid microarray testing with direct physician response for management of Staphyloccocus aureus bacteremia. Clin Infect Dis 2017 (published online Aug 17)

Ersoy SC, Heithoff DM, Barnes L, et al. Correcting a fundamental flaw in the paradigm for antimicrobial susceptibility testing. EBioMedicine 2017 (published online May 29)

Fisher K, Trupka T, Micek ST, et al. A prospective one-year microbiologic survey of combined pneumonia and respiratory failure. Surg Infect (Larchmt) 2017 (published online Sep 7)

Foster RA, Kuper K, Lu ZK, et al. Pharmacists' familiarity with and institutional utilization of rapid diagnostic technologies for antimicrobial stewardship. Infect Control Hosp Epidemiol 2017 (published online May 11)

Fung AWS, Beriault D, Diamandis EP, et al. The role of procalcitonin in diagnosis of sepsis and antibiotic stewardship: opportunities and challenges. Clin Chem 2017 (published online Jun 20)

Galiana A, Coy J, Gimeno A, et al. Evaluation of the Sepsis Flow Chip assay for the diagnosis of blood infections. PLoS One 2017 (published online May 18)

Garcia R, Spitzer ED. Promoting appropriate urine culture management to improve health care outcomes and the accuracy of catheter-associated urinary tract infections. Am J Infect Control 2017 (published online May 2)

Gilbert DN. Role of procalcitonin in the management of infected patients in the intensive care unit. Infect Dis Clin North Am 2017 Sep;31(3):435-53

Grodin L, Conigliaro A, Lee SY, et al. Comparison of urinary tract infection antibiograms stratified by emergency department patient disposition. Am J Emerg Med 2017 (published online Mar 23)

Guarascio AJ, Brickett LM, Porter TJ, et al. Development of a statewide antibiogram to assess regional trends in antibiotic-resistant ESKAPE organisms. J Pharm Pract 2017 (published online Oct 10)

Hardy V, Thompson M, Keppel GA, et al. Qualitative study of primary care clinicians' views on point-of-care testing for C-reactive protein for acute respiratory tract infections in family medicine. BMJ Open 2017 (published online Jan 25)

Harris AM, Bramley AM, Jain S, et al. Influence of antibiotics on the detection of bacteria by culture-based and culture-independent diagnostic tests in patients hospitalized with community-acquired pneumonia. Open Forum Infect Dis 2017 (published online Feb 10)

Hayakawa K, Mezaki K, Kobayakawa M, et al. Impact of rapid identification of positive blood cultures using the Verigene system on antibiotic prescriptions: a prospective study of community-onset bacteremia in a tertiary hospital in Japan. PLoS One 2017 (published online Jul 24)

Hombach M, Jetter M, Keller PM, et al. Rapid detection of ESBL, carbapenemases, MRSA and other important resistance phenotypes within 6–8 h by automated disc diffusion antibiotic susceptibility testing. J Antimicrob Chemother 2017 (published online Aug 9)

Hwan An J, Kim YH, Moon JE, et al. Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: can it predict and reduce subsequent infections and the use of colistin? Am J Infect Control 2017 (published online Feb 24)

Ibrahim WH, Mushtaq K, Raza T, et al. Effects of procalcitonin-guided treatment on antibiotic use and need for mechanical ventilation in patients with acute asthma exacerbation: meta-analysis of randomized controlled trials. Int J Infect Dis 2017 (published online Oct 13)

Jorgensen H, Zurayk M, Yeung S, et al. Emergency department urinary antibiograms differ by specific patient group. J Clin Micro 2017 Sep;55(9):2629-36

Katchanov J, Kluge S, MacKenzie CR, et al. “Nudging” in microbiological reports: a strategy to improve prescribing. Infection 2017 Feb;45(1):123-7

Keitel K, Kagoro F, Samaka J, et al. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): a randomized, controlled non-inferiority trial. PLoS Med 2017 (published online Oct 23)

Khalid Saeed D, Hasan R, Naim M, et al. Readiness for antimicrobial resistance (AMR) surveillance in Pakistan: a model for laboratory strengthening. Antimicrob Resist Infect Control 2017 (published online Sep 29)

Kock R, Wullenweber J, Horn D, et al. Implementation of short incubation MALDI-TOF MS identification from positive blood cultures in routine diagnostics and effects on empiric antimicrobial therapy. Antimicrob Resist Infect Control 2017 (published online Jan 14)

Korayem GB, Zangeneh TT, Matthias KR. Urinary tract infections recurrence and development of urinary-specific antibiogram for kidney transplant recipients. J Glob Antimicrob Resist 2017 (published online Aug 28)

Lesho E, Snesrud E, Kwak Y, et al. Pseudomonas endocarditis with an unstable phenotype: the challenges of isolate characterization and carbapenem stewardship with a partial review of the literature. Antimicrob Resist Infect Control 2017 (published online Aug 29)

Li Y, Yang X, Zhao W. Emerging microtechnologies and automated systems for rapid bacterial identification and antibiotic susceptibility testing. SLAS Technol 2017 (published online Aug 29)

Manca C, Hill C, Hujer AM, et al. Leading antibacterial laboratory research by integrating conventional and innovative approaches: the laboratory center of the Antibacterial Resistance Leadership Group. Clin Infect Dis 2017 (published online Mar 2)

Masia M, Padilla S, Ortiz de la Tabla V, et al. Procalcitonin for selecting the antibiotic regimen in outpatients with low-risk community-acquired pneumonia using a rapid point-of-care testing: a single-arm clinical trial. PLoS One 2017 (published online Apr 20)

Maurer FP, Christner M, Hentschke M, et al. Advances in rapid identification and susceptibility testing of bacteria in the clinical microbiology laboratory: implications for patient care and antimicrobial stewardship programs. Infect Dis Rep 2017 (published online Mar 30)

McGregor JC, Pakyz AL. Enhancing the utility of antibiotic susceptibility reporting as a tool for antimicrobial stewardship. Curr Treat Options Infect Dis 2017 (published online Jan 30)

Morgan DJ, Malani P, Diekema DJ. Diagnostic stewardship—leveraging the laboratory to improve antimicrobial use. JAMA 2017 (published online Jul 31)

Mukhopadhyay S, Puopolo KM. Clinical and microbiologic characteristics of early-onset sepsis among VLBW infants: opportunities for antibiotic stewardship. Pediatr Infect Dis J 2017 (published online Feb 9)

Nora D, Salluh J, Martin-Loeches I, et al. Biomarker-guided antibiotic therapy-strengths and limitations. Ann Transl Med 2017 May;5(10):208

O’Donnell S, Gaughan L, Skally M, et al. The potential contribution of 16S ribosomal RNA PCR to antimicrobial stewardship in culture-negative infection. J Hosp Infect 2017 (published online Aug 22)

Ostrosky-Zeichner L, Andes D. The role of in vitro susceptibility testing in the management of Candida and Aspergillus. J Infect Dis 2017 (published online Sep 5)

Pavia AT. Reducing diagnostic uncertainty to improve treatment of respiratory infections. Lancet Respir Med 2017 (published online Apr 6)

Perlin DS, Wiederhold NP. Culture-independent molecular methods for detection of antifungal resistance mechanisms and fungal identification. J Infect Dis 2017 (published online Sep 5)

Pontrelli G, De Crescenzo F, Buzzetti R, et al. Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis. BMC Infect Dis 2017 (published online Apr 24)

Rhee C. Using procalcitonin to guide antibiotic therapy. Open Forum Infect Dis 2016 (published online Dec 7)

Sager R, Kutz A, Mueller B, et al. Procalcitonin-guided diagnosis and antibiotic stewardship revisited. BMC Med 2017 (published online Jan 24)

Sanguinetti M, Posteraro B. New approaches for antifungal susceptibility testing. Clin Microbiol Infect 2017 (published online Apr 1)

Schuetz P, Bretscher C, Bernasconi L, et al. Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis. Expert Rev Mol Diagn 2017 (published online Apr 26)

Schuetz P, Mueller B. Procalcitonin-guided antibiotic stewardship from newborns to centennials. Lancet 2017 (published online Jul 12)

Schuetz P, Wirz Y, Sager R, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis 2017 (published online Oct 13)

Schuetz P, Wirz Y, Sager R, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 2017 (published online Oct 13)

Self WH, Balk RA, Grijalva CG, et al. Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia. Clin Infect Dis 2017 (published online Apr 12)

Self WH, Rosen J, Sharp SC, et al. Diagnostic accuracy of FebriDx: a rapid test to detect immune responses to viral and bacterial upper respiratory infections. J Clin Med 2017 (published online Oct 7)

Semret M, Schiller I, Jardin BA, et al. Multiplex respiratory virus testing for antimicrobial stewardship: a prospective assessment of antimicrobial utilization and clinical outcomes among hospitalized adults. J Infect Dis 2017 (published online Jun 19)

Shapiro DS, Friedmann R, Husseini A, et al. Can procalcitonin contribute to the diagnosis of Clostridium difficile colitis? Isr Med Assoc J 2017 May;19(5):313-6

Shinde S, Gupta R, Raut SS, et al. Carba NP as a simpler, rapid, cost-effective, and a more sensitive alternative to other phenotypic tests for detection of carbapenem resistance in routine diagnostic laboratories. J Lab Physicians 2017 Apr-Jun;9(2):100-3

Skodvin B, Aase K, Brekken AL, et al. Addressing the key communication barriers between microbiology laboratories and clinical units: a qualitative study. J Antimicrob Chemother 2017 (published online Jun 13)

Stocker M, van Herk W, el Helou S, et al. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns). The Lancet 2017 (published online Jul 12)

Swe Swe-Han K, Mlisana KP, Pillay M. Analysis of clinical and microbiological data on Acinetobacter baumannii strains assist the preauthorization of antibiotics at the patient level for an effective antibiotic stewardship program. J Infect Public Health 2017 (published online Feb 22)

Tchesnokova V, Avagyan H, Rechkina E, et al. Bacterial clonal diagnostics as a tool for evidence-based empiric antibiotic selection. PLoS One 2017 (published online Mar 28)

Tsalik EL, Petzold E, Kreiswirth BN, et al. Advancing diagnostics to address antibacterial resistance: the diagnostics and devices committee of the Antibacterial Resistance Leadership Group. Clin Infect Dis 2017 (published online Mar 2)

Tsuboi M, Hayakawa K, Mezaki K, et al. Impact of prompt intervention in response to positive blood culture results during weekends by collaboration between infectious disease specialists and microbiology laboratory staff. Eur J Clin Microbiol Infect Dis 2017 (published online May 25)

Tuite AR, Gift TL, Chesson HW, et al. Impact of rapid susceptibility testing and antibiotic selection strategy on the emergence and spread of antibiotic resistance in gonorrhea. J Infect Dis 2017 (published online Aug 31)

Vallabhaneni S, Sapiano M, Weiner LM, et al. Antifungal susceptibility testing practices at acute care hospitals enrolled in the National Healthcare Safety Network, United States, 2011─2015. Open Forum Infect Dis 2017 (published online Aug 16)

van den Bijllaardt W, Buiting AG, Mouton JW, et al. Shortening the incubation time for antimicrobial susceptibility testing by disk diffusion for Enterobacteriaceae: how short can it be and are the results accurate? Int J Antimicrob Agents 2017 (published online Mar 3)

Vourli S, Dafopoulou K, Vrioni G, et al. Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates. J Antimicrob Chemother 2017 (published online Jun 12)

Wilson NM, Alangaden G, Tibbetts RJ, et al. T2 magnetic resonance assay improves timely management of candidemia. J Antimicrob Steward 2017;1(1):12-8

Yunoki T, Matsumura Y, Yamamoto M, et al. Genetic identification and antimicrobial susceptibility of clinically isolated anaerobic bacteria: a prospective multicenter surveillance study in Japan. Anaerobe 2017 (published online Sep 18)

Zankari E, Allesoe R, Joensen KG, et al. PointFinder: a novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens. J Antimicrob Chemother 2017 (published online Jul 19)

Zhang T, Wang Y, Yang Q, et al. Procalcitonin-guided antibiotic therapy in critically ill adults: a meta-analysis. BMC Infect Dis 2017 (published online Jul 24)

Zhao Z, Lan F, Liu M, et al. Evaluation of automated systems for aminoglycosides and fluoroquinolones susceptibility testing for carbapenem-resistant Enterobacteriaceae. Antimicrob Resist Infect Control 2017 (published online Aug 1)

Back to top

2016

Ammar AA, Lam SW, Duggal A, et al. Compliance with procalcitonin algorithm antibiotic recommendations for patients in medical intensive care unit. Pharmacother 2016 (published online Dec 20)

Banerjee R, Humphries R. Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae. Virulence 2016 May 11:1-13

Bauchner H. Genetics and the evaluation of the febrile child. JAMA 2016;316(8):824-5

Bogaerts P, Cuzon G, Evrard S, et al. Evaluation of a DNA microarray for rapid detection of the most prevalent extended-spectrum β-lactamases, plasmid-mediated cephalosporinases and carbapenemases in Enterobacteriaceae, Pseudomonas and Acinetobacter. Int J Antimicrob Agents 2016 Aug;48(2):189-93

Bouza E, Alcala L, Reigadas E. Optimizing the diagnostic testing of Clostridium difficile infection. Expert Rev Anti Infect Ther 2016 (published online Jul 27)

Brady AC, Lewis JS 2nd, Pfeiffer CD. Rapid detection of bla(OXA) in carbapenem-susceptible Acinetobacter radioresistens bacteremia leading to unnecessary antimicrobial administration. Diagn Microbiol Infect Dis 2016 (published online May 5)

Brennan MB, Osterby K, Schulz L, et al. Impact of low procalcitonin results on antibiotic administration in hospitalized patients at a tertiary care center. Infect Dis Ther 2016 (published online Jun 1)

Brink AJ, Van Wyk J, Moodley VM, et al. The role of appropriate diagnostic testing in acute respiratory tract infections: an antibiotic stewardship strategy to minimise diagnostic uncertainty in primary care. S Afr Med J 2016 May 10;106(6):554-61

Cabral L, Afreixo V, Almeida L, et al. The use of procalcitonin (PCT) for diagnosis of sepsis in burn patients: a meta-analysis. PLOS One 2016 (published online Dec 22)

Cairns KA, Doyle JS, Trevillyan JM, et al. The impact of a multidisciplinary antimicrobial stewardship team on the timeliness of antimicrobial therapy in patients with positive blood cultures: a randomized controlled trial. J Antimicrob Chemother 2016 (published online Aug 2)

Carreno JJ, Lomaestro BM, Jacobs AL, et al. Assessment of time to clinical response in patients with sepsis treated before and after implementation of a matrix-assisted laser desorption ionization time-of-flight blood culture identification algorithm. Infect Control Hosp Epidemiol 2016 Aug;37(8):916-23

Cunha CB. Relation of diagnostic accuracy of viral respiratory polymerase chain reaction to specimen number and source in severe adenovirus pneumonia: antimicrobial stewardship implications. Infect Control Hosp Epidemiol 2016 (published online Jul 26)

de Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis 2016 Feb 29;16(7):819-27

Delisle G, Quach C, Domingo MC, et al. Escherichia coli antimicrobial susceptibility profile and cumulative antibiogram to guide empirical treatment of uncomplicated urinary tract infections in women in the province of Québec, 2010–15. J Antimicrob Chemother 2016 (published online Aug 3)

Do NTT, Ta NTD, Tran NTH, et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Glob Health 2016 (published online Aug 2)

Doern CD. The confounding role of antimicrobial stewardship programs in understanding the impact of technology on patient care. J Clin Microbiol 2016 (published online Aug 17)

Downes KJ, Weiss SL, Gerber JS, et al.; Centers for Disease Control and Prevention Epicenters Program. A pragmatic biomarker-driven algorithm to guide antibiotic use in the pediatric intensive care unit: the optimizing antibiotic strategies in Sepsis (OASIS) study. J Pediatric Infect Dis Soc 2016 (published online May 4)

Emonet S, Charles PG, Harbarth S, et al. Rapid molecular determination of methicillin resistance in staphylococcal bacteraemia improves early targeted antibiotic prescribing: a randomized clinical trial. Clin Microbiol Infect 2016 (published online Jul 27)

Fakih MG, Khatib R. Improving the culture of culturing: critical asset to antimicrobial stewardship. Infect Control Hosp Epidemiol 2016 (published online Dec 29)

Fritzenwanker M, Imirzalioglu C, Chakraborty T, et al. Modern diagnostic methods for urinary tract infections. Expert Rev Anti Infect Ther 2016 (published online Sep 14)

Gandra S, Merchant AT, Laxminarayan R. A role for private sector laboratories in public health surveillance of antimicrobial resistance. Future Microbiol 2016;11(6):709-12

Hayden RT, Clinton LK, Hewitt C, et al. Rapid antimicrobial susceptibility testing using forward laser light scatter technology. J Clin Microbiol 2016 (published online Aug 24)

Heil EL, Johnson JK. Impact of CLSI breakpoint changes on microbiology laboratories and antimicrobial stewardship programs. J Clin Microbiol 2016 Apr;54(4):840-4

Hellyer TP, Anderson NH, Parker J, et al. Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial. Trials 2016 Jul 16;17(1):318

Herberg JA, Kaforou M, Wright VJ, et al. Diagnostic test accuracy of a 2-transcript host RNA signature for discriminating bacterial vs viral infection in febrile children. JAMA 2016;316(8):835-45

Heyerly A, Jones R, Bokhart G, et al. Implementation of a pharmacist-directed antimicrobial stewardship protocol utilizing rapid diagnostic testing. Hosp Pharm 2016 Nov;51(10);815-22

Hohn A, Heising B, Schutte JK, et al. Procalcitonin-guided antibiotic treatment in critically ill patients. Langenbecks Arch Surg 2016 (published online Jun 10)

Hughes A, Gwyn L, Harris S, et al. Evaluating a point-of-care C-reactive protein test to support antibiotic prescribing decisions in a general practice. Clin Pharm 2016 (published online Oct 12)

Humphries RM, Dien Bard J. Point-counterpoint: reflex cultures reduce laboratory workload and improve antimicrobial stewardship in patients suspected of having urinary tract infections. J Clin Microbiol 2016 Feb;54(2):254-8

Igawa G, Casey M, Sawabe E, et al. Comparison of agar dilution and broth microdilution methods for Clostridium difficile antimicrobial susceptibility testing. J Glob Antimicrob Resist 2016 Aug 26;7:43-5

Johnson LS, Patel D, King EA, et al. Impact of microbiology cascade reporting on antibiotic de-escalation in cefazolin-susceptible gram-negative bacteremia. Eur J Clin Microbiol Infect Dis 2016 Jul;35(7):1151-7

Khosla R, Khosla SG, Becker KL, et al. Pleural fluid procalcitonin to distinguish infectious from noninfectious etiologies of pleural effusions. J Hosp Med 2016 May;11(5):363-5

Koncelik DL, Hernandez J. The impact of implementation of rapid QuickFISH testing for detection of Coagulase-Negative Staphylococci at a community-based hospital. Am J Clin Pathol 2016 Jan;145(1):69-74

Langford BJ, Seah J, Chan A, et al. Antimicrobial stewardship in the microbiology lab: impact of selective susceptibility reporting on ciprofloxacin utilization and gram-negative susceptibility in a hospital setting. J Clin Microbiol 2016 (published online Jul 6)

Liang B, Wheeler JS, Blanchette LM. Impact of combination antibiogram and related education on inpatient fluoroquinolone prescribing patterns for patients with health care-associated Pneumonia. Ann Pharmacother 2016 Mar;50(3):172-9

Lockwood AM, Perez KK, Musick WL,et al. Integrating rapid diagnostics and antimicrobial stewardship in two community hospitals improved process measures and antibiotic adjustment time. Infect Control Hosp Epidemiol 2016 Apr;37(4):425-32

MacVane SH, Hurst JM, Boger MS, et al. Impact of a rapid multiplex polymerase chain reaction blood culture identification technology on outcomes in patients with vancomycin-resistant Enterococcal bacteremia. Infect Dis (Lond) 2016 May 19:1-6

MacVane SH, Hurst JM, Steed LL. The role of antimicrobial stewardship in the clinical microbiology laboratory: stepping up to the plate. Open Forum Infect Dis 2016 Sep 21;3(4)

MacVane SH, Nolte FS. Benefits of adding a rapid PCR-based blood culture identification panel to an established antimicrobial stewardship program. J Clin Microbiol 2016 (published online Aug 3)

Mahajan P, Kuppermann N, Mejias A, et al. Association of RNA biosignatures with bacterial infections in febrile infants aged 60 days or younger. JAMA 2016;316(8):846-57

Malcolmson C, Ng K, Hughes S, et al. Impact of matrix-assisted laser desorption and ionization time-of-flight and antimicrobial stewardship intervention on treatment of bloodstream infections in hospitalized children. J Pediatric Infect Dis Soc 2016 (published Jun 23)

Marra AR, Edmond MB, Ford BA, et al. Failure of risk-adjustment by test method for C. difficile laboratory-identified event reporting. Infect Control Hosp Epidemiol 2016 (published online Oct 17)

McElvania TeKippe E. The added cost of rapid diagnostic testing and active antimicrobial stewardship, is it worth it? J Clin Microbiol 2016 (published online Nov 9)

Mellmann A, Bletz S, Boking T, et al. Real-time genome sequencing of resistant bacteria provides precision infection control in an institutional setting. J Clin Microbiol 2016 (published online Aug 24)

Messacar K, Hurst AL, Child J, et al. Clinical impact and provider acceptability of real-time antimicrobial stewardship decision support for rapid diagnostics in children with positive blood culture results. J Pediatric Infect Dis Soc 2016 (published online Aug 19)

Messacar K, Parker SK, Todd JK, et al. Implementation of rapid molecular infectious disease diagnostics: the role of diagnostic and antimicrobial stewardship. J Clin Microbiol 2016 (published online Dec 28)

Minejima E, Wong-Beringer A. Implementation of rapid diagnostics with antimicrobial stewardship. Expert Rev Anti Infect Ther 2016 (published online Sep 7)

Morency-Potvin P, Schwartz DN, Weinstein RA. Antimicrobial stewardship: how the microbiology laboratory can right the ship. Clin Microbiol Rev 2016 Dec 14;30(1):381-407

Mothes A, Leotard S, Nicolle I, et al. Community-acquired pneumonia and positive urinary antigen tests: Factors associated with targeted antibiotic therapy. Med Mal Infect 2016 (published online Jul 1)

Mullin KM, Kovacs CS, Fatica C, et al. A multifaceted approach to reduction of catheter-associated urinary tract infections in the intensive care unit with an emphasis on “stewardship of culturing.” Infect Control Hosp Epidemiol 2016 (published online Nov 17)

Neuner EA, Pallotta AM, Lam SW, et al. Experience with rapid microarray-based diagnostic technology and antimicrobial stewardship for patients with gram-positive bacteremia. Infect Control Hosp Epidemiol 2016 (published online Aug 8)

O’Donnell LA, Guarascio AJ. The intersection of antimicrobial stewardship and microbiology: educating the next generation of health care professionals. FEMS Microbiol Lett 2016 (published online Dec 16)

Osthoff M, Gurtler N, Bassetti S, et al. Impact of MALDI-TOF mass spectrometry based identification directly from positive blood cultures on patient management: a controlled clinical trial. Clin Microbiol Infect 2016 (published online Aug 25)

Oviano M, Sparbier K, Jose Barba M, et al. Universal protocol for the rapid automated detection of carbapenem-resistant gram-negative bacilli directly from blood cultures by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF/MS). Int J Antimicrob Agents 2016 (published online Oct 20)

Oviano M, Torres I, Gonzalez M, et al. Evaluation of a novel procedure for rapid detection of carbapenemase-producing Enterobacteriaceae (CPE) using the LightMix modular carbapenemase kits. J Antimicrob Chemother 2016 (published online Aug 26)

Papanicolas LE, Nelson R, Warner MS. Influence of antimicrobial susceptibility reporting on junior doctors’ decision to prescribe antimicrobials inappropriately. J Antimicrob Chemother 2016 (published online Dec 20)

Pardo J, Klinker KP, Borgert SJ, et al. Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel. Diagn Microbiol Infect Dis 2016 Feb;84(2):159-64

Perez LR, Narvaez GA, Dias CG. Improving compliance with antibiotic stewardship: what Is the role of initial microscopy on the management of mechanically ventilated patients? Infect Control Hosp Epidemiol 2016 (published online Dec 20)

Ray ST, Drew RJ, Hardiman F, et al. Rapid identification of microorganisms by filmArray blood culture identification panel improves clinical management in children. Pediatr Infect Dis J 2016 May;35(5):e134-8

Riedel S, Carroll KC. Early identification and treatment of pathogens in sepsis: molecular diagnostics and antibiotic choice. Clin Chest Med 2016 Jun;37(2):191-207

Rivard KR, Durnkow LE, Draper HM, et al. Impact of rapid diagnostic testing for chlamydia and gonorrhea on appropriate antimicrobial utilization in the emergency department. Diagn Microbiol Infect Dis 2016 (published online Oct 18)

Rosa R, Simkins J, Camargo JF, et al. Solid organ transplant antibiograms: an opportunity for antimicrobial stewardship. Diagn Microbiol Infect Dis 2016 Dec;86(4):460-3

Ryan S, Gillespie E, Stuart RL. A parainfluenza virus type 3 outbreak at a residential aged care facility: the role of microbiologic testing in early identification and antimicrobial stewardship. Am J Infect Control 2016 (published online Sep 21)

Santiago RD, Bazan JA, Brown NV, et al. Evaluation of pharmacist impact on culture review process for patients discharged from the emergency department. Hosp Pharm 2016 Oct;51(9):738-43

Scerbo MH, Kaplan HB, Dua A, et al. Beyond blood culture and gram stain analysis: A review of molecular techniques for the early detection of bacteremia in surgical patients. Surg Infect (Larchmt) 2016 Jun;17(3):294-302

Schmidt K, Mwaigwisya S, Crossman LC, et al. Identification of bacterial pathogens and antimicrobial resistance directly from clinical urines by nanopore-based metagenomic sequencing. J Antimicrob Chemother 2016 (published online Sep 25)

Schoepp NG, Khorosheva EM, Schlappi TS, et al. Digital quantification of DNA replication and chromosome segregation enables determination of antimicrobial susceptibility after only 15 minutes of antibiotic exposure. Angew Chem Int Ed Engl 2016 (published online Jun 30)

Schuetz P, Mueller B. Procalcitonin in critically ill patients: time to change guidelines and antibiotic use in practice. Lancet Infect Dis 2016 Jul;16(7):758-60

Severine B, Poirel L, Nordmann P. Real-time PCR for detection of plasmid-mediated polymyxin resistance (mcr-1) from cultured bacteria and stools. J Antimicrob Chemother 2016 Aug;71(8):2318-20

Shaddock EJ. How and when to use common biomarkers in community-acquired pneumonia. Pneumonia 2016 (published online Oct 28)

Spiekerman KM, Patel SJ, Patel R, et al. Availability, perceptions, and characteristics of antibiograms among Illinois pediatricians. Infect Drug Resist 2016 (published online Dec 5)

Suda KJ, Patel UC, Sabzwari R, et al. Bacterial susceptibility patterns in patients with spinal cord injury and disorder (SCI/D): an opportunity for customized stewardship tools. Spinal Cord 2016 Nov;54(11):1001-9

Teethaisong Y, Eumkeb G, Chumnarnsilpa S, et al. Phenotypic detection of AmpC β-lactamases, extended-spectrum- β-lactamases and metallo-β-lactamases in Enterobacteriaceae using a resazurin microtitre assay with inhibitor-based methods. J Med Microbiol 2016 (published online Aug 1)

Timbrook TT, Morton JB, McConeghy KW, et al. The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review & meta-analysis. Clin Infect Dis 2016 (published online Sep 26)

Trevino SE, Pence MA, Marschall J, et al. Rapid MRSA PCR on respiratory specimens from ventilated patients with suspected pneumonia: a tool to facilitate antimicrobial stewardship. Eur J Clin Microbiol Infect Dis 2016 (published online Dec 21)

van der Does Y, Rood PP, Haagsma JA, et al. Procalcitonin-guided therapy for the initiation of antibiotics in the ED: a systematic review. Am J Emerg Med 2016 Jul;34(7):1286-93

Veesenmeyer AF, Olson JA, Hersh AL, et al. A retrospective study of the impact of rapid diagnostic testing on time to pathogen identification and antibiotic use for children with positive blood cultures. Infect Dis Ther 2016 (published online Nov 10)

Verroken A, Defourny L, le Polain de Waroux O, et al. Clinical impact of MALDI-TOF MS identification and rapid susceptibility testing on adequate antimicrobial treatment in Sepsis with positive blood cultures. PLoS One 2016 May;11(5):e0156299

Walker T, Dumadag S, Lee CJ, et al. Clinical impact of laboratory implementation of Verigene BC-GN microarray-based assay for detection of gram-negative bacteria in positive blood cultures. J Clin Microbiol 2016 Jul;54(7):1789-96

Wenzler E, Goff DA, Mangino JE, et al. Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremia. Diagn Microbiol Infect Dis 2016 Jan;84(1):63-8

Wenzler E, Wong JR, Goff DA, et al. Controversies in antimicrobial stewardship: focus on new rapid diagnostic technologies and antimicrobials. Antibiotics (Basel) 2016 Jan 14;5(1)

Wick J, Beaulac K, Doron S. Evaluation of a healthcare-associated urinary tract infection combination antibiogram. Infect Control Hosp Epidemiol 2016 Sep;37(9):1101-4

Wu CT, Chen CL, Lee HY, et al. Decreased antimicrobial resistance and defined daily doses after implementation of a clinical culture-guided antimicrobial stewardship program in a local hospital. J Microbiol Immunol Infect 2016 (published online Jan 22)

Yee C, Suarthana E, Dendukuri N, et al. Evaluating the impact of the multiplex respiratory virus panel polymerase chain reaction test on the clinical management of suspected respiratory viral infections in adult patients in a hospital setting. Am J Infect Control 2016 (published online Jun 13)

Yu D, Stach L, Newland JG, et al. Integrating a rapid diagnostic test and antimicrobial stewardship: optimizing discharge antibiotics in skin and soft tissue infections. Pediatr Infect Dis J 2016 (published online Sep 19)

Back to top

2015

Aitken SL, Hemmige VS, Koo HL, et al. Real-world performance of a microarray-based rapid diagnostic for gram-positive bloodstream infections and potential utility for antimicrobial stewardship. Diagn Microbiol Infect Dis 2015 Jan;81(1):4-8

Albrich WC, Harbarth S. Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting. Intensive Care Med 2015 Oct;41(10):1739-51

Al-Tawfiq JA, Momattin H, Al-Habboubi F, et al. Restrictive reporting of selected antimicrobial susceptibilities influences clinical prescribing. J Infect Public Health 2015 May-Jun;8(3):234-41

Bauer KA, Goff DA. When diagnostic technology is ahead of the hospital budget: what is antimicrobial stewardship to do? Clin Infect Dis 2015 Aug 1;61(3):486-7

Bielicki JA, Sharland M, Johnson AP, et al. Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data. J Antimicrob Chemother 2015 (published online Nov 30)

Boyles TH, Davis K, Crede T, et al. Blood cultures taken from patients attending emergency departments in South Africa are an important antibiotic stewardship tool, which directly influences patient management. BMC Infect Dis 2015 Oct 6;15:410

Box MJ, Sullivan EL, Ortwine KN, et al. Outcomes of rapid identification for gram-positive bacteremia in combination with antibiotic stewardship at a community-based hospital system. Pharmacotherapy 2015 Mar;35(3):269-76

Brechot N, Hekimian G, Chastre J, et al. Procalcitonin to guide antibiotic therapy in the ICU. Int J Antimicrob Agents 2015 Dec;46(Suppl 1):S19-24

Coorevits L, Boelens J, Claeys G. Direct susceptibility testing by disk diffusion on clinical samples: a rapid and accurate tool for antibiotic stewardship. Eur J Clin Microbiol Infect Dis 2015 Jun;34(6):1207-12

Hill JN, Suda KJ, Ramanathan S, et al. Development of a unit-specific antibiogram and planning for implementation: Preimplementation findings. Am J Infect Control 2015 Nov 1;43(11):1264-7

Holm A, Cordoba G, Sorensen TM, et al. Point of care susceptibility testing in primary care — does it lead to a more appropriate prescription of antibiotics in patients with uncomplicated urinary tract infections? Protocol for a randomized controlled trial. BMC Fam Pract 2015 Aug 21;16:106

Hohn A, Heising B, Hertel S, et al. Antibiotic consumption after implementation of a procalcitonin-guided antimicrobial stewardship programme in surgical patients admitted to an intensive care unit: a retrospective before-and-after analysis. Infection 2015 Aug;43(4):405-12

Klepser ME, Adams AJ, Klepser DG. Antimicrobial stewardship in outpatient settings: leveraging innovative physician-pharmacist collaborations to reduce antibiotic resistance. Health Secur 2015 May-Jun;13(3):166-73

Meili M, Muller B, Kulkarni P, et al. Management of patients with respiratory infections in primary care: procalcitonin, C-reactive protein or both? Expert Rev Respir Med 2015 Oct;9(5):587-601

Mertz D, Brooks A, Irfan N, et al. Antimicrobial stewardship in the intensive care setting — a review and critical appraisal of the literature. Swiss Med Wkly 2015 Dec 21;145:w14220

Mwaigwisya S, Assiri RA, O'Grady J. Emerging commercial molecular tests for the diagnosis of bloodstream infection. Expert Rev Mol Diagn 2015 May;15(5):681-92

Pardo J, Klinker KP, Borgert SJ, et al. Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel. Diagn Microbiol Infect Dis 2015 (published online Oct 29)

Schuetz P, Aujesky D, Muller C, et al. Biomarker-guided personalised emergency medicine for all — hope for another hype? Swiss Med Wkly 2015 Feb 19;145:w14079

Schuetz P, Balk R, Briel M, et al. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective. Clin Chem Lab Med 2015 Mar;53(4):583-92

Sothoron C, Ferreira J, Guzman N, et al. A stewardship approach to optimize antimicrobial therapy through use of a rapid microarray assay on blood cultures positive for gram-negative bacteria. J Clin Microbiol 2015 Nov;53(11):3627-9

Southern TR, VanSchooneveld TC, Bannister DL, et al. Implementation and performance of the BioFire FilmArray blood culture identification panel with antimicrobial treatment recommendations for bloodstream infections at a Midwestern academic tertiary hospital. Diagn Microbiol Infect Dis 2015 Feb;81(2):96-101

Timbrook T, Maxam M, Bosso J. Antibiotic discontinuation rates associated with positive respiratory viral panel and low procalcitonin results in proven or suspected respiratory infections. Infect Dis Ther 2015 Sep;4(3):297-306

Warhurst G, Dunn G, Chadwick P, et al. Rapid detection of health-care-associated bloodstream infection in critical care using multipathogen real-time polymerase chain reaction technology: a diagnostic accuracy study and systematic review. Health Technol Assess 2015 May;19(35)

Back to top

2014

Aitken SL, Beyda ND, Shah DN, et al. Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics. Ann Pharmacother 2014 Jun;48(6):683-90

Avdic E, Carroll KC. The role of the microbiology laboratory in antimicrobial stewardship programs. Infect Dis Clin North Am 2014 Jun;28(2):215-35

Barraud O, Francois B, Chainier D, et al. Value of integron detection for predicting antibiotic resistance in patients with gram-negative septicaemia. Int J Antimicrob Agents 2014 Oct;44(4):351-3

Bauer KA, Perez KK, Forrest GN, et al. Review of rapid diagnostic tests used by antimicrobial stewardship programs. Clin Infect Dis 2014 Oct 15;59(Suppl 3):S134-45

Branda JA, Lewandrowski K. Utilization management in microbiology. Clin Chim Acta 2014 Jan 1;427:173-7

Crandon JL, MacVane SH, Nicolau DP. Clinical laboratory-based assay methodologies may underestimate and increase variability of vancomycin protein binding in hospitalized patients. Pharmacotherapy 2014 Feb;34(2):203-9

Hill JT, Tran KD, Barton KL, et al. Evaluation of the nanosphere Verigene BC-GN assay for direct identification of gram-negative bacilli and antibiotic resistance markers from positive blood cultures and potential impact for more-rapid antibiotic interventions. J Clin Microbiol 2014 Oct;52(10):3805-7

Housman ST, Sutherland CA, Nicolau DP. Pharmacodynamic profile of commonly utilised parenteral therapies against meticillin-susceptible and meticillin-resistant Staphylococcus aureus collected from US hospitals. Int J Antimicrob Anents 2014 Sep;44(3):235-41

Jain JG, Housman ST, Nicolau DP. Humanized tissue pharmacodynamics of cefazolin against commonly isolated pathogens in skin and skin structure infections. J Antimicrob Chemother 2014 Sep;69(9):2443-7

Koser CU, Ellington MJ, Peacock SJ. Whole-genome sequencing to control antimicrobial resistance. Trends Genet 2014 Sep;30(9):401-7

Kothari A, Morgan M, Haake DA. Emerging technologies for rapid identification of bloodstream pathogens. Clin Infect Dis 2014 Jul 15;59(2):272-8

Langsjoen J, Brady C, Obenauf E, et al. Nasal screening is useful in excluding methicillin-resistant Staphylococcus aureus in ventilator-associated pneumonia. Am J Infect Control 2014 Sep;42(9):1014-5

Lee LY, Korman TM, Graham M. Rapid time to results and high sensitivity of the CarbaNP test on early cultures. J Clin Microbiol 2014 Nov;52(11):4023-6

Leis JA, Rebick GW, Daneman N, et al. Reducing antimicrobial therapy for asymptomatic bacteriuria among noncatheterized inpatients: a proof-of-concept study. Clin Infect Dis 2014 Apr;58(7):980-3

MacFadden DR, Ridgway JP, Robicsek A, et al. Predictive utility of prior positive urine cultures. Clin Infect Dis 2014 Nov 1;59(9):1265-71

Machen A, Drake T, Wang YF. Same day identification and full panel antimicrobial susceptibility testing of bacteria from positive blood culture bottles made possible by a combined lysis-filtration method with MALDI-TOF VITEK mass spectrometry and the VITEK2 system. PLoS One 2014 Feb 14;9(2):e87870

McCulloh RJ, Andrea S, Reinert S, et al. Potential utility of multiplex amplification respiratory viral panel testing in the management of acute respiratory infection in children: a retrospective analysis. J Pediatric Infect Dis Soc 2014 Jun;3(2):146-53

Meisner M. Update on procalcitonin measurements. Ann lab Med 2014 Jul;34(4):263-73

Nagel JL, Huang AM, Kunapuli A, et al. Impact of antimicrobial stewardship intervention on coagulase-negative Staphylococcus blood cultures in conjunction with rapid diagnostic testing. J Clin Microbiol 2014 Aug;52(8):2849-54

Pardo J, Klinker KP, Borgert SJ, et al. Time to positivity of blood cultures supports antibiotic de-escalation at 48 hours. Ann Pharmacother 2014 Jan;48(1):33-40

Peppard WJ, Ledeboer NA. Implementation of polymerase chain reaction to rule out Clostridium difficile infection is associated with reduced empiric antibiotic duration of therapy. Hosp Pharm 2014 Jul;49(7):639-43

Perez KK, Olsen RJ, Musick WL, et al. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant gram-negative bacteremia. J Infect 2014 Sep;69(3):216-25

Prescott JF. The resistance tsunami, antimicrobial stewardship, and the golden age of microbiology. Vet Microbiol 2014 Jul 16;171(3-4):273-8

Salluh JI, Nobre V, Povoa P. Using procalcitonin to guide antimicrobial duration in sepsis: asking the same questions will not bring different answers. Crit Care 2014 May 13;18(3):142

Schuetz P, Kutz A, Grolimund E, et al. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial. Int J Cardiol 2014 Aug 20;175(3):464-72

Shehabi Y, Sterba M, Garrett PM, et al. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. a randomized controlled trial. Am J Respir Crit Care Med 2014 Nov 15;190(10):1102-10

So W, Crandon JL, Zhanel GG, et al. Comparison of in vivo and in vitro pharmacodynamics of a humanized regimen of 600 milligrams of ceftaroline fosamil every 12 hours against Staphylococcus aureus at initial inocula of 106 and 108 CFU per milliliter. Antimicrob Agent Chemother 2014 Nov;58(11)6931-3

Terp S, Krishnadasan A, Bowen W, et al. Introduction of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing and antibiotic selection among hospitalized patients with purulent skin infections. Clin Infect Dis 2014 Apr;58(8):e129-32

Tuite N, Reddington K, Barry T, et al. Rapid nucleic acid diagnostics for the detection of antimicrobial resistance in gram-negative bacteria: is it time for a paradigm shift? J Antimicrob Chemother 2014 Jul;69(7):1729-33

Vazquez Melendez EL, Farrell JJ, Hujer AM, et al. Culture negative empyema in a critically ill child: an opportunity for rapid molecular diagnostics. BMC Anesthesiol 2014 Nov 22;14:107

Back to top

2013

Coupat C, et al. Selective reporting of antibiotic susceptibility data improves the appropriateness of intended antibiotic prescriptions in urinary tract infections: a case-vignette randomised study. Eur J Clin Microbiol Infect Dis 2013 May;32(5):627-36

Dhiman N, et al. Evaluation of the BinaxNOW Staphylococcus aureus test for rapid identification of Gram-positive cocci from VersaTREK blood culture bottles. J Clin Microbiol 2013 Sep;51(9):2939-42

Dudley MN, et al. Background and rationale for revised Clinical and Laboratory Standards Institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam. Clin Infect Dis 2013;56:1301-9

Farrell JJ, et al. "Salvage microbiology": detection of bacteria directly from clinical specimens following initiation of antimicrobial treatment. PLoS One 2013;8(6):e66349

Gawronski, KM, et al. A stewardship program's retrospective evaluation of vancomycin AIC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. Clin Ther 2013 Jun;35(6):772-9

Geiger K, Brown J. Rapid testing for methicillin-resistant Staphylococcus aureus: implications for antimicrobial stewardship. Am J Health Syst Pharm 2013;70:335-42

Hombach M, et al. The critical influence of the intermediate category on interpretation errors in revised EUCAST and CLSI antimicrobial susceptibility testing guidelines. Clin Microbiol Infect 2013;19:E59-71

Huang AM, et al. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis 2013 Nov;57(9):1237-45

McGregor JC, et al. Comparison of antibiograms developed for inpatients and primary care outpatients. Diagn Microbiol Infect Dis 2013 May;76(1):73-9

O'Brien DJ, et al. Maximizing the impact of antimicrobial stewardship: the role of diagnostics, national and international efforts. Curr Opin Infect Dis 2013 Aug;26(4):352-8

Patel R. Matrix-assisted laser desorption ionization-time of flight mass spectrometry in clinical microbiology. Clin Infect Dis 2013 Aug;57(4):564-72

Rimawi RH, et al. The impact of penicillin skin testing on clinical practice and antimicrobial stewardship. J Hosp Med 2013 Jun;8(6):341-5

Sango A, et al. Stewardship approach for optimizing antimicrobial therapy through use of a rapid microarray assay on blood cultures positive for Enterococcus species. J Clin Microbiol 2013 Dec;51(12):4008-11

Schuetz P, et al. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis. Curr Opin Crit Care 2013 Oct;19(5):453-60

Sridharan P, et al. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills? Surg Infect (Larchmt) 2013 Dec;14(6):489-511

Trienski TL, et al. Evaluation and use of a rapid Staphylococcus aureus assay by an antimicrobial stewardship program. Am J Health Syst Pharm 2013 Nov 1;70(21):1908-12

van Belkum A, et al. Rapid clinical bacteriology and its future impact. Ann Lab Med 2013;33:14-27

Zadroga R, et al. Comparison of 2 blood culture media shows significant differences in bacterial recovery for patients on antimicrobial therapy. Clin Infect Dis 2013 Mar;56(6):790-7

Back to top

2012

Aldeyab MA, et al. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother 2012;67:2988-96

Asin E, et al. Comparison of antimicrobial pharmacokinetic/pharmacodynamic breakpoints with EUCAST and CLSI clinical breakpoints for Gram-positive bacteria. Int J Antimicrob Agents 2012;40:313-22

Baron EJ, Tenover FC. Methicillin-resistant Staphylococcus aureus diagnostics: state of the art. Expert Opin Med Diagn 2012;6:585-92

Frye AM, et al. Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia. J Clin Microbiol 2012;50:127-33

Goff DA, et al. Using rapid diagnostic tests to optimize antimicrobial selection in antimicrobial stewardship programs. Pharmacotherapy 2012;32:677-87

Heil EL, et al. Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of candida infections. Am J Health Syst Pharm 2012;69:1910-4

Herbert C, et al. Demonstration of the weighted-incidence syndromic combination antibiogram: an empiric prescribing decision aid. Infect Control Hosp Epidemiol 2012;33:381-8

Katsios CM, et al. An antimicrobial stewardship program improves antimicrobial treatment by culture site and the quality of antimicrobial prescribing in critically ill patients. Critical Care 2012;16:R216

Kinnunen P, et al. Self-assembled magnetic bead biosensor for measuring bacterial growth and antimicrobial susceptibility testing. Small 2012;8:2477-82

Perez KK, et al. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 2013 Sep;137(9):1247-54

Peter H, et al. Direct detection and genotyping of Klebsiella pneumoniae carbapenemases from urine by use of a new DNA microarray test. J Clin Microbiol 2012;50:3990-8

Riedel S. Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis. Diagn Microbiol Infect Dis 2012;73:221-7

Schulz LT, et al. Can the antibiogram be used to assess microbiologic outcomes after antimicrobial stewardship interventions? A critical review of the literature. Pharmacotherapy 2012;32:668-76

van der Bij AK, et al. Clinical breakpoint changes and their impact on surveillance of antimicrobial resistance in Escherichia coli causing bacteraemia. Clin Microbiol Infect 2012;18:E466-72

Wong JR, et al. Antimicrobial stewardship pharmacist interventions for coagulase-negative staphylococci positive blood cultures using rapid polymerase chain reaction. Ann Pharmacother 2012;46:1484-90

Xu R, et al. Antibiogram compliance in University HealthSystem Consortium participating hospitals with Clinical and Laboratory Standards Institute guidelines. Am J Health Syst Pharm 2012;69:598- 606

Back to top

2011

Coghe F, et al. The role of the laboratory in choosing antibiotics. J Matern Fetal Neonatal Med 2011;24:18-20

Dhiman N, et al. Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast. J Clin Microbiol 2011;49:1614-6

Holtzman C, et al. Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention. J Clin Microbiol 2011 49:1581-2

Laakso S, et al. Evaluation of high-throughput PCR and microarray-based assay in conjunction with automated DNA extraction instruments for diagnosis of sepsis. PLoS One 2011;6:e26655

Liew YX, et al. Use of procalcitonin (PCT) to guide discontinuation of antibiotic use in an unspecified sepsis is an antimicrobial stewardship program (ASP). Eur J Clin Microbiol Infect Dis 2011;30:853-5.

Oliveira PR, et al. Impact of restriction of cefepime use on the antimicrobial susceptibility of Gram- negative bacilli related to healthcare-associated infections in an orthopedic hospital. Infect Drug Resist 2011;4:149-54

Pogue JM, et al. Role of unit-specific combination antibiograms for improving the selection of appropriate empiric therapy for Gram-negative pneumonia. Infect Control Hosp Epidemiol 2011;32:289-92

Back to top

2010

Bauer KA, et al. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis 2010;51:1074-80

Bulik CC, et al. Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods. J Clin Microbio 2010 Jul;48(7):2402-6

Parta M, et al. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results. Infect Control Hosp Epidemiol 2010;31:1043-8

Tenover FC. Potential impact of rapid diagnostic tests on improving antimicrobial use. Ann N Y Acad Sci 2010;1213:70-80

Back to top

2000-2009

Carver PL, Lin SW, DePestel DD, et al. Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a university hospital. J Clin Microbiol 2008 Jul;46(7):2381-3

Forrest GN, Mankes K, Jabra-Rizk MA, et al. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J Clin Microbiol 2006 Sep;44(9):3381-3

Forrest GN, Mehta S, Weekes E, et al. Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. J Antimicrob Chemother 2006 Jul;58(1):154-8

Forrest GN, Roghmann MC, Toombs LS, et al. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother 2008 Oct;52(10):3558-63

Hermsen ED, Shull SS, Klepser DG, et al. Pharmacoeconomic analysis of microbiologic techniques for differentiating staphylococci directly from blood culture bottles. J Clin Microbiol 2008 Sep;46(9):2924-9

Kuper KM, Boles DM, Mohr JF, et al. Antimicrobial susceptibility testing: a primer for clinicians. Pharmacotherapy 2009 Nov;29(11):1326-43

Lehmann LE, Alvarez J, Hunfeld KP, et al. Potential clinical utility of polymerase chain reaction in microbiological testing for sepsis. Crit Care Med 2009 Dec;37(12):3085-90

Ly T, Gulia J, Pyrgos V, et al. Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Ther Clin Risk Manag 2008 Jun;4(3):637-40

MacKenzie FM, Gould IM, Bruce J, et al. The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals. J Hosp Infect 2007 Jun;65(Suppl 2):73-81

Back to top

Stewardship: Measurement

(Overall measurement approaches [days of therapy vs. defined daily dose], measurements of expenditures, impact measurements)

Recently Added
2017
2016

2015
2014
2013
2012
2011
2010
2000-2009 

Recently Added

Bork JT, Morgan DJ, Heil EL, et al. Peer comparison of anti-MRSA agent prescription in the inpatient setting. Infect Control Hosp Epidemiol 2017 (published online Oct 25)

Back to top

2017

Andreassen AES, Jacobsen CM, Freiesleben de Blasio B, et al. The impact of methicillin-resistant S. aureus on length of stay, readmissions and costs: a register based case-control study of patients hospitalized in Norway. Antimicrob Resist Infect Control 2017 (published online Jul 6)

Axente C, Licker M, Moldovan R, et al. Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit. BMC Infect Dis 2017 (published online May 22)

Baur D, Gladstone BP, Burkert F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis 2017 (published online Jun 16)

Bias TE, Vincent WR 3rd, Trustman N, et al. Impact of an antimicrobial stewardship initiative on time to administration of empirical antibiotic therapy in hospitalized patients with bacteremia. Am J Health Syst Pharm 2017 Apr 1;74(7):511-9

Bork JT, Morgan DJ, Heil EL, et al. Peer comparison of anti-MRSA agent prescription in the inpatient setting. Infect Control Hosp Epidemiol 2017 (published online Oct 25)

Coulter S, Roberts JA, Hajkowicz K, et al. The use of bloodstream infection mortality to measure the impact of antimicrobial stewardship interventions: assessing the evidence. Infect Dis Rep 2017 (published online Mar 30)

Courter JD, Parker SK, Thurm C, et al. Accuracy of administrative data for antimicrobial administration in hospitalized children. J Pediatr Infect Dis Soc 2017 (published online Aug 18)

de Kraker MEA, Abbas M, Huttner B, et al. Good epidemiological practice: a narrative review of appropriate scientific methods to evaluate the impact of antimicrobial stewardship interventions. Clin Mircrobiol Infect 2017 (published online May 29)

Dilworth TJ, Rose WE, Sakoulas G, et al. Dissecting out the direct impacts of large-scale antimicrobial stewardship interventions on clinical outcomes: can confounding be overcome? Clin Infect Dis 2017 (published online Jul 29)

Echevarria K, Groppi J, Kelly AA, et al. Development and application of an objective staffing calculator for antimicrobial stewardship programs in the Veterans Health Administration. Am J Health Syst Pharm 2017 (published online Sep 25)

Forst G, de With K, Weber N, et al. Validation of adapted daily dose definitions for hospital antibacterial drug use evaluation: a multicentre study. J Antimicrob Chemother 2017 (published online Jul 24)

Gonzalez-Ramallo VJ, Miron-Rubio M, Mujal A, et al. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by hospital at home units in Spain. Int J Antimicrob Agents 2017 (published online May 9)

Goycochea-Valdivia WA, Moreno-Ramos F, Pano-Pardo JR, et al. Identifying priorities to improve paediatric in-hospital antimicrobial use by cross-sectional evaluation of prevalence and appropriateness of prescription. Enferm Infecc Microbiol Clin 2017 (published online Mar 8)

Graber CJ, Jones MM, Chou AF, et al. Association of inpatient antimicrobial utilization measures with antimicrobial stewardship activities and facility characteristics of Veterans Affairs medical centers. J Hosp Med 2017 May;12(5):301-9

Honda H, Ohmagari N, Tokuda Y, et al. Antimicrobial stewardship in inpatient settings in the Asia Pacific region: a systematic review and meta-analysis. Clin Infect Dis 2017 May 15;64(suppl 2):S110-S126

Howard P, Huttner B, Beovic B, et al. ESGAP inventory of target indicators assessing antibiotic prescriptions: a cross-sectional survey. J Antimicrob Chemother 2017 (published online Jul 19)

Huvane J, Komarow L, Hill C, et al. Fundamentals and catalytic innovation: the statistical and data management center of the antibacterial resistance leadership group. Clin Infect Dis 2017 (published online Mar 2)

Kallen MC, Prins JM. A systematic review of quality indicators for appropriate antibiotic use in hospitalized adult patients. Infect Dis Rep 2017 (published online Mar 30)

Kauf TL, Prabhu VS, Medic G, et al. Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections. BMC Infect Dis 2017 (published online Apr 28)

Kavanagh KT, Abusalem S, Calderon LE. The incidence of MRSA infections in the United States: is a more comprehensive tracking system needed? Antimicrob Resist Infect Control 2017 (published online Apr 7)

Leal JR, Conly J, Henderson EA, et al. How externalities impact an evaluation of strategies to prevent antimicrobial resistance in health care organizations. Antimicrob Resist Infect Control 2017 (published online Jun 2)

Livorsi DJ, O’Leary E, Pierce T, et al. A novel metric to monitor the influence of antimicrobial stewardship activities. Infect Control Hosp Epidemiol 2017 (published online May 5)

Mitchell ED, Murray CC, Meads D, et al. Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review. BMJ Open 2017 (published online Apr 20)

Molina J, Penalva G, Gil-Navarro MV, et al. Long-term impact of an educational antimicrobial stewardship program on hospital-acquired candidemia and multidrug-resistant bloodstream infections: a quasi-experimental study of interrupted time-series analysis. Clin Infect Dis 2017 (published online Aug 7)

Momattin H, Al-Ali AY, Mohammed K, et al. Benchmarking of antibiotic usage: an adjustment to reflect antibiotic stewardship program outcome in a hospital in Saudi Arabia. J Infect Public Health 2017 (published online Aug 29)

Murdoch F, Danial J, Morris AK, et al. The Scottish enhanced Staphylococcus aureus bacteraemia surveillance program: the first 18 months data in children. J Hosp Infection 2017 (published online Jun 20)

Naylor NR, Zhu N, Hulscher M, et al. Is antimicrobial stewardship cost-effective? A narrative review of the evidence. Clin Microbiol Infect 2017 (published online Jun 19)

Neilly MDJ, Guthrie B, Hernandez Santiago V, et al. Has primary care antimicrobial use really been increasing? Comparison of changes in different prescribing measures for a complete geographic population 1995–2014. J Antimicrob Chemother 2017 (published online Jul 19)

Oberje EJM, Tanke MAC, Jeurissen PPT. Antimicrobial stewardship initiatives throughout Europe: proven value for money. Infect Dis Rep 2017 (published online Mar 30)

O’Leary EN, van Santen KL, Webb AK, et al. Uptake of antibiotic stewardship programs in U.S. acute care hospitals: findings from the 2015 National Healthcare Safety Network Annual Hospital Survey. Clin Infect Dis 2017 (published online Jul 29)

Ouldali N, Bellettre X, Milcent K, et al. Impact of implementing national guidelines on antibiotic prescriptions for acute respiratory tract infections in pediatric emergency departments: an interrupted time series analysis. Clin Infect Dis 2017 (published online Jul 5)

Owens R, Jones LF, Moore M, et al. Self-assessment of antimicrobial stewardship in primary care: self-reported practice using the TARGET primary care self-assessment tool. Antibiotics (Basel) 2017 (published online Aug 16)

Parker SK, Hurst AL, Thurm C, et al. Anti-infective acquisition costs for a stewardship program: getting to the bottom line. Clin Infect Dis 2017 (published online Jul 23)

Pollara G, Bali S, Marks M, et al. Time efficiency assessment of antimicrobial stewardship strategies. Clin Infect Dis 2017 (published online Mar 13)

Rawson TM, Moore LSP, Hernandez B, et al. A systematic review of clinical decision support systems for antimicrobial management: Are we failing to investigate these interventions appropriately? Clin Microbiol Infect 2017 (published online Mar 4)

Ruiz-Ramos J, Frasquet J, Roma E, et al. Cost-effectiveness analysis of implementing an antimicrobial stewardship programme in critical care units. J Med Econ 2017 (published online Mar 26)

Schouten JA, Berrevoets MAH, Hulscher ME. Quality indicators to measure appropriate antibiotic use: some thoughts on the Black Box. Clin Infect Dis 2017 (published online Feb 18)

Schweitzer VA, van Smeden M, Postma DF, et al. Response Adjusted for Days of Antibiotic Risk (RADAR): evaluation of a novel method to compare strategies to optimise antibiotic use. Clin Microbiol Infect 2017 (published online May 10)

Seidelman J, Dicks KV, Durkin MJ, et al. Using clinical scenarios to understand preventability of Clostridium difficile infections by inpatient antibiotic stewardship programs. Infect Control Hosp Epidemiol 2017 (published online Mar 13)

Shea KM, Hobbs AL, Jaso TC, et al. Effect of a healthcare-system respiratory fluoroquinolone restriction program to alter utilization and impact rates of C. difficile infection. Antimicrob Agents Chemother 2017 (published online Mar 27)

Snyder GM, McCoy C, D’Agata EMC. Quantifying antimicrobial exposure: hazards in populations with end-stage renal disease. Infect Control Hosp Epidemiol 2017 Mar;38(3):360-3

Suda KJ, Hicks LA, Roberts RM, et al. Antibiotic expenditures by medication, class, and health care setting in the United States, 2010–2015. Clin Infect Dis 2017 (published online Aug 25)

Sun D, McCarthy TJ, Liberman DB. Cost-effectiveness of watchful waiting in acute otitis media. Pediatrics 2017 (published online Mar 1)

Toma M, Davey PG, Marwick CA, et al. A framework for ensuring a balanced accounting of the impact of antimicrobial stewardship interventions. J Antimicrob Chemother 2017 (published online Aug 31)

van Daalen FV, Opmeer BC, Prins JM, et al. The economic evaluation of an antibiotic checklist as antimicrobial stewardship intervention. J Antimicrob Chemother 2017 (published online Aug 1)

van Daalen FV, Prins JM, Opmeer BC, et al. The effect of an antibiotic checklist on length of hospital stay and appropriate antibiotic use in adult patients treated with intravenous antibiotics: a stepped wedge cluster randomised trial. Clin Microbiol Infect 2017 (published online Jan 31)

van Werkhoven CH, Postma DF, Mangen MJJ, et al. Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia: results from a cluster randomized cross-over trial. BMC Infect Dis 2017 (published online Jan 10)

Watson JR, Wang L, Klima J, et al. Healthcare claims data: an underutilized tool for pediatric outpatient antimicrobial stewardship. Clin Infect Dis 2017 (published online Mar 9)

Wei X, Yin J, Walley JD, et al. Impact of China's essential medicines scheme and zero-mark-up policy on antibiotic prescriptions in county hospitals: a mixed methods study. Trop Med Int Health 2017 (published online Jun 30)

Zhang ZG, Chen F, Ou Y. Impact of an antimicrobial stewardship programme on antibiotic usage and resistance in a tertiary hospital in China. J Clin Pharm Ther 2017 (published online May 8)

Back to top

2016

Akpan MR, Ahmad R, Shebl NA, et al. A review of quality measures for assessing the impact of antimicrobial stewardship programs in hospitals. Antibiotics (Basel) 2016 Jan 13;5(1)

Anderson DJ, Juthani-Mehta M, Morgan DJ. Research methods in healthcare epidemiology and antimicrobial stewardship: Randomized controlled trials. Infect Control Hosp Epidemiol 2016 Jun;37(6):629-34

Barnes SL, Kasaie P, Anderson DJ, et al. Research methods in healthcare epidemiology and antimicrobial stewardship—mathematical modeling. Infect Control and Hosp Epidemiol 2016 (published online Aug 8)

Borde JP, Nussbaum S, Hauser S, et al. Implementing an intensified antibiotic stewardship programme targeting daptomycin use in orthopaedic surgery: a cost-benefit analysis from the hospital perspective. Infection 2016 Jun;44(3):301-7

Caplinger C, Crane K, Wilkin M, et al. Evaluation of a protocol to optimize duration of pneumonia therapy at hospital discharge. Am J Health Syst Pharm 2016 (published online Nov 2)

Dela-Pena J, Kerstenetzky L, Schulz L, et al. Top 1% of inpatients administered antimicrobial agents comprising 50% of expenditures: a descriptive study and opportunities for stewardship intervention. Infect Control Hosp Epidemiol 2016 (published online Dec 5)

Dik JWH, Hendrix R, Poelman R, et al. Measuring the impact of antimicrobial stewardship programs. Expert Rev Anti Infect Ther 2016 Jun;14(6):569-75

Drees M, Gerber JS, Morgan DJ, et al. Research methods in healthcare epidemiology and antimicrobial stewardship: use of administrative and surveillance databases. Infect Control Hosp Epidemiol 2016 (published online Aug 30)

Fodero KE, Horey AL, Krajewski MP, et al. Impact of an antimicrobial stewardship program on patient safety in veterans prescribed vancomycin. Clin Ther 2016 Mar;38(3):494-502

Garcell HG, Arias AV, Fernandez EA, et al. Antibiotic consumption during a 4-year period in a community hospital with an antimicrobial stewardship program. Oman Med J 2016 Sep;31(5):352-6

García-Martínez L, Gracia-Ahulfinger I, Machuca I, et al. Impact of the PROVAUR stewardship programme on linezolid resistance in a tertiary university hospital: a before-and-after interventional study. J Antimicrob Chemother 2016 (published online May 30)

Jayaraman SP, Jiang Y, Resch S, et al. Cost-effectiveness of a model infection control program for preventing multi-drug-resistant organism infections in critically ill surgical patients. Surg Infect (Larchmt) 2016 (published online Jul 11)

Karanika S, Paudel S, Grigoras C, et al. Clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs: a systematic review and meta-analysis. Antimicrob Agents Chemother 2016 (published online May 31)

Lanbeck P, Ragnarson Tennvall G, Resman F. A cost analysis of introducing an infectious disease specialist-guided antimicrobial stewardship in an area with relatively low prevalence of antimicrobial resistance. BMC Health Serv Res 2016 (published online Jul 27)

Le Coz P, Carlet J, Roblot F, et al. Human resources needed to perform antimicrobial stewardship teams' activities in French hospitals. Med Mal Infect 2016 Jun;46(4):200-6

Luepke KH, Suda KJ, Boucher H, et al. Past, present, and future of antibacterial economics: increasing bacterial resistance, limited antibiotic pipeline, and societal implications. Pharmacother 2016 (published online Nov 12)

Lynch JB. Promoting value through antimicrobial stewardship. Healthc Financ Manage 2016 Mar;70(3):38-41

McElvania TeKippe E. The added cost of rapid diagnostic testing and active antimicrobial stewardship, is it worth it? J Clin Microbiol 2016 (published online Nov 9)

Michaelidis CI, Fine MJ, Lin CJ, et al. The hidden societal cost of antibiotic resistance per antibiotic prescribed in the United States: an exploratory analysis. BMC Infect Dis 2016 Nov 8;16(1):655

Moehring RW, Anderson DJ, Cochran RL, et al. Expert consensus on metrics to assess the impact of patient-level antimicrobial stewardship interventions in acute care settings. Clin Infect Dis 2016 (published online Dec 7)

Morgan DJ, Safdar N, Milstone AM, et al. Research methods in healthcare epidemiology and antimicrobial stewardship. Infect Control Hosp Epidemiol 2016 Jun;37(6):627-8

Murri R, de Belvis AG, Fantoni M, et al.; collaborative SPES Group. Impact of antibiotic stewardship on perioperative antimicrobial prophylaxis. Int J Qual Health Care 2016 Jun 9

Nguyen-Ha PT, Howrie D, Crowley K, et al. A quality assessment of a collaborative model of a pediatric antimicrobial stewardship program. Pediatrics 2016 Apr;137(4):e20150316

Okumura LM, Riveros BS, Gomes-da-Silva MM, et al. A cost-effectiveness analysis of two different antimicrobial stewardship programs. Braz J Infect Dis 2016 May-Jun;20(3):255-61

Patel TS, Kaakeh R, Nagel JL, et al. Cost analysis of implementing MALDI-TOF plus real-time antimicrobial stewardship intervention for bloodstream infections. J Clin Microbiol 2016 (published online Oct 19)

Pollack LA, Plachouras D, Sinkowitz-Cochran R, et al. A concise set of structure and process indicators to assess and compare antimicrobial stewardship programs among EU and US hospitals: results from a multinational expert panel. Infect Control Hosp Epidemiol 2016 (published online Jul 15)

Rhodes NJ, Wagner JL, Gilbert EM, et al. Days of therapy and antimicrobial days: similarities and differences between consumption metrics. Infect Control Hosp Epidemiol 2016 Aug;37(8):971-3

Rutman L, Wright DR, O’Callaghan J, et al. A comprehensive approach to pediatric pneumonia: relationship between standardization, antimicrobial stewardship, clinical testing, and cost. J Healthc Qual 2016 (published online Nov 1)

Schuts EC, Hulscher ME, Mouton JW, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis 2016 (published online Mar 2)

Schweizer ML, Braun BI, Milstone AM. Research methods in healthcare epidemiology and antimicrobial stewardship-quasi-experimental designs. Infect Control Hosp Epidemiol 2016 (published online Jun 7)

Snyder GM, Young H, Varman M, et al. Research methods in healthcare epidemiology and antimicrobial stewardship-observational studies. Infect Control Hosp Epidemiol 2016 Jun 20;37(6):627-8

Stojanovic I, Schneider JE, Wei L, et al. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a Chinese hospital system perspective. Clin Chem Lab Med 2016 (published online Sep 22)

Tabah A, Cotta MO, Garnacho-Montero J, et al.; Working Group for Antimicrobial Use in the ICU. A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit. Clin Infect Dis 2016 Apr 15;62(8):1009-17

Tan C, Ritchie M, Alldred J, et al. Validating hospital antibiotic purchasing data as a metric of inpatient antibiotic use. J Antimicrob Chemother 2016 Feb;71(2):547-53

Timbrook TT, Hurst JM, Bosso JA. Impact of an antimicrobial stewardship program on antimicrobial utilization, bacterial susceptibilities, and financial expenditures at an academic medical center. Hosp Pharm 2016 Oct;51(9):703-11

Van den Bosch CM, Hulscher ME, Natsch S, et al. Applicability of generic quality indicators for appropriate antibiotic use in daily hospital practice: a cross-sectional point-prevalence multicenter study. Clin Microbiol Infect 2016 (published online Jul 15)

Van Parys J, Stevens MP, Moczygemba LR, et al. Antimicrobial stewardship program members' perspectives on program goals and national metrics. Clin Ther 2016 (published online Jul 5)

Vercheval C, Gillet M, Maes N, et al. Quality of documentation on antibiotic therapy in medical records: evaluation of combined interventions in a teaching hospital by repeated point prevalence survey. Eur J Clin Microbiol Infect Dis 2016 (published online Jun 2)

Zachariah P, Newland JG, Gerber JS, et al.; SHARPS Collaborative Project Group. Costs of antimicrobial stewardship programs at US children's hospitals. Infect Control Hosp Epidemiol 2016 Mar 29:1-3

Back to top

2015

Boel J, Sogaard M, Andreasen V, et al. Evaluating antibiotic stewardship programs in patients with bacteremia using administrative data: a cohort study. Eur J Clin Microbiol Infect Dis 2015 Jul;34(7):1475-84

Chowers M, Carmeli Y, Shitrit P, et al. Cost analysis of an intervention to prevent methicillin-resistant Staphylococcus aureus (MRSA) transmission. PLoS One 2015 Sep 25;10(9):e0138999

Coulter S, Merollini K, Roberts JA, et al. The need for cost-effectiveness analyses of antimicrobial stewardship programmes: a structured review. Int J Antimicrob Agents 2015 Aug;46(2):140-9

Dik JW, Hendrix R, Friedrich AW, et al. Cost-minimization model of a multidisciplinary antibiotic stewardship team based on a successful implementation on a urology ward of an academic hospital. PLoS One 2015 May 8;10(5):e0126106

Dik JW, Vemer P, Friedrich AW, et al. Financial evaluations of antibiotic stewardship programs-a systematic review. Front Microbiol 2015 Apr 16;6:317

Del Arco A, Tortajada B, de la Torre J, et al. The impact of an antimicrobial stewardship programme on the use of antimicrobials and the evolution of drug resistance. Eur J Clin Microbiol Infect Dis 2015 Feb;34(2):247-51

Drekonja DM, Filice GA, Greer N, et al. Antimicrobial stewardship in outpatient settings: a systematic review. Infect Control Hosp Epidemiol 2015 Feb;36(2):142-52

Evans SR, Rubin D, Follmann D, et al. Desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR). Clin Infect Dis 2015 Sep 1;61(5):800-6

Jenkins TC, Knepper BC, Shihadeh K, et al. Long-term outcomes of an antimicrobial stewardship program implemented in a hospital with low baseline antibiotic use. Infect Control Hosp Epidemiol 2015 Jun;36(6):664-72

Lambert ML, Bruyndonckx R, Goossens H, et al. The Belgian policy of funding antimicrobial stewardship in hospitals and trends of selected quality indicators for antimicrobial use, 1999-2010: a longitudinal study. BMJ Open 2015 Feb 13;5(2):e006916

Loo LW, Liew YX, Lee W, et al. Impact of antimicrobial stewardship program (ASP) on outcomes in patients with acute bacterial skin and skin structure infections (ABSSSIs) in an acute-tertiary care hospital. Infect Dis Ther 2015 Sep;4(Suppl 1):15-25

Madaras-Kelly K, Jones M, Remington R, et al. Description and validation of a spectrum score method to measure antimicrobial de-escalation in healthcare associated pneumonia from electronic medical records data. BMC Infect Dis 2015 Apr 25;15:197

Maeda M, Takuma T, Seki H, et al. Effect of interventions by an antimicrobial stewardship team on clinical course and economic outcome in patients with bloodstream infection. J Infect Chemother 2015 (published online Dec 9)

Munoz P, Valerio M, Vena A, et al. Antifungal stewardship in daily practice and health economic implications. Mycoses 2015 Jun;58 Suppl 2:14-25

Pakyz AL, Moczygemba LR, Wang H, et al. An evaluation of the association between an antimicrobial stewardship score and antimicrobial usage. J Antimicrob Chemother 2015 May;70(5):1588-91

Smith MJ, Gerber JS, Hersh AL. Inpatient antimicrobial stewardship in pediatrics: a systematic review. J Pediatric Infect Dis Soc 2015 Dec;4(4):e127-35

van den Bosch CM, Geerlings SE, Natsch S, et al. Quality indicators to measure appropriate antibiotic use in hospitalized adults. Clin Infect Dis 2015 Jan 15;60(2):281-91

You J. Antimicrobial stewardship programs - cost-minimizing or cost-effective? Expert Opin Pharmacother 2015 Feb;16(2):155-7

Back to top

2014

Aldeyab MA, McElnay JC, Scott MG, et al. A modified method for measuring antibiotic use in healthcare settings: implications for antibiotic stewardship and benchmarking. J Antimicrob Chemother 2014 Apr;69(4):1132-41

Bansal D, Mangla S, Undela K, et al. Measurement of adult antimicrobial drug use in tertiary care hospital using defined daily dose and days of therapy. Indian J Pharm Sci 2014 May;76(3):211-7

Burnpass JB, McDaneld PM, DePestel DD, et al. Outcomes and metrics for antimicrobial stewardship: survey of physicians and pharmacists. Clin Infect Dis 2014 Oct 15;59 Suppl 3:S108-11

DePestel DD, Eiland EH 3rd, Lusardi K, et al. Assessing appropriateness of antimicrobial therapy: in the eye of the interpreter. Clin Infect Dis 2014 Oct 15;59(Suppl 3):S154-61

Dodds Ashley ES, Kaye KS, DePestel DD, et al. Antimicrobial stewardship: philosophy versus practice. Clin Infect Dis 2014 Oct 15;59(Suppl 3):S112-21

Fukuda T, Watanabe H, Ido S, et al. Contribution of antimicrobial stewardship programs to reduction of antimicrobial therapy costs in community hospital with 429 beds-before-after comparative two-year trial in Japan. J Pharm Policy Pract 2014 Aug 5;7(1):10

Guillot J, Lebel D, Roy H, et al. Usefulness of defined daily dose and days of therapy in pediatrics and obstetrics-gynecology: a comparative analysis of antifungal drugs (2000-2001, 2005-2006, and 2010-2011). J Pediatr Pharmacol Ther 2014 Jul;19(3):196-201

Hermsen ED, McDaneld PM, Eiland ED 3rd, et al. Breaking down the barriers: challenges with development and implementation of an industry-sponsored antimicrobial stewardship data collection and analysis tool. Clin Infect Dis 2014 Oct 15;59(Suppl 3):S179-84

Ibrahim OM, Polk RE. Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. Infect Dis Clin North Am 2014 Jun;28(2):195-214

Lee TC, Frenette C, Jayaraman D, et al. Antibiotic self-stewardship: trainee-led structured antibiotic time-outs to improve antimicrobial use. Ann Intern Med 2014 Nov 18;161(10 Suppl):S53-8

McGregor JC, Furuno JP. Optimizing research methods used for the evaluation of antimicrobial stewardship programs. Clin Infect Dis 2014 Oct 15;59(Suppl 3):S185-92

Morris AM. Antimicrobial stewardship programs: appropriate measures and metrics to study their impact. Curr Treat Options Infect Dis 2014;6(2):101-12

Seah XF, Ong YL, Tan SW, et al. Impact of an antimicrobial stewardship program on the use of carbapenems in a tertiary women's and children's hospital, Singapore. Pharmacotherapy 2014 Nov;34(11):1141-50

Septimus E. Antimicrobial stewardship-qualitative and quantitative outcomes: the role of measurement. Curr Infect Dis Rep 2014 Nov;16(11):433

Van den Bosch CM, Hulscher ME, Natsch S, et al. Development of quality indicators for antimicrobial treatment in adults with sepsis. BMC Infect Dis 2014 Jun 20;14:345

Yu K, Rho J, Morcos, M, et al. Evaluation of dedicated infectious diseases pharmacists on antimicrobial stewardship teams. Am J Health Syst Pharm 2014 Jun 15;71(12):1019-28

Back to top

2013

Antworth A, et al. Impact of an antimicrobial stewardship program comprehensive care bundle on management of candidemia. Pharmacotherapy 2013;33:137-143

Bassi J, et al. Measuring value for money: a scoping review on economic evaluation of health information systems. J Am Med Inform Assoc 2013 Jul-Aug;20(4):792-801

Cappelletty D, et al. Evaluating the impact of a pharmacist's absence from an antimicrobial stewardship team. Am J Health Syst Pharm 2013 Jun 15;70(12):1065-9

Chung GW, et al. Antimicrobial stewardship: a review of prospective audit and feedback systems and an objective evaluation of outcomes. Virulence 2013;4:151-7

Gravatt LA, et al. Challenges in measuring antibiotic consumption. Curr Infect Dis Rep 2013 Dec;15(6):559-63

Hawn MT, et al. Timing of surgical antibiotic prophylaxis and the risk of surgical site infection. JAMA Surg 2013 Jul;148(7):649-57

Hong SY, et al. Evaluation of programmatic changes to an antimicrobial stewardship program with house officer feedback. J Eval Clin Pract 2013;19:388-92

Lin YS, et al. Impact of an antimicrobial stewardship program with multidisciplinary cooperation in a community public teaching hospital in Taiwan. Am J Infect Control 2013 Nov;41(11):1069-72

Malani AN, et al. Clinical and economic outcomes from a community hospital's antimicrobial stewardship program. Am J Infect Control 2013;41:145-148

Mohammadi S, et al. Clinical outcomes of a Veterans Affairs outpatient antimicrobial treatment program. South Med J 2013 Jun;106(6):345-9

Retamar P, et al. Evaluating the quality of antimicrobial prescribing: is standardisation possible? Enferm Infecc Microbiol Clin 2013 Sep;31(Suppl 4):25-30

Rimawi RH, et al. Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome. Crit Care Med 2013 Sep;41(9):2099-107

Sick AC, et al. Sustained savings from a longitudinal cost analysis of an internet-based preapproval antimicrobial stewardship program. Infect Control Hosp Epidemiol 2013;34:573-80

Suda KJ, et al. A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009. J Antimicrob Chemother 2013 Mar;68(3):715-8

Ullman MA, et al. The economic impact of starting, stopping, and restarting an antibiotic stewardship program: a 14-year experience. Antibiotics (Basel) 2013 Apr 24;2(2):256-64

Vettese N, et al. Outcomes associated with a thrice-weekly antimicrobial stewardship programme in a 253-bed community hospital. J Clin Pharm Ther 2013 Oct;38(5):401-4

Willmann M, et al. Time series analysis as a tool to predict the impact of antimicrobial restriction in antibiotic stewardship programs using the example of multidrug-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2013;57:1797-803

Back to top

2012

Beardsley JR, et al. Show me the money: long-term financial impact of an antimicrobial stewardship program. Infect Control Hosp Epidemiol 2012;33:398-400

Duszynska W, et al. Continuous infusion of piperacillin/tazobactam in ventilator-associated pneumonia: a pilot study on efficacy and costs. Int J Antimicrob Agents 2012;39:153-8

Griffith M, et al. Antimicrobial stewardship programs: methods of operation and suggested outcomes. Expert Rev Anti Infect Ther 2012;10:63-73

Hamblin S, et al. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach. J Trauma Acute Care Surg 2012;73:1484-90

Hübner C, et al. Cost-analysis of PCR-guided pre-emptive antibiotic treatment of Staphylococcus aureus infections: an analytic decision model. Eur J Clin Microbiol Infect Dis 2012;31:3065-72

Ibrahim OM, Polk RE. Benchmarking antimicrobial drug use in hospitals. Expert Rev Anti Infect Ther 2012;10:445-57

Khadem TM, et al. Antimicrobial stewardship: a matter of process or outcome? Pharmacotherapy 2012;32:688-706.

Magedanz L, et al. Impact of the pharmacist on a multidisciplinary team in an antimicrobial stewardship program: a quasi-experimental study. Int J Clin Pharm 2012;34:290-4

Manns B, et al. Evaluating the impact of a novel restricted reimbursement policy for quinolone antibiotics: a time series analysis. BMC Health Serv Res 2012;12:290

McGowan JE. Antimicrobial stewardship — the state of the art in 2011: focus on outcome and methods. Infect Control Hosp Epidemiol 2012;33:331-7

Morris AM, et al. Use of a structured panel process to define quality metrics for antimicrobial stewardship programs. Infect Control Hosp Epidemiol 2012 May;33(5):500-6

Neidell MJ, et al. Costs of healthcare- and community-associated infections with antimicrobial- resistant versus antimicrobial-susceptible organisms. Clin Infect Dis 2012;55:807-15

Niwa T, et al. Outcome measurement of extensive implementation of antimicrobial stewardship in patients receiving intravenous antibiotics in a Japanese university hospital. Int J Clin Pract 2012;66:999-1008

Nowak MA, et al. Clinical and economic outcomes of a prospective antimicrobial stewardship program. Am J Health Syst Pharm 2012;69:1500-8

Slekovec C, et al. Impact of a region wide antimicrobial stewardship guideline on urinary tract infection prescription patterns. Int J Clin Pharm 2012;34:325-9

Standiford HC, et al. Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program. Infect Control Hosp Epidemiol 2012 Apr;33(4):338-45

Stevenson KB, et al. The economics of antimicrobial stewardship: the current state of the art and applying the business case model. Infect Control Hosp Epidemiol 2012 Apr;33(4):389-97

Back to top

2011

Altunsoy A, et al. The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey. Int J Med Sci 2011;8:339-44

Dumartin C, et al. Antibiotic stewardship programmes: legal framework and structure and process indicator in Southwestern French hospitals, 2005-2008. J Hosp Infect 2011;77:123-8

Enoch DA, et al. Outcome for Gram-negative bacteraemia when following restrictive empirical antibiotic guidelines. QJM 2011;104:411-9

Goff DA. Antimicrobial stewardship: bridging the gap between quality care and cost. Curr Opin Infect Dis 2011;24:S11-20

Heintz BH, et al. Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center. Ann Pharmacother 2011;45:1329-37

Kaki R, et al. Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother 2011;66:1223-30

McIntosh KA, et al. A quality improvement initiative to improve adherence to national guidelines for empiric management of community-acquired pneumonia in emergency departments. Int J Qual Health Care 2011;23:142-50

Nadeau MC, Kuti EL. Clinical and economic impact of intravenous to oral conversion therapy programs. Conn Med 2011;75:25-9

Slain D, et al. Impact of a multimodal antimicrobial stewardship program on Pseudomonas aeruginosa susceptibility and antimicrobial use in the intensive care unit setting. Crit Care Res Pract 2011;2011:416426

Talpaert MJ, et al. Impact of guidelines and enhanced antibiotic stewardship on reducing broad- spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother 2011;66:2168-74

Thakkar K, et al. A quality improvement programme to increase compliance with an anti-infective prescribing policy. J Antimicrob Chemother 2011;66:1916-20

Back to top

2010

McGarry LJ, et al. Economic assessment of doripenem versus imipenem in the treatment of ventilator-associated pneumonia. J Med Econ 2010 Mar;13(1):142-7

Meyer E, et al. Impact of a change in antibiotic prophylaxis on total antibiotic use in a surgical intensive care unit. Infection 2010;38:19-24

Miyawaki K, et al. Impact of antimicrobial stewardship by infection control team in a Japanese teaching hospital. Yakugaku Zasshi 2010;130:1105-11

Rattanaumpawan P, et al. Effectiveness of drug use evaluation and antibiotic authorization on patients' clinical outcomes, antibiotic consumption, and antibiotic expenditures. Am J Infect Control 2010;38:38-43

Back to top

 

2000-2009

Bhavnani SM, Callen WA, Forrest A, et al. Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in U.S. hospitals. Am J Health Syst Pharm 2003 Oct 1;60(19):1962-70

Carling P, Fung T, Killion A, et al. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp epidemiol 2003 Sep;24(9):699-706

Chang MT, Wu TH, Wang CY, et al. The impact of an intensive antimicrobial control program in a Taiwanese medical center. Pharm World Sci 2006 Aug;28(4):257-64

Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis 2003 Jun 1;36(11):1433-7

Gentry CA, Greenfield RA, Slater LN, et al. Outcomes of an antimicrobial control program in a teaching hospital. Am J Health Syst Pharm 2000 Feb 1;57(3):268-74

Gross R, Morgan AS, Kinky DE, et al. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 2001 Aug 1;33(3):289-95

Kuti JL, Le TN, Nightingale CH, et al. Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from i.v. to oral. Am J Health Syst Pharm 2002 Nov 15;59(22):2209-15

MacDougall C, Polk RE. Variability in rates of use of antibacterials among 130 US hospitals and risk-adjustment models for interhospital comparison. Infect Control Hosp Epidemiol 2008 Mar;29(3):203-11

McCollum M, Rhew DC, Parodi S. Cost analysis of switching from i.v. vancomycin to p.o. linezolid for the management of methicillin-resistant Staphylococcus species. Clin Ther 2003 Dec;25(12):3173-89

Paladino JA. Economics of antibiotic use policies. Pharmacotherapy 2004 Dec;24(12 Pt 2):232S-8S

Polk RE, Fox C, Mahoney A, et al. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007 Mar 1;44(5):664-70

Ramsay C, Brown E, Hartman G, et al. Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing. J Antimicrob Chemother 2003 Nov;52(5):764-71

Ruttimann S, Keck B, Hartmeier C, et al. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis 2004 Feb 1;38(3):348-56

Scheetz MH, Bolon MK, Postelnick M, et al. Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis. J Antimicrob Chemother 2009 Apr;63(4):816-25

Shardell M, Harris AD, El-Kamary SS, et al. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis 2007 Oct 1;45(7):901-7

Vlahovic-Palcevski V, Morovic M, Palcevski G. Antibiotic utilization at the university hospital after introducing an antibiotic policy. Eur J Clin Pharmacol 2000 Apr;56(1):97-101

Back to top

Stewardship: Special Populations

(Immunocompromised patients, residents of nursing homes and skilled nursing facilities, neonatal intensive care units, terminally ill patients)

Recently Added
2017
2016

2015
2014
2013
2012
2011
2010

Recently Added

Cortes-Penfield NW, Trautner BW, Jump RLP. Urinary tract infection and asymptomatic bacteriuria in older adults. Infect Dis Clin 2017 Dec;31(4):673-88

March A, Aschbacher R, Sieghel F, et al. Colonization of residents and staff of an Italian long-term care facility and an adjacent acute care hospital geriatric unit by multidrug-resistant bacteria. New Microbiol 2017 (published online Oct 10)

McElligott M, Welham G, Pop-Vicas A, et al. Antibiotic stewardship in nursing facilities. Infect Dis Clin 2017 Dec;31(4):619-38

Money N, Newman J, Demissie S, et al. Anti-microbial stewardship: antibiotic use in well-appearing term neonates born to mothers with chorioamnionitis. J Perinatol 2017 (published online Oct 5)

Murray MT, Johnson CL, Cohen B, et al. Use of antibiotics in paediatric long term care facilities. J Hosp Infect 2017 (published online Oct 27)

Mushtaq A, Awali RA, Chandramohan S, et al. Implementing an antibiotic stewardship program at a long-term acute care hospital in Detroit, Michigan. Am J Infect Control 2017 (published online Oct 12)

Powers K, Beganovic M, Gockenbach N, et al. Development of a neonatal intensive care unit-specific antibiogram: comparison to the hospital antibiogram and assessment of patient factors on susceptibility. J Antimicrob Steward 2017;1(1):19-28

Walker S, Datta A, Massoumi RL, et al. Antibiotic stewardship in the newborn surgical patient: a quality improvement project in the neonatal intensive care unit. Surgery 2017 (published online Oct 16)

Back to top

2017

Alevizakos M, Gaitanidis A, Andreatos N, et al. Bloodstream infections due to ESBL-producing Enterobacteriaceae among patients with malignancy: a systematic review and meta-analysis. Int J Antimicrob Agents 2017 (published online Jul 10)

Alevizakos M, Mylonakis E. Colonization and infection with extended-spectrum beta-lactamase producing Enterobacteriaceae in patients with malignancy. Expert Rev Anti Infect Ther 2017 (published online Jun 29)

Aliyu S, Smaldone A, Larson E. Prevalence of multidrug-resistant gram-negative bacteria among nursing home residents: a systematic review and meta-analysis. Am J Infect Control 2017 May;45(5):512-8

Amissah NA, van Dam L, Ablordey A, et al. Epidemiology of Staphylococcus aureus in a burn unit of a tertiary care center in Ghana. PLoS One 2017 (published online Jul 13)

Averbuch D, Tridello G, Hoek J, et al. Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant patients: intercontinental prospective study of Infectious Diseases Working Party of the European Bone Marrow Transplantation group. Clin Infect Dis 2017 (published online Jul 26)

Brakemeier S, Taxeidi SI, Zukunft B, et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae-related urinary tract infection in kidney transplant recipients: risk factors, treatment, and long-term outcome. Transplant Proc 2017 Oct;49(8):1757-65

Carter RR, Montpetite MM, Jump RL. Mixed-methods pilot study to assess perceptions of antimicrobial stewardship in nursing homes. J Am Geriatr Soc 2017 (published online Feb 2)

Clock SA, Jia H, Patel S, et al. Infant colonization with methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococci preceding neonatal intensive care unit discharge. J Pediatric Infect Dis Soc 2017 (published online Mar 1)

Cortes-Penfield NW, Trautner BW, Jump RLP. Urinary tract infection and asymptomatic bacteriuria in older adults. Infect Dis Clin 2017 Dec;31(4):673-88

Daneman N, Campitelli MA, Giannakeas V, et al. Influences on the start, selection and duration of treatment with antibiotics in long-term care facilities. CMAJ 2017 (published online Jun 26)

Dasgupta M, Brymer C, Elsayed S. Treatment of asymptomatic UTI in older delirious medical in-patients: a prospective cohort study. Arch Gerontol Geriatr 2017 (published online May 31)

Feldstein D, Sloane PD, Feltner C. Antibiotic stewardship programs in nursing homes: a systematic review. J Am Med Dir Assoc 2017 (published online Aug 7)

Flokas ME, Alevizakos M, Shehadeh F, et al. ESBL-producing Enterobacteriaceae colonization in long-term care facilities (LTCFs): a systematic review and meta–analysis. Int J Antimicrob Agents 2017 (published online Aug 3)

Fuchs A, Li G, Anker JVD, et al. Optimising β-lactam dosing in neonates: a review of pharmacokinetics, drug exposure and pathogens. Curr Pharm Des 2017 (published Sep 25)

Giufre M, Ricchizzi E, Accogli M, et al. Colonization by multidrug-resistant organisms in long-term care facilities in Italy: a point-prevalence study. Clin Microbiol Infect 2017 (published online Apr 12)

Hennig S, Staatz CE, Natanek D, et al. Antimicrobial stewardship in paediatric oncology: impact on optimising gentamicin use in febrile neutropenia. Pediatr Blood Cancer 2017 (published online Sep 13)

Horikoshi Y, Kaneko T, Morikawa Y, et al. The north wind and the sun: pediatric antimicrobial stewardship program combining restrictive and persuasive approaches in hematology-oncology ward and hematopoietic stem cell transplant unit. Pediatr Infect Dis J 2017 (published online Aug 17)

Hubner NO, Dittmann K, Begunk R, et al. Infection control measures and prevalence of multidrug-resistant organisms in non-hospital care settings in northeastern Germany: results from a one-day point prevalence study. J Hosp Infect 2017 (published online Aug 7)

Hui K, Nalder M, Buising K, et al. Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodialysis: an observational study. BMC Nephrol 2017 (published online May 12)

Johnson CL, Saiman L. A blueprint for targeted antimicrobial stewardship in neonatal intensive care units. Infect Control Hosp Epidemiol 2017 Oct;38(10):1144-6

Jones W, Drake C, Mack D, et al. Developing mobile clinical decision support for nursing home staff assessment of urinary tract infection using goal-directed design. Appl Clin Inform 2017 (published online Jun 20)

Jump RLP, Gaur S, Katz MJ, et al. Template for an antibiotic stewardship policy for post-acute and long-term care settings. J Am Med Dir Assoc 2017 (published online Sep 18)

Katz MJ, Gurses AP, Tamma PD, et al. Implementing antimicrobial stewardship in long-term care settings: an integrative review using a human factors approach. Clin Infect Dis 2017 (published online Jun 20)

Kim HS, Park BK, Kim SK, et al. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study. BMC Infect Dis 2017 (published online Jul 17)

Kistler CE, Zimmerman S, Scales K, et al. The antibiotic prescribing pathway for presumed urinary tract infections in nursing home residents. J Am Geriatr Soc 2017 (published online Mar 28)

Ko BS, Chen WT, Kung HC, et al. 2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan. J Microbiol Immunol Infect 2017 (published online Aug 4)

Koseck K, Steinberg A, Caliendo G, et al. Comparison of the rates of Clostridium difficile and bacteremia after delaying fluoroquinolone prophylaxis from day 0 to day +3 post autologous stem cell transplantation. Transpl Infect Dis 2017 (published online Apr 29)

Krishna A, Pervaiz A, Lephart P, et al. Prevalence of Clostridium difficile infection in acute care hospitals, long-term care facilities, and outpatient clinics: is Clostridium difficile infection underdiagnosed in long-term care facility patients? Am J Infect Control 2017 (published online Jun 8)

Lavrentieva A. Antibiotic stewardship in burn patients: From theory to reality and vice versa. Burns 2017 (published online Feb 4)

Li X, Xu X, Yang X, et al. Risk factors for the infection and/or colonization of extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit: a meta-analysis. Int J Antimicrob Agents 2017 (published online Jul 18)

Lin IW, Huang CY, Pan SC, et al. Duration of colonization with and risk factors for prolonged carriage of multidrug resistant organisms among residents in long-term care facilities. Antimicrob Resist Infect Control 2017 (published online Aug 25)

March A, Aschbacher R, Sieghel F, et al. Colonization of residents and staff of an Italian long-term care facility and an adjacent acute care hospital geriatric unit by multidrug-resistant bacteria. New Microbiol 2017 (published online Oct 10)

McElligott M, Welham G, Pop-Vicas A, et al. Antibiotic stewardship in nursing facilities. Infect Dis Clin 2017 Dec;31(4):619-38

Mody L, Green MT, Saint S, et al. Comparing catheter-associated urinary tract infection prevention programs between veterans affairs nursing homes and non–veterans affairs nursing homes. Infect Control Hosp Epidemiol 2017 Mar;38(3):287-93

Mohsen L, Ramy N, Saied D, et al. Emerging antimicrobial resistance in early and late-onset neonatal sepsis. Antimicrob Resist Infect Control 2017 (published Jun 13)

Money N, Newman J, Demissie S, et al. Anti-microbial stewardship: antibiotic use in well-appearing term neonates born to mothers with chorioamnionitis. J Perinatol 2017 (published online Oct 5)

Mulanovich V, Kontoyiannis DP. Acute myeloid leukemia and the infectious diseases consultant. Leuk Lymphoma 2017 (published online Sep 15)

Murray MT, Johnson CL, Cohen B, et al. Use of antibiotics in paediatric long term care facilities. J Hosp Infect 2017 (published online Oct 27)

Mushtaq A, Awali RA, Chandramohan S, et al. Implementing an antibiotic stewardship program at a long-term acute care hospital in Detroit, Michigan. Am J Infect Control 2017 (published online Oct 12)

Nour I, Eldegla HE, Nasef N, et al. Risk factors and clinical outcomes for carbapenem-resistant gram-negative late-onset sepsis in a neonatal intensive care unit. J Hosp Infect 2017 (published online Jun 2)

Nzegwu NI, Rychalsky MR, Nallu LA, et al. Implementation of an antimicrobial stewardship program in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2017 (published online Jul 26)

Panigrahi P, Chandel DS, Hansen NI, et al. Neonatal sepsis in rural India: timing, microbiology and antibiotic resistance in a population-based prospective study in the community setting. J Perinatol 2017 (published online May 11)

Powers K, Beganovic M, Gockenbach N, et al. Development of a neonatal intensive care unit-specific antibiogram: comparison to the hospital antibiogram and assessment of patient factors on susceptibility. J Antimicrob Steward 2017;1(1):19-28

Robilotti E, Holubar M, Seo SK, et al. Feasibility and applicability of antimicrobial stewardship in immunocompromised patients. Curr Opin Infect Dis 2017 (published online May 24)

Roukens M, Verhoef L, Stobberingh E, et al. Surveillance of antimicrobial use in Dutch long-term care facilities. J Antimicrob Chemother 2017 (published online Jan 18)

Ruiz-Ramos J, Frasquet J, Poveda-Andres JL, et al. Impact of an antimicrobial stewardship program on critical haematological patients. Farm Hosp 2017 Jul 1;41(4):479-87

Ryan S, Gillespie E, Stuart RL. Urinary tract infection surveillance in residential aged care. Am J Infect Control 2017 (published online Aug 22)

Satlin MJ, Walsh TJ. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant enterococci: three major threats to hematopoietic stem cell transplant recipients. Transpl Infect Dis 2017 (published online Aug 16)

Scales K, Zimmerman S, Reed D, et al. Nurse and medical provider perspectives on antibiotic stewardship in nursing homes. J Am Geriatr Soc 2017 Jan;65(1):165-71

Simonson W. Antibiotic stewardship: revisiting quinolone antibiotics. Geriatr Nurs 2017 (published online Mar 22)

Sloane PD, Kistler CE, Reed D, et al. Urine culture testing in community nursing homes: gateway to antibiotic overprescribing. Infect Control Hosp Epidemiol 2017 (published online Jan 31)

Snyder GM, McCoy C, D’Agata EMC. Quantifying antimicrobial exposure: hazards in populations with end-stage renal disease. Infect Control Hosp Epidemiol 2017 Mar;38(3):360-3

Walker S, Datta A, Massoumi RL, et al. Antibiotic stewardship in the newborn surgical patient: a quality improvement project in the neonatal intensive care unit. Surgery 2017 (published online Oct 16)

Wang J, Foxman B, Mody L, et al. Network of microbial and antibiotic interactions drive colonization and infection with multidrug-resistant organisms. Proc Natl Acad Sci USA 2017 (published online Sep 12)

Wattier RL, Levy ER, Sabnis AJ, et al. Reducing second gram-negative antibiotic therapy on pediatric oncology and hematopoietic stem cell transplantation services. Infect Control Hosp Epidemiol 2017 (published online Jul 31)

Webb BJ, Healy R, Majers J, et al. Prediction of bloodstream infection due to vancomycin-resistant Enterococci in patients undergoing leukemia induction or hematopoietic stem cell transplantation. Clin Infect Dis 2017 (published online Mar 20)

Wilson BM, Shick S, Carter RR, et al. An online course improves nurses' awareness of their role as antimicrobial stewards in nursing homes. Am J Infect Control 2017 (published online Feb 8)

Worth LJ, Spelman T, Holt SG, et al. Epidemiology of infections and antimicrobial use in Australian haemodialysis outpatients: findings from a Victorian surveillance network, 2008-2015. J Hosp Infect 2017 (published online May 30)

Zegers SHJ, Dieleman J, van der Bruggen T, et al. The influence of antibiotic prophylaxis on bacterial resistance in urinary tract infections in children with spina bifida. BMC Infect Dis 2017 (published online Jan 12)

Zollner-Schwetz I, Zechner E, Ullrich E, et al. Colonization of long term care facility patients with MDR-gram-negatives during an Acinetobacter baumannii outbreak. Antimicrob Resist Infect Control 2017 (published online May 16)

Zuccaro V, Columpsi P, Sacchi P, et al. How to get along with antibiotic stewardship and empirical antibiotic treatment in cirrhotic patients. Dig Liver Dis 2017 (published online Jan 22)

Back to top

2016

Baker TM, Satlin MJ. The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies. Leuk Lymphoma 2016 (published online Jun 24)

Batina NG, Crnich CJ, Anderson DF, et al. Identifying conditions for elimination and epidemic potential of methicillin-resistant Staphylococcus aureus in nursing homes. Antimicrob Resist Infect Control 2016 Sep 22;5:32

Baugh CW, Wang TJ, Caterino JM, et al. ED management of patients with febrile neutropenia: guideline concordant or overly aggressive? Acad Emerg Med 2016 (published online Sep 9)

Beaulac K, Corcione S, Epstein L, et al. Antimicrobial stewardship in a long-term acute care hospital using offsite electronic medical record audit. Infect Control Hosp Epidemiol 2016 Apr;37(4):433-9

Brandt NJ, Heil E. Antimicrobial stewardship in the post-acute long-term care setting: case discussion and updates. J Gerontol Nurs 2016 Jul 1;42(7):10-4

Cabral L, Afreixo V, Almeida L, et al. The use of procalcitonin (PCT) for diagnosis of sepsis in burn patients: a meta-analysis. PLOS One 2016 (published online Dec 22)

Cantey JB, Wozniak PS, Pruszynski JE, et al. Reducing unnecessary antibiotic use in the neonatal intensive care unit (SCOUT): a prospective interrupted time-series study. Lancet Infect Dis 2016 (published online Jul 21)

Carr D, Barnes EH, Gordon A, et al. Effect of antibiotic use on antimicrobial antibiotic resistance and late-onset neonatal infections over 25 years in an Australian tertiary neonatal unit. Arch Dis Child Fetal Neonatal Ed 2016 (published online Oct 13)

Chen CH, Chang, MC, Chen KH, et al. Profiling the fecal carriage of β-lactamase genes in long-term care facility residents: a longitudinal study. Am J Infect Control 2016 (published online Aug 3)

Ciricillo J, Haslam D, Blum S, et al. Frequency and risks associated with Clostridium difficile-associated diarrhea after pediatric solid organ transplantation: a single-center retrospective review. Transpl Infect Dis 2016 (published online Aug 5)

Corcione S, Baietto L, Malvasio V, et al. Pharmacokinetics of colistin methanesulfonate (CMS) in burn patients. J Antimicrob Chemother 2016 (published online Sep 2)

Cowan RU, Kishan D, Walton AL, et al. Cleaning, resistant bacteria, and antibiotic prescribing in residential aged care facilities. Am J Infect Control 2016 Mar 1;44(3):e19-21

Cozar-Llisto A, Ramos-Martinez A, Cobo J. Clostridium difficile infection in special high-risk populations. Infect Dis Ther 2016 (published online Aug 11)

DiPippo AJ, Tverdek FP, Tarrand JJ, et al. Daptomycin non-susceptible Enterococcus faecium in leukemia patients: role of prior daptomycin exposure. J Infect 2016 (published online Nov 11)

Eke-Usim AC, Rogers MA, Gibson KE, et al. Constitutional symptoms trigger diagnostic testing before antibiotic prescribing in high-risk nursing home residents. J Am Geriatr Soc 2016 (published online Sep 22)

Ellis K, Rubal-Peace G, Chang V, et al. Antimicrobial stewardship for a geriatric behavioral health population. Antibiotics (Basel) 2016 Jan 19;5(1)

Feldstein D, Sloane PD, Weber D, et al. Current prescribing practices for skin and soft tissue infections in nursing homes. J Am Med Dir Assoc 2016 (published online Nov 18)

Fernandez J, Tandon P, Mensa J, et al. Antibiotic prophylaxis in cirrhosis: good and bad. Hepatology 2016 Jun;63(6):2019-31

Fleming A, Barry L, Byrne S, et al. Antimicrobial susceptibility of long term care facility and general practice urine samples in patients 65 years and older: an observational study. Eur J Public Health 2016 (published online Oct 24)

Frenette C, Sperlea D, Leharova Y, et al. Impact of an infection control and antimicrobial stewardship program on solid organ transplantation and hepatobiliary surgical site infections. Infect Control Hosp Epidemiol 2016 Oct 3:1-7

Giannella M, Tedeschi S, Bartoletti M, et al. Prevention of infections in nursing homes: antibiotic prophylaxis versus infection control and antimicrobial stewardship measures. Expert Rev Anti Infect Ther 2016 Feb;14(2):219-30

Hartel C, Hartz A, Bahr L, et al. Media stories on NICU outbreaks lead to an increased prescription rate of third-line antibiotics in the community of neonatal care. Infect Control Hosp Epidemiol 2016 Aug;37(8):924-30

Hebbard AI, Slavin MA, Reed C, et al. The epidemiology of Clostridium difficile infection in patients with cancer. Expert Rev Anti Infect Ther 2016 (published online Sep 8)

Kassett N, Sham R, Aleong R, et al. Impact of antimicrobial stewardship on physician practice in a geriatric facility. Can J Hosp Pharm 2016 (published online Dec 23)

Katz MJ, Roghmann MC. Healthcare-associated infections in the elderly: what's new. Curr Opin Infect Dis 2016 Aug;29(4):388-93

Kidd F, Dubourg D, Heller F, et al. Antimicrobial stewardship in long-term care facilities in Belgium: a questionnaire-based survey of nursing homes to evaluate initiatives and future developments. Antimicrob Resist Infect Control 2016 Mar 8;5:7

Manzoni P, Dall’Agnola A. Reducing unnecessary antibiotic exposure in preterm neonates: an achievable goal. Lancet Infect Dis 2016 (published online Jul 21)

Martin CM. Antibiotic stewardship in long-term care: a call to action. Consult Pharm 2016 Jul;31(7):358-64

McMaughan DK, Nwaiwu O, Zhao H, et al. Impact of a decision-making aid for suspected urinary tract infections on antibiotic overuse in nursing homes. BMC Geriatr 2016 Apr 15;16(1):81

Montoya A, Cassone M, Mody L. Infections in nursing homes: epidemiology and prevention programs. Clin Geriatr Med 2016 Aug;32(3):585-607

Morrill HJ, Mermel LA, Baier RR, et al. Antimicrobial stewardship in Rhode Island long-term care facilities: current standings and future opportunities. Infect Control Hosp Epidemiol 2016 May 17:1-4

Morrill HJ, Caffrey AR, Jump RL, et al. Antimicrobial stewardship in long-term care facilities: A call to action. J Am Med Dir Assoc 2016 Feb;17(2):183.e1-16

Mylotte JM. Antimicrobial stewardship in long-term care: metrics and risk adjustment. J Am Med Dir Assoc 2016 Jul;17(7)

Peterson LR, Boehm S, Beaumont JL, et al. Reduction of methicillin-resistant Staphylococcus aureus infection in long-term care is possible while maintaining patient socialization: a prospective randomized clinical trial. Am J Infect Control 2016 (published online Aug 1)

Pouch SM, Satlin MJ. Carbapenem-resistant Enterobacteriaceae in special populations: solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies. Virulence 2016 (Jul 28)

Rosello A, Horner C, Hopkins S, et al. Understanding the impact of interventions to prevent antimicrobial resistant infections in the long-term care facility: a review and practical guide to mathematical modeling. Infect Control Hosp Epidemiol 2016 (published online Dec 19)

Ryan S, Gillespie E, Stuart RL. A parainfluenza virus type 3 outbreak at a residential aged care facility: the role of microbiologic testing in early identification and antimicrobial stewardship. Am J Infect Control 2016 (published online Sep 21)

Sakabe D, de Sa Del Fiol F. Profile of infections and antimicrobial treatment among burn-injury patients. Am J Infect Control 2016 Aug 1;44(8):950-2

Seo SK, Lo K, Abbo LM. Current state of antimicrobial stewardship at solid organ and hematopoietic cell transplant centers in the United States. Infect Control Hosp Epidemiol 2016 (published online Jul 26)

Shipp KD, Chiang T, Karasick S, et al. Antibiotic stewardship challenges in a referral neonatal intensive care unit. Am J Perinatol 2016 Apr;33(5):518-24

Sloane PD, Huslage K, Kistler CE, et al. Optimizing antibiotic use in nursing homes through antibiotic stewardship. N C Med J 2016 Sep-Oct;77(5):324-9

Snyder GM, Patel PR, Kallen AJ, et al. Factors associated with the receipt of antimicrobials among chronic hemodialysis patients. Am J Infect Control 2016 (published online May 13)

So M, Yang DY, Bell C, et al. Solid organ transplant patients: are there opportunities for antimicrobial stewardship? Clin Transplant 2016 (published online Mar 18)

Trautner BW, Greene MT, Krein SL, et al. Infection prevention and antimicrobial stewardship knowledge for selected infections among nursing home personnel. Infect Control Hosp Epidemiol 2016 (published online Oct 4)

Van den Dool C, Haenen A, Leenstra T, et al. The role of nursing homes in the spread of antimicrobial resistance over the healthcare network. Infect Control Hosp Epidemiol 2016 Jul;37(7):761-7

Vicente M, Al Nahedh M, Parsad S, et al. Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia. J Oncol Pharm Pract 2016 (published online Sep 8)

Wolf J, Sun Y, Tang L, et al. Antimicrobial stewardship barriers and goals in pediatric oncology and bone marrow transplantation: A survey of antimicrobial stewardship practitioners. Infect Control Hosp Epidemiol 2016 Mar;37(3):343-7

Yang M, Vleck K, Bellantoni M, et al. Telephone survey of infection-control and antibiotic stewardship practices in long-term care facilities in Maryland. J Am Med Dir Assoc 2016 Jun 1;17(6):491-4

Yogo N, Gahm G, Knepper BC, et al. Clinical characteristics, diagnostic evaluation, and antibiotic prescribing patterns for skin infections in nursing homes. Front Med (Lausanne) 2016 (published online Jul 21)

Yu H, Baser O, Wang L. Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study. BMC Geriatr 2016 (published online Nov 25)

Back to top

2015

Backus D. Antimicrobial therapy in long-term care: controversy, colonization, and criteria. Consult Pharm 2015 Sep;30(9):513-22

Beckett CL, Harbarth S, Huttner B. Special considerations of antibiotic prescription in the geriatric population. Clin Microbiol Infect 2015 Jan;21(1):3-9

Bedenic B, Beader N, Godic-Torkar K, et al. Nursing home as a reservoir of carbapenem-resistant Acinetobacter baumannii. Microb Drug Resist 2015 Jun;21(3):270-8

Burns K, Roche F, Donlon S. Healthcare-associated infections and antimicrobial use in long-term care facilities: the Irish experience with the HALT surveys. J Hosp Infect 2015 Apr;89(4):276-80

Cailes B, Vergnano S, Kortsalioudaki C, et al. The current and future roles of neonatal infection surveillance programmes in combating antimicrobial resistance. Early Hum Dev 2015 Nov;91(11):613-8

Campbell DJ, Brown FG, Craig JC, et al. Assessment of current practice and barriers to antimicrobial prophylaxis in peritoneal dialysis patients. Nephrol Dial Transplant 2015 (published online Apr 22)

Cantey JB, Wozniak PS, Sanchez PJ. Prospective surveillance of antibiotic use in the neonatal intensive care unit: results from the SCOUT study. Pediatr Infect Dis J 2015 Mar;34(3):267-72

Chopra T, Goldstein EJ. Clostridium difficile infection in long-term care facilities: a call to action for antimicrobial stewardship. Clin Infect Dis 2015 May 15;60(Suppl 2):S72-6

Cotten CM. Antibiotic stewardship: reassessment of guidelines for management of neonatal sepsis. Clin Perinatol 2015 Mar;42(1):195

Crnich CJ, Jump R, Trautner B, et al. Optimizing antibiotic stewardship in nursing homes: a narrative review and recommendations for improvement. Drugs Aging 2015 Sep;32(9):699-716

Daneman N, Bronskill SE, Gruneir A, et al. Variability in antibiotic use across nursing homes and the risk of antibiotic-related adverse outcomes for individual residents. JAMA Intern Med 2015 Aug;175(8):1331-9

Doernberg SB, Dudas V, Trivedi KK. Implementation of an antimicrobial stewardship program targeting residents with urinary tract infections in three community long-term care facilities: a quasi-experimental study using time-series analysis. Antimicrob Resist Infect Control 2015 Dec 1;4:54

Dyar OJ, Pagani L, Pulcini C. Strategies and challenges of antimicrobial stewardship in long-term care facilities. Clin Microbiol Infect 2015 Jan;21(1):10-9

Fleming A, Bradley C, Cullinan S, et al. Antibiotic prescribing in long-term care facilities: a meta-synthesis of qualitative research. Drugs Aging 2015 Apr;32(4):295-303

Holzmann-Pazgal G, Khan AM, Northrup TF, et al. Decreasing vancomycin utilization in a neonatal intensive care unit. Am J Infect Control 2015 Nov 1;43(11):1255-7

Jump RL, Heath B, Crnich CJ, et al. Knowledge, beliefs, and confidence regarding infections and antimicrobial stewardship: a survey of Veterans Affairs providers who care for older adults. Am J Infect Control 2015 Mar 1;43(3):298-300

Kram JJ, Borlaug G, Safdar N, et al. Development and distribution of educational materials for carbapenem-resistant Enterobacteriaceae among acute and long-term care facilities. WMJ 2015 Apr;114(2):48-51

Lim CJ, Stuart RL, Kong DC. Antibiotic use in residential aged care facilities. Aust Fam Physician 2015 Apr;44(4):192-6

Mills JP, Talati NJ, Alby K, et al. The epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization and infection among long-term acute care hospital residents. Infect Control Hosp Epidemiol 2015 (published online Oct 12)

Osowicki J, Gwee A, Noronha J, et al. Australia-wide point prevalence survey of antimicrobial prescribing in neonatal units: how much and how good? Pediatr Infect Dis J 2015 Aug;34(8):e185-90

Pano-Pardo JR, Schuffelmann-Gutierrez C, Escosa-Garcia L, et al. Opportunities to improve antimicrobial use in paediatric intensive care units: a nationwide survey in Spain. Clin Microbiol Infect 2015 (published online Oct 21)

Schulman J, Dimand RJ, Lee HC, et al. Neonatal intensive care unit antibiotic use. Pediatrics 2015 May;135(5):826-33

Shipp KD, Chiang T, Karasick S, et al. Antibiotic stewardship challenges in a referral neonatal intensive care unit. Am J Perinatol 2015 (published online Dec 18)

Stuart RL, Marshall C, Orr E, et al. Survey of infection control and antimicrobial stewardship practices in Australian residential aged-care facilities. Intern Med J 2015 May;45(5):576-80

Tzialla C, Borghesi A, Pozzi M, et al. Neonatal infections due to multi-resistant strains: epidemiology, current treatment, emerging therapeutic approaches and prevention. Clin Chim Acta 2015 Dec 7;451(Pt A):71-7

van Buul LW, van der Steen JT, Achterberg WP, et al. Effect of tailored antibiotic stewardship programmes on the appropriateness of antibiotic prescribing in nursing homes. J Antimicrob Chemother 2015 Jul;70(7):2153-62

van Buul LW, Veenhuizen RB, Achterberg WP, et al. Antibiotic prescribing in Dutch nursing homes: how appropriate is it? J Am Med Dir Assoc 2015 Mar;16(3):229-37

Wu LD, Walker SA, Elligsen M, et al. Antibiotic use and need for antimicrobial stewardship in long-term care. Can J Hosp Pharm 2015 Nov-Dec;68(6):445-9

Back to top

2014

Abbo LM, Ariza-Heredia EJ. Antimicrobial stewardship in immunocompromised hosts. Infect Dis Clin North Am 2014 Jun;28(2):263-79

Balkhy HH, Zingg W. Update on infection control challenges in special pediatric populations. Curr Opin Infect Dis 2014 Aug;27(4):370-8

Cantey JB, Patel SJ. Antimicrobial stewardship in the NICU. Infect Dis Clin North Am 2014 Jun;28(2):247-61

Fleet E, Gopal Rao G, Patel B, et al. Impact of implementation of a novel antimicrobial stewardship tool on antibiotic use in nursing homes: a prospective cluster randomized control pilot study. J Antimicrob Chemother 2014 Aug;69(8):2265-73

Hum RS, Cato K, Sheehan B, et al. Developing clinical decision support within a commercial electronic health record system to improve antimicrobial prescribing in the neonatal ICU. Appl Clin Inform 2014 Apr 9;5(2):368-87

Klastersky J, Georgala A. Strategies for the empirical management of infection in cancer patients with emphasis on the emergence of resistant gram-negative bacteria. Crit Rev Oncol Hematol 2014 Dec;92(3):268-78

Lim CJ, Kong DC, Stuart RL. Reducing inappropriate antibiotic prescribing in the residential care setting: current perspectives. Clin Interv Aging 2014 Jan 13;9:165-77

Lim CJ, Kwong MW, Stuart RL, et al. Antibiotic prescribing practice in residential aged care facilities — health care providers' perspectives. Med J Aust 2014 Jul 21;201(2):98-102

Lim CJ, Kwong M, Stuart RL, et al. Antimicrobial stewardship in residential aged care facilities: need and readiness assessment. BMC Infect Dis 2014 Jul 23;14:410

Mazer L, Tapper EB, Piatkowski G, et al. The need for antibiotic stewardship and treatment standardization in the care of cirrhotic patients with spontaneous bacterial peritonitis — a retrospective cohort study examining the effect of ceftriaxone dosing. F1000 Res 2014 Feb 14;3:57

Mikulska M, Del Bono V, Viscoli C. Bacterial infections in hematopoietic stem cell transplantation recipients. Curr Opin Hematol 2014 Nov;21(6):451-8

Mortensen E, Trivedi KK, Rosenberg J, et al. Multidrug-resistant Acinetobacter baumannii infection, colonization, and transmission related to a long-term care facility providing subacute care. Infect Control Hosp Epidemiol 2014 Apr;35(4):406-11

Nace DA, Drinka PJ, Crnich CJ. Clinical uncertainties in the approach to long term care residents with possible urinary tract infection. J Am Med Dir Assoc 2014 Feb;15(2):133-9

Nicolle LE. Antimicrobial stewardship in long term care facilities: what is effective? Antimicrob Resist Infect Control 2014 Feb 12;3(1):6

Nicolle LE. Infection prevention issues in long-term care. Curr Opin Infect Dis 2014 Aug;27(4):363-9

Popoola VO, Budd A, Wittig SM, et al. Methicillin-resistant Staphylococcus aureus transmission and infections in a neonatal intensive care unit despite active surveillance cultures and decolonization: challenges for infection prevention. Infect Control Hosp Epidemiol 2014 Apr;35(4):412-8

Rhee SM, Stone ND. Antimicrobial stewardship in long-term care facilities. Infect Dis Clin North Am 2014 Jun;28(2):237-46

Rosa RG, Goldani LZ, dos Santos RP. Association between adherence to an antimicrobial stewardship program and mortality among hospitalised cancer patients with febrile neutropaenia: a prospective cohort study. BMC Infect Dis 2014 May 23;14:286

Sanders J, Pallotta A, Bauer S, et al. Antimicrobial stewardship program to reduce antiretroviral medication errors in hospitalized patients with human immunodeficiency virus infection. Infect Control Hosp Epidemiol 2014 Mar;35(3):272-7

Satlin MJ, Jenkins SG, Walsh TJ. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis 2014 May;58(9):1274-83

Shane AL, Stoll BJ. Neonatal sepsis: progress towards improved outcomes. J Infect 2014 Jan;68(Suppl1):S24-32

Venkatachalam I, Yang HL, Fisher D, et al. Multidrug-resistant gram-negative bloodstream infections among residents of long-term care facilities. Infect Control Hosp Epidemiol 2014 May;35(5):519-26

Waters VJ, Ratjen FA. Is there a role for antimicrobial stewardship in cystic fibrosis? Ann Am Thorac Soc 2014 Sep;11(7):1116-9

Back to top

2013

Boivin Y, et al. Antibiotic prescription in nursing homes for dependent elderly people: a cross-sectional study in Franche-Comte. Med Mal Infect 2013 Apr;43(4):163-9

Chong Y, et al. Antibiotic rotation for febrile neutropenic patients with haematological malignancies: clinical significance of antibiotic heterogeneity. PLoS One 2013;8:e54190

Cookson B, et al. Development and assessment of national performance indicators for infection prevention and control and antimicrobial stewardship in European long-term care facilities. J Hosp Infect 2013 Sep;85(1):45-53

D'Agata EM, et al. Antimicrobial use and stewardship programs among dialysis centers. Semin Dial 2013 Jul-Aug;26(4):457-64

Daneman N, et al. Prolonged antibiotic treatment in long-term care: role of the prescriber. JAMA Intern Med 2013 Apr 22;173(8):673-82

Donlon S, et al. A national survey of infection control and antimicrobial stewardship structures in Irish long-term care facilities. Am J Infect Control 2013 Jun;41(6):554-7

Gomez DS, et al. Individualised vancomycin doses for paediatric burn patients to achieve PK/PD targets. Burns 2013;39:445-50

Lepainteur M, et al. Prevalence of resistance to antiseptics and mupirocin among invasive coagulase- negative staphylococci from very preterm neonates in NICU: the creeping threat? J Hosp Infect 2013 Apr;83(4):333-6

Moro ML, et al. Antimicrobial resistance and stewardship in long-term care settings. Future Microbiol 2013 Aug;8(8):1011-25

Back to top

2012

Chapman AK, et al. Implementation of computerized provider order entry in a neonatal intensive care unit: impact on admission workflow. Int J Med Inform 2012;81:291-5

Jamal JA, et al. Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy, and extracorporeal membrane oxygenation. Curr Opin Crit Care 2012;18:460-71

Jump RL, et al. Effective antimicrobial stewardship in a long-term care facility through an infectious disease consultation service: keeping a LID on antibiotic use. Infect Control Hosp Epidemiol 2012 Dec;33(12):1185-92

Patel SJ, Saiman L. Principles and strategies of antimicrobial stewardship in the neonatal intensive care unit. Semin Perinatol 2012;36:431-6

Rolston KV, et al. Antimicrobial de-escalation in cancer patients. Infection 2012 Apr;40(2):223-4

Silva DC, et al. Vancomycin serum concentrations in pediatric oncologic/hematologic intensive care patients. Braz J Infect Dis 2012;16:361-5.

van Buul LW, et al. Antibiotic use and resistance in long term care facilities. J Am Med Dir Assoc 2012 Jul;13(6):568.e1-13

Back to top

2011

Chiu CH, et al. Effectiveness of a guideline to reduce vancomycin use in the neonatal intensive care unit. Pediatr Infect Dis J 2011;30:273-8

Van Schooneveld T, et al. Survey of antimicrobial stewardship practices in Nebraska long-term care facilities. Infect Control Hosp Epidemiol 2011 Jul;32(7):732-4

Back to top

2010

Milstone AM, et al. Role of decolonization in a comprehensive strategy to reduce methicillin-resistant Staphylococcus aureus infections in the neonatal intensive care unit: an observational cohort study. Infect Control Hosp Epidemiol 2010 May;31(5):558-60

Murki S, et al. Restriction of cephalosporins and control of extended spectrum beta-lactamase producing Gram-negative bacteria in a neonatal intensive care unit. Indian Pediatr 2010;47:785-8

Back to top

Infection Control & Stewardship

Recently Added
2016

2015
2014
2013
2012
2011
2000-2009 

Recently Added

Renaudin L, Llorens M, Goetz C, et al. Impact of discontinuing contact precautions for MRSA and ESBLE in an intensive care unit: a prospective noninferiority before and after study. Infect Control Hosp Epidemiol 2017 (published online Sep 20)

Back to top 

2016

Apisarnthanarak A, Ratz D, Khacharoenporn T, et al. National survey of practices to prevent methicillin-resistant Staphylococcus aureus and multidrug-resistant Acinetobacter baumannii in Thailand. Clin Infect Dis 2017 May;64(suppl 2):S161-S166

Buford VR, Kumar V, Kennedy BR. Relationship of various infection control interventions to the prevalence of multidrug-resistant Pseudomonas aeruginosa among US hospitals. Am J Infect Control 2016 Apr 1;44(4):381-6

Cheon S, Kim MJ, Yun SJ, et al. Controlling endemic multidrug-resistant Acinetobacter baumannii in intensive care units using antimicrobial stewardship and infection control. Korean J Intern Med 2016 Mar;31(2):367-74

Dik JW, Poelman R, Friedrich AW, et al. An integrated stewardship model: antimicrobial, infection prevention and diagnostic (AID). Future Microbiol 2016 Jan;11(1):93-102

Fakih MG, Skierczynski B, Bufalino A, et al. Taking advantage of public reporting: an infection composite score to assist evaluating hospital performance for infection prevention efforts. Am J Infect Control 2016 (published online Sep 16)

Frenette C, Sperlea D, Tesolin J, et al. Influence of a 5-year serial infection control and antibiotic stewardship intervention on cardiac surgical site infections. Am J Infect Control 2016 (published online Apr 25)

Frost SA, Alogso MC, Metcalfe L, et al. Chlorhexidine bathing and health care-associated infections among adult intensive care patients: a systematic review and meta-analysis. Crit Care 2016 (published online Nov 23)

Giannella M, Tedeschi S, Bartoletti M, et al. Prevention of infections in nursing homes: antibiotic prophylaxis versus infection control and antimicrobial stewardship measures. Expert Rev Anti Infect Ther 2016 Feb;14(2):219-30

Goodman KE, Simner PJ, Tamma PD, et al. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE). Expert Rev Anti Infect Ther 2016 Nov;14(1):95-108

Gupta R, Hannon E, Huprikar S, et al. Getting to zero: reduction in the incidence of multidrug-resistant organism infections using an integrated infection control protocol in an intensive care unit. Am J Infect Control 2016 (published online Aug 27)

He JC, Golob JF, Brajcich BC, et al. Benefit of TeamSTEPPS rounding improvement project on infection-related monitoring. Surg Infect (Larchmt) 2016 (published online Aug 11)

Hussein K, Rabino G, Eluk O, et al. The association between infection control interventions and CRE incidence in an endemic hospital. J Hosp Infect 2017 (published online Jul 22)

Jayaraman SP, Jiang Y, Resch S, et al. Cost-effectiveness of a model infection control program for preventing multi-drug-resistant organism infections in critically ill surgical patients. Surg Infect (Larchmt) 2016 (published online Jul 11)

Kawamura H, Matsumoto K, Shigemi A, et al. A bundle that includes active surveillance, contact precaution for carriers, and cefazolin-based antimicrobial prophylaxis prevents methicillin-resistant Staphylococcus aureus infections in clean orthopedic surgery. Am J Infect Control 2016 Feb;44(2)

Kobayashi K, Imagama S, Kato D, et al. Collaboration with an infection control team for patients with infection after spine surgery. Am J Infect Control 2017 Jul 1;45(7):767-70

Leis JA. Advancing infection prevention and antimicrobial stewardship through improvement science. BMJ Qual Saf 2017 (published online Jun 14)

Mellmann A, Bletz S, Boking T, et al. Real-time genome sequencing of resistant bacteria provides precision infection control in an institutional setting. J Clin Microbiol 2016 (published online Aug 24)

Nagel JL, Kaye KS, LaPlante KL, et al. Antimicrobial stewardship for the infection control practitioner. Infect Dis Clin North Am 2016 Sep;30(3):771-84

O’Horo JC, Farrell A, Sohail MR, et al. Carbapenem-resistant Enterobacteriaceae and endoscopy: an evolving threat. Am J Infect Control 2016 (published online May 11)

Renaudin L, Llorens M, Goetz C, et al. Impact of discontinuing contact precautions for MRSA and ESBLE in an intensive care unit: a prospective noninferiority before and after study. Infect Control Hosp Epidemiol 2017 (published online Sep 20)

Schwaber MJ, Carmeli Y. The impact of a carbapenem-resistant Enterobacteriaceae outbreak on facilitating development of a national infrastructure for infection control in Israel. Clin Infect Dis 2017 (published online Jul 19)

Teerawattanapong N, Kengkla K, Dilokthornsakul P, et al. Prevention and control of multidrug-resistant gram-negative bacteria in adult intensive care units: a systematic review and network meta-analysis. Clin Infect Dis 2017 May;64(suppl 2):S51-S60

van Kleef E, Deeny SR, Jit M, et al. The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy. Vaccine 2016 (published online Oct 7)

Back to top

2015

Branch-Elliman W, Stanislawski M, Strymish J, et al. Cardiac electrophysiology laboratories: a potential target for antimicrobial stewardship and quality improvement? Open Forum Infect Dis 2015 Fall;2(Suppl 1):133.78

Bryce E, Grant J, Scharf S, et al. Horizontal infection prevention measures and a risk-managed approach to vancomycin-resistant enterococci: an evaluation. Am J Infect Control 2015 Nov 1;43(11):1238-43

Chen CH, Lin LC, Chang YJ, et al. Infection control programs and antibiotic control programs to limit transmission of multi-drug resistant Acinetobacter baumannii Infections: evolution of old problems and new challenges for institutes. Int J Environ Res Public Health 2015 Jul 30;12(8):8871-82

Chen CH, Lin LC, Chang YJ, et al. Long-term effectiveness of infection and antibiotic control programs on the transmission of carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex in central Taiwan. Med Mal Infect 2015 Jul;45(7):264-72

Gerlich MG, Piegsa J, Schafer C, et al. Improving hospital hygiene to reduce the impact of multidrug-resistant organisms in health care--a prospective controlled multicenter study. BMC Infect Dis 2015 Oct 22;15:441

Goodman KE, Simner PJ, Tamma PD, et al. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE). Expert Rev Anti Infect Ther 2015 (published online Nov 4)

Murni IK, Duke T, Kinney S, et al. Reducing hospital-acquired infections and improving the rational use of antibiotics in a developing country: an effectiveness study. Arch Dis Child 2015 May;100(5):454-9

Viale P, Giannella M, Bartoletti M, et al. Considerations about antimicrobial stewardship in settings with epidemic extended-spectrum beta-lactamase-producing or carbapenem-resistant Enterobacteriaceae. Infect Dis Ther 2015 Sep;4(Suppl 1):65-83

Whitelaw AC. Role of infection control in combating antibiotic resistance. S Afr Med J 2015 Apr 10;105(5):421

Back to top

2014

Chandy SJ, Michael JS, Veeraraghavan B, et al. ICMR programme on antibiotic stewardship, prevention of infection & ontrol (ASPIC). Indian J Med Res 2014 Feb;139(2):226-30

Cheng VC, Tai JW, Chen JH, et al. Proactive infection control measures to prevent nosocomial transmission of vancomycin-resistant enterococci in Hong Kong. J Formos Med Assoc 2014 Oct;113(10):734-41

Di Pentima MC, Chan S, Briody C, et al. Driving forces of vancomycin-resistant E. faecium and E. faecalis blood-stream infections in children. Antimicrob Resist Infect Control 2014 Sep 1;3:29

Gagliotti C, Cappelli V, Carretto E, et al. Control of carbapenemase-producing Klebsiella pneumoniae: a region-wide intervention. Euro Surveill 2014 Oct 30;19:43

Kim NH, Han WD, Song KH, et al. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance. Am J Infect Control 2014 Dec;42(12):1270-3

Landelle C, Marimuthu K, Harbarth S. Infection control measures to decrease the burden of antimicrobial resistance in the critical care setting. Curr Opin Crit Care 2014 Oct;20(5):499-506

Luna CM, Rodriguez Noriega E, Bavestrello L, et al. Gram-negative infections in adult intensive care units of Latin America and the Caribbean. Crit Care Res Pract 2014;2014:480463

Osman MF, Askari R. Infection control in the intensive care unit. Surg Clin North Am 2014 Dec;94(6):1175-94

Ruhnke M, Arnold R, Gastmeier P. Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria. Lancet Oncol 2014 Dec;15(13):606-19

Savard P, Perl TM. Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose. Clin Microbiol Infect 2014 Sep;20(9):854-61

Zoutman DE, Ford BD, Sopha K. Working relationships of infection prevention and control programs and environmental services and associations with antibiotic-resistant organisms in Canadian acute care hospitals. Am J Infect Control 2014 Apr;42(4):349-52

Back to top

2013

Donlon S, et al. A national survey of infection control and antimicrobial stewardship structures in Irish long-term care facilities. Am J Infect Control 2013 Jun;41(6):554-7

Kim YC, et al. Trend of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in an institution with a high rate of MRSA after the reinforcement of antibiotic stewardship and hand hygiene. Am J Infect Control 2013 May;41(5):e39-43

Back to top

2012

Moehring RW, Anderson DJ. Antimicrobial stewardship as part of the infection prevention effort. Curr Infect Dis Rep 2012;14:592-600

Moody J, et al. Antimicrobial stewardship: a collaborative partnership between infection preventionists and healthcare epidemiologist. Infect Control Hosp Epidemiol 2012 Apr;33(4):322-7

Back to top

2011

Dortch MJ, et al. Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant Gram-negative healthcare- associated infections. Surg Infect (Larchmt) 2011;12:15-25

Wilkinson K, et al. Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions. Am J Infect Control 2011;39:177-82

Back to top

2000-2009

Conterno LO, Shymanski J, Ramotar K, et al. Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum beta-lactamase-producing organisms in a non-outbreak setting. J Hosp Infect 2007 Apr;65(4):354-60

Ofner-Agostini M, Varia M, Johnston L, et al. Infection control and antimicrobial restriction practices for antimicrobial-resistant organisms in Canadian tertiary care hospitals. Am J Infect Control 2007 Nov;35(9):563-8

Back to top

Clostridium difficile

Recently Added
2017
2016

2015
2014
2013
2012
2011
2010
2000-2009 

Recently Added

Bedford L, Aliyu SH, Brown NM, et al. Multidisciplinary review is an effective tool in reducing Clostridium difficile infection in hospitals. J Hosp Infect 2017 (published online Sep 27)

Cataldo MA, Granata G, Petrosillo N. Clostridium difficile infection: new approaches to prevention, non-antimicrobial treatment, and stewardship. Expert Rev Anti Infect Ther 2017 (published online Oct 5)

DiDiodato G, McArthur L. Interhospital patient transfers between Ontario's academic and large community hospitals increase the risk of Clostridium difficile infection. Am J Infect Control 2017 (published online Sep 25)

Luo R, Barlam T. A 10-year review of Clostridium difficile infection in acute care hospitals in the United States: a nationwide analysis 2005-2014. J Hosp Infect 2017 (published online Oct 7)

Parthasarathy M, Bowers D, Groot-Wassink T. Do pre-operative oral antibiotics increase Clostridium difficile infection rates? An analysis of 13 959 colectomy patients. Colorectal Dis 2017 (published online Oct 16)

Spigaglia P, Barbanti F, Castagnola E, et al. Clostridium difficile causing pediatric infections: new findings from a hospital-based study in Italy. Anaerobe 2017 (published online Oct 21)

Xiao M, Cheng JW, Kudinha T, et al. National antimicrobial stewardship and fluoroquinolone-resistant Clostridium difficile in China. Infect Drug Resist 2017 (published online Oct 13)

Back to top 

2017

Adams DJ, Eberly MD, Rajnik M, et al. Risk factors for community-associated Clostridium difficile infection in children. J Pediatr 2017 (published online Apr 7)

Alonso CD, Braun DA, Patel I, et al. A multicenter, retrospective, case-cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipients. Transpl Infect Dis 2017 (published online May 24)

Anderson PA, Bernatz J, Safdar N. Clostridium difficile infection: an orthopaedic surgeon's guide to epidemiology, management, and prevention. J Am Acad Orthop Surg 2017 Mar;25(3):214-23

Balch A, Wendelboe AM, Vesely SK, et al. Antibiotic prophylaxis for surgical site infections as a risk factor for infection with Clostridium difficile. PLoS One 2017 (published online Jun 16)

Barker AK, Ngam C, Musuuza JS, et al. Reducing Clostridium difficile in the inpatient setting: a systematic review of the adherence to and effectiveness of C. difficile prevention bundles. Infect Control Hosp Epidemiol 2017 (published online Mar 27)

Barkin JA, Sussman DA, Fifadara N, et al. Clostridium difficile infection and patient-specific antimicrobial resistance testing reveals a high metronidazole resistance rate. Dig Dis Sci 2017 (published online Jan 23)

Barlow G, Patterson J, Stultz J, et al. Associations between antimicrobial stewardship program elements and Clostridium difficile infection performance. Am J Infect Control 2017 (published online Jul 28)

Bartlett JG. Bezlotoxumab—a new agent for Clostridium difficile infection. N Engl J Med 2017 (published online Jan 26)

Bartlett JG. Clostridium difficile infection. Infect Dis Clin North Am 2017 Sep;31(3):489-95

Basch CH, Hillyer GC, Garcia P, et al. Clostridium difficile on YouTube: a need for greater focus on prevention. J Infect Public Health 2017 (published online Aug 26)

Baur D, Gladstone BP, Burkert F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis 2017 (published online Jun 16)

Bedford L, Aliyu SH, Brown NM, et al. Multidisciplinary review is an effective tool in reducing Clostridium difficile infection in hospitals. J Hosp Infect 2017 (published online Sep 27)

Bernatz JT, Safdar N, Hetzel S, et al. Antibiotic overuse is a major risk factor for Clostridium difficile infection in surgical patients. Infect Control Hosp Epidemiol 2017 (published online Jul 31)

Bhogal R, Pillay D. Identifying antibiotics associated with Clostridium difficile infection. Clin Pharm 2017 (published online Apr 28)

Brown KA, Daneman N, Jones M, et al. The drivers of acute and long-term care C. difficile infection rates: a retrospective multilevel cohort study of 251 facilities. Clin Infect Dis 2017 (published online Jun 8)

Burnett E, Corlett J. Understanding risk perceptions and responses of the public and health care professionals toward Clostridium difficile: a qualitative interpretive description study. Am J Infect Control 2017 Feb 1;45(2):133-8

Burton HE, Mitchell SA, Watt M. A systematic literature review of economic evaluations of antibiotic treatments for Clostridium difficile infection. Pharmacoeconomics 2017 (published online Sep 5)

Caroff DA, Yokoe DS, Klompas M. Evolving insights into the epidemiology and control of Clostridium difficile in hospitals. Clin Infect Dis 2017 (published online May 17)

Cataldo MA, Granata G, Petrosillo N. Clostridium difficile infection: new approaches to prevention, non-antimicrobial treatment, and stewardship. Expert Rev Anti Infect Ther 2017 (published online Oct 5)

Ciorba MA. Reducing fluoroquinolone usage is a key step in controlling the burden of Clostridium difficile infection. Gastroenterology 2017 (published online Jun 28)

Collins DA, Selvey LA, Celenza A, et al. Community-associated Clostridium difficile infection in emergency department patients in western Australia. Anaerobe 2017 (published online Aug 11)

DiDiodato G, McArthur L. Interhospital patient transfers between Ontario's academic and large community hospitals increase the risk of Clostridium difficile infection. Am J Infect Control 2017 (published online Sep 25)

Dingle KE, Didelot X, Quan TP, et al. Effects of control interventions on Clostridium difficile infection in England: an observational study. Lancet Infect Dis 2017 (published online Jan 24)

Endres B, Basseres E, Rashid T, et al. A protocol to characterize the morphological changes of Clostridium difficile in response to antibiotic treatment. J Vis Exp 2017 (published online May 25)

Eze P, Balsells E, Kyaw MH, et al. Risk factors for Clostridium difficile infections—an overview of the evidence base and challenges in data synthesis. J Glob Health 2017 (published online Jun 4)

Farber J, Illiger S, Berger F, et al. Management of a cluster of Clostridium difficile infections among patients with osteoarticular infections. Antimicrob Resist Infect Control 2017 (published online Feb 15)

Gomez S, Chaves F, Orellana MA. Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection. Anaerobe 2017 (published online Aug 19)

Gross AE, Johannes RS, Gupta V, et al. The effect of a piperacillin/tazobactam shortage on antimicrobial prescribing and Clostridium difficile risk in 88 U.S. medical centers. Clin Infect Dis 2017 (published online Apr 24)

Harnvoravongchai P, Pipatthana M, Chankhamhaengdecha S, et al. Insights into drug resistance mechanisms in Clostridium difficile. Essays Biochem 2017 Mar 3;61(1):81-9

Kennedy C, Waldron C, Skally M, et al. The epidemiology of Clostridium difficile infection in a national kidney transplant centre. Clin Transplant 2017 (published online Mar 15)

Khanafer N, Vanhems P, Barbut F, et al. Factors associated with Clostridium difficile infection: a nested case-control study in a three year prospective cohort. Anaerobe 2017 (published online Mar 6)

Koseck K, Steinberg A, Caliendo G, et al. Comparison of the rates of Clostridium difficile and bacteremia after delaying fluoroquinolone prophylaxis from day 0 to day +3 post autologous stem cell transplantation. Transpl Infect Dis 2017 (published online Apr 29)

Krishna A, Pervaiz A, Lephart P, et al. Prevalence of Clostridium difficile infection in acute care hospitals, long-term care facilities, and outpatient clinics: is Clostridium difficile infection underdiagnosed in long-term care facility patients? Am J Infect Control 2017 (published online Jun 8)

Kwon SS, Gim JL, Kim MS, et al. Clinical and molecular characteristics of community-acquired Clostridium difficile infections in comparison with those of hospital-acquired C. difficile. Anaerobe 2017 (published online Jun 24)

Li C, Duan J, Liu S, et al. Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a university hospital in central China. Infection 2017 (published online May 11)

Luo R, Barlam T. A 10-year review of Clostridium difficile infection in acute care hospitals in the United States: a nationwide analysis 2005-2014. J Hosp Infect 2017 (published online Oct 7)

Ma GK, Brensinger CM, Wu Q, et al. Increasing incidence of multiply recurrent Clostridium difficile infection in the United States: a cohort study. Ann Intern Med 2017 (published online Jul 4)

Marshall LL, Peasah S, Stevens GA. Clostridium difficile infection in older adults: systematic review of efforts to reduce occurrence and improve outcomes. Consult Pharm 2017 Jan;32(1):24-41

Nanayakkara D, Nanda N. Clostridium difficile infection in solid organ transplant recipients. Curr Opin Organ Transplant 2017 (published online May 24)

Nicholson MR, Freswick PN, Di Pentima MC, et al. The use of a computerized provider order entry alert to decrease rates of Clostridium difficile testing in young pediatric patients. Infect Control Hosp Epidemiol 2017 (published online Feb 21)

Njoku JC, Van Schooneveld TC, Rupp ME, et al. Lack of benefit with combination therapy for Clostridium difficile infection. Infect Control Hosp Epidemiol 2017 (published online Feb 6)

Parthasarathy M, Bowers D, Groot-Wassink T. Do pre-operative oral antibiotics increase Clostridium difficile infection rates? An analysis of 13 959 colectomy patients. Colorectal Dis 2017 (published online Oct 16)

Patel I, Wungjiranirun M, Theethira T, et al. Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality. J Antimicrob Chemother 2017 Feb;72(2):574-81

Putsathit P, Maneerattanaporn M, Piewngam P, et al. Antimicrobial susceptibility of Clostridium difficile isolated in Thailand. Antimicrob Resist Infect Control 2017 (published online Jun 8)

Salazar CL, Reyes C, Atehortua S, et al. Molecular, microbiological and clinical characterization of Clostridium difficile isolates from tertiary care hospitals in Colombia. PLoS One 2017 (published online Sep 13)

Scappaticci GB, Perissinotti AJ, Nagel JL, et al. Risk factors and impact of Clostridium difficile recurrence on haematology patients. J Antimicrob Chemother 2017 (published online Feb 10)

Seidelman J, Dicks KV, Durkin MJ, et al. Using clinical scenarios to understand preventability of Clostridium difficile infections by inpatient antibiotic stewardship programs. Infect Control Hosp Epidemiol 2017 (published online Mar 13)

Shapiro DS, Friedmann R, Husseini A, et al. Can procalcitonin contribute to the diagnosis of Clostridium difficile colitis? Isr Med Assoc J 2017 May;19(5):313-6

Siehnel JT, Lavigne JE, Rightmier EA, et al. A retrospective study of patient factors that indicate provider nonadherence to an institutional Clostridium difficile treatment guideline. J Pharm Pract 2017 (published online Jan 1)

Sirbu BD, Soriano MM, Manzo C, et al. Vancomycin taper and pulsed regimen with careful follow up for patients with recurrent Clostridium difficile infection. Clin Infect Dis 2017 (published online Jun 7)

Skoutelis A, Pefanis A, Tsiodras S, et al. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: the C. DEFINE study. PLoS One 2017 (published online Aug 16)

Smith EZ, Northup PG, Argo CK. Predictors of mortality in cirrhosis inpatients with Clostridium difficile infection. J Clin Gastroenterol 2017 (published online Jun 21)

Spigaglia P, Barbanti F, Castagnola E, et al. Clostridium difficile causing pediatric infections: new findings from a hospital-based study in Italy. Anaerobe 2017 (published online Oct 21)

Stevens VW, Nelson RE, Schwab-Daugherty EM, et al. Comparative effectiveness of vancomycin and metronidazole for the prevention of recurrence and death in patients with Clostridium difficile infection. JAMA Intern Med 2017 (published online Feb 6)

Suljagic V, Miljkovic I, Starcevic S, et al. Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case–control study. Antimicrob Resist Infect Control 2017 (published online Mar 27)

Tariq R, Cho J, Kapoor S, et al. Low risk of primary Clostridium difficile infection with tetracyclines: a systematic review and meta-analysis. Clin Infect Dis 2017 (published online Sep 18)

Wong S, Santullo P, O’Driscoll J, et al. Use of antibiotic and prevalence of antibiotic-associated diarrhoea in-patients with spinal cord injuries: a UK national spinal injury centre experience. Spinal Cord 2017 (published online Jan 31)

Xiao M, Cheng JW, Kudinha T, et al. National antimicrobial stewardship and fluoroquinolone-resistant Clostridium difficile in China. Infect Drug Resist 2017 (published online Oct 13)

Xu Q, Chen Y, Gu S, et al. Hospital-acquired Clostridium difficile infection in mainland China: a seven-year (2009-2016) retrospective study in a large university hospital. Sci Rep 2017 (published online Aug 29)

Back to top 

2016

Aldrete SD, Kraft CS, Magee MJ, et al. Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period. Transpl Infect Dis 2016 (published online Dec 10)

Argamany JR, Delgado A, Reveles KR. Clostridium difficile infection health disparities by race among hospitalized adults in the United States, 2001 to 2010. BMC Infect Dis 2016 (published online Aug 27)

Awali RA, Kandipalli D, Pervaiz A, et al. Risk factors associated with interfacility transfers among patients with Clostridium difficile infection. Am J Infect Control 2016 (published online May 17)

Balsells E, Filipescu T, Kyaw MH, et al. Infection prevention and control of Clostridium difficile: a global review of guidelines, strategies, and recommendations. J Glob Health 2016 Dec;6(2)

Batzing-Feigenbaum J, Schulz M, Schulz M, et al. Outpatient antibiotic prescription: a population-based study on regional age-related use of cephalosporins and fluoroquinolones in Germany. Dtsch Arztebl Int 2016 Jul 1;113(26):454-9

Bintz J, Lenhart S, Lanzas C. Antimicrobial stewardship and environmental decontamination for the control of Clostridium difficile transmission in healthcare settings. Bull Math Biol 2016 (published online Nov 8)

Bloomfield LE, Riley TV. Epidemiology and risk factors for community-associated Clostridium difficile infection: a narrative review. Infect Dis Ther 2016 (published online Jul 1)

Bond SE, Boutlis CS, Yeo WW, et al. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting. J Hosp Infect 2016 (published online Dec 18)

Bouza E, Alcala L, Reigadas E. Optimizing the diagnostic testing of Clostridium difficile infection. Expert Rev Anti Infect Ther 2016 (published online Jul 27)

Brown KA, Jones M, Daneman N, et al. Importation, antibiotics, and Clostridium difficile infection in veteran long-term care: a multilevel case-control study. Ann Intern Med 2016 Jun 21;164(12):787-94

Brumley PE, Malani AN, Kabara JJ, et al. Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection. J Antimicrob Chemother 2016 Mar;71(3):836-40

Bui C, Zhu E, Donnelley MA, et al. Antimicrobial stewardship programs that target only high-cost, broad-spectrum antimicrobials miss opportunities to reduce Clostridium difficile infections. Am J Infect Control 2016 Dec 1;44(12):1684-6

Carignan A, Poulin S, Martin P, et al. Efficacy of secondary prophylaxis with vancomycin for preventing recurrent Clostridium difficile infections. Am J Gastroenterol 2016 (published online Sep 13)

Cassir N, Delaroziere JC, Dubourg G, et al. A regional outbreak of Clostridium difficile PCR-ribotype 027 infections in southeastern France from a single long-term care facility. Infect Control Hosp Epidemiol 2016 (published online Aug 3)

Chalmers JD, Akram AR, Singanayagam A, et al. Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia. J Infect 2016 (published online Apr 19)

Chang GY, Dembry LM, Banach DB. Epidemiology of Clostridium difficile infection in hospitalized oncology patients. Am J Infect Control 2016 Nov 1;44(11):1408-10

Chauv S, Fontaine GV, Hoang QP, et al. Risk of resistant organisms and Clostridium difficile with prolonged systemic antibiotic prophylaxis for central nervous system devices. Neurocrit Care 2016 (published online Feb 26)

Cheng MP, Parkes LO, Lee TC. Efficacy of oral vancomycin in preventing recurrent Clostridium difficile infection in patients treated with systemic antimicrobial agents. Clin Infect Dis 2016 (published online Aug 27)

Chopra T, Awali RA, Biedron C, et al. Predictors of Clostridium difficile infection-related mortality among older adults. Am J Infect Control 2016 (published online Jul 13)

Chopra T, Goldstein EJ, Gorbach SL. Rethinking strategies to select antibiotic therapy in CDI. Pharmacotherapy 2016 (published online Nov 9)

Cioni G, Viale P, Frasson S, et al. Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE study. BMC Infect Dis 2016 Nov 8;16(1):656

Cooper CC, Jump RL, Chopra T. Prevention of infection due to Clostridium difficile. Infect Dis Clin North Am 2016 (published online Sep 19)

Cozar-Llisto A, Ramos-Martinez A, Cobo J. Clostridium difficile infection in special high-risk populations. Infect Dis Ther 2016 (published online Aug 11)

Croft L, Ladd J, Doll M, et al. Inappropriate antibiotic use and gastric acid suppression preceding Clostridium difficile infection. (Letter) Infect Control Hosp Epidemiol 2016 Apr;37(4):494-5

Culligan EP, Sleator RD. Advances in the microbiome: applications to Clostridium difficile infection. J Clin Med 2016 Sep 21;5(9)

Dang UT, Zamora I, Hevener KE, et al. Rifamycin resistance in Clostridium difficile is generally associated with a low fitness burden. Antimicrob Agents Chemother 2016 (published online Jul 5)

Davies K, Davis G, Barbut F, et al. Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID). Eur J Clin Microbiol Infect Dis 2016 (published online Sep 2)

Davis BM, Yin J, Blomberg D, et al. Impact of a prevention bundle on Clostridium difficile infection rates in a hospital in the southeastern United States. Am J Infect Control 2016 (published online Aug 7)

Evans ME, Kralovic SM, Simbartl LA, et al. Effect of a Clostridium difficile infection prevention initiative in Veterans Affairs acute care facilities. Infect Control Hosp Epidemiol 2016 Jun;37(6):720-2

Faden HS, Ma CX. Trends in oral antibiotic, proton pump inhibitor, and histamine 2 receptor blocker prescription patterns for children compared with adults: implications for Clostridium difficile infection in the community. Clin Pediatr (Phila) 2016 Jul;55(8):712-6

Falcone M, Venditti M, Sanguinetti M, et al. Management of candidemia in patients with Clostridium difficile infection. Expert Rev Anti Infect Ther 2016 Jul;14(7):679-85

Feher C, Mensa J. A comparison of current guidelines of five international societies on Clostridium difficile infection management. Infect Dis Ther 2016 (published online Jul 28)

Forster AJ, Daneman N, van Walraven C. Influence of antibiotics and case exposure on hospital-acquired Clostridium difficile infection independent of illness severity. J Hosp Infect 2016 (published online Oct 14)

Freedberg DE, Salmasian H, Cohen B, et al. Receipt of antibiotics in hospitalized patients and risk for Clostridium difficile infection in subsequent patients who occupy the same bed. JAMA Intern Med 2016 (published online Oct 10)

Fuereder T, Koni D, Gleiss A, et al. Risk factors for Clostridium difficile infection in hemato-oncological patients: a case control study in 144 patients. Sci Rep 2016 Aug 11;6:31498

Furuya-Kanamori L, Clements AC, Foster NF, et al. Asymptomatic Clostridium difficile colonisation in two Australian tertiary hospitals, 2012-2014: a prospective, repeated cross-sectional study. Clin Microbiol Infect 2016 (published online Sep 8)

Graber CJ. Clostridium difficile infection: stewardship's lowest hanging fruit? Lancet Infect Dis 2016 (published online Nov 4)

Grigoras CA, Zervou FN, Zacharioudakis IM, et al. Isolation of C. difficile carriers alone and as part of a bundle approach for the prevention of Clostridium difficile infection (CDI): a mathematical model based on clinical study data. PLoS One 2016 Jun 3;11(6):e0156577

Guerreiro I, Achonu C, Volkening G, et al. Using expert process to combat Clostridium difficile infections. Am J Infect Control 2016 (published online Jul 19)

Hammond DA, Hughes CA, Painter JT, et al. Impact of targeted educational interventions on Clostridium difficile infection treatment in critically ill adults. Hosp Pharm 2016 Dec;51(11):901-6

Haran JP, Wu G, Bucci V, et al. Antibiotic-associated diarrhoea in emergency department observation unit patients. Epidemiol Infect 2016 Jul;144(10):2176-83

Hebbard AI, Slavin MA, Reed C, et al. The epidemiology of Clostridium difficile infection in patients with cancer. Expert Rev Anti Infect Ther 2016 (published online Sep 8)

Hecker MT, Ho E, Donskey CJ. Fear of failure: engaging patients in antimicrobial stewardship after fecal transplantation for recurrent Clostridium difficile infection. Infect Control Hosp Epidemiol 2016 (published online Oct 21)

Huebner NO, Dittman K, Henck V, et al. Epidemiology of multidrug resistant bacterial organisms and Clostridium difficile in German hospitals in 2014: results from a nationwide one-day point prevalence of 329 German hospitals. BMC Infect Dis 2016 (published online Sep 2)

Hunter JC, Mu Y, Dumyati GK, et al. Burden of nursing home-onset Clostridium difficile infection in the United States: estimates of incidence and patient outcomes. Open Forum Infect Dis 2016 Jan 18;3(1):ofv196

Jacob J, Wu J, Han J, et al. Clostridium difficile in an urban, university-affiliated long-term acute-care hospital. Infect Control Hosp Epidemiol 2016 (published online Dec 7)

Jamal WY, Rotimi VO. Surveillance of antibiotic resistance among hospital- and community-acquired toxigenic Clostridium difficile isolates over 5-year period in Kuwait. PLoS One 2016 Aug 18;11(8)

Jasiak NM, Alaniz C, Rao K, et al. Recurrent Clostridium difficile infection in intensive care unit patients. Am J Infect Control 2016 Jan 1;44(1):36-40

Jin D, Luo Y, Huang C, et al. Molecular epidemiology of Clostridium difficile infection in hospitalized patients in eastern China. J Clin Microbiol 2016 (published online Dec 14)

Kandel CE, Gill S, McCready J, et al. Reducing co-administration of proton pump inhibitors and antibiotics using a computerized order entry alert and prospective audit and feedback. BMC Infect Dis 2016 (published online Jul 22)

Karaaslan A, Soysal A, Yukut N, et al. Hospital acquired Clostridium difficile infection in pediatric wards: a retrospective case-control study. Springerplus 2016 Aug 11;5(1):1329

Kavanagh K, Pan J, Marwick C, et al. Cumulative and temporal associations between antimicrobial prescribing and community-associated Clostridium difficile infection: population-based case–control study using administrative data. J Antimicrob Chemother 2016 (published online Dec 20)

Keeley AJ, Beeching NJ, Stott KE, et al. Clostridium difficile: a healthcare-associated infection of unknown significance in adults in sub-Saharan Africa. Malawi Med J 2016 Jun;28(2):66-9

Kelly SG, Yarrington M, Zembower TR, et al. Inappropriate Clostridium difficile testing and consequent overtreatment and inaccurate publicly reported metrics. Infect Control Hosp Epidemiol 2016 (published online Sep 26)

Khanafer N, Oltra L, Hulin M, et al. Clostridium difficile infection in a French university hospital: eight years of prospective surveillance study. Medicine (Baltimore) 2016 Jun;95(23):e3874

Kociolek LK, Gerding DN, Osmolski JR, et al. Differences in the molecular epidemiology and antibiotic susceptibility of Clostridium difficile isolates in pediatric and adult patients. Antimicrob Agents Chemother 2016 Aug;60(8):4896-90

Kotila SM, Mentula S, Ollgren J, et al. Community- and healthcare-associated Clostridium difficile infections, Finland, 2008-2013. Emerg Infect Dis 2016 Oct;22(10):1747-53

Kuntz JL, Smith DH, Petrik AF, et al. Predicting the risk of Clostridium difficile infection upon admission: A score to identify patients for antimicrobial stewardship efforts. Perm J 2016 Winter;20(1):20-5

Lawes T, Lopez-Lozano JM, Nebot CA, et al. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis. Lancet Infect Dis 2016 (published online Nov 4)

Leal JR, Heitman SJ, Conly JM, et al. Cost-effectiveness analysis of the use of probiotics for the prevention of Clostridium difficile-associated diarrhea in a provincial healthcare system. Infect control Hosp Epidemiol 2016 (published online Jul 5)

Lefevre-Tantet-Etchebarne D, Sivadon-Tardy V, Davido B, et al. Community-acquired Clostridium difficile infections in emergency departments. Med Mal Infect 2016 (published online Jul 1)

Leibovici-Weissman Y, Atamna A, Schlesinger A, et al. Risk factors for short- and long-term mortality in very old patients with Clostridium difficile infection: a retrospective study. Geriatr Gerontol Int 2016 (published online Sep 20)

Lewis PO, Litchfield JM, Tharp JL, et al. Risk and severity of hospital-acquired Clostridium difficile infection in patients taking pump inhibitors. Pharmacotherapy 2016 (published online Jul 25)

Lubbert C, Zimmermann L, Borchert J, et al. Epidemiology and recurrence rates of Clostridium difficile infections in Germany: a secondary data analysis. Infect Dis Ther 2016 (published online Oct 21)

Lytvyn L, Mertz D, Sadeghirad B, et al. Prevention of Clostridium difficile infection: a systematic survey of clinical practice guidelines. Infect Control Hosp Epidemiol 2016 (published online Jun 7)

Marra AR, Edmond MB, Ford BA, et al. Failure of risk-adjustment by test method for C. difficile laboratory-identified event reporting. Infect Control Hosp Epidemiol 2016 (published online Oct 17)

McKinley L, Becerra B, Moriarty H, et al. Vancomycin-resistant Enterococcus co-colonization rates with methicillin-resistant Staphylococcus aureus and Clostridium difficile in critically ill veterans. Am J Infect Control 2016 (published online Apr 7)

Nanwa N, Kwong JC, Krahn M, et al. The economic burden of hospital acquired Clostridium difficile infection: a population-based matched cohort study. Infect Control Hosp Epidemiol 2016 (published online Jun 20)

Olsen MA, Young-Xu Y, Stwalley D, et al. The burden of Clostridium difficile infection: estimates of the incidence of CDI from US administrative databases. BMC Infect Dis 2016 Apr 22;16:177

Pant C, Deshpande A, Gilroy R, et al. Rising incidence of Clostridium difficile related discharges among hospitalized children in the United States. Infect Control Hosp Epidemiol 2016 Jan;37(1):104-6

Patterson JA, Edmond MB, Hohmann SF, et al. Association between high-risk medication usage and healthcare facility-onset C. difficile infection. Infect Control Hosp Epidemiol 2016 (published online Apr 21)

Peretz A, Ben Shlomo I, Nitzan O, et al. Clostridium difficile infection: associations with chemotherapy, radiation therapy, and targeting therapy treatments. Curr Med Chemo 2016 (published online Oct 28)

Press A, Ku B, McCullagh L, et al. Developing a clinical prediction rule for first hospital-onset Clostridium difficile infections: a retrospective observational study. Infect Control Hosp Epidemiol 2016 Aug;37(8):896-900

Radcliff TA, Lorden AL, Zhao H. Clostridium difficile infection in Texas hospitals, 2007-2011. Infect Control Hosp Epidemiol 2016 Mar;37(3):357-9

Reeves JS, Evans ME, Simbartl LA, et al. Clostridium difficile infections in Veterans Health Administration long-term care facilities. Infect Control Hosp Epidemiol 2016 Mar;37(3):295-300

Schwab EM, Wilkes J, Korgenski K, et al. Risk factors for recurrent Clostridium difficile infection in pediatric inpatients. Hosp Pediatr 2016 Jun;6(6):339-44

Shah DN, Aitken SL, Barragan LF, et al. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study. J Hosp Infect 2016 Jul;93(3):286-9

Shah DN, Chan FS, Kachru N, et al. A multi-center study of fidaxomicin use for Clostridium difficile infection. Springerplus 2016 Aug 2;5(1):1224

Sheitoyan-Pesant C, Abou Chakra CN, Pepin J, et al. Clinical and healthcare burden of multiple recurrences of Clostridium difficile infection. Clin Infect Dis 2016 Mar 1;62(5):574-80

Shorr AF, Zilberberg MD, Wang L, et al. Mortality and costs in Clostridium difficile infection among the elderly in the United States. Infect Control Hosp Epidemiol 2016 (published online Aug 30)

Spigaglia P. Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection. Ther Adv Infect Dis 2016 Feb;3(1):23-42

Starn ES, Hampe H, Cline T. The cost-efficiency and care effectiveness of probiotic administration with antibiotics to prevent hospital-acquired Clostridium difficile infection. Qual Manag Health Care 2016 Oct/Dec;25(4):238-43

Stevenson EC, Major GA, Spiller RC, et al. Co-infection and emergence of rifamycin resistance during a recurrent Clostridium difficile infection. J Clin Microbiol 2016 (published online Aug 24)

Stites SD, Cooblall CA, Aronovitz J, et al. The tipping point: patients predisposed to Clostridium difficile infection and a hospital antimicrobial stewardship programme. J Hosp Infect 2016 (published online Aug 24)

Tang C, Cui L, Xu Y, et al. The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis. Sci Rep 2016 (published online Nov 29)

Tariq R, Kahnna S. Clostridium difficile infection: updates in management. Indian J Gastroenterol 2016 (published online Dec 20)

van Beurden YH, Dekkers OM, Bomers MK, et al. An outbreak of Clostridium difficile ribotype 027 associated with length of stay in the intensive care unit and use of selective decontamination of the digestive tract: a case control study. PLoS One 2016 Aug 17;11(8)

van Kleef E, Deeny SR, Jit M, et al. The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy. Vaccine 2016 (published online Oct 7)

Vardakas KZ, Trigkidis KK, Boukouvala E, et al. Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis. Int J Antimicrob Agents 2016 Jul;48(1):1-10

Vella V, Aylin PP, Moore L, et al. Bed utilisation and increased risk of Clostridium difficile infections in acute hospitals in England in 2013/2014. BMJ Qual Saf 2016 (published online Sep 6)

Vickers RJ, Tillotson G, Goldstein EJC, et al. Ridinilazole: a novel therapy for Clostridium difficile infection. Int J Antimicrob Agents 2016 Aug;48(2):137-43

Welch HK, Nagel JL, Patel TS, et al. Effect of an antimicrobial stewardship intervention on outcomes for patients with Clostridium difficile infection. Am J Infect Control 2016 (published online Aug 31)

Whiddon AR, Dawson KL, Fuentes A, et al. Postoperative antimicrobials after lung transplantation and the development of multidrug-resistant bacterial and Clostridium difficile infections: an analysis of 500 non-cystic fibrosis lung transplant patients. Clin Transplant 2016 Jul;30(7):767-73

White H, Wiselka M, Bell D. A multi-faceted approach of one teaching hospital NHS trust during the Clostridium difficile epidemic-antibiotic management and beyond. Antibiotics (Basel) 2016 Feb 26;5(1):13

Wilcox MH, Chalmers JD, Nord CE, et al. Role of cephalosporins in the era of Clostridium difficile infection. J Antimicrob Chemother 2016 (published online Sep 22)

Yu H, Baser O, Wang L. Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study. BMC Geriatr 2016 (published online Nov 25)

Zhang S, Palazuelos-Munoz S, Balsells EM, et al. Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study. BMC Infect Dis 2016 Aug 25;16(1):447

Zycinska K, Chmielewska M, Lenartowicz B, et al. Antibiotic treatment of hospitalized patients with pneumonia complicated by Clostridium difficile infection. Adv Exp Med Biol 2016 (published online Sep 13)

Back to top

2015

Abdelsattar ZM, Krapohl G, Alrahmani L, et al. Post-operative burden of hospital-acquired Clostridium difficile infection. Infect Control Hosp Epidemiol 2015 Jan;36(1):40-6

Aguado JM, Anttila VJ, Galperine T, et al. Highlighting clinical needs in Clostridium difficile infection: the views of European healthcare professionals at the front line. J Hosp Infect 2015 Jun;90(2):117-25

Brown K, Valenta K, Fisman D, et al. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Intern Med 2015 Apr;175(4):626-33

Bouza E, Rodriguez-Creixems M, Alcala L, et al. Is Clostridium difficile infection an increasingly common severe disease in adult intensive care units? A 10-year experience. J Crit Care 2015 Jun;30(3):543-9

Buckel WR, Avdic E, Carroll KC, et al. Gut check: Clostridium difficile testing and treatment in the molecular testing era. Infect Control Hosp Epidemiol 2015 Feb;36(2):217-21

Chopra T, Neelakanta A, Dombecki C, et al. Burden of Clostridium difficile infection on hospital readmissions and its potential impact under the Hospital Readmission Reduction Program. Am J Infect Control 2015 Apr 1;43(4):314-7

Chopra T, Goldstein EJ. Clostridium difficile infection in long-term care facilities: a call to action for antimicrobial stewardship. Clin Infect Dis 2015 May 15;60(Suppl 2):S72-6

Crowther GS, Wilcox MH. Antibiotic therapy and Clostridium difficile infection — primum non nocere — first do no harm. Infect Drug Resist 2015 Sep 15;8:333-7

Daneman N, Guttmann A, Wang X, et al. The association of hospital prevention processes and patient risk factors with the risk of Clostridium difficile infection: a population-based cohort study. BMJ Qual Saf 2015 Jul;24(7):435-43

 Dantes R, Mu Y, Hicks LA, et al. Association between outpatient antibiotic prescribing practices and community-associated Clostridium difficile infection. Open Forum Infect Dis 2015 Aug 11;2(3):ofv113

Evans CT, Safdar N. Current trends in the epidemiology and outcomes of Clostridium difficile infection. Clin Infect Dis 2015 May 15;60(Suppl 2):S66-71

Goldstein EJ, Johnson S, Maziade PJ, et al. Pathway to prevention of nosocomial Clostridium difficile infection. Clin Infect Dis 2015 May 15;60(Suppl 2):S148-58

Hikone M, Ainoda Y, Tago S, et al. Risk factors for recurrent hospital-acquired Clostridium difficile infection in a Japanese university hospital. Clin Exp Gastroenterol 2015 Jul 14;8:191-6

Khanafer N, Voirin N, Barbut F, et al. Hospital management of Clostridium difficile infection: a review of the literature. J Hosp Infect 2015 Jun;90(2):91-101

Knight DR, Giglio S, Huntington PG, et al. Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14. J Antimicrob Chemother 2015 Nov;70(11):2992-9

Le Saux N, Gravel D, Mulvey M, et al. Healthcare-associated Clostridium difficile infection and strain diversity in pediatric hospitals in the Canadian nosocomial infection surveillance program, 2007-2011. J Pediatric Infect Dis Soc 2015 Dec;4(4):e151-4

Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium infection in the United States. N Engl J Med 2015 Feb 26;372(9):825-34

Llewelyn MJ, Hand K, Hopkins S, et al. Antibiotic policies in acute English NHS trusts: implementation of 'Start Smart-Then Focus' and relationship with Clostridium difficile infection rates. J Antimicrob Chemother 2015 Apr;70(4):1230-5

Magee G, Strauss ME, Thomas SM, et al. Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: a multicenter retrospective study of inpatients, 2009-2011. Am J Infect Control 2015 Nov 1;43(11):1148-53. doi: 10.1016/j.ajic.2015.06.004

Revolinski S. Implementation of a clinical decision support alert for the management of Clostridium difficile infection. Antibiotics (Basel) 2015 Dec 21;4(4):667-74

Saint S, Fowler KE, Krein SL, et al. Clostridium difficile infection in the United States: a national study assessing preventive practices used and perceptions of practice evidence. Infect Control Hosp Epidemiol 2015 Aug;36(8):969-71

Sarma JB, Marshall B, Cleeve V, et al. Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis. J Hosp Infect 2015 Sep;91(1):74-80

Slayton RB, Scott RD, Baggs J, et al. The cost-benefit of federal investment in preventing Clostridium difficile infections through the use of a multifaceted infection control and antimicrobial stewardship program. Infect Control Hosp Epidemiol 2015 Jun;36(6):681-7

Tartof SY, Rieg GK, Wei R, et al. A comprehensive assessment across the healthcare continuum: risk of hospital-associated Clostridium difficile infection due to outpatient and inpatient antibiotic exposure. Infect Control Hosp Epidemiol 2015 Dec;36(12):1409-16

Van Esch G, Van Broeck J, Delmee M, et al. Surveillance of Clostridium difficile infections in a long-term care psychogeriatric facility: outbreak analysis and policy improvement. Arch Public Health 2015 Apr 6;73(1):18

Wenzler E, Mulugeta SG, Danziger LH. The antimicrobial stewardship approach to combating Clostridium difficile. Antibiotics (Basel) 2015 Jun 17;4(2):198-215

Wong KK, Fraser TG, Shrestha NK, et al. Low incidence of Clostridium difficile infection (CDI) in patients treated with outpatient parenteral antimicrobial therapy (OPAT). Infect Control Hosp Epidemiol 2015 Jan;36(1):110-2

Yeung SS, Yeung JK, Lau TT, et al. Evaluation of a Clostridium difficile infection management policy with clinical pharmacy and medical microbiology involvement at a major Canadian teaching hospital. J Clin Pharm Ther 2015 Dec;40(6):655-60

Young-Xu Y, Kuntz JL, Gerding DN, et al. Clostridium difficile infection among Veterans Health Administration patients. Infect Control Hosp Epidemiol 2015 Sep;36(9):1038-45

Back to top

2014

Allen UD, Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Clostridium difficile in paediatric populations. Paediatr Child Health 2014 Jan;19(1):43-54

Banach DB, Francois J, Blash S, et al. Active surveillance for carbapenem-resistant Enterobacteriaceae using stool specimens submitted for testing for Clostridium difficile. Infect Control Hosp Epidemiol 2014 Jan;35(1):82-4

Beran V, Chmelar D, Vobejdova J, et al. Sensitivity to antibiotics of Clostridium difficile toxigenic nosocomial strains. Folia Microbiol (Praha) 2014 May;59(3):209-15

Brown KA, Fisman DN, Moineddin R, et al. The magnitude and duration of Clostridium difficile infection risk associated with antibiotic therapy: a hospital cohort study. PLoS One 2014 Aug 26;9(8):e105454

Buchler AC, Rampini SK, Stelling S, et al. Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich. BMC Infect Dis 2014 Nov 26;14:607

Chahine EB, Sucher AJ, Mantei K. Fidaxomicin: a novel macrolide antibiotic for Clostridium difficile infection. Consult Pharm 2014 Sep;29(9):614-24

Chilton CH, Crowther GS, Freeman J, et al. Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure. J Antimicrob Chemother 2014 Feb;69(2):451-62

Chung P, Currie B, Guo Y, et al. Investigation to identify a resource-efficient case-control methodology for determining antibiotics associated with Clostridium difficile infection. Am J Infect Control 2014 Oct;42(10 Suppl):S264-8

Cornely OA, Nathwani D, Ivanescu C, et al. Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison. J Antimicrob Chemother 2014 Nov;69(11):2892-900

Cruz-Rodriguez NC, Hernandez-Garcia R, Salinas-Caballero AG, et al. The effect of pharmacy restriction of clindamycin on Clostridium difficile infection rates in an orthopedics ward. Am J Infect Control 2014 Jun;42(6):e71-3

D'Agostino RB Sr, Collins SH, Pencina KM, et al. Risk estimation for recurrent Clostridium difficile infection based on clinical factors. Clin Infect Dis 2014 May;58(10:1386-93

Doh YS, Kim YS, Jung HJ, et al. Long-term clinical outcome of Clostridium difficile infection in hospitalized patients: a single center study. Intest Res 2014 Oct;12(4):299-305

Dubberke ER, Schaefer E, Reske KA, et al. Attributable inpatient costs of recurrent Clostridium difficile infections. Infect Control Hosp Epidemiol 2014 Nov;35(11):1400-8

DuPont HL. Challenges and opportunities in the management of Clostridium difficile infection. Expert Rev Gastroenterol Hepatol 2014 Nov;8(8):863-74

Esmaily-Fard A, Tverdek FP, Crowther DM, et al. The use of fidaxomicin for treatment of relapsed Clostridium difficile infections in patients with cancer. Pharmacotherapy 2014 Nov;34(11):1220-5

Feazel LM, Malhotra A, Perencevich EN, et al. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. J Antimicrob Chemother 2014 Jul;69(7):1748-54

Ferreyra JA, Wu KJ, Hryckowian AJ, et al. Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance. Cell Host Microb 2014 Dec 10;16(6):770-7

Fisher BT, Sammons JS, Li Y, et al. Variation in risk of hospital-onset Clostridium difficile infection across beta-lactam antibiotics in children with new-onset acute lymphoblastic leukemia. J Pediatric Infect Dis Soc 2014 Dec;3(4):329-35

Garneau JR, Valiquette L, Fortier LC. Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam. BMC Infet Dis 2014 Jan 15;14:29

Haran JP, Hayward G, Skinner S, et al. Factors influencing the development of antibiotic associated diarrhea in ED patients discharged home: risk of administering IV antibiotics. Am J Emerg Med 2014 Oct;32(10):1195-9

Honda H, Dubberke ER. The changing epidemiology of Clostridium difficile infection. Curr Opin Gastroenterol 2014 Jan;30(1):54-62

Johnson S, Louie T, Gerding DN, et al. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clin Infect Dis 2014 Aug 1;59(3):345-54

Kamboj M, Babady NE, Marsh JW, et al. Estimating risk of C. difficile transmission from PCR positive but cytotoxin negative cases. PLoS One 2014 Feb 11;9(2):e88262

Keshavamurthy S, Koch CG, Fraser TG, et al. Clostridium difficile infection after cardiac surgery: prevalence, morbidity, mortality, and resource utilization. J Thorac Cardiovasc Surg 2014 Dec;148(6):3157-65

Knecht H, Neulinger SC, Heinsen FA, et al. Effects of beta-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea. PLoS One 2014 Feb 28;9(2):e89417

Lee JH, Lee Y, Lee K, et al. The changes of PCR ribotype and antimicrobial resistance of Clostridium difficile in a tertiary care hospital over 10 years. J Med Microbiol 2014 Jun;63(Pt 6):819-23

Locher HH, Caspers P, Bruyere T, et al. Investigations of the mode of action and resistance development of cadazolid, a new antibiotic for treatment of Clostridium difficile infections. Antimicrob Agents Chemother 2014;58(2):901-8

Luciano JA, Zuckerbraun BS. Clostridium difficile infection: prevention, treatment, and surgical management. Surg Clin North Am 2014 Dec;94(6):1335-49

Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin "allergy" in hospitalized patients: a cohort study. J Allergy Clin Immunol 2014 Mar;133(3):790-6

Matsumoto K, Kanazawa N, Shigemi A, et al. Factors affecting treatment and recurrence of Clostridium difficile infections. Biol Pharm Bull 2014;37(11):1811-5

Mathur H, Rea MC, Cotter PD, et al. The potential for emerging therapeutic options for Clostridium difficile infection. Gut Microbes 2014;5(6):696-710

Mullane K. Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance. Ther Adv Chronic Dis 2014 Mar;5(2):69-84

Na JY, Park JM, Lee KS, et al. Clinical characteristics of symptomatic Clostridium difficile infection in children: conditions as infection risks and whether probiotics is effective. Pediatr Gastroenterol Hepatol Nutr 2014 Dec;17(4):232-8

Nathwani D, Cornely OA, Van Engen AK, et al. Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection. J Antimicrob Chemother 2014 Nov;69(11):2901-12

O'Horo JC, Jindai K, Kunzer B, et al. Treatment of recurrent Clostridium difficile infection: a systematic review. Infection 2014 Feb;42(1):43-59

Oleastro M, Coelho M, Giao M, et al. Outbreak of Clostridium difficile PCR ribotype 027 — the recent experience of a regional hospital. BMC Infect Dis 2014 Apr 17;14:209

Ostrowsky B, Ruiz R, Brown S, et al. Lessons learned from implementing Clostridium difficile-focused antibiotic stewardship interventions. Infect Control Hosp Epidemiol 2014 Oct;35(Suppl 3):S86-95

Pakyz AL, Jawahar R, Wang Q, et al. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres. J Antimicrob Chemother 2014 Apr;69(4):1127-31

Parmar SR, Bhatt V, Yang J, et al. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies. J Oncol Pharm Pract 2014 Jun;20(3):172-82

Rodriguez S, Hernandez MB, Tarchini G, et al. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection. Clin Gastroenterol Hepatol 2014 Nov;12(11):1856-61

Samady W, Bush R, Pong A, et al. Predictors of Clostridium difficile infections in hospitalized children. J Hosp Med 2014 Feb;9(2):94-8

Samady W, Pong A, Fisher E. Risk factors for the development of Clostridium difficile infection in hospitalized children. Curr Opin Pediatr 2014 Oct;26(5):568-72

Shivashankar R, Khanna S, Kammer PP, et al. Clinical predictors of recurrent Clostridium difficile infection in out-patients. Aliment Pharmacol Ther 2014 Sep;40(5):518-22

Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother 2014 Apr;69(4):881-91

Smith LA, Chan CK, Halm M, et al. Development and validation of a Clostridium difficile risk assessment tool. AACN Adv Crit Care 2014 Oct-Dec;25(4):334-46

Taori SK, Wroe A, Hardie A, et al. A prospective study of community-associated Clostridium difficile infections: the role of antibiotics and co-infections. J Infect 2014 Aug;69(2):134-44

Thomas A, Khan F, Uddin N, et al. Tigecycline for severe Clostridium difficile infection. Int J Infect Dis 2014 Sep;26:171-2

Tickler IA, Goering RV, Whitmore JD, et al. Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013. Antimicrob Agents Chemother 2014 Jul;58(7):4214-8

Tschudin-Sutter S, Tamma PD, Milstone AM, et al. The prediction of complicated Clostridium difficile infections in children. Infect Control Hosp Epidemiol 2014 Jul;35(7):901-3

Tschudin-Sutter S, Tamma PD, Milstone AM, et al. Predictors of first recurrence of Clostridium difficile infections in children. Pediatr Infect Dis J 2014 Apr;33(4):414-6

Turner RB, Smith CB, Martello JL, et al. Role of doxycycline in Clostridium difficile infection acquisition. Ann Pharmacother 2014 Jun;48(6):772-6

Vargo CA, Bauer KA, Mangino JE, et al. An antimicrobial stewardship program's real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series. Pharmacotherapy 2014 Sep;34(9):901-9

Varier RU, Biltaji E, Smith KJ, et al. Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection. Clin Microbiol Infect 2014 Dec;20(12):1343-51

Vassallo A, Tran MC, Goldstein EJ. Clostridium difficile: improving the prevention paradigm in healthcare settings. Expert Rev Anti Infect Ther 2014 Sep;12(9):1087-102

Vehreschild MJ, Weitershagen D, Biehl LM, et al. Clostridium difficile infection in patients with acute myelogenous leukemia and in patients undergoing allogeneic stem cell transplantation: epidemiology and risk factor analysis. Biol Blood Marrow Transplant 2014 Jun;20(6)823-8

Walters PR, Zuckerbraun BS. Clostridium difficile infection: clinical challenges and management strategies. Crit Care Nurse 2014 Aug;34(4):24-34

Wendt JM, Cohen JA, Mu Y, et al. Clostridium difficile infection among children across diverse US geographic locations. Pediatrics 2014 Apr;133(4):651-8

Wenisch JM, Equiluz Bruck S, Fudel M, et al. Decreasing Clostridium difficile infections by an antimicrobial stewardship program that reduces moxifloxacin use. Antimicrob Agents Chemother 2014 Sep;58(9):5079-83

Yakob L, Riley TV, Paterson DL, et al. Assessing control bundles for Clostridium difficile: a review and mathematical model. Emerg Microbes Infect 2014 Jun;3(6):e43

Zilberberg MD, Reske K, Olsen M, et al. Development and validation of a recurrent Clostridium difficile risk-prediction model. J Hosp Med 2014 Jul;9(7):418-23

Zilberberg MD, Reske K, Olsen M, et al. Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study. BMC Infect Dis 2014 Jun 4;14:306

Back to top

2013

Brakovich B, et al. War on the spore: Clostridium difficile disease among patients in a long-term acute care hospital. J Healthc Qual 2013 May-Jun;35(3):15-21

Haines CF, et al. Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes. AIDS 2013 Nov 13;27(17):2799-807

Jardin CG, et al. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy. J Hosp Infect 2013 Sep;85(1):28-32

Jury LA, et al. A Clostridium difficile infection (CDI) stewardship initiative improves adherence to practice guidelines for management of CDI. Infect Control Hosp Epidemiol 2013 Nov;34(11):1222-4

Montoya M, et al. Antimicrobial selection and its impact on the incidence of Clostridium difficile- associated diarrhea. J Pharm Pract 2013 Oct;26(5):483-7

Piacenti FJ, et al. Antimicrobial stewardship and Clostridium difficile-associated diarrhea. J Pharm Pract 2013 Oct;26(5):506-13

Srigley JA, et al. Inappropriate use of antibiotics and Clostridium difficile infection. Am J Infect Control 2013 Nov;41(11):1116-8

Stanley JD, et al. Clostridium difficile infection. Curr Probl Surg 2013 Jul;50(7):302-37

Back to top

2012

Aldeyab MA, et al. An evaluation of the impact of antibiotic stewardship on reducing the use of high- risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother 2012;67:2988-96

CDC. Preventing Clostridium difficile infections. (Vital signs) MMWR 2012 Mar 9;61:157-62

Tschudin-Sutter S et al. Clostridium difficile: novel insights on an incessantly challenging disease. Curr Opin Infect Dis 2012 Aug;25(4):405-11

Wiegand PN, et al. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. J Hosp Infect 2012 May;81(1):1-14

Back to top

2011

Aldeyab MA, et al. Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures. Infect Control Hosp Epidemiol 2011;32:210-9

Polgreen PM, et al. Using oral vancomycin prescriptions as a proxy measure for Clostridium difficile infections: a spatial and time series analysis. Infect Control Hosp Epidemiol 2011 Jul;32(7):723-6

Wilkinson K, et al. Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions. Am J Infect Control 2011;39:177-82

Back to top

2010

Bartlett JG. Clostridium difficile: progress and challenges. Ann N Y Acad Sci 2010 Dec;1213:62-9

Back to top

 

2000-2009

Valiquette L, Cossette B, Garant MP, et al. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007 Sep 1;45 Suppl 2:S112-21

Weiss K, Boisvert A, Chagnon M, et al. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007. Infect Control Hosp Epidemiol 2009 Feb;30(2):155-62

Wilcox MH, Freeman J, Fawley W, et al. Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea. J Antimicrob Chemother 2004 Jul;54(1):168-72

Back to top

Veterinary, Ag, Environment

Recently Added
2017
2016

2015
2014

Recently Added

Agnoletti F, Brunetta R, Bano L, et al. Longitudinal study on antimicrobial consumption and resistance in rabbit farming. Int J Antimicrob Agents 2017 (published online Oct 27)

Balch J, Schoen JH, Patel PK. Should physicians consider the environmental effects of prescribing antibiotics? AMA J Ethics 2017 Oct;19(10):957-65

Lam TJGM, Jansen J, Wessels RJ. The RESET Mindset Model applied on decreasing antibiotic usage in dairy cattle in the Netherlands. Ir Vet J 2017 (published online Feb 23)

Schriiver R, Stijntjes M, Rodriguez-Bano J, et al. A review of antimicrobial resistance surveillance programmes in livestock and meat thereof in Europe with a focus on antimicrobial resistance patterns in humans. Clin Microbiol Infect 2017 (published online Sep 29)

Back to top

2017

Abdi RD, Mengstie F, Beyi AF, et al. Determination of the sources and antimicrobial resistance patterns of Salmonella isolated from the poultry industry in southern Ethiopia. BMC Infect Dis 2017 (published online May 18)

Agnoletti F, Brunetta R, Bano L, et al. Longitudinal study on antimicrobial consumption and resistance in rabbit farming. Int J Antimicrob Agents 2017 (published online Oct 27)

Ahmad V, Khan MS, Sajid Jamal QM, et al. Antimicrobial potential of bacteriocins: in therapy, agriculture and food preservation. Int J Antimicrob Agents 2017 Jan;49(1):1-11

Argudin MA, Deplano A, Meghraoui A, et al. Bacteria from animals as a pool of antimicrobial resistance genes. Antibiotics (Basel) 2017 (published online Jun 6)

Asiimwe BB, Baldan R, Trovato A, et al. Prevalence and molecular characteristics of Staphylococcus aureus, including methicillin resistant strains, isolated from bulk can milk and raw milk products in pastoral communities of south-west Uganda. BMC Infect Dis 2017 (published online Jun 13)

Balch J, Schoen JH, Patel PK. Should physicians consider the environmental effects of prescribing antibiotics? AMA J Ethics 2017 Oct;19(10):957-65

Barlow RS, McMillan KE, Duffy LL, et al. Antimicrobial resistance status of Enterococcus from Australian cattle populations at slaughter. PLoS One 2017 (published online May 18)

Brower CH, Mandel S, Hayer S, et al. The prevalence of extended-spectrum beta-lactamase-producing multidrug-resistant Escherichia Coli in poultry chickens and variation according to farming practices in Punjab, India. Environ Health Perspect 2017 (published online Jul 20)

Brown K, Uwiera RRE, Kalmokoff ML, et al. Antimicrobial growth promoter use in livestock: a requirement to understand their modes of action to develop effective alternatives. Int J Antimicrob Agents 2017 Jan;49(1):12-24

Caudell MA, Quinlan MB, Subbiah M, et al. Antimicrobial use and veterinary care among agro-pastoralists in northern Tanzania. PLoS One 2017 (published online Jan 26)

Gomez DE, Arroyo LG, Poljak Z, et al. Implementation of an algorithm for selection of antimicrobial therapy for diarrhoeic calves: Impact on antimicrobial treatment rates, health and faecal microbiota. Vet J 2017 Aug;226:15-25

Guardabassi L. Antimicrobial resistance: a global threat with remarkable geographical differences. N Z Vet J 2017 Mar;65(2):57-9

Guardabassi L, Damborg P, Stamm I, et al. Diagnostic microbiology in veterinary dermatology: present and future. Vet Dermatol 2017 (published online Jan 29)

Hardefeldt LY, Browning GF, Thursky KA, et al. Cross-sectional study of antimicrobials used for surgical prophylaxis by bovine veterinary practitioners in Australia. Vet Rec 2017 (published online Sep 11)

Hardefeldt LY, Browning GR, Thursky K, et al. Antimicrobials used for surgical prophylaxis by equine veterinary practitioners in Australia. Equine Vet J 2017 (published online Jun 13)

Hardefeldt LY, Holloway S, Trott DJ, et al. Antimicrobial prescribing in dogs and cats in Australia: results of the Australasian Infectious Disease Advisory Panel survey. J Vet Intern Med 2017 (published online May 17)

Islam MA, Islam M, Hasan R, et al. Environmental spread of NDM-1-producing multi-drug resistant bacteria in Dhaka, Bangladesh. Appl Environ Microbiol 2017 (published online May 19)

Johns I. Antimicrobial stewardship in the treatment of equine bacterial infections. Vet J 2017 Jan;219:4-5

Koch BJ, Hungate BA, Price LB. Food-animal production and the spread of antibiotic resistance: the role of ecology. Front Ecol Environ 2017 (published online Jun 26)

Lam TJGM, Jansen J, Wessels RJ. The RESET Mindset Model applied on decreasing antibiotic usage in dairy cattle in the Netherlands. Ir Vet J 2017 (published online Feb 23)

Leger DF, Newby NC, Reid-Smith R, et al. Estimated antimicrobial dispensing frequency and preferences for lactating cow therapy by Ontario dairy veterinarians. Can Vet J 2017 Jan;58(1):26-34

Lhermie G, Grohn YT, Raboisson D. Addressing antimicrobial resistance: an overview of priority actions to prevent suboptimal antimicrobial use in food-animal production. Front Microbiol 2017 (published online Jan 6)

Music MS, Hrenovic J, Goic-Barisic I, et al. Emission of extensively-drug resistant Acinetobacter baumannii from hospital settings to the natural environment. J Hosp Infect 2017 (published online Apr 11)

Peng S, Feng Y, Wang Y, et al. Prevalence of antibiotic resistance genes in soils after continually applied with different manure for 30 years. J Hazard Mater 2017 Jun 27;340:16-25

Price LB. Bacterial whack-a-mole: reconsidering the public health relevance of using carbadox in food animals. MBio 2017 (published online Sep 26)

Priya AK, Balagangatharathilagar M, Chandrasekaran D, et al. Prevalence of enteropathogens and their antibiotic sensitivity pattern in puppies with hemorrhagic gastroenteritis. Vet World 2017 Aug;10(8):859-63

Purohit MR, Chandran S, Shah H, et al. Antibiotic resistance in an Indian rural community: a ‘One-Health’ observational study on commensal coliform from humans, animals, and water. Int J Environ Res Public Health 2017;14(4):386

Schriiver R, Stijntjes M, Rodriguez-Bano J, et al. A review of antimicrobial resistance surveillance programmes in livestock and meat thereof in Europe with a focus on antimicrobial resistance patterns in humans. Clin Microbiol Infect 2017 (published online Sep 29)

Strom G, Halje M, Karlsson D, et al. Antimicrobial use and antimicrobial susceptibility in Escherichia coli on small- and medium-scale pig farms in north-eastern Thailand. Antimicrob Resist Infect Control 2017 (published online Jul 17)

Venter H, Henningsen ML, Begg SL. Antimicrobial resistance in healthcare, agriculture and the environment: the biochemistry behind the headlines. Essays Biochem 2017 Mar 3;61(1):1-10

Vikram A, Rovira P, Agga GE, et al. Impact of “raised without antibiotics” beef cattle production practices on occurrences of antimicrobial resistance. Appl Environ Microbiol 2017 (published online Sep 8)

Wepking C, Avera B, Badgley B, et al. Exposure to dairy manure leads to greater antibiotic resistance and increased mass-specific respiration in soil microbial communities. Proc R Soc Lond B Biol Sci 2017 (published online Mar 29)

Yassin AK, Gong J, Kelly P, et al. Antimicrobial resistance in clinical Escherichia coli isolates from poultry and livestock, China. PLoS One 2017 (published online Sep 21)

Back to top

2016

Aitken SL, Dilworth TJ, Heil EL, et al. Agricultural applications for antimicrobials. A danger to human health: an official position statement of the society of infectious diseases pharmacists. Pharmacotherapy 2016 Apr;36(4):422-32

Bae D, Kweon O, Khan AA. Isolation and characterization of antimicrobial-resistant nontyphoidal Salmonella enterica serovars from imported food products. J Food Prot 2016 Aug;8:1348-54

Bean TG, Bergstrom E, Thomas-Oates J, et al. Evaluation of a novel approach for reducing emissions of pharmaceuticals to the environment. Environ Manage 2016 (published online Jun 24)

Beier RC, Franz E, Bono JL, et al. Disinfectant and antimicrobial susceptibility profiles of the big six non-O157 Shiga toxin–producing Escherichia coli strains from food animals and humans. J Food Prot 2016 Aug;8:1355-70

Collignon PC, Conly JM, Andremont A, et al. World Health Organization ranking of antimicrobials according to their importance in human medicine: a critical step for developing risk management strategies to control antimicrobial resistance from food animal production. Clin Infect Dis 2016 (published online Jul 20)

Coyne LA, Latham SM, Wiliams NJ, et al. Understanding the culture of antimicrobial prescribing in agriculture: a qualitative study of UK pig veterinary surgeons. J Antimicrob Chemother 2016 (published online Aug 11)

Dierikx CM, Hengeveld PD, Veldman KT, et al. Ten years later: still a high prevalence of MRSA in slaughter pigs despite a significant reduction in antimicrobial usage in pigs the Netherlands. J Antimicrob Chemother 2016;71(9):2414-8

Dorado-Garcia A, Mevius DJ, Jacobs JJH, et al. Quantitative assessment of antimicrobial resistance in livestock during the course of a nationwide antimicrobial use reduction in the Netherlands. J Antimicrob Chemother 2016 (published online Sep 1)

Elmahdi S, DaSilva LV, Parveen S. Antibiotic resistance of Vibrio parahaemolyticus and Vibrio vulnificus in various countries: a review. Food Microbiol 2016 Aug;57:128-34

Fowler H, Davis MA, Perkins A, et al. A survey of veterinary antimicrobial prescribing practices, Washington State 2015. Vet Rec 2016 (published online Nov 2)

Grontvedt CA, Elstrom P, Stegger M, et al. MRSA CC398 in humans and pigs in Norway: A “One Health” perspective on introduction and transmission. Clin Infect Dis 2016 (published online Aug 11)

Guo Y, Zhou H, Qin L, et al. Frequency, antimicrobial resistance and genetic diversity of Klebsiella pneumoniae in food samples. PLoS One 2016 Apr 14;11(4):e0153561

Habing G, Djordjevic C, Schuenemann GM, et al. Understanding antimicrobial stewardship: disease severity treatment thresholds and antimicrobial alternatives among organic and conventional calf producers. Prev Vet Med 2016 Aug 1;130:77-85

Hocquet D, Muller A, Bertrand X. What happens in hospitals does not stay in hospitals: antibiotic-resistant bacteria in hospital wastewater systems. J Hosp Infect 2016 Aug;93(4):395-402

Johnson TJ. Carbapenemase-producing Enterobacteriaceae in swine production in the United States: impact and opportunities. Antimicrob Agents Chemother 2016 (published online Dec 5)

Kempf I, Jouy E, Chauvin C. Colistin use and colistin resistance in bacteria from animals. Int J Antimicrob Agents 2016 Dec;48(6):598-606

Lammie SL, Hughes JM. Antimicrobial resistance, food safety, and one health: the need for convergence. Annu Rev Food Sci Technol 2016;7:287-312

Larsen J, Stegger M, Andersen PS, et al. Evidence for human adaptation and foodborne transmission of livestock-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2016 (published online Sep 20)

Mollenkopf DF, Stull JW, Mathys DA, et al. Carbapenemase-producing Enterobacteriaceae recovered from the environment of a swine farrow-to-finish operation in the United States. Antimicrob Agents Chemother 2016 (published online Dec 5)

Narver HL. Antimicrobial stewardship in laboratory animal facilities. J Am Assoc Lab Anim Sci 2016 (published online Dec 14)

Ojo OE, Fabusoro E, Majasan AA, et al. Antimicrobials in animal production: usage and practices among livestock farmers in Oyo and Kaduna States of Nigeria. Trop Anim Health Prod 2016 Jan;48(1):189-97

Petra B, Majda G, Matjaz O, et al. Antimicrobial susceptibility patterns of Clostridium difficile isolates from family dairy farms. Zoonoses Public Health 2016 (published online Aug 3)

Pomba C, Rantala M, Greko C, et al. Public health risk of antimicrobial resistance transfer from companion animals. J Antimicrob Chemother 2016 (published online Dec 20)

Prescott JF, Boerlin P. Antimicrobial use in companion animals and Good Stewardship Practice. Vet Rec 2016 Nov 12;179(19):486-8

Queenan K, Hasler B, Rushton J. A One Health approach to antimicrobial resistance surveillance: is there a business case for it? Int J Antimicrob Agents 2016 (published online Jul 23)

Rhouma M, Beaudry F, Letellier A. Resistance to colistin: what is the fate for this antibiotic in pig production? Int J Antimicrob Agents 2016 Aug;48(2):119-26

Robinson TP, Bu DP, Carrique-Mas J, et al. Antibiotic resistance: mitigation opportunities in livestock sector development. Animal 2016 (published online Aug 13)

Tuerena I, Williams NJ, Nuttall T, et al. Antimicrobial-resistant Escherichia coli in hospitalised companion animals and their hospital environment. J Small Anim Prac 2016 Jul;57(7):339-47

Toombs-Ruane LJ, Benschop J, Burgess S, et al. Multidrug resistant Enterobacteriaceae in New Zealand: a current perspective. N Z Vet J 2016 (published online Dec 7)

Toombs-Ruane LJ, Riley CB, Kendall AT, et al. Antimicrobial susceptibility of bacteria isolated from neonatal foal samples submitted to a New Zealand veterinary pathology laboratory (2004 to 2013). N Z Vet J 2016 Mar;64(2):107-11

van Dijk L, Hayton A, Main DCJ, et al. Participatory policy making by dairy producers to reduce anti-microbial use on farms. Zoonoses Public Health 2016 (published online Dec 27)

Wang S, Zeng X, Yang Q, et al. Antimicrobial peptides as potential alternatives to antibiotics in food animal industry. Int J Mol Sci 2016 May 3;17(5):603

Zawack K, Li M, Booth JG, et al. Monitoring antimicrobial resistance in the food supply chain and its implications for FDA policy initiatives. Antimicrob Agents Chemother 2016 Sep;60(9):5302-11

Zhang H, Zhai Z, Li Q, et al. Characterization of extended-spectrum β-lactamase–producing Escherichia coli isolates from pigs and farm workers. J Food Prot 2016 Sep;79:1630-4

Back to top

2015

Aarestrup FM. The livestock reservoir for antimicrobial resistance: a personal view on changing patterns of risks, effects of interventions and the way forward. Philos Trans R Soc Lond B Biol Sci 2015 Jun 5;370(1670):20140085

Abdalrahman LS, Stanley A, Wells H, et al. Isolation, virulence, and antimicrobial resistance of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) strains from Oklahoma retail poultry meats. Int J Environ Res Public Health 2015 May 29;12(6):6148-61

Agga GE, Arthur TM, Durso LM, et al. Antimicrobial-resistant bacterial populations and antimicrobial resistance genes obtained from environments impacted by livestock and municipal waste. PLoS One 2015 Jul 21;10(7):e0132586

Argudin MA, Vanderhaeghen W, Vandendriessche S, et al. Antimicrobial resistance and population structure of Staphylococcus epidermidis recovered from animals and humans. Vet Microbiol 2015 Jul 9;178(1-2):105-13

Berendonk TU, Manaia CM, Merlin C, et al. Tackling antibiotic resistance: the environmental framework. Nat Rev Microbiol 2015 May;13(5):310-7

Bjork KE, Kopral CA, Wagner BA, et al. Comparison of mixed effects models of antimicrobial resistance metrics of livestock and poultry Salmonella isolates from a national monitoring system. Prev Vet Med 2015 Dec 1;122(3):265-72

Catry B, Cavaleri M, Baptiste K, et al. Use of colistin-containing products within the European Union and European Economic Area (EU/EEA): development of resistance in animals and possible impact on human and animal health. Int J Antimicrob Agents 2015 Sep;46(3):297-306

Dahshan H, Abd-Elall AM, Megahed AM, et al. Veterinary antibiotic resistance, residues, and ecological risks in environmental samples obtained from poultry farms, Egypt. Environ Monit Assess 2015 Feb;187:2

Donado-Godoy P, Byrne BA, Leon M, et al. Prevalence, resistance patterns, and risk factors for antimicrobial resistance in bacteria from retail chicken meat in Colombia. J Food Prot 2015 Apr;78(4):751-9

Donado-Godoy P, Castellanos R, Leon M, et al. The establishment of the Colombian integrated program for antimicrobial resistance surveillance (COIPARS): a pilot project on poultry farms, slaughterhouses and retail market. Zoonoses Public Health 2015 Apr;62(Suppl 1):58-69

Doyle ME. Multidrug-resistant pathogens in the food supply. Foodborne Pathog Dis 2015 Apr;12(4):261-79

Economou V, Gousia P. Agriculture and food animals as a source of antimicrobial-resistant bacteria. Infect Drug Resist 2015 Apr 1;8:49-61

Fletcher S. Understanding the contribution of environmental factors in the spread of antimicrobial resistance. Environ Health Prev Med 2015 Jul;20(4):243-52

Guardabassi L, Prescott JF. Antimicrobial stewardship in small animal veterinary practice: from theory to practice. Vet Clin North Am Small Anim Pract 2015 Mar;45(2):361

Hanon JB, Jaspers S, Butaye P, et al. A trend analysis of antimicrobial resistance in commensal Escherichia coli from several livestock species in Belgium (2011-2014). Prev Vet Med 2015 Dec 1;122(4):443-52

Hiki M, Kawanishi M, Abo H, et al. Decreased resistance to broad-spectrum cephalosporin in Escherichia coli from healthy broilers at farms in Japan after voluntary withdrawal of ceftiofur. Foodborne Pathog Dis 2015 Jul;12(7):639-43

Huijbers PM, Blaak H, de Jong MC, et al. Role of the environment in the transmission of antimicrobial resistance to humans: a review. Environ Sci Technol 2015 Oct 20;49(20):11993-2004

Jones PJ, Marier EA, Tranter RB, et al. Factors affecting dairy farmers' attitudes towards antimicrobial medicine usage in cattle in England and Wales. Prev Vet Med 2015 Sep 1;121(1-2):30-40

Leger DF, Newby NC, Reid-Smith R, et al. Antimicrobial dispensing by Ontario dairy veterinarians. Can Vet J 2015 Jul;56(7):723-9

McCrackin MA, Helke KL, Galloway AM, et al. Effect of antimicrobial use in agricultural animals on drug-resistant foodborne campylobacteriosis in humans: a systematic literature review. Crit Rev Food Sci Nutr 2015 (published online Nov 18)

McIntosh W, Dean W. Factors associated with the inappropriate use of antimicrobials. Zoonoses Public Health 2015 Apr;62(Suppl 1):22-8

Meek RW, Vyas H, Piddock LJ. Nonmedical uses of antibiotics: time to restrict their use? PLoS Biol 2015 Oct 7;13(10):e1002266

Menz J, Schneider M, Kummerer K. Usage pattern-based exposure screening as a simple tool for the regional priority-setting in environmental risk assessment of veterinary antibiotics: a case study of north-western Germany. Chemosphere 2015 May;127:42-8

Ojo OE, Fabusoro E, Majasan AA, et al. Antimicrobials in animal production: usage and practices among livestock farmers in Oyo and Kaduna States of Nigeria. Trop Anim Health Prod 2015 (published online Nov 2)

Paulson JA, Zaoutis TE, Council on Environmental Health, et al. Nontherapeutic use of antimicrobial agents in animal agriculture: implications for pediatrics. Pediatrics 2015 Dec;136(6):e1670-7

Rushton J. Antimicrobial use in animals: how to assess the trade-offs. Zoonoses Public Health 2015 Apr;62(Suppl 1):10-21

Sahin O, Kassem II, Shen Z, et al. Campylobacter in poultry: ecology and potential interventions. Avian Dis 2015 Jun;59(2):185-200

Scott HM, Midgley G, Loneragan GH. Antimicrobials in animal agriculture: parables and policy. Zoonoses Public Health 2015 Apr;62(Suppl 1):3-9

Speksnijder DC, Jaarsma AD, van der Gugten AC, et al. Determinants associated with veterinary antimicrobial prescribing in farm animals in the Netherlands: a qualitative study. Zoonoses Public Health 2015 Apr;62(Suppl 1):39-51

Speksnijder DC, Jaarsma DA, Verheij TJ, et al. Attitudes and perceptions of Dutch veterinarians on their role in the reduction of antimicrobial use in farm animals. Prev Vet Med 2015 Oct 1;121(3-4):365-73

Speksnijder DC, Mevius DJ, Bruschke CJ, et al. Reduction of veterinary antimicrobial use in the Netherlands. The Dutch success model. Zoonoses Public Health 2015 Apr;62(Suppl 1):79-87

Tellez G, Laukova A, Latorre JD, et al. Food-producing animals and their health in relation to human health. Microb Ecol Health Dis 2015 Feb 2;26:25876

Van Boeckel TP, Brower C, Gilbert M, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci U S A 2015 May 5;112(18):5649-54

Visschers VH, Backhans A, Collineau L, et al. Perceptions of antimicrobial usage, antimicrobial resistance and policy measures to reduce antimicrobial usage in convenient samples of Belgian, French, German, Swedish and Swiss pig farmers. Prev Vet Med 2015 Apr 1;119(1-2):10-20

Weese JS, Giguere S, Guardabassi L, et al. ACVIM consensus statement on therapeutic antimicrobial use in animals and antimicrobial resistance. J Vet Intern Med 2015 Mar-Apr;29(2):487-98

Woolhouse M, Ward M, van Bunnik B, et al. Antimicrobial resistance in humans, livestock and the wider environment. Philos Trans R Soc Lond B Biol Sci 2015 Jun 5;370(1670):20140083

Back to top

2014

Bengtsson